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11. Executive Summary..
Introduction
Innovations, such as treatment interventions, programs and therapies, may be costly to develop 
and evaluate and there is increasing political and financial pressure to ensure that effective 
and cost-effective health care and professional services are available where needed. However, 
even when practitioners are aware of the evidence for best practice and are willing to change 
their behaviour, actually making the required changes in the context of long established patterns 
of behaviour can be difficult, particularly if the organisational environment is not conducive to 
change. Moreover, innovations are not self-executing. Even simple programs that require only 
small changes may benefit from an effective implementation strategy. 
The National Centre for Education and Training on Addiction (NCETA) undertook a systematic 
literature review of the most commonly used strategies designed to increase the uptake of 
innovations into professional practice. Analyses were undertaken to evaluate their effectiveness 
and to determine their relevance and applicability for use in the alcohol and other drugs (AOD) 
field. By evaluating and synthesising the evidence from a wide range of sources, NCETA 
aimed to identify the key factors underlying successful dissemination strategies and develop a 
framework for dissemination and implementation of innovations in the AOD field.
Methods
A rigorous and systematic search of a wide range of electronic databases, journals, websites 
and bibliographies was undertaken, resulting in 4,650 citations. From these, a total of 651 
potentially relevant articles were collected and examined. Pre-determined selection criteria were 
applied and the total evidence base for this review was 25 existing systematic reviews and 85 
additional primary studies. Studies were critically appraised according to the strength of the 
evidence (level of evidence, quality of evidence and statistical precision), size of the effect and 
relevance of the evidence (NHMRC, 2000). 
Sixteen dissemination and implementation strategies were evaluated.  
These are listed in Table 1.
The effectiveness of dissemination interventions were assessed in terms of: 
1. Process outcomes: changes in behaviour or practice, and compliance with  
recommended guidelines
2. Patient outcomes: the impact of an intervention on patients’ or clients’ health status, 
functional ability, management of their problem and quality of life.
For each of the 16 dissemination strategies examined, a brief description, summary of the 
evidence on their effectiveness, key success factors, and relevance to the AOD field is provided 
(see Chapters 7-9). 
2Table 1. Dissemination and implementation strategies
Professional interventions: to change knowledge / behaviour of individual 
health care professionals
 1. Educational materials
 2. Local consensus processes
 3. Educational meetings
 4. Educational outreach (academic detailing)
 5. Local opinion leaders
 6. Patient-mediated interventions
 7. Prompts and reminders
 8. Audit and feedback
 9. Financial incentives
 10. Electronic educational sources
Organisational interventions: to change the setting or systems in which health 
care professionals work
 11. Record and office systems
 12. Multi-disciplinary collaborative approaches
 13. Alternative care approaches
 14. Continuous quality improvement
Other interventions
 15. Mass media
 16. Multi-faceted interventions
Results
Overall, there was a paucity of evidence specific to the AOD field. Therefore, most evidence is 
drawn from the general health and medical fields. Available evidence was typically of average 
quality, with most studies prone to some degree of bias. Findings from the better quality studies 
indicated that some strategies may provide small improvements in professional practice, including 
preventive care, treatment, disease management and rehabilitation or palliative care. 
Table 2 provides a summary of the 16 strategies assessed and their effectiveness for improving 
practitioners’ behaviour and patients’ outcomes in different clinical areas. Strategies that 
demonstrated more robust evidence of effectiveness, particularly in some clinical areas, are 
highlighted. 
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Table 2. Summary of effectiveness of all strategies across a range of clinical areas
Strategy Clinical areas Process outcomes
Patient 
outcomes
Professional interventions
1. Educational materials Disease management
Prescribing
Preventive care
NS
+
NS
NS
NA
NA
2. Local consensus processes Disease management
Preventive care
+
+
+
NA
3. Educational meetings Disease/pain management
Prescribing/test ordering
+
+
+
NA
Preventive care
Counselling/communication
++
++
+
NA
Diagnosis NS NS
4. Educational outreach visits Disease/pain management + NS
NS
+
Prescribing/test ordering ++
Preventive care +
5. Local opinion leaders Adherence to guidelines
Prescribing
Referrals 
+
NS
+
NS
NS
NA
6. Patient-mediated interventions Disease management
Prescribing
Preventive care
NS
+
+
+
NA
NS
7. Prompts and reminders Disease/pain management ++ +
+
NS
NS
NS
Prescribing/test ordering ++
Preventive care +++
Diagnosis
Adherence to guidelines
+
+
8. Audit and feedback Disease management ++ +
NA
NA
NS
Prescribing/test ordering ++
Preventive care ++
Adherence to guidelines +
9. Financial incentives Preventive care
General medicine
NS
NS
NS
NS
10. Electronic educational resources Preventive care + NA
Organisational interventions 
11. Record and office systems Preventive care + NA
12. Multi-disciplinary collaborations Disease management + +
13. Alternative care providers Disease management + +
14. Continuous quality improvement Disease management + +
Other interventions 
15. Mailouts and mass media Referral NS NA
16. Multi-faceted interventions Disease/pain management
Prescribing/test ordering
+
+
NS
NA
+
NA
NA
Preventive care ++
Diagnosis
Counselling 
NS
+
+ indicates minimal effect in few outcomes; ++ indicates small improvement in most outcomes; 
+++ indicates robust improvement in most outcomes; NA = not assessed; NS = not significant. 
 indicates more effective strategies
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From the available evidence, strategies found to be effective for changing the behaviour of 
individual health care professionals (professional interventions) were:
Educational meetings• 
Educational outreach• 
Prompts and reminders• 
Audit and feedback. • 
Educational materials alone were not shown to be very effective for improving professional 
practice. However, their effect was enhanced when delivered in conjunction with other more 
effective strategies. 
Opinion leaders have shown little evidence of effectiveness in changing practitioner behaviour. 
However, of the few studies undertaken to evaluate the effectiveness of opinion leaders, study 
quality was generally poor to average. 
Compared to the literature evaluating the effectiveness of professional interventions, there 
were few available studies evaluating organisational strategies. However, results indicated 
that change at the organisational level is facilitated if implementation strategies consider the 
following factors:
Clarity of purpose of a program or innovation• 
Limitations of time and resources within an organisation• 
Existing workloads and expectations• 
Staff cohesion, communication and openness to change• 
Workplace culture.• 
Even if staff are aware of the need to change and accept that an innovation will fulfil their needs, 
the organisational culture may moderate the effectiveness of strategies used to facilitate uptake. 
Multi-faceted interventions may also be useful across a broad range of AOD-related areas of 
practice. However, due to the heterogeneity of studies that comprised different combinations 
of interventions in diverse settings, it was not possible to identify which particular combination 
was most effective. Evidence showed that using more strategies was not necessary to improve 
practice; just a small number of well-chosen strategies targeted to the behaviour and tailored to 
the setting. 
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The strategies that were more consistently effective in areas that may be relevant for the 
AOD field are listed in Table 3:
Table 3. Summary of effective strategies for AOD-related activities in 
different clinical areas
Effective dissemination strategies Clinical area (examples of AOD-related activities)
Educational meetings (interactive) Preventive care
Advice on smoking cessation• 
Advice on AOD use in pregnancy• 
Advice on risky drinking• 
Alcohol and / or drug screening• 
AOD contraindications with medications• 
Treatment
Pharmacotherapy• 
Brief interventions• 
Motivational interviewing• 
Cognitive behavioural therapy• 
Referral to specialist• 
Educational outreach visits Preventive care
Treatment
Management and rehabilitation
Pharmacotherapy monitoring• 
Management of depression• 
Management of AOD-related illness• 
Management of relapse• 
Prompts and reminders Preventive care
Treatment
Management and rehabilitation
Audit and feedback Preventive care
Management and rehabilitation 
Multi-faceted interventions Management and rehabilitation
6 executive summary
Key findings
Of the 16 dissemination strategies evaluated in this review, the four most successful strategies 
that have shown benefits across different clinical areas were:
1. Interactive educational meetings
2. Educational outreach visits
3. Prompts and reminders
4. Audit and feedback.
Successful uptake of innovations into practice may be influenced by the characteristics of 
effective dissemination strategies and contextual factors that may facilitate or inhibit the 
implementation process. Knowing the key elements of successful implementation strategies 
means that time and resources will not be wasted on elements that do not enhance the 
implementation process. While the available evidence must be interpreted with caution,  
overall results indicate that the most successful implementation strategies include the  
following features:
Clear and succinct message, with simple, focussed objectives that require  • 
small practical changes
Reliable and credible source, with accurate, evidence-based information• 
Interactive format that is appealing, persuasive and encourages participation• 
Tailored information that is personalised and modified to the local setting• 
Relevance of information to the practitioner and their client needs• 
Clear identification of roles and activities• 
Systems or procedures that are accessible and easy to use, with little  • 
effort required to comply 
Assessment of, and focus on barriers to change• 
Address changes at multiple levels, including the individual practitioner behaviour, • 
organisational structure and culture, and health system policy
Organisational changes that require practitioners to respond or take action • 
(e.g., automatic prompts and obligatory responses)
Reinforced messages, with additional materials and support• 
Sustainability of strategy over a prolonged period.• 
Contextual factors that may enhance the effectiveness of strategies included:
Identifying the need for change• 
Making the target audience aware of the need to change and motivating • 
them to change
Providing adequate resources and staffing to integrate changes into • 
existing systems
Evaluating and monitoring the fidelity of an innovation over time to ensure • 
that all staff are “with the program”.
executive summary 7
While few studies assessed the impact of dissemination strategies on client outcomes, 
those that did showed little or no benefit to clients’ health, functional status, quality of life or 
satisfaction with treatment or service received. However, since studies were typically 
conducted over relatively short time periods, longer follow-up and reinforcement of changes 
may be necessary to detect sustained improvements at the level of the client. 
In conclusion:
1. All strategies examined were effective to some extent
2. Some strategies appeared to be more effective than others in bringing 
about changes in practitioners’ behaviour
3. No single strategy was effective in all situations.
Findings from this review highlight the need for the careful selection of dissemination 
strategies to ensure the best match with content area and target audience or behaviour. 
It also underscores the need for further and better quality research in the area of research 
dissemination in general, with the inclusion of suitable control groups. Given the lack of 
studies conducted in the AOD field, or pertaining to AOD-related issues, it is essential that 
dissemination and implementation strategies used in this area be evaluated appropriately 
where possible. 
Evidence on costs of implementation strategies and the theoretical basis for using such 
strategies are addressed in two additional reports:
1. Effective dissemination: An examination of the costs of implementation 
strategies for the AOD field
2. Effective dissemination: An examination of the theories and models of 
change for research dissemination.
executive summary
92..Rationale for the Review
Substantial resources, both financial and human, have been invested into research and 
development of innovations, such as interventions, programs, procedures, or guidelines to 
reduce harms associated with alcohol and other drug (AOD) use. As a result, much is known 
about which innovations are effective. However, despite evidence of effectiveness of good 
quality interventions and programs, often little use is made of them to achieve important 
outcomes for clients with AOD-related problems. That is, effective interventions and programs 
are not self-executing and require additional dedicated effort to facilitate their implementation. 
This has led to the development of a broad range of dissemination and implementation 
strategies to introduce good quality research into practice. 
However, the selection of strategies to encourage uptake and implementation of innovations 
is rarely based on rigorous evaluation of the effectiveness of different approaches, but rather 
on a variety of factors, including motivational, organisational and fiscal pressures. Grol 
(1997) suggests that “evidence-based medicine should be complemented by evidence-based 
implementation” (Grol, 1997). That is, the same strength of evidence should be used for 
determining which implementation strategies to use to get innovations adopted into practice as 
is used for determining which innovations / interventions to use to address clients’ needs.
To achieve evidence-based implementation, the National Centre for Education and Training 
on Addiction (NCETA) sought to identify and evaluate the effectiveness of dissemination and 
implementation strategies through the systematic literature review process, which aims to:
Condense and integrate empirically-supported evidence gathered from a wide • 
range of sources
Minimise bias and the effects of chance, which are known shortcomings of • 
non-systematic, narrative reviews
Generate inferences that provide a basis for decision-making (Khan, Ter Riet, • 
Glanville, Sowden, & Kleijnen, 2001). 
This review focused on identifying and appraising dissemination strategies designed to  
increase the uptake and implementation of innovations by the alcohol and other drug (AOD) 
workforce. This project examined strategies designed to change professional and organisational 
practice at different phases of the research-to-practice process. In addition, this project 
sought to identify the key success factors of effective dissemination strategies that enable the 
innovations to be implemented. 
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3..Introduction
Evidence-based health care aims to deliver the best, most current evidence from research and 
apply it judiciously across the continuum of care, from prevention to palliation. However, one of 
the most consistent findings across all areas of health and medical research is the inevitable 
gap between evidence-based knowledge and the application of research findings in practice. 
This is due largely to the time lag between advances in clinical research and the dissemination 
of information that may improve the quality of health care. The terms “research-practice gap” 
or “failure of success” are commonly used to describe this trend (Backer, 2000; Robbins, 
Bachrach, & Szapocznik, 2002). 
Although research may indicate that the use of specific innovations has the potential to provide 
significant benefits to patients or clients, the uptake and implementation of these innovations by 
practitioners is frequently limited. Even simple innovations require some degree of individual or 
organisational change stimulated by a dedicated implementation strategy. That is, information is 
a necessary but insufficient lever to induce change in professional practice or processes. 
A key to the efficient adoption of research innovations into practice is determining:
“what works for whom, in what circumstances, and in what respects”  
(Pawson, 2006, p 25). 
3.1. Burden of disease and prevalence of AOD problems
Problems associated with the use of alcohol and other drugs (AOD), and the well-established 
comorbidity with mental illnesses (Kessler, 2004), impact on individuals’ health and the broader 
social environment, making a substantial contribution to morbidity and mortality across all 
age groups in Australia. The report, Statistics on drug use in Australia 2006 (AIHW, 2007), 
showed that while smoking rates have declined over the period 1991 to 2004, drinking patterns 
have remained relatively unchanged over the last fifteen years. Use of various illicit drugs 
continues at worrying levels with substantial increases in some instances (as in the case of 
methamphetamine) and some recorded decreases (as in the case of cannabis). In 2003, 
approximately 8% of the burden of disease was attributable to the use of tobacco, 3% to alcohol 
use and 2% to illicit drug use (AIHW, 2007).
The impact of substance-related problems on individual health includes the development of 
cancers, heart disease, infectious diseases, road and workplace fatalities / injuries and danger 
to the health of infants born to mothers affected by substance-related problems. In the social 
environment, suicide, road fatalities and injuries (passengers, pedestrians, occupants of other 
vehicles), assaults, domestic violence and unemployment are potential consequences of alcohol 
and / or drug-related problems (Collins & Lapsley, 1996; NHMRC, 2001). 
3.2. Management and treatment of AOD-related problems
A wide range of research-based innovations, such as treatment interventions, tools (e.g., those 
used for screening), programs and guidelines, have been developed to minimise harms related 
to AOD use. These innovations may be applied across the continuum of health care, including 
preventive health, treatment of acute or chronic dependence, substance use management and 
rehabilitation of clients with AOD problems and / or associated mental illnesses. Box 1 lists 
examples of AOD-related activities across the continuum of care that may benefit from effective 
dissemination of innovations. 
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Box 1. AOD-related activities
Level of Care Examples in AOD field
Preventive care Advice on smoking cessation 
Advice on alcohol or drug use in pregnant women
Advice on risks of alcohol or drug use (e.g., risky and high risk drinking)
Alcohol or drug screening
Contraindications of alcohol use with other medication
Treatment Prescribing of pharmacotherapies or therapeutic drugs for treatment of 
dependence (e.g., methadone, nicotine replacement therapy)
Brief interventions
Motivational interviewing
Cognitive behavioural therapy
Management Maintenance and management of clients on pharmacotherapies (e.g., outcome 
monitoring for opioid substitution treatment)
Management of depression and other psychological conditions associated with 
use of AOD
Management of chronic illness related to use of AOD (e.g., hepatitis C, liver 
cirrhosis, HIV)
Rehabilitation Management of relapse in clients with AOD dependence
Palliative care Treatment for clients with terminal illness related to use of AOD (e.g., cancer)
Effective innovations have the potential to minimise the deleterious effects of harmful AOD 
use. Although a number of successful interventions have been identified and, in some cases 
empirically validated, their adoption into clinical practice has often been limited. For example, 
brief interventions used as a secondary prevention strategy for problem drinkers, smokers and 
in some instances, illicit drug users, are generally effective. However, while brief intervention, 
which has also demonstrated cost-effectiveness (Effective Health Care Bulletin, 1993; Wutzke, 
Shiell, Gomel, & Conigrave, 2001), led to 10-16% reduction in alcohol use in intervention 
groups compared to no-intervention control groups (Moyer, Finney, Swearingen, & Vergun, 
2002), its uptake into practice has been slow (Roche & Freeman, 2004). In contrast, regardless 
of evidence that school-based drug education interventions have little or no long-term effect 
on reducing or preventing drug and alcohol use in young people, they continue to be used 
extensively (Foxcroft, 2005; Kaner et al., 2007; White & Pitts, 1998). 
Despite substantial investment of resources into the development, validation and evaluation of 
effective innovations (across all areas of research), once distributed, they frequently languish 
unused due to lack of investment into helping potential users understand, adopt and implement 
the innovation. That is, dissemination of validated innovations or best practice may not result in 
sustained changes at the individual, organisational, or community levels unless efforts are made 
to support and facilitate the uptake of the innovation. 
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3.3. Dissemination and implementation of innovations 
3.3.1. Definitions and terms
For the purposes of this review, innovations are the treatments, programs, preventive care 
and other activities aimed at clients; whereas dissemination or implementation strategies are 
the efforts used to facilitate adoption of innovations into practice and are aimed at the level of 
the practitioner or organisation. While the term “intervention” is used to describe some clinical 
actions aimed at clients (e.g., brief intervention), in this review it refers primarily to the specific 
implementation interventions (strategies) evaluated in the studies. 
Dissemination and implementation are two separate, yet related processes that represent 
the end-point goal of successful adoption of an innovation into practice. Dissemination is the 
process of informing others of an innovation, whereas implementation follows the decision to 
adopt an innovation and refers to how the innovation is put into practice (Gotham, 2004). 
Information dissemination and implementation, knowledge transfer, knowledge translation, 
information transfer, technology transfer and diffusion of innovation are all terms used to 
describe the mechanisms needed to transmute research findings into effective changes in 
health practice or policy. Dissemination strategies are defined in this report as any strategy 
used to facilitate the dissemination and implementation of innovations, such as programs, tools, 
interventions, or guidelines, through a planned or systematic process. They include not only 
the distribution of innovations, but also the activities that occur between the development of 
an innovation and its application in an appropriate setting. Dissemination is an active process 
that involves a cascade of events, which are not necessarily linear in nature, and a collection of 
stakeholders, such as researchers, healthcare providers, program evaluators, administrators, 
frontline workers, organisations and public policy makers. 
3.3.2. Research – to – practice gap
Research on dissemination strategies spans diverse fields from agriculture to manufacturing 
and medicine and includes both ‘hard’ technologies, such as specialised equipment or computer 
programs, and ‘soft’ technologies, such as educational techniques or training workshops 
(Schoenwald & Hoagwood, 2001). One of the most common tools for improving the quality of 
health care is clinical practice guidelines (CPGs). While the development of disease-specific 
CPGs is well-established, strategies for disseminating information and implementing change 
in health care practice have been applied inconsistently and studies indicate that the extent to 
which CPGs are incorporated into clinical practice is disappointing (Karuza et al., 1995). For 
example, gaps between the development of evidence-based best practice, such as CPGs, and 
the actual use of such guidelines has led to the underuse, overuse, or misuse of health care 
services (Chassin & Galvin, 1998). In a review of 48 studies on quality of care in the US, less 
than 50% of patients received the recommended care. Moreover, in 20-30% of cases, the care 
given ranged from ineffective to potentially detrimental (Schuster, McGlynn, & Brook, 1998). 
The underlying reasons for the gulf between formulating best practice and implementing best 
practice have been debated at length. Uptake and implementation of innovations typically 
require changes in professional practice that may occur at several different levels – patient / 
client, health care provider, health care team, health care organisation, or the wider environment 
(e.g., public policy changes). Barriers to uptake may be related to knowledge, existing culture or 
belief system of a group, routine practices, available resources, or individual characteristics of 
the providers, end-users and the innovation to be implemented. 
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There are three key elements to consider when addressing the research – to – practice gap. 
They are:
1. Attributes of the evidence supporting a change in practice: While evaluation of 
such attributes is beyond the scope of this review, evidence supporting the use of 
dissemination strategies is drawn from studies that used dissemination strategies 
to implement a wide range of innovations. Such innovations vary in complexity from 
practice that is relatively easy to change, has clearly defined benefits and is well-
accepted by practitioners, to practice that requires more effort to change behaviour and 
/ or organisational systems and has less robust evidence base to support the change. 
In the latter case, practitioners may feel less willing to comply with changes that they 
are not convinced will be beneficial. Thus, the attributes of the innovation that is being 
implemented may impact on the results of studies evaluating the dissemination strategies 
used to facilitate implementation.
2. Barriers and facilitators to changing practice: Contextual factors including costs, 
availability of resources (human and financial) and the prevailing culture within a 
workplace may also impact on the capacity and commitment to change. While barriers 
and facilitators are discussed in the context of the evidence, a comprehensive and 
systematic examination of the barriers and facilitators to change was beyond the scope 
of this review.
3. Effectiveness of dissemination and implementation strategies.
3.3.3. Dissemination of AOD-related materials, programs and services
The dissemination challenge in the AOD field is complicated further by a combination of 
characteristics that distinguish the AOD workforce from other healthcare workers (Skinner, 
Freeman, Shoobridge, & Roche, 2003). Frontline workers in the AOD field come from a broad 
range of disciplines and backgrounds, including medicine, social work, psychology, teaching 
and the criminal justice system. As a result, their educational qualifications, training in AOD 
issues, and understanding or appreciation of research varies considerably. In some sections 
of the AOD workforce, other factors, such as the rapid turnover of staff, poor pay, and overall 
low status, may impact on their capacity and motivation to adopt new research concepts and 
implement innovations. Consequently, effective dissemination strategies must bridge the 
conceptual and cultural distance between the research centre and the AOD workforce. This may 
require tailoring dissemination strategies for the very disparate target audiences that make up 
the AOD workforce. 
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4..Objectives and Research Questions
4.1. Primary objectives
To undertake a systematic literature review of the effectiveness of different dissemination • 
and implementation strategies that are used in, or relevant to, the AOD field (i.e., 
dissemination of innovations used by the AOD workforce).
To identify key success factors / components of the dissemination strategies that • 
influence uptake and implementation.
To develop a framework for dissemination strategies relevant to the AOD field.• 
4.2. Research questions
The primary research question was:
Which dissemination and implementation strategies are most likely to be effective in • 
encouraging uptake of innovations by workers in the AOD field?
Secondary research questions were: 
Which strategies have been used to influence changes in the work practices of health • 
care professionals, allied health care workers, or frontline workers in the AOD field?
Have these strategies been successful in changing individual behaviour and • 
workplace practices?
What are the key factors underlying the successful uptake and implementation of • 
dissemination strategies?
Which dissemination strategies are likely to be relevant to the AOD field?• 
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5..Methods
Research on the effectiveness of dissemination strategies and the barriers to, or facilitators 
of, dissemination and implementation strategies is extensive. A scoping search revealed two 
important features in the literature:
Systematic reviews and studies evaluating dissemination strategies specifically in an • 
AOD setting or pertaining to AOD-related issues were sparse
The literature evaluating dissemination strategies in the general medical • 
field was abundant.
Therefore, this project was conducted in two stages: 
Stage 1: A descriptive evaluation of existing systematic literature reviews of dissemination 
research in medical and health literature. 
The scoping search revealed a number of existing systematic reviews that were used to inform 
this project. Although the focus of some reviews varied from that of this study (e.g., broad 
or specific strategies; targeted behaviours; characteristics of the target groups; barriers to 
implementation), studies that were included in those existing reviews were also deemed to be 
relevant to this project. 
Since several existing reviews contained many of the same studies, another systematic review 
of essentially the same body of research was unwarranted. Therefore, to avoid unnecessary 
duplication of effort, existing systematic reviews were critically appraised and an overview of the 
findings from the highest quality reviews is presented. In particular, effective dissemination and 
implementation strategies pertaining to workers in the AOD field were examined. 
Stage 2: A systematic search and evaluation of research on dissemination strategies relevant 
to the AOD field. 
Literature searches were extended to include relevant additional studies that were not covered 
by existing systematic reviews and studies that focused specifically on AOD–related problems 
or were set in an AOD context. Given that AOD-related problems frequently co-occur with 
mental health problems, search terms were expanded to include the mental health literature.
For this report, dissemination interventions were allocated to categories that have been 
described previously by the Effective Practice and Organisation of Care (EPOC) review group 
taxonomy (EPOC, 2002). For interpretive purposes, these categories have been separated into 
16 professional, organisational and ‘other’ strategies (see Table 4).
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Table 4. List of interventions for dissemination and implementation (modified from 
EPOC taxonomy) a
Type of strategy Description
1. Professional Interventions - oriented to changes in professional practice
Educational materials Distribution of published / printed recommendations for care,  
including clinical practice guidelines, audiovisual materials and electronic 
publications. Materials are delivered personally or through mass mailings.
Local consensus processes Inclusion of participating providers in discussion to ensure that they agree that 
the chosen clinical problem is important and the approach to managing the 
problem is appropriate. E.g., modification of clinical practice guidelines to 
local setting.
Educational meetings 
(continuing medical 
education)
Healthcare providers participate in conferences, lectures, 
workshops or traineeships.
Didactic – minimal participant interactions (lectures, seminars) 
Interactive – participation with discussion or practice (workshops)
Educational outreach visits 
(academic detailing)
Use of a trained person who meets with providers in their practice setting to give 
information with the intent of changing the provider’s practice. 
Local opinion leaders 
(includes product 
champions)
Use of providers nominated by their colleagues as ‘educationally influential’. The 
investigators explicitly state that their colleagues identified the opinion leaders.
Patient-mediated 
interventions
New clinical information (not previously available) collected directly from patients 
and given to the provider.
Prompts and reminders 
(including decision support)
Patient- or encounter-specific information, provided verbally, on paper, or 
on electronically, which is designed to prompt a health professional to recall 
information. This usually occurs through general education, in medical records 
or by interactions with peers, reminding them to perform or avoid some action to 
aid individual patient care. Computer-aided decision support and drugs dosage 
are included.
Audit and feedback Any summary of clinical performance of healthcare over a specified period. 
The summary may also include recommendations for clinical action. The 
information may be obtained from medical records, computerised databases or 
observations from patients.
Financial incentives Any payment system that rewards health care providers for specified clinical 
actions. Examples include fee-for-service, target payments, and capitation.
Electronic educational 
sources
Healthcare providers use electronic, internet, ,or on-line databases to access 
information relevant to all levels of health care for patients.
2. Organisational interventions - oriented to changes in organisational practice
Record and office systems Any structured or unstructured system used for storage and exchange of 
information. Examples include electronic medical records, care plans, 
flow charts.
Multi-disciplinary 
collaborative approaches 
(integrated care)
Use of complementary inter-professional collaborations (nurses, physicians, 
psychologists, pharmacists, dieticians) to plan care for patients. Examples 
include integrated care, collaborative care, continuity of care.
Alternative care approaches Use of alternative health professionals, such as nurse practitioners, or 
alternative settings, such as specialist clinics, to deliver specialised program of 
care. Examples include revision of professional roles; chronic care clinics; and 
therapeutic communities.
Continuous quality 
improvement
Any iterative process for improving the quality of health care that involves 
repeated cycles of “plan-do-check-act”.
3. Other interventions
Mass media 1. varied use of communication that reaches great numbers of people including 
television, radio, newspapers, posters, leaflets and booklets, alone or in 
conjunction with other interventions.
2. targeted at the population level.
Multi-faceted interventions Use of more than one strategy in combination or sequentially.
a This table has been modified from the EPOC taxonomy (EPOC, 2002). Some strategies, which were 
described by EPOC, were not included here as no studies or existing reviews met the inclusion criteria 
for evaluation.
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5.1. Inclusion criteria
Studies were included in the review if they satisfied predetermined inclusion criteria  
(Table 5) and provided relevant information addressing the research questions. 
Uncertainties about inclusion status were resolved by group consensus. 
Table 5. Study selection criteria
Selection criteria Inclusion criteria
Target audience Health care organisations or groups of health care professionals that implement 
strategies to deliver health services. These health care organisations include 
hospitals, clinics, rehabilitation centres, or groups of staff working together as a 
team (doctors, nurses, mental health workers), social workers, psychologists, 
counsellors, youth workers, crisis care workers, ambulance officers, pharmacists, 
public health workers, general welfare workers, police, school counsellors, 
teachers, correctional services officers, drug treatment providers).
Intervention Dissemination and implementation strategies to induce change in professional 
practice or process (see Table 4). Information is required on the method of 
dissemination, the process of implementation, the target group adopting the 
innovation, the materials used in the intervention, and the client group targeted for 
improved health outcomes. Studies evaluating the effectiveness of the individual 
innovations (e.g., brief interventions, cognitive behavioural therapy) being 
disseminated are excluded. 
Comparator “Usual” or standard dissemination strategies, including no intervention or passive 
dissemination strategies (e.g., mailout of clinical practice guidelines or standard 
training session).
Outcomes Effectiveness:
Process outcomes: - Any objective measures of utilisation of innovation – 
assessment of participation (change in practice or process, including surrogate 
outcomes (e.g., audit of records / charts, +/- feedback); measures of compliance 
with innovation (fidelity to intervention); assessment of participant satisfaction; 
assessment of efficiency (change in productivity of organisation).
If objective measures are lacking – subjective measures, such as self-report 
questionnaires may be included if they include longer-term follow-up evaluation 
(e.g., >3 months after intervention). 
Client outcomes: Any objective measures of impact of implementing the 
innovation on clients – patient functional ability or health status, number of 
hospitalisations, patient / client ability to manage their disease / drug problem, 
patient / client quality of life, satisfaction with intervention.
Study design Limited to comparative studies: systematic reviews of controlled studies; 
randomised controlled trials; quasi-experimental controlled studies (e.g., cohort 
studies), controlled before-and-after studies, interrupted time series with at least 3 
measures before and 3 after implementation.
Study duration A study period of at least 3 months is preferred to demonstrate a sustainable 
change. If unavailable, a shorter study period will be considered.
Language Restrict to English language publications, unless the study provides a higher 
level of evidence.
Baseline performance Baseline measurements or control group performance must be included when 
assessing effectiveness so that potential “ceiling effects” may be determined.
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5.2. Search Strategy
The medical and health literature was searched to identify: 
relevant systematic reviews on dissemination strategies used to improve  • 
the uptake and implementation of innovations across all areas of health  
care (Stage 1).
relevant recent research (not included in existing systematic literature reviews) that • 
evaluated the effectiveness and cost-effectiveness 1 of dissemination strategies in the 
general and medical fields, including the AOD and mental 
health fields (Stage 2). 
The search period was 1966 to March 2005. Table 6 lists the bibliographic databases that were 
used for these searches. Table 7 lists other potentially relevant sources of literature that were 
canvassed, including grey literature. 
Table 6. Bibliographic databases
Electronic database Time period
AustHealth 1997 – March 2005
Australian Medical Index 1996 – March 2005
Australian Public Affairs Information Service 
(APAIS) - Health (Informit)
1990 – March 2005
Cinahl 1977 – March 2005
Cochrane Library – including, Cochrane Database 
of Systematic Reviews, Database of Abstracts of 
Reviews of Effects, the Cochrane Central Register 
of Controlled Trials (CENTRAL), the Health 
Technology Assessment Database, the NHS 
Economic Evaluation Database
1966 – March 2005
Current Contents 1993 – March 2005
Cochrane Effective Practice and Organisation 
of Care (EPOC) register
1995 – March 2005
Health Services/technology assessment 
text (HSTAT)
www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat
National Coordinating Centre for Health 
Technology Assessment
www.hta.nhsweb.nhs.uk/
PubMed and Medline 1966 – March 2005
PapersFirst 1993 – March 2005
PsycInfo 1983 – March 2005
Web of Science – Science Citation Index Expanded 1995 – March 2005
1 Cost considerations are included in a separate associated report.
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 Table 7. Other sources of information
Specialty Websites Website address
National
Alcohol and other Drugs Council of  
Australia (ADCA)
www.adca.org.au/resource/
Cooperative Research Centre for Aboriginal Health, 
Northern Territory
www.crcah.org.au
Drug and Alcohol Services of South Australia (DASSA) www.dassa.sa.gov.au/site/page.cfm 
Menzies School of Health Research, Darwin,  
Northern Territory
www.menzies.edu.au/
National Drug and Alcohol Research Centre (NDARC), 
Sydney
ndarc.med.unsw.edu.au/ndarc.nsf
National Drug Research Institute (NDRI), Perth www.curtin.edu.au/curtin/centre/ncrpda/
National Institute of Clinical Studies 
(NICS), Melbourne
www.nicsl.com.au
Primary Health Care Research and Information Service 
(Australia)
www.phcris.org.au/resources/research/
dissemination_frameset.html
International
Addiction Technology Transfer Center (ATTC), 
Missouri, USA
www.nattc.org/resPubs/techTransfer.html
Canadian Health Services Research Foundation 
(CHSRF), Canada
www.chsrf.ca/
Canadian Institutes of Health Research (CIHR), 
Canada
www.cihr-irsc.gc.ca/e/8505.html
Centre for Reviews and Dissemination, (CRD),  
York, UK
www.york.ac.uk/inst/crd/
Getting Research into Policy and Practice (GRIPP),  
UK
www.jsiuk-gripp-resources.net/gripp/do/
viewPages?pageID=1
Health Services Research Unit - University of Aberdeen 
(Scotland)
www.abdn.ac.uk/hsru/epp/index.shtml
Knowledge Integration and Network  
Expertise (Germany)
www.tim.rwth-aachen.de/forschung/kinx2/index.php
National Center for the Dissemination of Disability 
Research (NCDDR), Texas, USA
www.ncddr.org/
National Institute on Drug Abuse (NIDA), USA www.nida.nih.gov/
North East Addiction Technology Transfer Network 
(NeATTC), Pittsburgh, USA
www.neattc.org/index2.html
Substance Abuse and Mental Health Services 
Administration (SAMHSA), USA
www.samhsa.gov/index.aspx
Specialty Journals Location
Addiction Library or electronic access
Alcohol and Alcoholism Library or electronic access
Drug and Alcohol Review Library or electronic access
Health Education Research Library or electronic access
Health Services Research Library or electronic access
Journal of Community Psychology Library or electronic access
Journal of Continuing Education for Health 
Professionals
Library or electronic access
Journal of Drug Issues Library or electronic access
Journal of Substance Abuse Treatment Library or electronic access
Preventive Medicine Library or electronic access
Social Science and Medicine Library or electronic access
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5.3. Search terms
Electronic databases were searched using a combination of MeSH headings and text words, 
including the following: Dissemination – information dissemination, diffusion of innovation, 
technology transfer, knowledge transfer, knowledge translation, implementation, continuing 
medical education, reminders, prompts, opinion leaders, academic detailing, educational 
outreach, feedback, decision support; AOD and mental health – substance-related disorders, 
addictive behaviour, substance abuse, substance use, addiction, dependence, alcohol abuse, 
mental health service; Study population – health personnel, professional practice, social work, 
police, doctor, nurse, physician, clinician, health worker, social worker, counsellor, teacher; and 
Study design – randomised controlled trial, comparative study, cohort study, multicenter study, 
random allocation, meta-analysis, review. 
5.4. Critical appraisal
The evidence reported in studies that met the inclusion criteria were assessed according to 
the dimensions of evidence defined by the National Health and Medical Research Council 
(NHMRC, 2000). These dimensions of evidence (Table 8) contain three domains:
Strength of the evidence, which includes the level of evidence, quality of evidence  • 
and statistical precision
Size of the effect• 
Relevance of the evidence. • 
Table 8. Dimensions of evidence
Type of evidence Definition
Strength of the evidence
Level of evidence
I
II
III-1
III-2
III-3
IV
Quality of evidence
Statistical precision
The study design used, as an indicator of the degree to which bias has been 
eliminated by design.
Evidence obtained from a systematic review of all relevant randomised 
controlled trials.
Evidence obtained from at least one properly-designed randomised  
controlled trial.
Evidence obtained from well-designed quasi-randomised controlled trials 
(alternate allocation or some other method).
Evidence obtained from comparative studies (includ8ing systematic reviews of 
such studies) with concurrent controls and allocation not randomised, cohort 
studies, case-control studies, or interrupted time series with a control group.
Evidence obtained from comparative studies with historical control, two or more 
single arm studies, or interrupted time series without a parallel control group.
Evidence obtained from case series, either post-test or pre-test / post-test.
The methods used by investigators to minimise bias within a study design.
The p-value or, alternatively, the precision of the estimate of the effect. It reflects 
the degree of certainty about the existence of a true effect.
Size of the effect The distance of the study estimate from the “null” value and the inclusion of only 
clinically important effects in the confidence interval.
Relevance of evidence The usefulness of the evidence in clinical practice, particularly the 
appropriateness of the outcome measures used.
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Methodological components, such as concealment of allocation, blinding and completeness of 
data, have been shown to impact on treatment effect sizes (Moher et al., 1998; Schulz, Chalmers, 
Hayes, & Altman, 1995) and are included in the checklists, which are provided in Appendix A. 
These checklists were used to assess the quality of systematic reviews (Khan et al., 2001), 
comparative studies (EPOC, 2002) including randomised and concurrently controlled trials, 
controlled before-and-after studies and interrupted time series, and cohort studies 
(Downs & Black, 1998). 
5.5. Data extraction and synthesis of evidence
Reference citations from all literature sources were collated into an Endnote 10.0 library and 
duplicates were removed. If it was clear from citation information that studies did not meet the 
inclusion criteria, they were excluded, without retrieval. All other studies were retrieved for full-text 
assessment. Additional studies were collected by pearling 2 the reference lists of articles that met 
the selection criteria. These additional relevant studies were critically appraised and all studies 
that satisfied the inclusion criteria formed the evidence base. 
Using tables developed a priori, data for each of the relevant outcomes were extracted from the 
included studies by two researchers (PB and BL) and checked by each researcher for face validity. 
Tables of data from included studies for each of the 16 groups of dissemination interventions are 
provided in Appendix B.
5.6. Statistical and methodological considerations
All studies were examined for potential unit of analysis errors. Unit of analysis errors occur when 
the unit of allocation is the health care organisation, or group, and the unit of analysis is the 
individual client, or patient, as if there were no clustering by organisation or provider. This type of 
error overestimates the power of the study unless the clustering effect is adjusted for. Although 
the point estimate is not affected by a unit of analysis error, making it possible to examine the size 
of an effect, it is not appropriate to determine its statistical significance as it results in spuriously 
low p-values or artificially narrow confidence intervals (Grimshaw et al., 2003), thereby potentially 
overestimating the effectiveness of an intervention. 
A key factor in determining the effectiveness of particular strategies is to ensure that baseline 
scores between intervention and control groups are similar. Where they are not similar, it is 
important that such baseline differences be adjusted for, using appropriate statistical techniques. 
Thus, the final “post-intervention” measure reflects “real” changes, rather than differences that 
may have been present at baseline. Where baseline measures in intervention and control groups 
indicate that the usual procedures may be adequate (e.g., high percentage of participants already 
comply with best practice guidelines, demonstrating a “ceiling effect”), then the intervention used 
has little scope to demonstrate improvement. Studies that did not collect baseline measures were 
excluded. A decision tree regarding baseline measures was used by researchers when extracting 
data (see Figure 1).
2 Pearling involves searching the reference lists of studies that were included for assessment to identify 
additional relevant studies that were not located through the initial search strategy. Potentially relevant 
additional studies were then subjected to the selection criteria and critical appraisal procedures.
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Figure 1. Decision tree for managing baseline data 
Baseline data collected?
Baseline data 
for both groups 
reported?
Report change scores 
and relative change
Baseline scores 
similar or adjusted for?
Baseline scores 
reported as similar or 
adjusted for?
Include p values
Indicate  
adjustment method 
in table notes
Exclude 
p values
Include p values
Indicate in 
table notes if 
adjustment used
Exclude from table
Report results 
(and flaws) 
in text
ExcludeNo
No
No NoYesYes
Yes
Yes
Where baseline and follow-up data were reported for both intervention and control groups, 
a within-groups change score and between-groups relative change was calculated.
If the same data were reported in more than one published paper, only results from the most 
comprehensive or most recent article were included. Members of the reference group were 
contacted and requested to provide information on additional published or unpublished reports 
that were not identified in the literature searches. 
The heterogeneity in settings, interventions, populations and outcome measures of the included 
studies, and the frequency of potential unit of analysis errors precluded conducting a formal 
meta-analysis. Vote-counting methods (Table 9), which have been used in several systematic 
reviews to determine the effectiveness of strategies, were not used in this review. This approach 
has several weaknesses for interpreting research findings. It is an inefficient use of statistical 
information, which fails to consider the effect size or the precision of the estimate of the effect, 
and ignores some negative and inconclusive results. 
Follow-up score – baseline score = change score 
Change score (intervention group) / change score (control group) = relative change 
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Table 9. Vote-counting methods
Description of vote-counting methods Limitations
Add positive and negative comparisons across 
included studies
Ignores some negative and inconclusive results
Add the number of comparisons with statistically 
significant effects
Positive = statistically significant change in majority of 
outcomes measured (intervention is better than control)
Negative = statistically significant change in the opposite 
direction (control is better than intervention)
Inconclusive = no significant change or no overall 
positive findings
Fails to consider effect size
Fails to consider the precision of the estimate
Potential for publication bias as studies with unit 
of analysis errors are generally excluded
Source: (Gill et al., 1999; Grimshaw et al., 2004)
An alternative approach was used, whereby results were synthesised descriptively. All studies 
that were included and assessed for effectiveness were given a quality rating according to 
their efforts to minimise bias, as described in the EPOC checklist (EPOC, 2002) (Appendix A). 
Studies were described as:
Good (i.e., good protection against bias) if more than five criteria (out of a total of • 
seven criteria) were ‘DONE’
Average if 4-5 criteria were ‘DONE’• 
Poor if less than four criteria were ‘DONE’.• 
Standard statistical principles were used to determine statistical precision. Where possible, 
the effect size associated with outcomes in the included studies was assessed qualitatively. 
Effect sizes were described as small (≤5% improvement in practice); modest (>5% and ≤10%); 
moderate (>10% and ≤20%); and large (>20%). 
5.7. Evidence base
The initial search, which resulted in 6,100 citations published between 1966 and March 2005, 
was reduced to 4,650 following the removal of duplicates. Over 80% of citations were excluded 
during an initial screening of titles and abstracts. 
The main reasons for article exclusion of articles included:
Article type • - narrative reviews, case reports, editorials, letters, or  
discussion / opinion papers
Inappropriate study design•  – no controls, no baseline measures
Inadequate data•  – no relevant outcomes reported (may be due to poor reporting of 
results or lack of adequate comparator)
Inappropriate interventions•  – evaluation of individual interventions or treatments, such as 
psychopharmacotherapy (i.e., not dissemination strategy)
Multiple reports•  – duplication of data in several articles. 
A total of 651 full-text articles, including those from database searches, handsearching 
journals and pearling were retrieved for closer scrutiny. The total evidence base for this review 
comprised 25 systematic reviews and 85 studies. Data were not extracted for several studies 
(Mazmanian, Johnson, Zhang, Boothby, & Yeatts, 2001; Onion & Bartzokas, 1998; White et al., 
2004) as baseline data were either not reported, baseline scores were not reported as similar, 
or differences in baseline data were not adjusted for, making it difficult to determine whether 
reported differences between groups were due to the intervention. 
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5.8. Methodological Quality
All studies included in this review were rated for methodological quality (good, average, poor) 
according to the appropriate checklist criteria (Appendix A). There was substantial variability 
in methodological quality of the available evidence base across all strategies examined. Poor 
reporting of methods was a common flaw in many studies, making it difficult to accurately 
assess study quality. That is, it was often unclear whether established methodological criteria 
(EPOC, 2002) had been employed. In many studies, interventions were poorly described, 
making it difficult to compare across studies and to identify common features that may have 
contributed to a strategy’s success. 
Overall, the risk of bias was low in only 20-25% of studies (good quality), with adequate 
randomisation, concealment of allocation, blinded objective outcomes, and good follow-up of 
participants. Approximately 15-20% had high risk of bias (poor quality), with moderate risk in the 
remaining 60-65% (average quality). 
There were potential unit of analysis errors (potentially resulting in an overestimation of effect 
size) in cluster randomised controlled trials (RCTs) in 22% to 64% of the studies included in 
systematic reviews, and there was potential for contamination in several studies where patients 
were the unit of allocation. For example, studies included in one good systematic review 
(Thomson O’Brien et al., 2000a) had inadequate concealment of allocation (72%), unblinded 
assessment of outcomes (50%), unadjusted baseline differences (33%) and potential unit of 
analysis errors (33%). Other limitations in study quality included low statistical power due to 
small sample size and the presence of a possible ‘ceiling effect’ in some studies. 
Studies of health care providers that relied on self-selection of participants were likely to be 
comprised of a sample of highly motivated participants, with more positive attitudes toward the 
innovation and greater skills and knowledge in the targeted area of practice (Bekkering et al., 
2005; Forsetlund et al., 2003; Foy et al., 2004; Searle, Grover, Santin, & Weideman, 2002). 
Such characteristics imply a greater ‘readiness to change’ professional behaviour and may 
partly explain the apparent ceiling effect reported in some studies. 
Studies with relatively short follow-up periods (≤6 months) may have difficulty in detecting 
changes in behaviour that may take time to emerge (Searle et al., 2002). Conversely, for studies 
that only reported effects at 3-6 months follow-up, sustainability of the effect could not be 
determined. In some studies, generalisability to settings that differ from the study populations 
may be limited due to the particular exclusion / inclusion criteria, and differences in health care 
systems between countries and jurisdictions (e.g., financial incentives).
27
6..Results — Summary of Evidence
This chapter provides a brief description of the evidence that was gathered from existing 
systematic literature reviews and additional primary research that was not included in 
existing reviews.
Strategies to increase the uptake of new research may be approached from different 
perspectives. These include: 
Changing the knowledge, attitudes or behaviour of health care professionals • 
(professional interventions)
Changing the environment in which health care professionals work, such as the health • 
care system or practice setting (organisational interventions)
Combination of both perspectives to either tailor strategies to a specific target behaviour, • 
audience, or condition, or to apply a “scatter-gun” approach to reach a broader audience 
(other interventions). 
Any one of a combination of these approaches has been utilised in a large variety of settings. 
The following chapters (7-9) provide more detailed evidence on the key findings from an 
evaluation of the effectiveness of 16 dissemination interventions:
Professional interventions (Chapter 7)• 
Organisational interventions (Chapter 8)• 
Other interventions (Chapter 9).• 
Each intervention and the evidence of its effectiveness is outlined in chapters 7-9 in the 
following order: 1) a brief description of the intervention, with an overview of the number of 
existing systematic reviews and additional studies that have evaluated its effectiveness; 2) a 
brief summary of the evidence of effectiveness of the intervention; 3) key success factors of the 
intervention; and 4) the relevance of the findings to the AOD field. Where possible, evidence 
from the AOD setting has been presented. However, where none is available, the potential for 
a strategy’s application in the AOD setting is discussed. For example, management of AOD-
related problems has useful parallels with models of chronic disease and thus, successful 
strategies used to implement innovations for heart disease, diabetes, arthritis and depression 
may be transferable to the AOD context. 
6.1. Stage 1: Existing systematic reviews
Twenty-five existing systematic literature reviews were located. Where it was clear that an 
earlier review had been updated, only the updated version is presented in this assessment. 
Some studies were included and evaluated in more than one review and approaches to 
assessment differed between reviews (see Table 10).
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Table 10. Approaches to assessment in existing systematic reviews
Approach Reference
Reviews that focussed on one specific 
dissemination strategy, but included a broad 
range of conditions and target behaviours
(Balas et al., 2000; Currell & Urquhart, 2003; Garg et al., 
2005; Giuffrida et al., 2000; Hunt, Haynes, Hanna, & Smith, 
1998; Jamtvedt, Young, Kristoffersen, Thomson O’Brien, 
& Oxman, 2003; Shiffman, Liaw, Brandt, & Corb, 1999; 
Thomson O’Brien et al., 2001; Thomson O’Brien et al., 
2000a; Thomson O’Brien et al., 2000b)
Reviews that focussed on a broad range 
of dissemination strategies applied to more 
specific diseases or targeted behaviours
(Anderson & Jane-Llopis, 2004; Anderson, Laurant, Kaner, 
Wensing, & Grol, 2004; Gilbody, Whitty, Grimshaw, & 
Thomas, 2003; Gill et al., 1999; Gosden et al., 2000; Harvey, 
Glenny, Kirk, & Summerbell, 2002; Hulscher, Wensing, van 
Der Weijden, & Grol, 2001; Norris et al., 2002; Renders et al., 
2001; Weingarten et al., 2002)
Reviews that focussed on specific strategies 
for targeted behaviours or conditions
(Bennett & Glasziou, 2003; Lancaster, Silagy, & Fowler, 
2000; Tu & Davis, 2002; Walton, Harvey, Dovey, & 
Freemantle, 2001)
Reviews that focussed on broad strategies 
for multiple behaviours; specific conditions or 
targeted populations
(Beilby & Silagy, 1997; Grimshaw et al., 2004; Thomas, 
McColl, Cullum, Rousseau, & Soutter, 1999)
There was little consistency in the way the strategies were grouped in existing systematic 
reviews. For example, professional interventions included distribution of educational materials, 
educational meetings and seminars or training workshops in all reviews, while others also 
included combinations of educational outreach, audit and feedback, reminders, opinion leaders, 
and local consensus processes. Similarly, some reviews contrasted and compared didactic and 
interactive strategies, yet the types of interactive strategies varied between reviews. 
6.2. Stage 2: Additional studies
Where possible, strategies evaluated in the additional studies were grouped according 
to the EPOC taxonomy described in Table 4. In many cases, studies (and reviews) have 
included strategies that could fit into a number of categories. Results are presented under the 
dissemination strategy category that most closely relates to the stated aim of the study.  
Cross-references between strategies have been added throughout this report, where possible.
Eighty-five additional studies were identified that met the selection criteria. These were critically 
appraised and sorted into groups (Table 11). The following sections report on the effectiveness 
of the 16 strategies listed in Table 11 and described more fully in Table 4.
results - summary of evidence
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Table 11. Summary of additional primary research
Strategy Number of studies References
Professional interventions
Educational materials 1 (Dormuth et al., 2004)
Local consensus processes 3 (Baker et al., 2003; Butzlaff et al., 2004; Silagy et 
al., 2002)
Educational meetings 16 (Delvaux et al., 2004; Fallowfield et al., 2002; Fallowfield, 
Jenkins, Farewell, & Solis-Trapala, 2003; Glazier, Badley, 
Lineker, Wilkins, & Bell, 2005; Katz, Muehlenbruch, Brown, Fiore, 
& Baker, 2004; Kelly et al., 2000b; King et al., 2002; Mazmanian 
et al., 2001; Miller, Yahne, Moyers, Martinez, & Pirritano, 2004; 
Pill, Stott, Rollnick, & Rees, 1998; Premaratne et al., 1999; 
Razavi et al., 2003; Santoso, Suryawati, & Prawaitasari, 1996; 
Suggs et al., 1998; Young et al., 1998; Young & Ward, 2002)
Educational outreach visits 13 (Bernal-Delgado, Galeote-Mayor, Pradas-Arnal, & Peiro-Moreno, 
2002; Cranney, Barton, & Walley, 1999; Crotty et al., 2004; Dey 
et al., 2004; Finkelstein et al., 2001; Goldstein et al., 2003; Hall, 
Eccles, Barton, Steen, & Campbell, 2001; Majumdar et al., 2003; 
New et al., 2004; Solomon et al., 2001; Watson, Gunnell, Peters, 
Brookes, & Sharp, 2001; Watson et al., 2002; Weller et al., 2003)
Local opinion leaders 2 (Finkelstein et al., 2005; Gifford et al., 1999)
Patient-mediated interventions 3 1 (Thapar et al., 2002)
Prompts and reminders 12 (Bahrami et al., 2004; Frances, Alperin, Adler, & Grady, 2001; 
Goldberg, Mullen, Ries, Psaty, & Ruch, 1991; Goldberg et al., 
2000; McMullin et al., 2004; Murtaugh, Pezzin, McDonald, 
Feldman, & Peng, 2005; Ramsay, Eccles, Grimshaw, & Steen, 
2003; Sanders & Satyvavolu, 2002; Shaw, Samuels, Larusso, & 
Bernstein, 2000; Thapar et al., 2002; Tierney et al., 2005; Toth-
Pal, Nilsson, & Furhoff, 2004)
Audit and feedback 3 (Eccles et al., 2001; Kiefe et al., 2001; McCartney, MacDowell, 
& Thorogood, 2001)
Financial incentives 1 (Hillman et al., 1998)
Electronic educational sources 1 (Di Noia, Schwinn, Dastur, & Schinke, 2003)
Organisational interventions
Record and office systems 5 (Boekeloo et al., 2003; Boekeloo et al., 2004; Dietrich et al., 1992; 
Kinsinger, Harris, Qaquish, Strecher, & Kaluzny, 1998; McBride 
et al., 2000; Ockene et al., 1999)
Multi-disciplinary collaborative 
approach
1 (Diabetes Integrated Care Evaluation Team, 1994)
Alternative care approach 2 (Campbell et al., 1998; Sikka et al., 1999)
Continuous quality improvement 4 (Feifer & Ornstein, 2004; Irvine Doran et al., 2002; Rantz et al., 
2001; Solberg et al., 2000)
Other interventions
Mass media 1 (Matowe et al., 2002)
Multi-faceted interventions 19 (Bekkering et al., 2005; Cooke, Mattick, & Walsh, 2001; Flottorp, 
Havelsrud, & Oxman, 2003; Forsetlund et al., 2003; Foy et al., 
2004; Frijling et al., 2003; Frijling et al., 2002; Heller, D’Este, 
Lim, O’Connell, & Powell, 2001; Joseph et al., 2004; Langham 
et al., 2002; Lemelin, Hogg, & Baskerville, 2001; Margolis et al., 
2004; Nilsson et al., 2001; Philbin et al., 2000; Sanci et al., 2000; 
Schectman, Schroth, Verme, & Voss, 2003; Searle et al., 2002; 
Waldorff, Almind, Makela, Moller, & Waldemar, 2003; Wright et 
al., 2003; Young, D’Este, & Ward, 2002)
Total 85
results - summary of evidence
3 Patient-mediated interventions have been included in this category as this strategy aims to indirectly 
influence practitioners to change their behaviour.
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7..Professional Interventions
Professional interventions refer to strategies oriented directly toward increasing knowledge and 
changing the attitudes and behaviour of professionals. Those included here are: 
Educational materials• 
Local consensus processes• 
Educational meetings• 
Educational outreach visits• 
Local opinion leaders• 
Patient-mediated interventions• 
Prompts and reminders• 
Audit and feedback• 
Financial incentives• 
Electronic educational resources.• 
7.1. Educational Materials
Educational materials, in printed or electronic format, are published recommendations for clinical 
care or other information that is provided either personally, electronically or via mass mailings. 
They are presented in a variety of formats including bulletins, summaries, information posters 
and guidelines. Such resources are an integral part of other educational interventions, such as 
continuing medical education (CME) workshops or seminars. Educational materials typically 
accompany other dissemination strategies; for example, as part of a ‘usual care’ control group. This 
section examines studies that have assessed specifically the impact of disseminating educational 
materials alone.
Six systematic reviews of 2-18 studies (Gilbody et al., 2003; Gill et al., 1999; Grimshaw et al., 
2004; Grol & Grimshaw, 2003; Harvey et al., 2002; Hulscher et al., 2001; Tu & Davis, 2002) 
(Table 12) and one cluster RCT (Dormuth et al., 2004) (Table 13) assessed the effectiveness of 
educational materials. 
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Table 12. Effectiveness of distribution of educational materials - Systematic 
reviews summary 
Research area References Level and quality of evidence a Process outcomes b
Client 
outcomes c
Disease management (Tu & Davis, 
2002)
Level I: poor quality SR  
4 RCTs d
NS NS
Disease management (Gilbody et al., 
2003)
Level II: good quality SR  
22 average quality controlled 
studies
NS NS
Prescribing (Gill et al., 1999) Level II: good quality SR 
7 average – good quality  
controlled studies
+ in 3/7 
studies
NA
Prevention (5) 
Prescribing (4)
Disease 
management (6)
Adherence to 
guidelines (3)
(Grimshaw et 
al., 2004)
Level II: good quality SR 
18 poor quality controlled studies
+ in 7/18 
studies §  
Not 
sustained
NS in 1 
study
Disease management (Harvey et al., 
2002)
Level II: good quality SR  
2 poor quality controlled studies
NS NS
Preventive care (Hulscher et al., 
2001)
Level II: good quality SR 
3 poor-average quality controlled 
studies
NS NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; d quality not assessed; + indicates intervention was significantly more 
effective than control or usual care; ± indicates mixed effects (significant change in some, but not all 
outcome measures); § = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not 
significant; RCT = randomised controlled trial; SR = systematic review. 
Table 13. Effectiveness of distribution of educational materials - Primary 
research summary 
Research area References Level and quality of evidence a Process outcomes b
Patient 
outcomes c
Prescribing (Dormuth et al., 
2004)
Level II: good quality cluster RCT + NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control  
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures);  
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant;  
RCT = randomised controlled trial. 
7.1.1. How effective is distribution of educational materials?
One well-cited systematic review of 11 studies, which examined the distribution of educational 
materials, including clinical practice guidelines (CPGs), audio-visual materials, and electronic 
publications, reported that passive distribution of educational materials had no effect on 
improving professional practice (Freemantle et al., 1997). This review has since been withdrawn 
for updating and results have yet to be published.  
More recently, a good quality systematic review re-examined the primary research using an 
explicit analytical framework, rather than the vote-counting approach described in Table 9 
(Grimshaw et al., 2004). Despite overall weak methodological quality across the majority of 
professional interventions
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included studies, significant improvements were observed in the process of care, with most 
reporting small-moderate effects at best. However, with few head-to-head comparisons in good 
quality well-designed studies, the statistical significance of these improvements is not robust 
and subsequent follow-up measures taken in some studies resulted in decay effects (Grimshaw 
et al., 2004). 
One additional good quality cluster RCT (Dormuth et al., 2004) assessed the effect of regular 
distribution of printed educational materials in the form of a series of “therapeutic letters’ on 
physicians” prescribing behaviour (process outcomes) (Table 13 and Table 41, Appendix B). The 
impact of disseminating a series of 12 letters over a 2-year period was evaluated. A single letter 
distributed to physicians had no statistically significant effect on prescribing behaviour, whereas 
the combined effect of 12 letters was statistically robust (p<0.001). In contrast to the limited 
effectiveness demonstrated in the studies included in existing systematic reviews, findings from 
this RCT (Dormuth et al., 2004) suggest that regular repetition of key messages may weaken 
the barriers to changing behaviour. However, given the limited follow-up period (3-months) in 
most studies and lack of patient outcome data, neither the sustainability nor the effect on patient 
health outcomes can be predicted from this strategy when used alone. 
7.1.2. Key success factors of educational materials 
While the distribution of educational materials alone had limited impact on changing 
practitioners’ behaviour, evidence from the available research suggested that educational 
material was more likely to be used by the target audience when: 
The content was relevant to the practitioner and derived from a trustworthy  • 
and credible source
The information was clear, concise and persuasive• 
The format was appealing and easy to read• 
The message was repeated (reinforcement).• 
For example, improvement in practitioners’ prescribing was achieved using a series of concise, 
colourful 2-4 page bulletins, which were developed using input from relevant specialist working 
groups and comprised an easy-to-read question-answer format to provide clear messages 
(Dormuth et al., 2004). Messages contained in the letters targeted therapeutic issues that were 
identified as problematic by the working groups. 
The problem or clinical activity targeted by an intervention may also impact on the effectiveness 
of a strategy. For example, while distributing educational material was found to result in 
improvements in prescribing behaviour (Dormuth et al., 2004; Gill et al., 1999), there was limited 
or no impact on other areas of practice, such as management of depression (Gilbody et al., 
2003), or hypertension (Tu & Davis, 2002). It is possible that less complex activities associated 
with prescribing practice are more amenable to change via this mechanism compared to more 
demanding behaviours required in chronic disease management. 
7.1.3. Relevance to the AOD field
There was little evidence to support the use of educational materials alone to induce sustained 
changes in professional practice. Nevertheless, the value of distributing educational materials 
to the AOD field should not be underestimated and almost every dissemination strategy 
incorporates some form of educational materials. While distribution of educational materials 
alone was the least effective of a variety of education-based professional interventions  
designed to change doctors’ prescribing behaviour, 43% (3/7) of studies yielded a positive effect 
(Gill et al., 1999). Moreover, given that educational materials are easy to distribute in a wide 
variety of settings, and the production and implementation costs are relatively low compared  
to other more interactive and / or resource-intensive strategies, they should not be dismissed  
as ineffective. 
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7.2. Local Consensus Processes
Local consensus processes involved “the inclusion of participating providers in discussion 
to ensure that they agreed that the clinical problem was important and that the approach to 
managing the problem was appropriate” (EPOC, 2002). The most common, well-accepted 
and well-studied example of a dissemination and implementation strategy developed via local 
consensus processes is clinical practice guidelines (CPGs) 4. 
CPGs are defined as “systematically developed statements to assist practitioner decisions 
about appropriate health care for specific clinical circumstances” (Field & Lohr, 1990). However, 
‘systems’ used to develop statements vary widely and frequently rely on expert opinion 
and established practice patterns. More ‘systematic’ methods include the use of structured 
consensus statements by Delphi 5 or similar techniques (nominal group technique, iterated 
consensus rating) that facilitate development of consensus of opinion among a group of experts 
(Lomas, 1991). Evidence-based medicine, which emphasises clinical decision-making based 
on thorough evaluation of available research evidence, is often lacking in the development of 
CPGs. The basic protocol for the development of CPGs involves the following steps:
Clear definition of the clinical problem• 
A comprehensive review of the available evidence• 
Summary of the extracted data• 
Presentation of the data as outcome contingencies for decision-making• 
Clinical recommendations for practice (Canadian Taskforce on Preventative Health  • 
Care (CTFPHC), 1999). 
Many organised health care bodies (e.g., Diabetes Australia, Haemophilia Foundation of 
Australia, Royal College of Surgeons), general health care agencies (e.g., National Health and 
Medical Research Council, National Health Priorities Action Council), and specific drug and 
alcohol services (e.g., Drugs and Alcohol Services South Australia, Australian National Council 
on Drugs) develop and disseminate guidelines for specific disorders, problems and procedures. 
Although successful implementation of CPGs into practice has been shown to improve medical 
practice by improving the quality of care, decreasing inappropriate and ineffective practice, 
reducing overuse of health services, and lowering costs of delivering health services (Grimshaw 
et al., 1995), studies indicate that the extent to which practitioners incorporate CPGs into their 
clinical practice is often minimal (Karuza et al., 1995). The aim of disseminating CPGs is to 
increase awareness, understanding, and acceptance of a specific guideline and change the 
relevant clinical behaviours. 
Adequate dissemination is a prerequisite for successful implementation of CPGs and simple 
distribution does not guarantee their uptake and use. In order to turn knowledge into practice, 
other implementation strategies have been developed and used to disseminate and  
implement CPGS. 
Where additional tools or strategies have been used to enhance compliance with CPGs, such 
as opinion leaders (Gifford et al., 1999) or feedback (Eccles et al., 2001) the effectiveness 
of the strategies has been evaluated separately in subsequent sections of this report. 
Recent investigations have been undertaken into whether altering the format, or process of 
development, of standard, paper-based guidelines may increase the likelihood of successful 
dissemination and implementation.
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Materials’ section. Where they have been modified using local consensus processes and compared with 
standard guidelines, they have been evaluated in this section. 
5 The Delphi technique uses a systematic approach to develop criteria for the most appropriate medical 
procedures. Knowledge from the medical literature is combined with a systematic collation of multi-
disciplinary expert opinion.
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Two good quality randomised controlled trials (RCTs) (Baker et al., 2003; Butzlaff et al., 2004) 
and one poor quality RCT (Silagy et al., 2002), met the inclusion criteria for assessment of local 
consensus processes. Studies assessed whether modification of standard, paper-based CPGs 
increased practitioners’ adherence to guideline recommendations (Table 14). 
Table 14. Effectiveness of local consensus processes – Primary 
research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Primary health care 
provision
(Butzlaff et al., 2004) Level II: RCT 
Good quality
± NA
Disease prevention / 
management
(Baker et al., 2003) Level II: Cluster RCT 
Good quality
± § ±
(Silagy et al., 2002) Level II: Cluster RCT 
Poor quality
± NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; 
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control  
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures);  
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant;  
RCT = randomised controlled trial. 
7.2.1. How effective are local consensus processes?
The most common method of disseminating CPGs is via mass mailing to professional groups, 
even though evidence indicates that this is a less successful strategy for motivating behaviour 
change (Grimshaw et al., 2004). 
Overall, evidence from the better quality studies showed no statistically significant improvement 
in compliance with, or knowledge of, CPG recommendations when CPGs were modified. That 
is, neither a concise ‘prioritised’ format (with or without feedback) (Baker et al., 2003), nor an 
electronic version of CPGs (Butzlaff et al., 2004) was more effective in changing practitioners’ 
knowledge or behaviour compared to a full, paper version of CPGs. Baker et al. (2003) suggest 
that, although a more concise version of CPGs may have reduced the time physicians spent 
reading CPGs, it did not improve compliance with the CPG recommendations. Further, the 
inclusion of feedback had no additional benefit in achieving practitioners’ adherence to CPGs 
(Table 14 and Table 42, Appendix B) (see section 7.8. Audit and Feedback for more detail). 
In terms of improving patient outcomes, use of more concise CPGs resulted in overall better 
control of symptoms for angina, but the effects on symptoms for asthma were mixed in one 
study (Baker et al., 2003) (Table 14 and Table 43, Appendix B). Patient satisfaction with 
treatments for these conditions was unchanged by modifying CPGs. Patient satisfaction 
with medication for angina treatment was significantly reduced in groups where practitioners 
received review criteria, a concise version of CPGs with prioritised key recommendations for  
the majority of patients.
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7.2.2. Key success factors of local consensus processes
Based on the available evidence, modifying CPGs to suit the local environment, or to present 
them in an alternative format, failed to significantly improve practitioners’ adherence to CPG 
recommendations or impact significantly on patient health. From the practitioners’ perspective, 
although a brief version of CPGs reduced reading time, it did not induce more practitioners to 
use them. 
7.2.3. Relevance to the AOD field
All available studies were conducted in the primary health care setting with general practitioners 
as study participants. Studies tested the effectiveness of locally adapted CPGs versus standard 
national CPGs. The overall lack of effect and absence of testing in the AOD field make it difficult 
to predict how effective locally adapted CPGs may be for AOD professionals working in non-
clinical settings. It is possible that CPGs, which are developed in consultation with the end-users 
in the AOD field, may be more acceptable if additional strategies were used to promote their 
uptake. Participatory action research techniques 6 could be used to assess this hypothesis.
7.3. Educational Meetings (Continuing Medical Education)
Continuing Medical Education (CME) consists of educational activities that aim to maintain, 
develop, or increase the knowledge, skills, and professional performance of practitioners to 
provide services for patients, the public, or the profession (Accreditation Council for Continuing 
Medical Education). Examples of CME include educational conferences, meetings, seminars, 
workshops, lectures and symposia. CME formats, including distribution of educational materials, 
varied across studies in intensity (frequency and duration of sessions), complexity (didactic / 
interactive), and content (targeting specific disease, behaviour, or group). Typically, educational 
interventions were incorporated in most single interventions to some degree and were always 
included in multi-faceted interventions (see section 9.2. for more detail). 
The evidence base for specifically evaluating the effectiveness of CME comprised eight 
systematic reviews of 3-47 studies (Gilbody et al., 2003; Grimshaw et al., 2004; Hulscher et 
al., 2001; Lancaster et al., 2000; Renders et al., 2001; Thomson O’Brien et al., 2001; Tu & 
Davis, 2002; Weingarten et al., 2002) (Table 15) and 16 primary studies (Delvaux et al., 2004; 
Fallowfield et al., 2002; Fallowfield et al., 2003; Glazier et al., 2005; Katz et al., 2004; Kelly et 
al., 2000b; King et al., 2002; Mazmanian et al., 2001; Miller et al., 2004; Onion & Bartzokas, 
1998; Pill et al., 1998; Premaratne et al., 1999; Razavi et al., 2003; Santoso et al., 1996; Suggs 
et al., 1998; White et al., 2004; Young et al., 1998; Young & Ward, 2002) (Table 16). 
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audience to identify and address problems, initiate new research and evaluate outcomes. 
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Table 15. Educational meetings – Systematic reviews summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Disease 
management
(Tu & Davis, 2002) Level I: poor quality SR 
5 RCTs d
NS NS
Disease 
management
(Gilbody et al., 2003) Level II: good quality SR 
6 poor-average quality 
controlled studies
NS NS
Disease 
management (2)
Diagnosis (1)
(Grimshaw et al., 2004) Level II: good quality SR 
3 poor-average quality 
controlled studies
NS § NS
Preventive care (Hulscher et al., 2001) Level II: good quality SR 
5 poor-average quality 
controlled studies
+ in 4/5 
studies §
NA
Preventive care 
Prescribing 
Disease 
management
(Thomson O’Brien et al., 
2001)
Level II: good quality SR 
32 poor- average quality 
controlled studies
+ in 24/32 
studies §
+ in 3/8 
studies §
Disease 
management
(Renders et al., 2001) Level II: good quality SR 
13 poor-average quality 
controlled studies
± overall 
+ in 5/13 
studies §
± overall 
+ in 5/13 
studies §
Disease 
management 
Adherence to 
guidelines
(Weingarten et al., 2002) Level II: average quality SR 
47 poor-average quality 
controlled studies
+ in 12/24 
studies §
+ in 12/32 
studies §
Prevention (Lancaster et al., 2000) Level II: poor quality SR  
10 average-good quality 
RCTs
+ in 9/10 
studies
NS in 6/8 
studies
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures 
of implementation of an intervention, such as assessment of participation, compliance and efficiency; 
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life;d Study quality not assessed; + indicates intervention was significantly 
more effective than control or usual care; ± indicates mixed effects (significant change in some, but not 
all outcome measures); § = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not 
significant; RCT = randomised controlled trial; SR = systematic review. 
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Table 16. Effectiveness of educational meetings (CME) – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Drug prescribing / 
test-ordering / referral
(Santoso et al., 1996) Level III-1: Quasi-RCT 
Average quality
± NA
(Suggs et al., 1998) Level III-3: CBA design 
Average quality
± NA
Preventive care (Katz et al., 2004) Level II: Cluster RCT 
Good quality
+ ±
(Kelly et al., 2000b) Level II: Cluster RCT 
Poor quality
+ NA
(Young et al., 1998; 
Young & Ward, 2002)
Level III-1: Quasi-RCT 
Average quality
± NA
Counselling / 
communication skills
(Miller et al., 2004) Level III-1: Quasi-RCT 
Good quality
+ NA
(Fallowfield et al., 2003) Level III-1: Quasi-RCT 
Average quality
+ NA
(Razavi et al., 2003) Level III-1: Quasi-RCT 
Average quality
NS ±
Disease / pain 
management
(Pill et al., 1998) Level II: RCT 
Good quality
± not 
sustained
± not 
sustained
(King et al., 2002) Level II: Cluster RCT 
Average quality
NS NS
(Premaratne et al., 1999) Level II: RCT 
Good quality
± NS
(Fallowfield et al., 2002) Level III-1: Quasi-RCT 
Average quality
± NA
(Delvaux et al., 2004) Level III-1: Quasi-RCT 
Average quality
NS ±
(Glazier et al., 2005) Level III-3: CBA design 
Average quality
± NA
General practice (Mazmanian et 
al., 2001)
Level III-1: Quasi-RCT 
Average / poor quality
± NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control or 
usual care; ± indicates mixed effects (significant change in some, but not all outcome measures);  
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT =  
randomised controlled trial. Data for two studies were not extracted as baseline scores were not  
reported or adjusted for (Onion & Bartzokas, 1998; White et al., 2004), therefore relative change could  
not be determined.
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7.3.1. How effective are educational meetings (CME)?
Overall, the better quality studies included in systematic reviews showed small to moderate 
effects of CME, particularly where baseline scores were low (Hulscher et al., 2001; Thomson 
O’Brien et al., 2001). Similar results were reported in more recent primary studies. For example, 
using regression analysis to model and determine the magnitude of the relationship between 
variables, one quasi-RCT revealed that practitioners benefited most from an educational 
intervention if they had poorer knowledge or skills at baseline (Delvaux et al., 2004) and those 
attaining a high score pre-intervention also scored highly post-intervention (White et al., 2004) 7.
Compared to no-intervention controls, 75% of studies included in one systematic review 
(Thomson O’Brien et al., 2001) reported improvement in professional practice and 38% showed 
improvement in patient outcomes. Thomson O’Brien et al. (2001) also reported that educational 
strategies containing interactive elements showed small to moderate improvements while those 
that were primarily didactic had no significant effect. 
Hulscher et al. (2001) reported mixed effects in studies that used group sessions, with 
improvements ranging between 11% and 194%. By comparison, studies that used  
individual sessions showed small to moderate effect sizes, with improvements varying  
between 7% and 21%. These results were consistent with findings from primary research 
(Santoso et al., 1996). Table 44 and Table 45 (Appendix B) provide results for process and 
patient outcomes, respectively. 
Educational meetings produced improvements in drug prescribing (Santoso et al., 1996; Suggs 
et al., 1998; Thomson O’Brien et al., 2001), preventive care (Hulscher et al., 2001; Katz et al., 
2004; Kelly et al., 2000b; Lancaster et al., 2000) and disease management (Renders et al., 
2001; Thomson O’Brien et al., 2001; Weingarten et al., 2002). In addition, health care providers’ 
counselling and communication skills (Miller et al., 2004) were improved significantly with CME 
(Table 16 and Table 44, Appendix B). 
One study showed that including an additional element (telephone consultation) significantly 
increased the effectiveness of the intervention (Kelly, Sogolow, & Neumann, 2000a). In that 
study, it was found that a larger proportion of AIDs Service Organisations offered a  
research-based intervention to clients when their training workshop was followed up with a 
telephone consultation.
Of the few studies that measured patient effects, there was significant improvement in smoking 
cessation in one study (Katz et al., 2004), whereas others showed mixed effects, with small 
improvements in some outcomes, or no significant changes compared to controls (Table 45, 
Appendix B). 
The presence of potential ceiling effects resulting from practitioners’ self-selecting to participate 
in the educational intervention was a limiting factor in many studies. Study practitioners who 
volunteered to participate typically displayed above average levels of care or enthusiasm to 
improve, leaving little scope for further development or improved practice change (White et  
al., 2004).
The short follow-up period across most studies made it difficult to determine the sustainability of 
an intervention’s effect. Post-intervention measures taken immediately following implementation 
of an intervention may merely assess immediate recall of knowledge as opposed to sustained 
learning / attainment of knowledge, and thus be less likely to reflect long-term behaviour 
change. A longer follow-up period may be needed to determine retention of additional skills and 
knowledge and sustained behaviour change. For example, a follow-up study that measured 
outcomes 12 months post-intervention revealed evidence of sustained improvement in 
communication skills (Fallowfield et al., 2003). 
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difficult to determine true differences between groups.
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7.3.2. Key success factors of educational meetings (CME)
The highly variable results shown in the available studies examining the effectiveness of 
educational meetings may reflect the heterogeneity of the studies, particularly in the intensity 
and complexity of interventions, the mode of delivery, and the characteristics of the setting and 
target behaviour. 
Intensity of interventions ranged from a single 10-15 minute session to a 1-2 day workshop, 
to multiple hour-long sessions over an extended period. Similarly, the intervention delivery 
mode varied from passive, didactic formats of lectures and seminars to highly interactive group 
discussions and workshops. 
Evidence from the better quality studies indicates that educational meetings were more effective 
when they contained the following elements:
More interactive (less didactic) or personalised format•  (e.g., small groups,  
face-to-face sessions)
Simple (less complex) content• , which requires smaller magnitude of change  
(e.g., drug dosage and prescribing vs multiple recommendations with complex clinical 
decision-making)
More focused on a specific problem•  (tailored or personalised rather than generic)
Additional interventions•  (e.g., follow-up telephone consultation) or incentives (e.g., 
feedback on performance, CME points 8)
Motivated practitioners•  (self-selected practitioners may be more motivated to change).
As noted in section 7.1.2. above (see educational materials), the content / materials presented 
in CME should be appealing and readily-digestible, derived from a credible source, and contain 
content relevant to the health care provider.
A central tenet of effective training (and other forms of professional development gained through 
educational meetings) is health care providers’ capacity to apply newly developed knowledge 
and skills to their current practice. Educational interventions that require only modest time, 
financial or staff resource commitments may be more likely to influence the implementation of 
best practice by health care providers working in a ‘patient-rich, time-poor’ environment.
It is important to note that the duration of effect, or decay over time has not been adequately 
assessed to determine the sustainability of change attributed to the use of CME.
7.3.3. Relevance to the AOD field
Educational meetings were effective in both treatment and preventive care in AOD-related 
health care settings. A tutorial plus feedback delivered in a community setting improved 
practitioners’ adoption of guidelines for smoking cessation and resulted in improvements in the 
delivery of smoking cessation advice and nicotine replacement therapy (process outcomes) and 
higher abstinence among smokers (patient outcomes) (Katz et al., 2004). Similarly, a distance 
learning module used in a family practice (clinic) setting, improved the delivery of smoking 
cessation advice to patients (Young & Ward, 2002). Distance learning may be an effective 
option for health care providers who deliver AOD-related care in rural and remote locations. 
Workshops were also found to be an effective strategy. For example, workshops enhanced with 
a range of additional strategies, including feedback and coaching sessions, increased health 
care providers’ proficiency in motivational interviewing techniques for managing the care of 
patients / clients with AOD-related issues (Miller et al., 2004).
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current standards of their profession. Most health care professionals are required to satisfy criteria for 
CME points to retain registration in their practice.
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7.4. Educational Outreach Visits (Academic Detailing)
Educational outreach, also termed academic detailing, involves enlisting a change agent, such 
as a trained health educator or specialist, to visit health care providers in their own setting 
and deliver evidence-based information sessions about a well-defined intervention or clinical 
practice guideline. Outreach sessions vary considerably across different interventions. Typically, 
physicians or pharmacists, who have undertaken training in communication and behaviour 
modification techniques, provide a brief face-to-face education and feedback session with the 
purpose of motivating improvements in practice. Outreach visits may also involve reduction of 
administrative barriers by streamlining procedures in the office setting or using practice-enabling 
techniques, such as role-play to develop specific skills. 
Five systematic reviews containing 1-18 studies (Anderson & Jane-Llopis, 2004; Gilbody et al., 
2003; Gill et al., 1999; Thomson O’Brien et al., 2000a; Tu & Davis, 2002) (Table 17), and 13 
primary studies (Bernal-Delgado et al., 2002; Cranney et al., 1999; Crotty et al., 2004; Dey et 
al., 2004; Finkelstein et al., 2001; Goldstein et al., 2003; Hall et al., 2001; Majumdar et al., 2003; 
New et al., 2004; Solomon et al., 2001; Watson et al., 2001; Watson et al., 2002; Weller et al., 
2003) (Table 18) assessed the effectiveness of outreach visits.
Table 17. Effectiveness of educational outreach visits – Systematic reviews summary
Research area References Level and quality of evidence a Process outcomes
 b Patient 
outcomes c
Disease 
management
(Tu & Davis, 
2002)
Level I: poor quality SR  
1 RCT d
NS NS
Disease 
management
(Gilbody et al., 
2003)
Level II: good quality SR 
3 poor-average quality 
controlled studies
+ NS
Prescribing (Gill et al., 1999) Level II: good quality SR 
4 average-good quality 
RCTs
+ in 2/4 studies § NA
Prescribing (13) 
Preventive care (3) 
Disease 
management (2)
(Thomson 
O’Brien et al., 
2000a)
Level I: good quality SR 
18 poor-average quality 
RCTs
+ in 16/18 studies § NA
Preventive care (Anderson & 
Jane-Llopis, 
2004; Anderson 
et al., 2004)
Level II: good quality SR 
8 average quality 
controlled studies
+ Studies with 
outreach were 
significantly more 
effective in changing 
practitioners’ 
behaviour compared 
to those without an 
outreach intervention
+
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; d quality not assessed; + indicates intervention was significantly more 
effective than control or usual care; ± indicates mixed effects (significant change in some, but not all 
outcome measures); § = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not 
significant; RCT = randomised controlled trial; SR = systematic review. 
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Table 18. Effectiveness of educational outreach visits – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Drug prescribing / 
test-ordering
(Watson et al., 2001; 
Watson et al., 2002)
Level II: cluster RCT 
Good quality
NS NA
(Weller et al., 2003) Level II: RCT 
Good quality
+ short-term 
only
NA
(Finkelstein et al., 
2001)
Level III-1: Quasi RCT 
Average quality
+ NA
(Hall et al., 2001) Level II: RCT 
Average quality
NS NA
(Solomon et al., 2001) Level III-1: Quasi RCT 
Average / poor quality
± NA
Preventive care (Crotty et al., 2004) Level II: RCT 
Good / average quality
NS NS
(Goldstein et al., 2003) Level III-1: Quasi experimental 
Average quality
NS NS
Disease / pain 
management
(Cranney et al., 1999) Level II: Cluster RCT 
Good quality
+ NA
(Dey et al., 2004) Level II: RCT 
Good quality
NS NA
(Majumdar et al., 2003) Level III-3: CBA design 
Good quality
± ±
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; 
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; CBA = controlled before and after study; NA = not 
assessed; NS = not significant; RCT = randomised controlled trial. 
7.4.1. Effectiveness of educational outreach visits
In general, educational outreach visits were effective for improving professional practice in a 
range of different settings. Overall effect sizes were moderate-large, with 24-50% improvement 
(p<0.05) reported in studies that demonstrated benefit (Thomson O’Brien et al., 2000a). 
Evidence from both systematic reviews and primary research indicated that educational 
outreach visits produced improvements in practitioner behaviour (process outcomes) in 
prescribing / test-ordering, delivery of preventive care and disease management (Cranney et 
al., 1999; Finkelstein et al., 2001; Gilbody et al., 2003; Gill et al., 1999; Solomon et al., 2001; 
Thomson O’Brien et al., 2000a; Weller et al., 2003). Table 46 and Table 47 (Appendix B) provide 
data for process and patient outcomes, respectively.
In contrast, two RCTs reported no statistically significant improvement in appropriateness of 
prescribing when used in a community pharmacy setting (Hall et al., 2001; Watson et al., 2002). 
However, a possible ceiling effect may have masked potential improvements in these studies. 
Similarly, educational outreach visits did not significantly improve preventive care (falls reduction 
and stroke prevention) or pain management in two studies (Crotty et al., 2004; Dey et al., 2004). 
Few studies have assessed the impact of outreach visits on patient outcomes, and those that 
did generally failed to provide clinical benefit. However, one study of a travelling diabetes 
management program (Majumdar et al., 2003) showed that outreach visits to rural regions (US) 
improved patients’ blood pressure as well as their satisfaction with the care provided, but did not 
significantly improve patients’ cholesterol or blood sugar levels.
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The sustainability of the intervention effect was uncertain due to limited follow-up periods in the 
studies. For example, the improvement in test-ordering rates that was evident 6-months post-
intervention (Weller et al., 2003) was not sustained at 12-months follow-up, suggesting a decay 
effect of the intervention. Other primary studies that demonstrated positive effects of outreach 
visits on prescribing behaviour (Finkelstein et al., 2001; Solomon et al., 2001) failed to report the 
period of follow-up.
Data were not extracted for two studies (Bernal-Delgado et al., 2002; New et al., 2004) as 
baseline data were not reported or not adjusted for.
7.4.2. Key success factors of educational outreach visits 
Although educational outreach visits varied across studies, several attributes were identified that 
may increase their likelihood of success, including:
Interactive format,•  with active participation by practitioners, particularly for more  
complex topic areas
Use of specialist educators•  with credibility in the topic area
Use of additional strategies,•  such as feedback or follow-up support (Cranney et al., 
1999; Finkelstein et al., 2001; Solomon et al., 2001; Weller et al., 2003)
Targeting a defined group of professionals• 
Having clear educational and behavioural objectives• 
Assessing and addressing barriers to change• 
Identifying and repeating essential messages• 
Positively reinforcing messages in follow-up visits.• 
In addition, materials provided to the target audience should contain clear, simple messages, 
and include concise, graphic educational material (see section 7.1.2., Educational Materials). 
7.4.3. Relevance to the AOD field
Evidence from one study that examined the effectiveness of outreach visits in an AOD setting 
showed that outreach visits had no influence on practitioners’ counselling for smoking cessation 
(as reported by patients) (p=0.057) and minimal effect on patient quit rates (p=0.008) (Goldstein 
et al., 2003). However, results may have been influenced by a strong secular trend in smoking 
cessation rates shown in the control group due to a number of factors that occurred during 
the study period. These factors, which are likely to have motivated physicians to change their 
behaviour, include academic detailing of physicians by pharmaceutical companies  
marketing nicotine patches, annual assessment of smoking cessation counselling rates in 
control practices, and self-nomination of participants, who are likely to be more motivated to 
change behaviour. 
Educational outreach visits, which were effective for drug prescribing, test ordering and disease 
management, may be useful in the AOD field for a range of AOD-related activities, including 
encouraging practitioners to:
Prescribe pharmacotherapies appropriately• 
Provide AOD education and counselling• 
Screen for AOD use or depression• 
Monitor pharmacotherapy treatment• 
Manage AOD-related illness and depression.• 
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7.5. Local Opinion Leaders (including Product Champions)
Local opinion leaders, including ‘product champions’ and ‘peer leaders’ are health professionals 
identified by their colleagues in the community as ‘educationally influential’. Hiss et al. (1978) 
defined the opinion leader as one who: 
1) is recognised by his / her own community as an expert in their field (expertise)
2) is more likely than others to facilitate flow of new information (current knowledge)
3) has well developed interpersonal skills. 
The rationale behind the use of opinion leaders as an educational strategy is that new 
information will be integrated more efficiently into practice if a respected peer trains a 
practitioner, particularly when the opinion leader has been selected by the practitioner.
One good quality systematic review (Thomson O’Brien et al., 2000b) of 8 studies (Table 19), 
and two good quality RCTs (Finkelstein et al., 2005; Gifford et al., 1999) (Table 20) assessed  
the effectiveness of local opinion leaders or product champions (peer leaders) to change 
practice behaviour. 
Table 19. Effectiveness of local opinion leaders – Systematic reviews summary
Research area References Level and quality of  evidence a
Process 
outcomes b
Patient 
outcomes c
Adherence to 
guidelines
(Thomson O’Brien et 
al., 2000b)
Level I: good quality SR 
8 poor-average quality RCTs
+ in 2/8 
studies §
NS
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial; SR = systematic review. 
Table 20. Effectiveness of opinion leaders – Primary research summary
Research area References Level and quality of evidencea Process outcomesb
Patient 
outcomesc
Referral (Gifford et al., 1999) Level II: RCT Good quality ± NA
Medication 
dispensing
(Finkelstein et al., 
2005)
Level II: Cluster RCT Good 
quality
NS NS
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control or 
usual care; ± indicates mixed effects (significant change in some, but not all outcome measures);  
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant;  
RCT = randomised controlled trial. 
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7.5.1. Effectiveness of opinion leaders
Overall the evidence was mixed. Effectiveness of opinion leaders varied from not significant 
to small-modest effects in some process outcomes in the better quality studies. Patient 
outcomes were similar in both control and intervention groups. Thomson O’Brien et al. (2000) 
reported some improvement in at least one outcome in most studies, but statistically significant 
improvement in only two (of eight) trials, with small-modest effect sizes (i.e., <10% improvement 
in adherence to recommended practice). Two studies in Thomson O’Brien et al. (2000) reported 
that opinion leaders were more effective than audit and feedback at changing practice.
While use of opinion leaders had no significant impact on practitioners’ adherence to asthma 
guidelines (Finkelstein et al., 2005), there was improved adherence to three of six guideline 
recommendations for managing dementia (Gifford et al., 1999; Holloway, Gifford, Frankel, & 
Vickrey, 1999), where the guidelines related to procedural or referral clinical actions (Table 
48, Appendix B). In contrast, there was no effect on adherence to recommendations that 
pertained to testing, diagnosis or treatment. However, it is worth noting that adherence to two 
of the recommendations that showed no statistically significant change, were high at baseline 
indicating a potential ceiling effect that was likely to limit any scope for further improvement. 
Overall, patient outcomes were not significantly improved with the use of local opinion leaders 
(Table 49, Appendix B).
Most studies lacked information on how opinion leaders were identified and selected (Thomson 
O’Brien et al., 2000b), making it difficult to determine whether they were appropriate and 
comparable across studies. By comparison, one good quality RCT (Holloway et al., 1999) 
provided comprehensive details of the recruitment process for 12 local opinion leaders used 
as part of a multifaceted educational program to improve practitioners’ adoption of practice 
guidelines (Gifford et al., 1999). An overview of the opinion leader’s active involvement in 
the intervention, including membership on an expert advisory panel, review of the practice 
guidelines being implemented, and involvement in educational seminars was provided. Logistic 
regression was used to adjust for differences between opinion leaders in different geographical 
regions (Table 48, Appendix B). Evidence from Gifford et al. (1999) indicates some potential for 
benefit derived from using opinion leaders to change professional practice, notably in procedural 
and referral areas of clinical practice; while opinion leaders did not improve medication 
dispensing (Finkelstein et al., 2005) (Table 20).
7.5.2. Key success factors of local opinion leaders
Since the evidence assessed here is sparse and shows equivocal results, it is difficult to 
determine which factors may increase the likelihood of this strategy’s success. Most studies 
lacked detail of the characteristics, recruitment methods and role of opinion leaders (Thomson 
O’Brien et al., 2000b). However, Gifford et al. (1999) outlined various aspects of using opinion 
leaders which may increase their effectiveness. These include:
Process of identification and selection of opinion leaders. • Opinion leaders are more likely 
to be effective, respected peer educators if the population of clinicians whom they are to 
serve selects them.
Role and activities of the opinion leaders.•  Involving the opinion leader, as a recognised 
trusted source of information, in the review and development of the innovation (e.g., 
training) to be disseminated may ensure sustained commitment from the opinion leader, 
and therefore a greater likelihood of success from use of the strategy. 
7.5.3. Relevance to the AOD field
Evidence that opinion leaders may change professional practice was shown in some clinical 
actions (such as referral) that may be relevant to practitioners in the AOD field. 
One study undertaken in the AOD field that explored the characteristics of opinion leaders in 
substance abuse treatment agencies was useful for descriptive purposes, but did not meet 
the inclusion criteria for evaluation of effectiveness (Moore et al., 2004). Moore et al. (2004) 
reported that peer co-workers were identified as “a key source of information related to 
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treatment approaches for co-occurring mental health and substance abuse disorders and for 
substance use treatment in general”. Information sourced from peers was used more frequently 
and valued more highly than other sources of information, such as books, websites and  
external staff / consultants. Compared to their colleagues, peer co-workers identified as opinion 
leaders had:
Significantly more work experience in a specific field (e.g., mental health)• 
More postgraduate education• 
More confidence and willingness to work with problem clients (e.g., comorbidities)• 
Greater knowledge of diagnosis and treatment of clients with comorbidities. • 
Importantly, Moore et al. (2004) reported that more than 50% of opinion leaders were not  
formal supervisors and, as such, represented an underutilised credible resource within 
treatment agencies. 
7.6. Patient-Mediated Interventions
Patient-mediated, or patient-directed, interventions involve any information given to or received 
from patients, which is intended to influence professional practice. Examples of patient-
mediated interventions include patient education concerning a specific disease or condition, or 
patient-specific preventive care information in the form of leaflets, brochures, reminder letters, 
postcards and telephone calls (e.g., appointments or screening tests).
Three average-good quality systematic reviews of 7-16 studies (Gill et al., 1999; Grimshaw et 
al., 2004; Weingarten et al., 2002) assessed the effectiveness of patient-mediated interventions 
(Table 21). One additional primary study (Thapar et al., 2002) evaluated the effectiveness of a 
patient-held reminder card for epilepsy management (Table 22).
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Table 21. Effectiveness of patient-mediated interventions – Systematic reviews summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Preventive care & 
prescribing (5) 
Disease management (2)
(Grimshaw et al., 
2004)
Level II: good quality SR 
7 average quality studies
+ in 4/7 
studies §
NS
Prescribing (Gill et al., 1999) Level II: good quality SR 
8 average-good quality 
RCTs
+ in 5/8 
studies §
NA
Disease management (Weingarten et al., 
2002)
Level II: average  
quality SR  
16 average quality 
controlled studies
NA + in 6/16 
studies 
Small effect 
size
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; 
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); § = 
potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = randomised 
controlled trial; SR = systematic review.
Table 22. Effectiveness of patient-mediated interventions – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Disease management (Thapar et al., 2002) Level II: good quality RCT NS ±
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; 
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); § = 
potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = randomised 
controlled trial. 
7.6.1. How effective are patient-mediated interventions?
All studies contained in existing reviews observed improvements in the process of care, with 
moderate-large effects in cluster RCTs (21%, [95% confidence intervals 10.0, 25.4]) in one 
SR (Grimshaw et al., 2004); and 63% of studies in the other showing statistically significant 
improvements (Gill et al., 1999). In particular, patient-mediated interventions were effective for 
improving screening and vaccination rates. However, all cluster RCTs had potential unit of analysis 
errors, which may overestimate effects. 
Results from an additional RCT showed that practitioner behaviour was not influenced when 
patients held a reminder card for management of epilepsy care. Overall, patient outcomes were 
mixed, with non-significant or small effects on disease control. 
Data extracted from Thapar et al. (2002) are provided in Table 50 and Table 51 (Appendix B).
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7.6.2. Key success factors of patient mediated interventions
There were few evaluations of patient-directed interventions that met the selection criteria 
and all cluster RCTs contained potential unit of analysis errors. Therefore, evidence on the 
effectiveness of this strategy is not robust. However, factors that may contribute to 
effectiveness include:
Obligatory response•  – practitioners cannot ignore a patient’s direct request or question 
about their treatment, thereby compelling the practitioner to take action or justify why 
action is not needed
Simple content•  – small change required
Relevant and patient-specific.• 
7.6.3. Relevance to the AOD field
Patient-mediated interventions may be effective for delivering preventive care services in 
the AOD field and for prescribing medication (e.g., depression and AOD-related disorders or 
pharmacotherapy). AOD-related information disseminated to clients may encourage them to 
discuss the information with their practitioner where it pertains to their circumstances. 
7.7. Prompts and Reminders (including Decision Support)
A reminder (computerised or manual) is any intervention that provides an evidence-based 
summary of key clinical information to aid decision-making and to prompt the health care 
professional or practitioner to perform a clinical action or to record key information for 
effective client / patient management. Examples include concurrent or inter-visit reminders to 
health care professionals about recommended actions, including screening, chronic disease 
management, counselling or other preventive services, appropriate laboratory tests or enhanced 
administrative support (e.g., paper-based reminder messages attached to reports or in medical 
records, computerised decision support prompts incorporated in patient electronic records). 
Every visit to a practitioner is viewed as an opportunity to promote good health maintenance, 
such as immunising a child (Shaw et al., 2000) or performing a mammography when the 
records indicate they are due (Goldberg et al., 2000). 
Decision support systems are included in this intervention group as they serve a similar  
function by providing practitioners with key clinical information on which evidence-based 
decisions may be based. Decision support systems, which are often based on protocols or 
CPGs, may be computerised or manual, and are aimed at assisting the health care provider to 
make health-related decisions. The growing sophistication of computer hardware and software 
enables the information technology field to play a key role in decision-making for health care 
providers, including:
Matching evidence-based medical knowledge accessed from large databases to  • 
patient-specific information stored in electronic medical records
Performing complex evaluations• 
Calculating drug dosages• 
Generating reminders for a variety of preventive health care messages. • 
Eleven systematic reviews of 2-100 studies (Balas et al., 2000; Bennett & Glasziou, 2003;  
Garg et al., 2005; Grimshaw et al., 2004; Harvey et al., 2002; Hulscher et al., 2001; Hunt 
et al., 1998; Shiffman et al., 1999; Tu & Davis, 2002; Walton et al., 2001; Weingarten et al., 
2002) (Table 23) and 12 additional primary studies (Bahrami et al., 2004; Frances et al., 2001; 
Goldberg et al., 1991; Goldberg et al., 2000; McMullin et al., 2004; Murtaugh et al., 2005; 
Ramsay et al., 2003; Sanders & Satyvavolu, 2002; Shaw et al., 2000; Thapar et al., 2002; 
Tierney et al., 2005; Toth-Pal et al., 2004) (Table 24) evaluated the effectiveness of prompts, 
reminders and decision support.
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Table 23. Effectiveness of prompts and reminders – Systematic reviews summary
Research area References Level and quality of evidence a
Process  
outcomes b
Patient  
outcomes c
Prescribing (Walton et 
al., 2001)
Level I: good quality SR 
15 average-good quality 
RCTs
+ in 5/15 studies § + in 5/13 studies §
Preventive care (Balas et al., 
2000)
Level I: average quality SR 
33 average quality RCTs
+ in 26/33 studies § NA
Prescribing (Bennett & 
Glasziou, 
2003)
Level I: average quality SR 
17 good quality RCTs
+ in 7/17 studies § NA
Disease 
management
(Tu & Davis, 
2002)
Level I: poor quality SR 
3 RCTsd
+ in 3/3 studies §
Preventive care (21) 
Prescribing (29) 
Disease 
management (40)
Diagnosis (10)
(Garg et al., 
2005)
Level II: good quality SR 
100 average – good quality 
controlled studies
+ in 58/100 studies § 
Preventive care: 16/21
Prescribing: 15/24 
Disease mgt: 23/37 
Diagnosis: 4/10
+ in 9/38 studies § 
Preventive Care: 0/1
Prescribing: 4/5 
Disease mgt: 5/27 
Diagnosis: 0/5
Preventive care (17)
Prescribing (5)
Disease 
management (15)
Diagnosis (1)
(Grimshaw 
et al., 2004)
Level II: good quality  
SR 38 average quality 
controlled studies
+ in 24/38 studies §
Moderate effect size
NS (4)
Disease 
management
(Harvey et 
al., 2002)
Level II: good quality SR 
2 average quality cluster RCTs
+ in 2/2 § + in 1/2 §
Preventive care (Hulscher et 
al., 2001)
Level II: good quality SR 
11 poor-average quality 
controlled studies
+ in 9/11 studies § NA
Preventive care (19)
Prescribing (15)
Disease 
management (26)
Diagnosis (5)
(Hunt et al., 
1998)
Level II: good quality SR 
68 average-good quality 
controlled studies
+ in 43/65 studies §
Preventive care: 14/19 
Prescribing: 9/15 
Disease mgt: 19/26 
Diagnosis: 1/5
+ in 6/14 studies §
Disease 
management
(Weingarten 
et al., 2002)
Level II: average quality SR 
19 average quality 
controlled studies
+ in 6/10 studies § 
Moderate effect size
+ in 6/14 studies §
Small effect size
Preventive care (7)
Disease 
management (13)
(Shiffman et 
al., 1999)
Level II: poor quality SR 
25 average quality 
controlled studies
+ in 15/25 studies § + in 3/8 studies §
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; d quality not assessed; + indicates intervention was significantly more 
effective than control or usual care; ± indicates mixed effects (significant change in some, but not all 
outcome measures); § = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not 
significant; RCT = randomised controlled trial; SR = systematic review.
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Table 24. Effectiveness of prompts and reminders – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Preventive care (Shaw et al., 2000) Level II: RCT 
Good quality
NS NA
(Goldberg et al., 1991) Level III-1: Quasi-RCT 
Average quality
+ alcoholism 
screening rates
NS
(Goldberg et al., 2000) Level III-2 
Good quality
+ mammogram 
NS - faecal occult 
blood; cholesterol
NA
(Toth-Pal et al., 2004) Level III-2: non-RCT 
Poor quality
+ screening rates 
(e.g., diabetes, 
hypertension)
NA
Disease 
management
(Frances et al., 2001) Level II: RCT 
Average quality
NS NA
(Thapar et al., 2002) Level II: RCT 
Good quality
± ±
(Goldberg et al., 1991) Level III-1: Quasi-RCT 
Average quality
± NA
(Murtaugh et al., 2005) Level III-1: Quasi-RCT 
Average quality
± NA
Adherence to 
guidelines
(Bahrami et al., 2004) Level II: RCT 
Good quality
NS NS
(Ramsay et al., 2003) Level II: RCT 
Good quality
+ NS
(Tierney et al., 2005) Level II: RCT 
Poor quality
NS NS
Drug dosing / 
prescribing 
and medication 
management
(Frances et al., 2001) Level II: RCT  
Average quality
NS NS
(Sanders &  
Satyvavolu, 2002)
Level II: RCT  
Average quality
NS NS
(McMullin et al., 2004) Level III-2: Cohort study 
Average quality
± NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; 
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial. 
7.7.1. How effective are prompts and reminders?
In general, results from the best available evidence showed mixed effects for  
prompts and reminders for both process and patient measures (Table 52 and Table 53, 
Appendix B). Among the different research areas, reminders were most effective for preventive 
care across a variety of clinical settings. In other areas, results were mixed (e.g., prescribing, 
disease management and adherence to guidelines), with improvement in some outcomes and 
no significant difference compared to controls in others.
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Most good quality studies in the existing reviews showed significant improvement in process 
outcomes in several research areas. Reminders were most effective for delivering key 
messages for: 
Preventive care, with approximately 75% of studies demonstrating significant • 
improvement (Balas et al., 2000; Garg et al., 2005; Grimshaw et al., 2004; Hulscher et 
al., 2001; Hunt et al., 1998)
Drug dosing and prescribing, with 35-60% of studies showing improvement  • 
(Bennett & Glasziou, 2003; Garg et al., 2005; Grimshaw et al., 2004; Hunt et al., 
1998; Walton et al., 2001)
Disease management, with over 70% of studies showing improvement (Balas et al., • 
2000; Garg et al., 2005; Hunt et al., 1998). 
In contrast, less than 20% of studies demonstrated improvements in diagnostic practice (Garg 
et al., 2005; Hunt et al., 1998). 
Effect size varied across studies, with most reporting moderate to large effects for process 
outcomes in drug dosing, prescribing, referrals, preventive care and knowledge of practice 
guidelines, while patient outcomes showed mixed or non-significant effects. 
Few studies measured patient outcomes, such as improved health status or patient compliance 
with medication and medical advice. Of the studies that did, only 13% documented significant 
improvements (Garg et al., 2005). 
The better quality additional primary studies revealed statistically significant improvement 
in radiology referrals by GPs (i.e., referrals reduced) with the use of educational reminder 
messages (this effect was sustained at the same level from inception throughout the 
intervention period) (Ramsay et al., 2003). Similarly, the quality of care for patients with 
epilepsy improved when a reminder card was completed by the practitioner (Thapar et al., 
2002). In contrast, prompts and reminders had no significant effect on practitioner behaviour in 
administering routine preventive procedures, such as vaccinations, and no effect on improving 
knowledge of (as opposed to adherence to) clinical guidelines (Shaw et al., 2000). 
Improvements in practitioner adherence to practice guidelines and disease management 
were found for some outcomes, but not consistently across clinical settings. For example, 
uncomfortable or inconvenient procedures, such as sigmoidoscopy, were performed at lower 
rates compared to those which were less invasive (Balas et al., 2000). A decision support 
system in the form of a computer aided learning (CAL) package was unsuccessful in improving 
compliance with a dental treatment guideline, despite being specifically developed for the target 
group (Bahrami et al., 2004). Further, the CAL package was no more successful than a simple 
mailout of the guideline with opportunity to attend an education course. However, as pre-
intervention guideline compliance was high (ceiling effect), this result should be interpreted  
with caution.
Although most prompts were delivered prior to decision-making, those generated directly 
following a clinical decision also demonstrated some effect (Ramsay et al., 2003). In addition, 
different modes for generating or presenting prompts (tagged medical records or computer 
display) were equally effective in improving practice (Balas et al., 2000). Therefore, the 
effectiveness of prompts and reminders was not dependent on narrow time frames or  
specific modalities. 
Decision support systems may also have a positive effect on practitioners’ assessment of 
a health issue and identification of appropriate management for the identified health risk 
or condition, such as alcohol screening instruments to improve rates of patient referral to 
counselling (Goldberg et al., 1991).
Data were not extracted for one poor quality RCT (Tierney et al., 2005) as, although baseline 
scores were taken, they were not reported as being similar or adjusted for, making it difficult to 
ascertain the true effect of the intervention. 
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7.7.2. Key success factors of prompts and reminders (including decision support)
The studies that provided the evidence base for prompts and reminders were highly 
heterogeneous, both in quality and content (e.g., population, setting, design). However, several 
elements emerged that may enhance the strategy’s success, including: 
Ease of use.•  Strategies should be incorporated into existing systems and response to a 
prompt (accept or reject suggested course of action) should involve minimal input from 
the practitioner or patient (McMullin et al., 2004).
Clear and simple messages.•  Providers complied more readily with simple prompts for 
drug prescribing / dosing and preventive care services compared to more complex 
clinical decision-making for disease management or diagnosis. Educational reminder 
messages may be an easy-to-deliver response to information overload.
Relevant to practitioner’s needs. • Context-specific prompts can shift practice directions to 
more evidence-based care (Shiffman et al., 1999). Limitations of settings should be taken 
into account (e.g., time, resources, space, organisational infrastructure).
Credibility and accuracy of information. • Recommendations should be evidence-based 
and practical, so practitioners are persuaded to comply.
Automatic reminders.•  When the choice to see the message is eliminated, practitioners 
are more likely to respond (Garg et al., 2005; McMullin et al., 2004).
Obligatory response. • Acknowledgement of prompts may increase the likelihood of action 
(Hunt et al., 1998). Unsolicited reminders may ease workloads by directing the provider to 
priority tasks (McMullin et al., 2004; Murtaugh et al., 2005).
Use of additional tools assisted provider uptake. • Decision support systems were more 
effective in the presence of additional tools, such as feedback on performance, and 
educational materials.
Whether improvements in care have a direct effect on improved health status of patients 
is uncertain as the few studies that measured the impact on patients showed mixed or no 
significant effects (Table 53, Appendix B).
7.7.3. Relevance to the AOD field
Prompts and reminders, which were effective for improving patient care in a range of areas in 
the clinical setting, may be useful for delivering appropriate preventive care and treatment for 
clients with AOD-related problems. 
Potential AOD treatment and management areas that may benefit from the use of  
reminders include: 
Appropriate prescribing of pharmacotherapies (e.g., NRT, methadone) to eligible clients • 
during routine appointments
Advice on risks of AOD use during pregnancy (e.g., smoking cessation, alcohol and risks • 
of Foetal Alcohol Spectrum Disoder)
Monitoring of AOD-related problems (e.g., opioid substitution therapy, screening for • 
depression; measuring severity of dependence)
Appropriate use of brief interventions for eligible clients• 
Referral to specialist treatment (e.g., counselling)• 
Advice on relapse prevention, coping skills• 
Treatment for dependence• 
Treatment for conditions / complications associated with harmful AOD use  • 
(Hep C, HIV)
Management and treatment of comorbidity (e.g., depression, anxiety disorders).• 
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Problem areas that may be less amenable to the influence of reminders are those that tend 
to be more sensitive or embarrassing, or ones that deal with more contentious issues in 
AOD-related care (Balas et al., 2000), such as issues related to domestic violence or sexually 
transmitted diseases.
7.8. Audit and Feedback
Audit and feedback is “any summary of clinical performance of health care over a specified 
period, with or without recommendations for clinical action. The information may have been 
obtained from medical records, computerised databases, patients or by observation” (Oxman, 
Thomson, Davis, & Haynes, 1995). Practitioners receive reports of their performance that 
is compared to a benchmark standard of care stipulated by CPGs and / or to the mean 
performance of a peer group (Kiefe et al., 2001). Thus, audit and feedback works on the 
premise that practitioners will reflect on their past performance, recognise shortfalls in their 
practice and change their behaviour for future practice.
In contrast to prompts and reminders, which are delivered before, or at the time a clinical 
decision is made, feedback is delivered after decisions have been made. Thus, an evaluation 
of the consequences of decisions entails aggregating information on performance in order to 
change future decision-making (Bennett & Glasziou, 2003). Feedback may be:
Passive –•  Unsolicited information is provided, without the expectation that action  
will follow
Active – • Clinicians are actively engaged in the particular practice under review  
(Mugford, Banfield, & O’Hanlon, 1991). 
The rationale for audit and feedback is that health professionals, who may not be aware that 
their behaviour is not optimal, are more likely to change their behaviour if feedback shows that 
their clinical practice deviates from that of their peers or the recommended guidelines. Feedback 
involves providing individual practitioners with a report of their own specific professional 
practice, such as prescribing behaviour. A profile of their performance is presented, including a 
description of the discrepancies between their actual performance and that recommended by 
“gold standard” guidelines or compared to their peers.
Seven good to poor quality systematic reviews of 7-85 studies (Beilby & Silagy, 1997; Bennett 
& Glasziou, 2003; Gill et al., 1999; Grimshaw et al., 2004; Hulscher et al., 2001; Jamtvedt et 
al., 2003; Weingarten et al., 2002) (Table 25) and three additional primary studies (Eccles et al., 
2001; Kiefe et al., 2001; McCartney et al., 2001) (Table 26) evaluated the effectiveness of audit 
and feedback.
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Table 25. Effectiveness of audit and feedback – Systematic reviews summary
Research area References Level and quality of evidence a Process outcomes 
b Patient 
outcomes c
Preventive care (16)
Prescribing (18)
Disease 
management (30)
Test ordering (10)
Adherence to 
guidelines (11)
(Jamtvedt et al., 
2003)
Level I: good quality SR  
85 poor-good quality RCTs
Compliance with 
desired practice 
ranged from 9% 
absolute decrease 
to 71% absolute 
increase in 
performance d §
NS
Prescribing (Bennett & 
Glasziou, 2003)
Level I: average quality SR  
7 average quality RCTs
+ in 1/7 studies § NA
Prescribing and  
test ordering
(Beilby & Silagy, 
1997)
Level I: poor quality SR 
3 RCTse
+ NA
Prescribing (Gill et al., 1999) Level II: good quality SR 
33 average-good quality 
controlled studies
+ in 17/33 studies NA
Preventive care (3)
Test ordering (3)
Disease 
management (4)
(Grimshaw et al., 
2004)
Level II: good quality SR 
10 average quality 
controlled studies
+ in 6/10 studies §
Modest effect size
NS (1)
Preventive care (Hulscher et al., 
2001)
Level II: good quality SR  
11 poor-average quality 
controlled studies
+ in 2/3 studies § NA
Disease 
management
(Weingarten et 
al., 2002)
Level II: average quality SR 
32 average quality 
controlled studies
+ in 9/16 studies §
Moderate effect size
+ in 9/23 
studies §
Small effect 
size
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures 
of implementation of an intervention, such as assessment of participation, compliance and efficiency; 
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; d Increase in practitioner performance pertains to better compliance 
with recommended practice; decrease in performance is less compliance with recommended practice; e 
Study quality not assessed; + indicates intervention was significantly more effective than control or usual 
care; ± indicates mixed effects (significant change in some, but not all outcome measures); § = potential 
unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = randomised 
controlled trial; SR = systematic review. 
Table 26. Effectiveness of audit and feedback – Primary research summary
Research area References Level and quality of evidence a Process outcomes 
b Patient 
outcomes c
Prescribing / referral (McCartney et al., 
2001)
Level III-1: Average quality 
quasi-RCT
+ appropriate 
prescribing
± inappropriate 
prescribing
NA
Adherence to 
guidelines
(Eccles et al., 
2001)
Level II: Good quality 
Cluster RCT
NS NA
Disease 
management
(Kiefe et al., 2001) Level III-1: Average quality 
quasi-cluster RCT
± NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures 
of implementation of an intervention, such as assessment of participation, compliance and efficiency; 
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial.
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7.8.1. How effective is audit and feedback?
Process outcomes were significantly improved with the use of feedback in 14-60% of studies, 
whereas the impact on patients’ control of their disease was non-significant or small in the 
few studies that measured patient outcomes. Relevant studies were mostly included in two 
systematic reviews (Grimshaw et al., 2004; Jamtvedt et al., 2003). Grimshaw et al. (2004) 
reported small to moderate effects of 1-16% improvement in professional practice in 10 
studies, whereas Jamtvedt et al. (2003) examined 85 studies (5 studies were common to both 
reviews) and found highly variable results ranging from 9% reduction in performance to 71% 
improvement in practice. 
The better quality studies in Jamtvedt et al. (2003) showed significant improvements in process 
outcomes, such as delivery of preventive care, prescribing behaviour and level of hygiene 
in practice. In contrast, relatively small improvements were apparent in the few studies that 
measured patient outcomes, such as patients’ control of their disease (Weingarten et al., 2002). 
Jamtvedt et al. (2003) also reported that audit and feedback was most effective in conditions 
where the baseline adherence to recommended practice was low. An update of the Jamtvedt et 
al. review, comprising 118 studies, is now available (Jamtvedt, Young, Kristoffersen, O’Brien, & 
Oxman, 2006). Some of the studies added to the updated review are included in the additional 
primary studies in the present review. Results from the update confirm the association of low 
baseline performance with greater improvement, and showed an additional finding that higher 
‘intensity’ of feedback was associated with greater effectiveness. Intensity of feedback was 
categorised in terms of:
The recipient• 
The format• 
The source• 
The frequency• 
The duration• 
The content of feedback.• 
These categories were then combined to describe “intensive”, “moderately intensive” and “non-
intensive” feedback types. For example, “intensive” feedback comprised individual recipients 
and verbal format; or prolonged feedback, with a senior colleague as the source of feedback. 
In contrast, “non-intensive” feedback comprised group recipients with a less experienced 
colleague as the source of feedback; or written format without personal incentives (e.g., simple 
costs or numbers of tests). 
One good quality cluster RCT (Eccles et al., 2001) and two average quality quasi-RCTs 
(Kiefe et al., 2001; McCartney et al., 2001) investigated the effect of audit and feedback on 
changing practitioners’ clinical performance. Results from these additional studies indicated 
mixed effects for audit and feedback interventions on the behaviour of health professionals 
(process outcomes). Two studies showed significant improvement in practice, with modest 
effect size (Kiefe et al., 2001; McCartney et al., 2001) (Table 54). Both studies combined audit 
and feedback with additional elements, such as distribution of benchmark data to improve 
practitioners’ care for patients with diabetes mellitus (Kiefe et al., 2001), or educational material 
plus support for practitioners auditing patients to improve their hormone replacement therapy 
prescribing to women with a history of hysterectomy (McCartney et al., 2001). 
No significant improvement in practice was demonstrated with the standard audit and feedback 
strategy. However, due to the limited follow-up time (3-4 months) in both studies, sustainability 
of the benefits of an enhanced feedback intervention is unknown. It is also worth noting that 
study subjects (Kiefe et al., 2001) were recruited from a population of physicians participating 
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in the Ambulatory Care Quality Improvement (ACQI) project – an intensive quality improvement 
program that informed physicians of their individual performance compared to that of their 
peers. Study physicians may have performed higher than their counterparts not involved in the 
ACQI intervention, due to a heightened awareness of their performance. In contrast, Eccles 
et al. (2001) reported that an initial positive effect (compliance with guidelines) was eliminated 
once sources of random variation were added in data analysis.
7.8.2. Key success factors of audit and feedback
While there was variability between studies in the format, content, timing and source of the 
feedback provided and in the complexity of the behaviour targeted for change, none of these 
factors explained the variation in relative effects across studies. However, analyses by Jamtvedt 
et al. (2003) showed that feedback was most effective in circumstances where baseline 
adherence to recommended practice was low. That is, poorly performing professionals were 
more likely to change after becoming aware of the need to improve their practice, while those 
already performing well had little need or scope to change. Therefore, feedback strategies  
are more likely to be successful in settings where professionals’ practice has been identified 
as inadequate. 
Other factors that may increase the effectiveness of audit and feedback include:
Intensity of feedback. • Intensive feedback is more interactive (individual recipients; verbal 
feedback), uses a credible source (senior colleague), and is delivered over a prolonged 
period. Non-intensive feedback is delivered to a group by a less credentialled person, in 
written format, and contains information on costs or data without personal incentives for 
improvement (Jamtvedt et al., 2006; Jamtvedt et al., 2003).
Additional strategies.•  Standard feedback should be enhanced with other interventions 
(e.g., educational materials, audit support, public health promotion) (Eccles et al., 2001; 
Kiefe et al., 2001). 
It has been suggested that other factors, such as the content, complexity and frequency of 
feedback, or the motivation of professionals, may impact on the effectiveness of this strategy. 
For example, if feedback is infrequent, or the interval between action and feedback is too long, 
it is possible that the feedback becomes disassociated from the initial activity and may fail to 
influence subsequent actions. In contrast, if the feedback is too frequent and the interval too 
short, it may become tedious and be ignored. In addition, some practitioners / practices may be 
more responsive to improvement efforts. Few studies have specifically examined these factors 
and Jamtvedt et al. (2003) reported no evidence to support or refute the suggestion that these 
factors contribute to the effectiveness of audit and feedback strategies.
7.8.3. Relevance to the AOD field
Overall, while the evidence was mixed, feedback may be most effective in organisations or 
groups of professionals where professional practice is poor. 
Audit and feedback strategies are feasible in both clinical and non-clinical environments within 
the AOD field, provided that some objective measure of performance can be recorded for 
assessment. AOD areas where feedback may be useful are in delivery of preventive care, 
prescribing and test ordering. 
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7.9. Financial Incentives
Financial incentives involve some form of payment system, whereby individual practitioners 
receive remuneration that directly affects their personal disposable income.  
Financial incentives include:
Capitation – • The practitioner receives a payment for the services provided to each 
registered patient.
Salary – • The practitioner receives an annual salary for a specified number of hours per 
week, irrespective of the services provided or the number of  
patients attending.
Fee-for-service (FFS) –•  Practitioners are paid a fee for each item of care provided, such 
as consultations, immunisations, and prescriptions.
Target payments –•  Practitioners are remunerated for items of care (as in fee-for-service) 
only if they reach a certain target level of service (Gosden et al., 2000). 
It must be noted that financial incentives depend largely on the health care system that exists 
in a country. That is, effective financial incentive systems in one country may not be reproduced 
in another country, which has a different healthcare infrastructure. In addition, other non-
financial measures, such as CME and mandatory use of practice guidelines, may affect health 
professionals’ incomes and behaviour. The causal relationship between financial and non-
financial incentives is complex. 
Two systematic reviews of 2-4 studies (Giuffrida et al., 2000; Gosden et al., 2000) and one 
good quality quasi-RCT (Hillman et al., 1998) evaluated the effectiveness of financial incentives 
(Table 27 and Table 28.) 
Table 27. Effectiveness of financial incentives – Systematic reviews summary
Research area References Level and quality of evidence a Process outcomes b
Patient 
outcomes c
Preventive care (Giuffrida et al., 
2000)
Level II: good quality SR  
1 average quality RCT and 
1 average quality ITS
NS NS
General medicine (Gosden et al., 
2000)
Level II: good quality SR 
4 average quality controlled 
studies
± §
NS over 
time
± 
NS over 
time
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control  
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures);  
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant;  
RCT = randomised controlled trial; SR = systematic review. 
Table 28. Effectiveness of Financial Incentives – Primary research summary
Research area References Level and quality of evidence a Process 
outcomes b
Patient 
outcomes c
Preventive care (Hillman et al., 
1998)
Level III-1: Good quality 
Quasi-RCT
NS NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control  
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures);  
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant;  
RCT = randomised controlled trial. 
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7.9.1. How effective are financial incentives?
Two systematic reviews examined the effectiveness of different financial incentives on 
professional practice (Giuffrida et al., 2000; Gosden et al., 2000). The use of target payments 
for professional practice was inconclusive or improvements were non-significant (Giuffrida et al., 
2000). Gosden et al. (2000) reported some evidence for higher services under fee-for-service 
(FFS) compared to capitation or salary; decreased practitioner visits with salary compared to 
capitation; and increased costs with capitation compared to FFS. Patient outcomes were not 
assessed in these studies. Practitioners paid by FFS provided higher quality of primary care 
services compared with capitation or salary, but evidence was not robust or generalisable 
to different settings. Overall, financial incentives showed some evidence of effectiveness 
at reducing drug costs, reducing the number of days in hospital, and improving prescribing 
performance (Giuffrida et al., 2000). Giuffrida et al. (2000) (2 studies) reported overall positive 
(non-significant) effects of target payments for immunisation. 
On the other hand, Gosden et al. (2000) (4 studies) reported significant positive effects of 
capitation (compared to FFS) in the areas of: prescribing; days spent in hospital; recommended 
clinician visits; appropriate referrals; diagnostic services; hospitalisations; and emergency 
visits. However, several outcomes (clinician visits, emergency visits and hospitalisations) 
were non-significant at 12 months follow-up. There was also evidence of a larger number of 
services provided under FFS compared to capitation or salary; fewer recommended practitioner 
visits with salary compared to capitation; and higher administrative costs associated with 
capitation compared to FFS (Gosden et al., 2000). Importantly, settings, outcome measures and 
interventions varied substantially between studies that also lacked statistical power and had 
relatively high baseline rates (Giuffrida et al., 2000). 
Evidence from one additional primary study (Hillman et al., 1998) indicated that performance-
based financial incentives did not improve practitioners’ compliance with cancer screening 
guidelines in four screening areas: Pap smear test; colorectal screening; mammography and 
breast examination in a preventive care setting (Table 55, Appendix B). 
7.9.2. Key success factors of financial incentives
The available evidence on effectiveness of financial incentives was neither robust nor 
generalisable to different settings. Overall, studies that assessed the effectiveness of using 
performance-based financial incentives as a tool for raising practitioners’ awareness and 
compliance with evidence-based preventive practice showed inconclusive or mixed effects. 
However, several factors should be taken into consideration, including:
Magnitude of the financial incentive. • The level of reward should be appropriate relative to 
their overall income, yet must be sustainable by the organisation providing the incentive.
Concurrent incentives. • Competing incentives or disincentives may diminish the impact of 
a particular financial incentive scheme.
Mode and frequency of payments.•  Regular vs one-off payments. Uncoupling the action 
and consequence may occur if financial incentives are not paid at regular intervals. 
A financial incentive that is offered until an optimal level of care has been reached or 
certain practice has been undertaken may bring about progressive behaviour change 
toward sustainable evidence-based practice, whereas implementing a ‘withdrawal from 
payment until an optimal level of care has been achieved’ strategy may serve as a 
disincentive to change practice.
Further research is required to examine these and other factors in the Australian setting. 
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7.9.3. Relevance to the AOD field
The transferability and generalisability of results that contain geographic-specific characteristics 
is problematic. This is particularly the case for financial incentive strategies, which are 
constrained by the political and legislative infrastructure of a particular health system. Capitation 
and target-based incentives operate on a limited scale in Australia. 
However, some form of strategy involving financial incentives is feasible in both clinical and 
non-clinical environments provided that some objective measure of performance can be 
recorded for assessment. Australian health professionals receive some financial incentives as 
recognition of good performance, for example through programs established by the Australian 
Government such as the General Practice Immunisation Incentives (GPII) Scheme, the Service 
Incentive Payments Scheme (SIPS), which is associated with the management of some 
chronic conditions, and the Practice Incentives Program (PIP), which aid the implementation 
of national health-related strategies by supporting health professionals to provide quality care 
(www.hic.gov.au). These programs remain under continual review to ensure they are effective 
in improving health care outcomes. It is currently premature to make judgements regarding the 
effect of such programs, yet they may have applicability to the AOD field in future. For example, 
NSW Health currently administers the Pharmacy Incentive Scheme, which provides payment to 
pharmacists who provide Methadone / Buprenorphine pharmacotherapy dispensing services. 
Within the AOD field, financial resources are typically sparse, making the use of performance-
based financial incentives unlikely. Although limited availability of resources for the AOD field 
may preclude the use of financial incentives to induce behaviour change, other non-financial 
performance-based incentives, such as recognition of effort and contribution and support for 
professional development activities (CME) may be appropriate alternatives. 
7.10. Electronic Educational Sources
Due to the vast development of communication technologies and modalities, electronic 
educational sources, such as the Internet, on-line databases and CD-ROMs, are being used 
increasingly to disseminate information. In comparison to conventional print or paper-based 
modes of disseminating educational information, electronic sources offer a multitude of 
advantages such as:
time (quick access)• 
usability (convenient)• 
reduced cost for the party disseminating information and the intended user. • 
For example, the CD-ROM has the advantage of storing large volumes of high quality 
information in the form of text, graphics and other visual and audio media contained in a 
compact format that may be readily transferred from researcher / communicator to health 
care provider. In comparison to telephone, fax and postal services, the Internet, including 
communication through email and instant messaging, also has advantages, such as providing 
information in a convenient, unrestricted format that may be instantly exchanged and at low cost 
(once the system has been established).
Electronic information may be interactive and presented in a format that is visually appealing. It 
enables the user to navigate independently through the information in their preferred order and 
pace and to access information relevant to their practice needs. 
Not only is the Internet capable of digitalising conventional formats of information dissemination 
through the conversion of written reports into pdfs, for example, but technologies such as 
videoconferencing enable face-to-face interactions whilst overcoming the problem of  
geographic distance.
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Telemedicine, which is defined as “the use of telecommunications technology for medical 
diagnosis and patient care” (Currell, Urquhart, Wainwright, & Lewis, 2001), involves use of 
telecommunications to deliver medical services to sites distant from the health service provider. 
It utilises conventional telephone services, computer modems, satellites and other equipment to 
transmit and receive data. 
Potential limitations of using electronic sources to disseminate information are the need for a 
minimum level of computer literacy for locating and retrieving information and access to  
a computer. 
There were no available systematic reviews evaluating the effectiveness of electronic 
educational sources.
One primary study met the inclusion criteria for the electronic educational sources category 
(Table 29 and Table 56, Appendix B). A quasi-RCT (Di Noia et al., 2003) examined the 
effectiveness of electronic educational sources by comparing the Internet and CD-ROMs to 
pamphlets as strategies for disseminating drug use prevention programs to social workers in a 
community setting.
7.10.1. How effective are electronic educational sources?
Evidence from one average quality quasi-RCT showed that, when used in a community-based 
setting, disseminating prevention program materials via electronic sources including CD-ROMs 
and the Internet in comparison to pamphlet form provided a short- and long-term (sustained) 
benefit to practice (Di Noia et al., 2003). At 12-months follow-up, dissemination via the Internet 
resulted in the greatest improvement in process outcomes including agency workers’ perceived 
self-efficacy for obtaining and recommending prevention programs, and their likelihood of 
recommending effective prevention programs to clients. Patient outcomes were not assessed.
Table 29. Effectiveness of electronic educational sources – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Preventive care (Di Noia et al., 2003) Average quality 
Quasi-RCT 
+ NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures 
of implementation of an intervention, such as assessment of participation, compliance and efficiency; 
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial. 
7.10.2. Key success factors of electronic educational sources
The factors that are important to the success of educational materials more generally (see 
section 7.1.2, Educational materials) are also important to the success of electronic educational 
sources, with some additional elements, including: 
Accessibility. • Information was more accessible via the Internet compared with CD-ROM 
or pamphlet format.
Tailored to individuals. • Information was tailored to individuals within the  
broader target group to enhance the relevance and appeal of the content  
(Di Noia et al., 2003).
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7.10.3. Relevance to the AOD field
Di Noia et al. (2003) explored the dissemination of adolescent drug abuse prevention programs 
to agency workers in community-based settings including policy makers, school personnel 
and community service providers that influence public attitudes and support for youth-oriented 
programs. When disseminated via the Internet and CD-ROM, information about effective 
substance use prevention programs and best  
practice had a greater likelihood of increasing agency workers’ access to prevention program 
materials, self-efficacy for identifying and obtaining prevention programs and likelihood of 
requesting, implementing and recommending prevention programs to clients compared to 
pamphlets. Although this study was undertaken in the USA, it contains no geographical 
specificities and the findings are generalisable to the Australian AOD setting. 
Given that there was only one study that met the inclusion criteria, the evidence is  
not robust. However, results suggested that dissemination of best-practice  
information to AOD workers via electronic sources may be effectively used in preventive care 
settings. In addition, while dependent on the availability of Internet facilities, this strategy may be 
particularly useful for those in rural and remote communities in Australia. 
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8..Organisational Interventions
Organisational interventions refer to interventions that are oriented to change in 
organisational practices (see Table 4). Interventions included here are:
Record and / or office systems• 
Multi-disciplinary collaborations (integrated care)• 
Alternative care providers / settings• 
Continuous quality improvement.• 
Organisational factors impact on individuals’ participation and adoption of innovations. Moreover, 
a recent study has shown that even when staff are aware of the need for change and accept that 
an innovation will meet their needs, organisational culture moderates the likelihood of adopting the 
innovation (Simpson, Joe, & Rowan-Szal, 2007). 
8.1. Record and Office Systems
Record and office systems store and manage information that may be accessed and used 
to inform patient care. These systems aim to improve the flow of information within an 
organisation, and provide comprehensive up-to-date patient details and clear and precise care 
plans for individual patients. This strategy involves structural changes within an organisation to 
accommodate the system and procedures, as well as changes in staff behaviour to maintain 
and operate the system. 
“A nursing record system is the record of care planned and / or given to individual patients 
/ clients by qualified nurses, or by other care givers under the direction of a qualified nurse” 
(Currell & Urquhart, 2003). Used for the storage and exchange of information, nursing record 
systems vary considerably and include manual or computerised versions, centrally-held or 
patient-held records, and structured or unstructured systems. While the structured nursing 
record system involves entering data in a structured format (e.g., care plans and flow charts), 
with standardised phrasing and unambiguous terminology, the unstructured system allows 
unrestricted entry of information in freer format. 
Record systems may be one component of a multi-faceted office system (e.g., patient flow 
chart). An office-system is “an organised approach within a medical practice for routinely 
providing a given service (for example, cancer screening) to patients for whom this service is 
indicated” (Kinsinger et al., 1998). 
Office systems require that practice staff take an organisational level approach and work in a 
team. As a consequence, the onus for change does not lie with individual health care providers. 
The key to this strategy is segmenting an activity or health procedure into clearly defined steps, 
and then developing and implementing a process involving both practitioners and office staff to 
ensure the steps are performed for every appropriate patient. For example, one office system 
established the division of responsibilities amongst staff, clearly defined expectations and 
routines, and provided explanations for the use of medical record flow sheets (Dietrich et al., 
1992). Office systems typically comprise various tools such as:
flow sheets• 
chart prompts• 
patient care algorithms• 
patient education brochures• 
wall posters• 
patient held cards. • 
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These tools are integrated within usual practice procedures and adopted by all practice  
staff – both practitioners and office staff – to track patient care, prompt appropriate clinical 
actions, and provide patient education. Ideally, all steps are documented, activities are revised 
for improvement and the office system is tailored to the needs and work patterns of the 
individual practice. 
Two systematic reviews of 1-8 studies (Currell & Urquhart, 2003; Hulscher et al., 2001) 
assessed the effectiveness of record systems (Table 30) and five additional studies (Boekeloo 
et al., 2003; Boekeloo et al., 2004; Dietrich et al., 1992; Kinsinger et al., 1998; McBride et al., 
2000; Ockene et al., 1999) 9 (Table 31) assessed the effectiveness of office systems or office-
based interventions.
Table 30. Effectiveness of record systems – Systematic reviews summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Preventive care (Currell & Urquhart, 
2003)
Level II: good quality SR 
8 poor quality controlled 
studies
NS NS
Preventive care (Hulscher et al., 2001) Level II: good quality SR 
2 poor-average quality 
controlled studies
+ NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; c 
Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial; SR = systematic review. 
Table 31. Effectiveness of office systems – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Preventive care (Boekeloo et al., 2003; 
Boekeloo et al., 2004)
(adolescent alcohol use)
Level II: RCT 
Good quality
± improvement 
in most but not 
all outcomes
-
(McBride et al., 2000)
(heart disease 
prevention)
Level II: RCT 
Good quality
+ NA
(Kinsinger et al., 1998)
(breast cancer 
screening)
Level II: RCT 
Good quality
± NA
(Ockene et al., 1999)
(nutrition counselling)
Level III-1: Quasi RCT 
Average quality
NA +
(Dietrich et al., 1992)
(cancer prevention)
Level III-1: Quasi RCT 
Good quality
± improvement 
in most but not 
all outcomes
NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; c 
Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control  
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant;  
RCT = randomised controlled trial. 
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8.1.1. How effective are record and / or office systems?
One systematic review (Currell & Urquhart, 2003) evaluated the effectiveness of client-held 
records (compared with centrally-held) and computerised patient records (compared with 
manual record keeping). Record systems had no significant effect on nursing practice and 
patient outcomes, except in the following circumstances:
Identification of children’s pain intensity improved with the use of a paediatric pain • 
management sheet
Documentation standards improved after implementing two paper-based nursing • 
record systems
Nurses’ recording of care planning increased when a computerised planning system • 
was implemented (but with no significant change to patient outcomes).
One study in an existing systematic review (Hulscher et al., 2001) reported a significant 
improvement in the delivery of preventive health services after changing the flow of patients 
by booking appointments at 10 minute intervals. All review results should be considered with 
caution, however, as included studies were generally of poor to average quality and comprised 
small sample sizes. 
Office systems or office-based interventions evaluated in the five additional primary studies 
(Boekeloo et al., 2003; Boekeloo et al., 2004; Dietrich et al., 1992; Kinsinger et al., 1998; 
McBride et al., 2000; Ockene et al., 1999) comprised a wide variety of different components, 
which made evaluating effectiveness and identifying attributes of effectiveness challenging 
(Table 57 and Table 58, Appendix B). The process used to facilitate the development and 
implementation of office systems also differed. All studies were conducted in preventive health 
care settings. 
Office-based interventions had mixed effects for process outcomes, with most studies reporting 
improvement in some, but not all outcomes. Most studies showed improvements in the delivery 
of preventive health services, particularly for heart disease (McBride et al., 2000) and three out 
of five indicators for cancer (Kinsinger et al., 1998; Ockene et al., 1999) (Table 57, Appendix B). 
There was no additional effect gained in the presence of other strategies, such as educational 
meetings or materials (Dietrich et al., 1992). However, when two office systems were 
implemented concurrently and combined with a relevant conference, improvement in practice 
was greater than either system alone, which were better than controls (conference alone), and 
the improvement was sustained at 18 months follow-up (McBride et al., 2000). 
One study (Boekeloo et al., 2003) demonstrated no statistically significant improvements in 
patient-provider communication using a ‘patient-priming’ 10 program for improving patient-
provider communication. However, when combined with provider prompts, young people were 
more likely to talk to, and ask questions of, their health care provider during checkups than were 
young people in the control group. 
Patient outcomes also showed mixed effects, with improvements in saturated fat intake, weight 
loss and cholesterol levels in one study when a training program was combined with an office 
system (Ockene et al., 1999), yet a potentially adverse effect in another, where greater intent to 
drink and more binge drinking was reported in groups receiving an intervention (Boekeloo et al., 
2004) (Table 31 and Table 58, Appendix B). 
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8.1.2. Key success factors of office systems
Record and office systems typically address several potential practice environment barriers to 
change, such as the need for staff to work as a cohesive team and to develop strategic plans  
for consistent and thorough patient care. Record and office systems varied substantially across 
the studies. 
Characteristics of the record or office system. • Office-systems are typically multi-faceted 
and involve the simultaneous implementation of multiple activities. Each component 
that constitutes the office system appears to add value to different aspects of the overall 
desired behaviour change. For example, McBride et al. (2000) found different effects 
for two office systems implemented as part of the same study. One system, which used 
a quality improvement consultation intervention, set more goals, whereas the other, 
which used a dedicated prevention coordinator, achieved greater increases in the use 
of medical record tools and in the documentation of screening and management. Each 
intervention group demonstrated significant improvement compared to controls, yet in 
different practice areas.
Implementation environment. • The environment or setting in which office systems are 
implemented may impact on the effectiveness of this strategy. Practice change requires 
a team effort; system changes are needed to foster a supportive office environment that 
is receptive to change and that will improve services. One office system had a modest 
effect on performing breast cancer screening, despite tailoring the system to both breast 
cancer screening and the unique organisational needs of the practice (Kinsinger et al., 
1998). This study also evaluated the process of development and implementation of the 
office system. Results suggested that complete development and full acceptance of the 
system within a practice was a prerequisite for an effective office system.
Complexity of behaviours to be changed.•  When implementing record or office systems, 
health care organisations set goals for change. The complexity of behaviours to be 
changed may impact on the success of the intervention. For example, McBride et al. 
(2000) found that screening goals, particularly smoking screening, were more commonly 
set by organisations than were management goals. McBride et al. speculated that 
screening goals may be easier to achieve compared with more complex changes in 
provider and patient behaviour required for management goals. Similarly, smoking 
screening is deemed a less complex screening activity compared to cholesterol or cancer 
screening procedures as far as the level and type of patient-provider interaction required.
Tailoring system to needs. • Office systems can be tailored to the unique and diverse 
needs of individual practices and health care providers. This is an important factor for 
establishing motivation for change and maintenance of that change.
Including additional functionality by combining an office system with other tools (multi-• 
faceted). For example, a patient-mediated intervention was more effective when 
enhanced with provider prompts (Boekeloo et al., 2003).
It should be noted that Kinsinger et al. (1998) examined a number of factors to identify 
associations with improvement in performance over time. Results showed that change 
in performance over time was not associated with providers’ attitudes to, or beliefs in the 
effectiveness of the intervention (breast cancer screening), their stated readiness to change, or 
their perceptions of community standard of practice.
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8.1.3. Relevance to the AOD field
While no available studies specifically tested record or office systems in the AOD field, many 
were conducted in preventive health settings and may be transferable to preventive health care 
pertaining to AOD issues. 
Office systems may be a useful tool to improve health care providers’ skills in screening for 
alcohol and / or other drug (AOD) use. Screening and routine history-taking may assist health 
care providers to:
identify an AOD problem• 
monitor changes in clients’ behaviour or health condition• 
identify the need for early intervention• 
establish and implement a care and / or treatment plan depending on the needs of  • 
the client.
In an exploratory sub-study of a longitudinal study on young people’s alcohol behaviours, 
Boekeloo et al. (2003) assessed the effect of priming young patients to discuss alcohol with their 
primary care providers. They also examined whether additional effect was gained by prompting 
providers to discuss alcohol during a consultation. Alcohol-related discussion topics included: 
avoiding alcohol; effects of alcohol on decisions; resisting peer pressure to drink; dangers of 
drinking and driving; avoiding places where teenagers drink; avoiding other teenagers when 
they are drinking; and the risk of combining drinking and sex. Young patients were ‘primed’ to 
discuss alcohol-related topics via a 15-minute audio program created by the investigators. 
The program addressed communication and confidentiality issues as well as information 
regarding the risks of excessive alcohol consumption. Evidence suggests that priming alone 
was not effective in encouraging young people to communicate with their health care provider 
on alcohol-related matters, but communication improved when priming was reinforced with 
provider prompts.
8.2. Multi-Disciplinary Collaborative Approaches (Integrated care)
Multi-disciplinary collaborative strategies include any health care approach that involves 
complementary inter-professional collaboration (clinicians, nurses, pharmacists, social workers, 
psychologists), working together as a team to care for patients. This includes collaborative team 
care, continuity of care and case-management, which is frequently used in the management 
of patients with chronic diseases. The efficiency and quality of health care may depend on the 
extent to which inter-professional relationships are collaborative. 
Three systematic reviews of 1-12 studies (Gilbody et al., 2003; Grimshaw et al., 2004; Harvey et 
al., 2002; Renders et al., 2001) (Table 32) and one additional primary study (Diabetes Integrated 
Care Evaluation Team, 1994) (Table 33) evaluated the effectiveness of using a multi-disciplinary, 
inter-professional collaboration (or integrated care) approach to improve the delivery of health 
services. 
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Table 32. Effectiveness of multi-disciplinary approaches – Systematic reviews summary
Research area References Level and quality  of evidence a
Process 
outcomes b
Patient 
outcomes c
Disease 
management
(Gilbody et al., 2003) Level II: good quality SR 
12 average quality 
controlled studies
+ +
Disease 
management
(Grimshaw et al., 2004) Level II: good quality SR 
1 average quality RCT
NA + §
Disease 
management
(Renders et al., 2001) Level II: good quality SR 
4 average quality controlled 
studies
± § + §
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; c 
Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial; SR = systematic review. 
Table 33. Effectiveness of multi-disciplinary interventions (integrated care) – Primary 
research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Disease 
management 
(diabetes)
(Diabetes Integrated Care 
Evaluation Team, 1994)
Level III-1: Quasi-RCT 
Poor quality
± NS
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; c 
Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial. 
8.2.1. How effective is the multi-disciplinary approach (integrated care)?
As with other dissemination strategies, multi-disciplinary interventions varied substantially in 
their content, complexity, and targeted behaviours as well as the disciplines involved in the 
collaboration. Overall, multi-disciplinary team approaches were no more effective at changing 
professional practice or improving the health status, quality of life or disease-management of 
patients, than traditional care.
Enhancing the role of one health care professional in the mix 11 yielded mixed results, with 
some studies demonstrating a deterioration in performance (Grimshaw et al., 2004) and others 
showing no significant improvement or small significant improvement with some roles (e.g., 
pharmacists and dieticians) (Renders et al., 2001). There was also a wide range of effects on 
patients, with reduced hospital stay, reduced costs and increased satisfaction with care (Gilbody 
et al., 2003). 
Studies contained in one good quality review revealed positive effects on patient outcomes for 
multi-disciplinary care in a variety of formats, including combinations with revision of professional 
roles (i.e., improving the role of the nurse), formal integration of services, changes in medical record 
systems and patient education (Renders et al., 2001).
11 Revision of professional roles 
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Using computer-coordinated ‘integrated care’ for diabetes care, patients were given more frequent 
metabolic monitoring and screening for diabetic complications than patients who received 
conventional care (Diabetes Integrated Care Evaluation Team, 1994) (Table 59, Appendix B). 
However, overall the integrated care model had no distinct advantage over standard, conventional 
hospital care. Data were not extracted for process outcomes as  
baseline scores were not provided, nor reported as similar or adjusted for using appropriate 
statistical procedures.
Patient outcomes relating to metabolic control and psychological wellbeing were not significantly 
different between integrated care and conventional care. Since baseline levels for psychological 
wellbeing were not reported nor recorded as similar or adjusted for using appropriate statistical 
procedures, outcome data were not extracted.
8.2.2. Key success factors of multi-disciplinary (integrated care) interventions
Overall, evidence revealed mixed effects for a multi-disciplinary collaborative care approach, 
with poor study quality and heterogeneity between study interventions, settings, and populations. 
However, there are some characteristics that may increase the likelihood of success of a 
collaborative care approach:
Enhanced with additional strategies. • Including patient education with a collaborative care 
approach for management of depression symptoms improved treatment adherence and 
patient recovery (Gilbody et al., 2003).
Coordination of patient appointments with reminders to patient and provider. • Computer-
generated reminders about due consultations were sent to patients receiving integrated 
care. In addition, providers received the most recent clinical details (Diabetes Integrated 
Care Evaluation Team, 1994).
From the patient’s perspective, the most commonly perceived advantages of integrated care 
were (improved) accessibility, time savings, continuity of care, and reduced cost of attending 
appointments. However, the most commonly perceived disadvantage was reduced quality  
of care. 
8.2.3. Relevance to AOD field
The most relevant evidence for the AOD field is derived from one systematic review on 
management of depression – a common disorder associated with AOD-related problems. Gilbody 
et al. (2003) concluded that collaborative care approaches, including case management, were 
generally effective in improving the management of depression and patients’ adherence to 
medication. However, improvements were only sustained during the period of enhanced care. 
Given the high incidence of co-morbidities, and the complexity of AOD-related problems, clients 
commonly require assistance in a broad range of areas, including health, social services, 
housing, employment and legal services. Therefore, sound working relationships between these 
services are important. Good quality studies are needed to test the effectiveness of collaborative 
approaches between relevant services in the AOD field.
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8.3. Alternative Care Approaches
Traditionally, health care services are provided by health professionals in a general practice or 
hospital setting. A different approach is to introduce an alternative health care provider or setting 
in which patients receive treatment, recover from treatment, or manage a chronic disease. 
For example, tasks or consultations usually provided by a practitioner may be undertaken by 
a nurse practitioner. In diabetes management, it is common practice for a nurse educator to 
advise patients on lifestyle changes and disease management skills. 
Three systematic reviews (Grimshaw et al., 2004; Harvey et al., 2002; Renders et al., 2001) 
(Table 34) and two additional primary studies (Campbell et al., 1998; Sikka et al., 1999) (Table 
35) evaluated the effectiveness of using alternative care approaches to improve health care.
Table 34. Effectiveness of alternative care approaches – Systematic review summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Disease 
management
(Harvey et al., 
2002)
Level II: good quality SR 
13 poor-average quality 
controlled studies
+ in 2/13 studies 
§
+ in 2/13 studies 
§
Disease 
management
(Grimshaw et al., 
2004)
Level II: good quality SR 
1 average quality CBA
- NA
Disease 
management
(Renders et al., 
2001)
Level II: good quality SR 
4 average quality 
controlled studies
+ (1 study) + in 2/4 studies §
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; c 
Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial; SR = systematic review. 
Table 35. Effectiveness of alternative care approach – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomesb
Patient 
outcomesc
Secondary 
prevention 
(heart disease)
(Campbell et al., 
1998)
Level II: RCT 
Average quality
+ NA
Disease 
management  
(diabetes)
(Sikka et al., 1999) Level II: RCT  
Average quality
+ NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; c 
Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial. 
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8.3.1. How effective is the alternative care approach?
Evidence revealed mixed effects using an alternative approach to improve patient care. While 
some studies showed significant improvement in the management of obesity, including greater 
weight loss in patients treated by a dietician or professional therapist, most studies had small 
sample sizes, high drop-out rates and limited follow-up (Harvey et al., 2002). Results were 
similar for the management of diabetes, with small effect sizes in studies where improvements 
in the intervention group were significantly better than control (Renders et al., 2001). 
Nurse-led clinics implemented in general practice improved secondary prevention outcomes, 
with the exception of smoking cessation (Campbell et al., 1998) and a nurse case manager (as 
opposed to usual care provided by a primary care physician) improved renal assessment in 
patients with diabetes (Sikka et al., 1999) (Table 60, Appendix B).
8.3.2. Key success factors of alternative care approach
Evidence suggests that the effectiveness of an alternative care approach may be dependent on 
several factors:
Dedicated staff and clinical support for the approach:•  Sikka et al. (1999) attributed the 
success of their alternative care intervention to the support and participation of respected 
clinical staff, which created high comfort and confidence levels in patient safety and 
program value among general practitioners.
Behaviour amenable to change: • Campbell et al. (1998) noted that some behaviours may 
be more difficult to change than others. For example, medical treatment may be ‘easier’ 
to change than lifestyle components (e.g., smoking cessation in patients with diagnoses 
of heart disease). 
8.3.3. Relevance to AOD field
No studies in the existing systematic reviews or the additional studies specifically assessed the 
alternative care approach in an AOD setting. Of most relevance is the Campbell et al. (1998) 
study, which found that nurse-led clinics improved all aspects of secondary prevention except 
smoking cessation. However, no strong conclusions can be drawn due to the paucity of AOD-
related evidence. 
There is a range of tasks and procedures, particularly preventive health, screening and 
monitoring activities, which could be conducted by alternative care providers within an AOD 
setting. For example, methadone / buprenorphin maintenance treatment for eligible clients 
is dispensed by authorised pharmacists. Other potential tasks for alternative care providers 
include: implementing alcohol or other drug screening tools; providing advice on AOD use to 
pregnant women; and implementing outcome monitoring programs, such as pharmacotherapies 
dispensed through pharmacies. 
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8.4. Continuous Quality Improvement
Continuous quality improvement (CQI) usually involves an iterative process of problem-
solving and group decision-making that centres on the analysis of organisational systems 
and work processes, and is designed to achieve improvements in health outcomes. CQI 
focuses on improving processes that influence the flow of three principal factors – information 
(paper or electronic records), material (e.g., blood samples sent to a lab for testing), and 
patients. It is also widely used to implement CPGs (Brown et al., 2000). 
CQI models typically entail three phases:
Diagnostic phase –•  Identify a specific problem and use data analysis, brainstorming, 
process flowcharts to identify and prioritise the root causes of the problem, such as 
failure to adhere to recommended practice.
Remedial phase –•  Identify measurable outcomes (e.g., functional health, quality of 
life, satisfaction); define and test possible “solution tracks”; and recommend a selected 
number for implementation.
Implementation phase –•  Recommendations are put into practice using a series of  
limited changes. The product of this model then progresses through another cycle of 
the above phases.
Rapid cycle improvement is a similar format, used primarily in the Institute for Health Care 
Improvement Breakthrough Series for reducing adverse drug events and medication errors. 
Changes in the rapid cycle improvement method are tested on a smaller scale, without 
flowchart processes and extensive measuring. Studies assessing the effectiveness of rapid 
cycle improvement typically lacked control groups and failed to meet the inclusion criteria for 
the present review. 
One existing systematic review (Gilbody et al., 2003) (Table 36) and four additional primary 
studies (Feifer & Ornstein, 2004; Irvine Doran et al., 2002; Rantz et al., 2001; Solberg et al., 
2000) (Table 37) evaluated continuous quality improvement (CQI). 
Table 36. Effectiveness of continuous quality improvement – Systematic  
reviews summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Disease management (Gilbody et al., 
2003)
Level II: good quality SR 
2 average quality controlled 
studies
+ +
NS at 24 
months
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; c 
Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial; SR = systematic review. 
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Table 37. Effectiveness of continuous quality improvement – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Preventive care (Solberg et al., 
2000)
Level II: RCT 
Good quality
± NA
Disease management 
(cardiovascular and 
stroke)
(Feifer & Ornstein, 
2004)
Level III-1: quasi-RCT 
Average quality
NS NA
Patient care / 
management 
(nursing home care 
facilities)
(Rantz et al., 2001) Level III-1: quasi-RCT 
Average quality
± NA
Disease management 
and general medicine
(Irvine Doran et al., 
2002)
Level III-1: quasi-RCT 
Poor quality
NS NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; c 
Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial. 
8.4.1. How effective is continuous quality improvement?
One systematic review included two studies that evaluated CQI interventions in the 
management of patients with depression (Gilbody et al., 2003). The CQI interventions were 
very complex, with educational and organisational components, including clinician education, 
opinion leaders, patient-specific reminders, revision of professional roles, and multi-disciplinary 
integration of care. Both studies showed statistically significant improvement in medication 
adherence (p<0.001) and depression symptoms (p=0.03) at both six and 12 months. By 24 
months, the benefit for patient outcomes was no longer evident, although medication adherence 
persisted (p=0.04). 
Data were extracted for only two additional primary studies (Irvine Doran et al., 2002; Rantz 
et al., 2001) (Table 61, Appendix B). Rantz et al. (2001) tested the effectiveness of two quality 
improvement interventions and found that simply providing comparative performance feedback 
was not sufficient to change clinical practice, but when feedback was combined with academic 
detailing in the form of expert clinical consultation, this resulted in improvement, although not at 
a statistically significant level. 
One good quality RCT (Solberg et al., 2000) provided incomplete data (except in graph format), 
hence data for this study has not been extracted. Solberg et al. (2000) reported statistically 
significant improvement in delivering preventive care in only one of seven preventive care 
services. Data were not extracted from the Feifer and Ornstein (2004) study as baseline scores 
were not provided, nor reported as similar or adjusted for. 
The paucity of good quality empirical studies that evaluated whether CQI is effective in 
improving the quality of health care limited conclusions that could be drawn regarding the 
overall effectiveness of this approach. 
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8.4.2. Key success factors of continuous quality improvement
Solberg et al. (2000) suggest that the limited effect of their CQI intervention may be because 
the clinics recruited to this study were atypical and possibly resistant to change; the intervention 
was resource-intensive / time-consuming; CQI was not an appropriate mechanism for making 
preventive service improvements; and the intervention was not delivered satisfactorily.
Rantz et al. (2001) proposed that CQI was more likely to be effective under the  
following conditions: 
Clear standards of practice – • Improvements in practice occurred in areas where the 
standards are well understood and “staff could grasp the clinical changes needed for 
better management of these clinical problems” (Rantz et al., 2001, p. 535)
Limited number and scope of change required - • “While we can generate a myriad of 
quality indicator information for teams to examine, they can only focus on one or two 
areas for improvement at a time…there is a limit to the time and energy of staff that can 
be harnessed to implement and sustain change” (Rantz et al., 2001, p. 535)
Adequate staffing and resources to implement change - • “The problems of staff turnover 
and too few staff to participate in a quality improvement team also interfere with the 
number of areas that can be addressed, changed and sustained as an acceptable clinical 
practice” (Rantz et al., 2001, p. 535).
8.4.3. Relevance to AOD field
CQI interventions are typically time and resource intensive and are not supported by empirical 
evidence. CQI interventions that seek to alter workplace processes may not be appropriate / 
feasible in the AOD field that is often under-resourced and experiences high staff turnover.  
Staff who are retained are frequently under considerable time pressure. 
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9..Other Interventions
Other strategies that have emerged from the literature include marketing, mass media and 
multi-faceted strategies. These address the problem of dissemination and implementation 
by using a more general “scatter-gun” approach (mass media, mass mailouts), combining 
strategies (multi-faceted) or tailoring the strategy by identifying and breaking down the barriers 
to implementation. 
Other interventions that were evaluated included:
Mailouts• 
Multi-faceted interventions.• 
9.1. Mailouts
Mass media and mailouts are simple strategies that aim to deliver information to the general 
public or large groups of people in a specific target audience (e.g., general practitioners, AOD 
professionals). Television, radio and print media are used for dissemination of information that is 
of interest to public health in the general population. Other media include listservs, websites and 
email lists, particularly for disseminating information to target groups. 
One primary study evaluated the effectiveness of mailouts to facilitate change in practitioners’ 
behaviour (Matowe et al., 2002) (Table 38). 
9.1.1. How effective are mailouts?
Using the same population of general practitioners (GPs) as described previously by Eccles 
et al. (2001) (audit and feedback and reminder messages on GPs’ requests for lumbar spine 
and knee x-rays), Matowe et al. (2002) reported no significant effect of postal distribution 
of guidelines on GPs’ referral behaviour as determined by time series regressions (Table 
62, Appendix B). This is congruent with other evidence that simple, passive dissemination 
strategies are often less effective for changing behaviour and increasing uptake of evidence 
(Freemantle et al., 1997; Grimshaw et al., 2004). While significant improvements were observed 
for reminder messages with this population, audit and feedback and mass mailouts of guidelines 
had no effect. 
Table 38. Effectiveness of mail outs – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Referral 
(radiography)
(Matowe et al., 2002) Level III-3: Interrupted time 
series - no control 
Good quality
NS NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial. 
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9.1.2. Key success factors of mailouts
There were insufficient studies with methodological rigour to make a conclusive statement  
of effect.
9.1.3. Relevance to AOD field
While mailouts to the AOD field are common, there were no available studies that evaluated the 
effectiveness of this strategy in this area. Moreover, evidence in other health areas was sparse 
and precluded making firm conclusions about the effectiveness of this strategy.
9.2. Multi-faceted Interventions
Multi-faceted interventions employ two or more strategies (as detailed throughout this report) to 
address several aspects of health care from a variety of perspectives. Combining strategies is 
thought to address more of the barriers to change and thus increase the likelihood of influencing 
a wider group of individuals with different learning styles, values and motivation levels. 
Seven systematic reviews of 8-115 studies (Anderson & Jane-Llopis, 2004; Currell & Urquhart, 
2003; Gill et al., 1999; Grimshaw et al., 2004; Hulscher et al., 2001; Jamtvedt et al., 2003; 
Renders et al., 2001) (Table 39) and 19 additional primary studies (Bekkering et al., 2005; 
Cooke et al., 2001; Flottorp et al., 2003; Forsetlund et al., 2003; Foy et al., 2004; Frijling et al., 
2003; Frijling et al., 2002; Heller et al., 2001; Joseph et al., 2004; Langham et al., 2002; Lemelin 
et al., 2001; Margolis et al., 2004; Nilsson et al., 2001; Philbin et al., 2000; Sanci et al., 2000; 
Schectman et al., 2003; Searle et al., 2002; Waldorff et al., 2003; Wright et al., 2003; Young et 
al., 2002) (Table 40) evaluated the effectiveness of multi-faceted interventions. 
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Table 39. Effectiveness of multi-faceted interventions – Systematic reviews summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Preventive care (12)
Prescribing / test 
ordering (8)
Disease  
management (20)
(Jamtvedt et al., 2003) Level I: good quality 
SR  
40 average quality 
RCTs
+ in 19/40 studies 
§
NA
Preventive care (Anderson & 
Jane-Llopis, 2004; 
Anderson et al., 2004)
Level II: good quality 
SR 
16 average quality 
controlled studies
+ studies using 
multi-faceted 
interventions were 
more effective 
in changing 
practitioners’ 
behaviour 
compared to 
those with single 
interventions
+
Preventive care (Currell & Urquhart, 
2003)
Level II: good quality 
SR 
8 poor quality 
controlled studies
NS NS
Prescribing (Gill et al., 1999) Level II: good quality 
SR 
22 average quality 
controlled studies
+ in 11/22 studies 
§
NA
Preventive care (34)
Prescribing/test 
ordering (43)
Disease/pain 
management (27)
Counselling (2) 
Diagnosis (1)
Organisational 
change (8)
(Grimshaw et al., 
2004)
Level II: good quality 
SR 
115 average quality 
controlled studies
+ in 54/115 studies 
§
+ in 8/25 
studies §
Preventive care (Hulscher et al., 2001) Level II: good quality 
SR 
25 poor-average 
quality controlled 
studies
+
Small-moderate 
effect size
NA
Disease management (Renders et al., 2001) Level II: good quality 
SR 
20 poor-average 
quality controlled 
studies
± § ± §
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency;  
c Client outcomes = measures of impact on clients’ or patients’ health, such as health status, length of 
hospitalisation, and quality of life; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures); 
§ = potential unit of analysis errors in cluster RCTs; NA = not assessed; NS = not significant; RCT = 
randomised controlled trial; SR = systematic review. 
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Table 40. Effectiveness of multi-faceted interventions – Primary research summary
Research area References Level and quality of evidence a
Process 
outcomes b
Patient 
outcomes c
Disease prevention / 
management
Diabetes: 
(Frijling et al., 2002)
Level II: RCT 
Good quality
+ in 3/7 outcomes NS
Heart disease: 
(Frijling et al., 2003)
Level II: RCT 
Good quality
+ in 5/12 
outcomes
NA
Heart disease: 
(Langham et al., 2002)
Level II: RCT 
Good quality
+ NS
Heart disease: 
(Philbin et al., 2000)
Level III-1: quasi-RCT 
Good quality
NS NS
Heart disease: 
(Heller et al., 2001)
Level III-1: quasi-RCT 
Good quality
NS NA
Asthma and angina: 
(Wright et al., 2003)
Level III-2: Non-
randomised study 
Average quality
NS § NA
Preventive health 
care
Smoking cessation: 
(Young et al., 2002)
Level II: cluster RCT 
Good quality
+ in 2/13 
outcomes
NA
(Lemelin et al., 2001) Level III-1: quasi-RCT 
Good quality
+ NA
Adolescent health:  
(Sanci et al., 2000)
Level II-1: quasi-RCT 
Good quality
+ +
Smoking cessation: 
(Cooke et al., 2001)
Level III-1: quasi-RCT 
Average quality
NS NA
Smoking cessation: 
(Joseph et al., 2004) d
Level III-1: quasi-RCT 
Average quality
+ in 2/7 outcomes NS
Paediatrics: 
(Margolis et al., 2004)
Level II: RCT 
Good quality
+ NA
Evidence-based 
public health 
practice
(Forsetlund et al., 2003) Level II: RCT 
Good quality
± NA
Pain management Lower back pain: 
(Bekkering et al., 2005)
Level II: cluster RCT 
Average quality
+ § NA
Lower back pain: 
(Schectman et al., 2003)
Level II: RCT 
Good quality
+ NA
Referral for / 
performance of 
surgical procedure
Gynaecology: 
(Searle et al., 2002)
Level II: RCT 
Average quality
NS NA
Gynaecology (abortion): 
(Foy et al., 2004)
Level II: cluster RCT 
Poor quality
NS § NA
Prescribing Infection:  
(Flottorp et al., 2003)
Level III-1: quasi-RCT 
Poor quality
+ NA
Hypertension, peptic 
ulcer/dyspepsia & 
depression: 
(Nilsson et al., 2001)
Level III-1: quasi-RCT 
Poor quality
+ in 1/8 outcomes NA
Diagnostic 
evaluations
Dementia: 
(Waldorff et al., 2003)
Level III-3: CBA design 
Average quality
NS NA
a Quality of primary studies is determined by EPOC (2002) criteria; b process outcomes = measures of 
implementation of an intervention, such as assessment of participation, compliance and efficiency; c Client 
outcomes = measures of impact on clients’ or patients’ health, such as health status, length of hospitalisation, 
and quality of life; d Data were not extracted for Cooke et al (2001) as baseline and post-intervention scores 
for relevant outcomes were not provided; + indicates intervention was significantly more effective than control 
or usual care; ± indicates mixed effects (significant change in some, but not all outcome measures);  
§ = potential unit of analysis errors in cluster RCTs; CBA = controlled before and after study; NA = not 
assessed; NS = not significant; RCT = randomised controlled trial. 
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9.2.1. How effective are multi-faceted interventions?
Studies varied widely not only in their settings, quality and targeted behaviours, but also in the 
type and number of components combined in the intervention. This high degree of variability 
between studies made synthesis and interpretation of results difficult. 
One of the most well-cited reviews (Wensing, van der Weijden, & Grol, 1998), which has been 
updated more recently (Grimshaw et al., 2004), suggests that “some, but not all multi-faceted 
interventions are effective in inducing change in general practice”. However, there was no 
evidence to suggest that there are any additive effects when strategies are applied concurrently. 
For example, Grimshaw et al. (2004) evaluated 117 multi-faceted intervention studies with 
136 comparisons against controls (no intervention). With up to 11 strategies combined in one 
intervention, analysis showed no evidence of increased effectiveness with increased numbers of 
strategies per intervention.
The additional primary studies combined two to seven different strategies (Table 63 and 
Table 64, Appendix B). They typically involved a mix of professional (including educational) 
interventions and were occasionally complemented with organisational interventions (e.g., 
office systems). Consistent with findings from Grimshaw et al. (2004), there was no evidence 
of greater effectiveness in interventions containing more strategies. Moreover, complex multi-
faceted interventions may be implementing strategies with little evidence of effectiveness.
Overall, there were mixed effects, which probably reflected the heterogeneity of the 
interventions and the diversity of the targeted behaviours. Thus, it was not possible to isolate 
the effects of individual strategies. No particular combination of strategies was always effective; 
and no single common strategy appeared in all the successful multi-faceted interventions. 
Successful interventions generally demonstrated small to modest improvements in process 
outcomes, but benefits to patients were negligible in the few studies that measured patient 
outcomes. 
9.2.2. Key success factors of multi-faceted interventions
Due to the heterogeneity of studies that showed some effect, it was difficult to determine which 
components or combination of components were critical to the success of the intervention. 
Several successful studies reported consultation with representatives from the target population, 
or local consensus processes used in selecting the components of the multi-faceted intervention 
(Bekkering et al., 2005; Forsetlund et al., 2003; Joseph et al., 2004; Lemelin et al., 2001; Searle 
et al., 2002; Waldorff et al., 2003). In addition, interventions that addressed specific barriers 
to change, used a comprehensive plan, and / or used strategies aimed at different levels 
(professional, team, patient, organisation) showed improvements in outcomes (Joseph et al., 
2004; Lemelin et al., 2001; Sanci et al., 2000). 
The factors that are most likely to increase the effectiveness of multi-faceted interventions are:
tailoring the intervention to the work environment and context• 
using interactive strategies• 
providing reinforcement• 
including patient educational materials (for improved patient outcomes).• 
other interventions
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9.2.3. Relevance to AOD field
Two studies were focussed primarily on AOD issues (smoking cessation) (Joseph et al., 2004; 
Young et al., 2002), while another three included delivering smoking cessation advice as part 
of a suite of preventive health measures (Langham et al., 2002; Lemelin et al., 2001; Wright 
et al., 2003). Each intervention aimed to increase health care providers’ skills in delivery of 
smoking cessation services and support during routine consultations, and resulted in an overall 
moderate effect with improvement in some, but not all, study outcomes. Target populations 
included physicians, nurses, psychologists and pharmacists. Use of educational outreach and 
feedback on performance improved practitioners’ provision of advice about the use of nicotine 
replacement therapy in one study (Young et al., 2002). In another study (Joseph et al., 2004), 
educational outreach, CME, and organisational support improved one (documentation of 
smoking status) of seven process outcomes, with no effect on smoking cessation rates among 
smokers. 
Given the high degree of variability within the AOD workforce and the complexity of AOD issues, 
a multi-faceted intervention implemented in the AOD field would benefit from consensus or 
consultation with the local AOD professionals, tailoring for specific targeted populations and 
behaviours, and support at the organisational and individual level. 
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Appendix A Checklists
Systematic review critical appraisal checklist 
Source: (Khan et al., 2001) 
Title of assessment:
Title of systematic review:
Author(s):
Year:
Comparators:
Score :   /6
1. What is the review’s objective? 
What were the population/participants, interventions, outcomes  
and study designs?
2. What sources were searched to identify primary studies? 
What sources (eg databases) were searched and were any restrictions  
by date, language and type of publication used? Were other strategies  
used to identify research? 
3. What were the inclusion criteria and how were they applied?
4. What criteria were used to assess the quality of primary studies and how were they 
applied?
5. How were the data extracted from the primary studies?
6. How were the data synthesised? 
How were differences between studies investigated? 
How were the data combined? Was it reasonable to combine the studies? 
What were the summary results of the review? 
Do the conclusions flow from the evidence reviewed?
EPOC checklist – assessment of methodological quality
Source: (EPOC, 2002) 
Quality criteria for randomised controlled trials (RCTs & CCTs)
Seven standard criteria are used for randomised controlled trials and controlled clinical trials 
included in EPOC reviews:
a) Concealment of allocation (protection against selection bias)
Score DONE if the unit of allocation was by institution, team or professional and any random 
process is described explicitly, e.g., the use of random number tables or coin flips; the unit 
of allocation was by patient or episode of care and there was some form of centralised 
randomisation scheme, an on-site computer system or sealed opaque envelopes were used. 
Score NOT CLEAR if the unit of allocation is not described explicitly; the unit of allocation was 
by patient or episode of care and the authors report using a ‘list’ or ‘table’, ‘envelopes’ or ‘sealed 
envelopes’ for allocation. Score NOT DONE if the authors report using alternation such as 
reference to case record numbers, dates of birth, day of the week or any other such approach 
(as in CCTs); the unit of allocation was by patient or episode of care and the authors report 
using any allocation process that is entirely transparent before assignment such as an open list 
of random numbers or assignments; allocation was altered (by investigators, professionals or 
patients).
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b) Follow-up of professionals (protection against exclusion bias)
Score DONE if outcome measures obtained for 80-100% of subjects randomised. (Do not 
assume 100% follow up unless stated explicitly.); Score NOT CLEAR if not specified in 
the paper; Score NOT DONE if outcome measures obtained for less than 80% of subjects 
randomised.
c) Follow-up of patients or episodes of care
Score DONE if outcome measures obtained for 80-100% of subjects randomised or for patients 
who entered the trial. (Do not assume 100% follow up unless stated explicitly.) Score DONE if 
there is an objective data collection system; Score NOT CLEAR if not specified in the paper; 
Score NOT DONE if outcome measures obtained for less than 80% of subjects randomised or 
for less than 80% of patients who entered the trial.
d) Blinded assessment of primary outcome(s)* (protection against detection bias)
Score DONE if the authors state explicitly that the primary outcome variables were assessed 
blindly OR the outcome variables are objective, e.g., length of hospital stay, drug levels as 
assessed by a standardised test; Score NOT CLEAR if not specified in the paper; Score NOT 
DONE if the outcome(s) were not assessed blindly.
* Primary outcome(s) are those variables that correspond to the primary hypothesis or question as 
defined by the authors. In the event that some of the primary outcome variables were assessed in 
a blind fashion and others were not, score each separately and label each outcome variable clearly.
e) Baseline measurement
Score DONE if performance or patient outcomes were measured prior to the intervention, and 
no substantial differences were present across study groups; Score NOT CLEAR if baseline 
measures are not reported, or if it is unclear whether baseline measures are substantially 
different across study groups; Score NOT DONE if there are differences at baseline in main 
outcome measures likely to undermine the post intervention differences (e.g., are differences 
between the groups before the intervention similar to those found post intervention).
f) Reliable primary outcome measure(s)*
Score DONE if two or more raters with at least 90% agreement or kappa greater than or equal 
to 0.8 OR the outcome is obtained from some automated system e.g., length of hospital stay, 
drug levels as assessed by a standardised test; Score NOT CLEAR if reliability is not reported 
for outcome measures that are obtained by chart extraction or collected by an individual; Score 
NOT DONE if agreement is less than 90% or kappa is less than 0.8.
* In the event that some outcome variables were assessed in a reliable fashion and others were not, 
score each separately on the back of the form and label each outcome variable clearly.
g) Protection against contamination
Score DONE if allocation was by community, institution or practice and it is unlikely that the 
control received the intervention; Score NOT CLEAR if professionals were allocated within 
a clinic or practice and it is possible that communication between experimental and group 
professionals could have occurred; Score NOT DONE if it is likely that the control group 
received the intervention (e.g., cross-over trials or if patients rather than professionals were 
randomised).
Quality criteria for controlled before and after (CBA) designs
Seven standard criteria are used for CBAs included in EPOC reviews:
a) Baseline measurement
Score DONE if performance or patient outcomes were measured prior to the intervention, 
and no substantial differences were present across study groups (e.g., where multiple pre 
intervention measures describe similar trends in intervention and control groups); Score NOT 
CLEAR if baseline measures are not reported, or if it is unclear whether baseline measures  
are substantially different across study groups; Score NOT DONE if there are differences
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at baseline in main outcome measures likely to undermine the post intervention differences 
(e.g., are differences between the groups before the intervention similar to those found post 
intervention).
b) Characteristics for studies using second site as control
Score DONE if characteristics of study and control providers are reported and similar; Score 
NOT CLEAR if it is not clear in the paper e.g., characteristics are mentioned in the text but no 
data are presented; Score NOT DONE if there is no report of characteristics either in the text or 
a table OR if baseline characteristics are reported and there are differences between study and 
control providers.
c) Blinded assessment of primary outcome(s)* (protection against detection bias)
Score DONE if the authors state explicitly that the primary outcome variables were assessed 
blindly OR the outcome variables are objective e.g., length of hospital stay, drug levels as 
assessed by a standardised test; Score NOT CLEAR if not specified in the paper; Score NOT 
DONE if the outcomes were not assessed blindly.
* Primary outcome(s) are those variables that correspond to the primary hypothesis or question as 
defined by the authors. In the event that some of the primary outcome variables were assessed in 
a blind fashion and others were not, score each separately and label each outcome variable clearly.
d) Protection against contamination 
Studies using second site as control - Score DONE if allocation was by community, institution, 
or practice and is unlikely that the control group received the intervention; Score NOT CLEAR 
if providers were allocated within a clinic or practice and communication between experimental 
and group providers was likely to occur; Score NOT DONE if it is likely that the control group 
received the intervention (e.g., cross-over studies or if patients rather than providers were 
randomised).
e) Reliable primary outcome measure(s)*
Score DONE if two or more raters with at least 90% agreement or kappa greater than or equal 
to 0.8 OR the outcome is obtained from some automated system e.g., length of hospital stay, 
drug levels as assessed by a standardised test; Score NOT CLEAR if reliability is not reported 
for outcome measures that are obtained by chart extraction or collected by an individual; Score 
NOT DONE if agreement is less than 90% or kappa is less than 0.8.
* In the event that some outcome variables were assessed in a reliable fashion and others were not, score 
each separately and label each outcome variable clearly.
f) Follow-up of professionals (protection against exclusion bias)
Score DONE if outcome measures obtained 80-100% subjects allocated to groups. (Do not 
assume 100% follow-up unless stated explicitly.); Score NOT CLEAR if not specified in the 
paper; Score NOT DONE if outcome measures obtained for less than 80% of patients allocated 
to groups.
g) Follow-up of patients
Score DONE if outcome measures obtained 80-100% of patients allocated to groups or for 
patients who entered the study. (Do not assume 100% follow-up unless stated explicitly.); Score 
NOT CLEAR if not specified in the paper; Score NOT DONE if outcome measures obtained for 
less than 80% of patients allocated to groups or for less than 80% of patients who entered the 
study.
Quality criteria for interrupted time series (ITSs)
The following seven standard criteria should be used to assess the methodology quality of 
ITS designs included in EPOC reviews. Each criterion is scored DONE, NOT CLEAR or NOT 
DONE. The results of the quality assessment for each study are reported in the Table of 
Included Studies in RevMan. Examples can be obtained from the EPOC review group co-
ordinator.
appendix A checklists
92
a) Protection against secular changes
The intervention is independent of other changes. Score DONE if the intervention occurred 
independently of other changes over time; Score NOT CLEAR if not specified (will be treated as 
NOT DONE if information cannot be obtained from the authors); Score NOT DONE if reported 
that intervention was not independent of other changes in time.
b) Data were analysed appropriately
Score DONE if ARIMA models were used OR time series regression models were used to 
analyse the data and serial correlation was adjusted/tested for; Score NOT CLEAR if not 
specified (will be treated as NOT DONE if information cannot be obtained from the authors); 
Score NOT DONE if it is clear that neither of the conditions above not met.
Reason for the number of points pre and post intervention given - Score DONE if rationale 
for the number of points stated (e.g., monthly data for 12 months post-intervention was used 
because the anticipated effect was expected to decay) OR sample size calculation performed; 
Score NOT CLEAR if not specified (will be treated as NOT DONE if information cannot be 
obtained from the authors); Score NOT DONE if it is clear that neither of the conditions above 
met.
Shape of the intervention effect was specified - Score DONE if a rational explanation for the 
shape of intervention effect was given by the author(s); Score NOT CLEAR if not specified 
(will be treated as NOT DONE if information cannot be obtained from the authors); Score NOT 
DONE if it is clear that the condition above is not met
c) Completeness of data set
Score DONE if data set covers 80-100% of total number of participants or episodes of care 
in the study; Score NOT CLEAR if not specified (will be treated as NOT DONE if information 
cannot be obtained from the authors); Score NOT DONE if data set covers less than 80% of the 
total number of participants or episodes of care in the study.
d) Reliable primary outcome measure(s)*
Score DONE if two or more raters with at least 90% agreement or kappa greater than or equal 
to 0.8 OR the outcome is obtained from some automated system e.g., length of hospital stay, 
drug levels as assessed by a standardised test; Score NOT CLEAR if reliability is not reported 
for outcome measures that are obtained by chart extraction or collected by an individual (will be 
treated as NOT DONE if information cannot be obtained from the authors); Score NOT DONE if 
agreement is less than 90% or kappa is less than 0.8.
* In the event that some outcome variables were assessed in a reliable fashion and others  
were not, score each separately.
e) Protection against detection bias
Intervention unlikely to affect data collection - Score DONE if reported that intervention itself 
was unlikely to affect data collection (for example, sources and methods of data collection were 
the same before and after the intervention); Score NOT CLEAR if not reported (will be treated 
as NOT DONE if information cannot be obtained from the authors); Score NOT DONE if the 
intervention itself was likely to affect data collection (for example, any change in source or 
method of data collection reported).
Blinded assessment of primary outcome(s)* - Score DONE if the authors state explicitly that the 
primary outcome variables were assessed blindly OR the outcome variables are objective e.g., 
length of hospital stay, drug levels as assessed by a standardised test; Score NOT CLEAR if 
not specified (will be treated as NOT DONE if information cannot be obtained from the authors); 
Score NOT DONE if the outcomes were not assessed blindly.
* Primary outcome(s) are those variables that correspond to the primary hypothesis or question as  
defined by the authors. In the event that some of the primary outcome variables were assessed in  
a blind fashion and others were not, score each separately and label each outcome variable clearly.
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I]
R
el
at
iv
e 
ch
an
g
e
U
se
 o
f a
pp
ro
pr
ia
te
sc
re
en
in
g
59
.6
58
.8
-0
.8
[-
3,
 2
]
67
.7
66
.1
-1
.6
[-
5,
1]
2.
0
U
se
 o
f a
sp
iri
n
81
.5
87
.4
+
5.
9
[1
, 1
1]
80
.8
81
.7
+
0.
9
[-
2,
 4
]
0.
2
T
re
at
m
en
t o
pt
io
ns
15
.3
22
.1
6.
8
[2
, 1
2]
17
.4
23
.1
+
5.
7
[1
,1
1]
0.
8
C
rit
er
ia
 fo
r 
ca
ro
tid
en
da
rt
ec
to
m
y
69
.8
63
.4
-6
.4
[-
12
, 2
]
70
.2
65
.3
-4
.9
[-
9,
 1
]
0.
8
(S
ila
gy
 e
t a
l.,
20
02
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
 p
oo
r
G
P
s 
(n
=
24
3)
w
ith
in
 2
 D
iv
is
io
ns
of
 G
en
er
al
P
ra
ct
ic
e,
A
de
la
id
e,
A
us
tr
al
ia
Lo
ca
lly
 a
da
pt
ed
 C
P
G
s
fo
r 
st
ro
ke
 p
re
ve
nt
io
n
(S
P
) 
an
d 
m
an
ag
em
en
t
of
 L
ow
er
 U
rin
ar
y 
T
ra
ct
S
ym
pt
om
s 
(L
U
T
S
)
in
 M
en
In
ve
st
ig
at
io
ns
 fo
r
ca
ro
tid
 s
te
no
si
s
86
.4
93
.2
+
6.
8
[2
, 1
3]
92
.6
91
.8
-0
.8
[-
4,
 3
]
0.
1
a
 p
re
- 
a
n
d
 p
o
st
-i
n
te
rv
e
n
tio
n
 s
co
re
s 
w
e
re
 n
o
t 
in
cl
u
d
e
d
 d
u
e
 t
o
 s
p
a
ce
 r
e
st
ri
ct
io
n
s 
–
 a
va
ila
b
le
 o
n
 r
e
q
u
e
st
; 
b
 m
u
lti
va
ri
a
te
 r
e
g
re
ss
io
n
 a
n
a
ly
si
s 
u
si
n
g
 g
e
n
e
ra
lis
e
d
 e
st
im
a
tin
g
 e
q
u
a
tio
n
s 
(G
E
E
) 
to
 a
cc
o
u
n
t 
fo
r 
b
a
se
lin
e
d
iff
e
re
n
ce
s;
  
c  
a
 q
u
e
st
io
n
n
a
ir
e
 r
e
fe
rr
in
g
 t
o
 4
 c
lin
ic
a
l t
o
p
ic
s 
co
ve
re
d
 b
y 
th
e
 C
P
G
s 
(d
e
m
e
n
tia
, 
co
n
g
e
st
iv
e
 h
e
a
rt
 f
a
ilu
re
, 
u
ri
n
a
ry
 t
ra
ct
 in
fe
ct
io
n
 a
n
d
 p
re
ve
n
tio
n
 o
f 
co
lo
re
ct
a
l c
a
rc
in
o
m
a
) 
te
st
e
d
 t
h
e
 p
h
ys
ic
ia
n
’s
 k
n
o
w
le
d
g
e
a
n
d
 d
e
te
rm
in
e
d
 if
 it
 w
a
s 
co
n
si
st
e
n
t 
w
ith
 t
h
e
 C
P
G
s 
fo
r 
e
a
ch
 c
lin
ic
a
l t
o
p
ic
;. 
d
 D
iv
is
io
n
 A
 r
e
ce
iv
e
d
 t
h
e
 s
ta
n
d
a
rd
/o
ri
g
in
a
l v
e
rs
io
n
 o
f 
L
U
T
S
 C
P
G
s 
a
n
d
 a
ct
e
d
 a
s 
a
 c
o
n
tr
o
l g
ro
u
p
 f
o
r 
D
iv
is
io
n
 B
; 
e
 D
iv
is
io
n
 B
 r
e
ce
iv
e
d
 lo
ca
lly
a
d
a
p
te
d
 C
P
G
s 
fo
r 
L
U
T
S
 a
n
d
 a
ct
e
d
 a
s 
a
 c
o
n
tr
o
l g
ro
u
p
 f
o
r 
D
iv
is
io
n
 A
; 
f 
a
u
th
o
rs
 s
ta
te
d
 n
o
 s
ig
n
ifi
ca
n
t 
d
iff
e
re
n
ce
s 
b
e
tw
e
e
n
 g
ro
u
p
s 
a
t 
b
a
se
lin
e
; 
g
 D
iv
is
io
n
 B
 r
e
ce
iv
e
d
 t
h
e
 s
ta
n
d
a
rd
/o
ri
g
in
a
l v
e
rs
io
n
 o
f 
S
P
 C
P
G
s 
a
n
d
 a
ct
e
d
a
s 
a
 c
o
n
tr
o
l g
ro
u
p
 f
o
r 
D
iv
is
io
n
 A
; 
h
 D
iv
is
io
n
 B
 r
e
ce
iv
e
d
 lo
ca
lly
 a
d
a
p
te
d
 C
P
G
s 
fo
r 
S
P
; 
i  
N
e
w
co
m
b
e
's
 te
st
 f
o
r 
d
iff
e
re
n
ce
s 
in
 p
a
ir
e
d
 p
ro
p
o
rt
io
n
s 
w
a
s 
u
se
d
 f
o
r 
w
ith
in
-D
iv
is
io
n
 c
h
a
n
g
e
s 
in
 k
n
o
w
le
d
g
e
 b
e
tw
e
e
n
 t
h
e
 f
ir
st
 a
n
d
se
co
n
d
 s
u
rv
e
y;
 C
I 
=
 c
o
n
fid
e
n
ce
 in
te
rv
a
l; 
C
P
G
 =
 c
lin
ic
a
l p
ra
ct
ic
e
 g
u
id
e
lin
e
; 
G
P
s 
=
 g
e
n
e
ra
l p
ra
ct
iti
o
n
e
rs
; 
L
U
T
S
 =
 lo
w
e
r 
u
ri
n
a
ry
 t
ra
ct
 s
ym
p
to
m
s;
 N
S
 =
 n
o
t 
si
g
n
ifi
ca
n
t;
 P
S
A
 =
 p
ro
st
a
te
 s
p
e
ci
fic
 a
n
tig
e
n
; 
R
C
T
 =
ra
n
d
o
m
is
e
d
 c
o
n
tr
o
lle
d
 t
ri
a
l; 
S
D
 =
 s
ta
n
d
a
rd
 d
e
vi
a
tio
n
; 
S
P
 =
 s
tr
o
ke
 p
re
ve
n
tio
n
.
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1
1
4
 T
a
b
le
 4
4
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
lo
c
a
l 
c
o
n
s
e
n
s
u
s
 p
ro
c
e
s
s
e
s
 –
 P
a
ti
e
n
t 
o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
 q
u
al
it
y
o
f 
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
In
te
rv
en
ti
o
n
P
at
ie
n
t 
o
u
tc
o
m
es
 (
h
ea
lt
h
 s
ta
tu
s)
A
ss
es
sm
en
t 
o
f 
p
at
ie
n
t 
d
is
ea
se
 s
ym
p
to
m
s
S
ta
n
d
ar
d
 C
P
G
s
n=
27
R
ev
ie
w
 c
ri
te
ri
a
n=
27
C
ri
te
ri
a 
+ 
fe
ed
b
ac
k
n=
27
E
ff
ec
t
M
ea
su
re
O
ut
co
m
e 
m
ea
su
re
s
%
 c
h
an
g
e 
a
%
 c
h
an
g
e 
a
R
el
at
iv
e
ch
an
g
e
%
 c
h
an
g
e 
a
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e 
b
S
ym
pt
om
s 
fo
r 
as
th
m
a,
 m
ea
n 
sc
or
e 
±
S
D
 c
-5
.8
-2
.7
0.
5
+
11
.2
1.
9
0.
02
S
ym
pt
om
s 
fo
r 
an
gi
na
, m
ea
n 
sc
or
e 
±
S
D
  d
P
hy
si
ca
l l
im
ita
tio
n
+
2.
5
-4
.9
2.
0
-3
.5
1.
4
0.
15
A
ng
in
a 
st
ab
ili
ty
-3
.0
+
8.
7
2.
9
+
4.
1
1.
4
0.
03
A
ng
in
a 
fr
eq
ue
nc
y
-2
.4
+
15
.1
6.
4
+
4.
6
2.
0
<
0.
00
1
D
is
ea
se
 p
er
ce
pt
io
n
-4
.9
+
13
.0
2.
7
+
6.
8
1.
4
<
0.
00
1
A
st
hm
a 
tr
ea
tm
en
t, 
%
 o
f p
at
ie
nt
s 
sa
tis
fie
d
A
st
hm
a 
tr
ea
te
d
sa
tis
fa
ct
or
ily
+
0.
8
-0
.3
0.
4
-1
.4
1.
8
0.
83
S
at
is
fa
ct
or
y
ex
pl
an
at
io
ns
ab
ou
t a
st
hm
a
+
1.
6
+
0.
7
0.
4
-1
.4
0.
9
0.
75
A
ng
in
a 
tr
ea
tm
en
t, 
%
 o
f p
at
ie
nt
s 
sa
tis
fie
d
S
at
is
fa
ct
io
n 
w
ith
m
ed
ic
at
io
n
+
0.
9
-6
.1
6.
8
-0
.3
0.
3
0.
03
(B
ak
er
 e
t a
l.,
20
03
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
 g
oo
d
G
en
er
al
pr
ac
tic
es
(n
=
81
)
N
or
th
er
n
E
ng
la
nd
, U
K
In
te
rv
en
tio
n 
1:
P
rio
rit
is
ed
 r
ev
ie
w
cr
ite
ria
 C
P
G
s
In
te
rv
en
tio
n 
2:
R
ev
ie
w
 c
rit
er
ia
 e
nh
an
ce
d
w
ith
 fe
ed
ba
ck
S
at
is
fa
ct
or
y
ex
pl
an
at
io
ns
 a
bo
ut
an
gi
na
 s
ym
pt
om
s
+
1.
8
+
3.
2
1.
8
+
3.
0
1.
7
0.
91
a 
pr
e-
 a
nd
 p
os
t-
in
te
rv
en
tio
n 
sc
or
es
 w
er
e 
no
t i
nc
lu
de
d 
du
e 
to
 s
pa
ce
 r
es
tr
ic
tio
ns
 –
 a
va
ila
bl
e 
on
 r
eq
ue
st
; b
 m
ul
til
ev
el
 m
od
el
lin
g 
us
in
g 
a 
ra
nd
om
 e
ffe
ct
s 
m
od
el
 a
t t
he
 p
ra
ct
ic
e 
le
ve
l; 
c 
se
lf-
re
po
rt
 A
st
hm
a 
S
ym
pt
om
s
Q
ue
st
io
nn
ai
re
, h
ig
h 
sc
or
e 
in
di
ca
te
s 
se
ve
re
 s
ym
pt
om
s;
 d
 s
el
f-
re
po
rt
 S
ea
ttl
e 
A
ng
in
a 
Q
ue
st
io
nn
ai
re
, l
ow
 s
co
re
 in
di
ca
te
s 
se
ve
re
 s
ym
pt
om
s;
 C
P
G
 =
 c
lin
ic
al
 p
ra
ct
ic
e 
gu
id
el
in
e;
 R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l;
S
D
 =
 s
ta
nd
ar
d 
de
vi
at
io
n.
 T
ab
le
 4
3.
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 T
a
b
le
 4
4
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
e
d
u
c
a
ti
o
n
a
l 
m
e
e
ti
n
g
s
 (
C
M
E
) 
–
 P
ro
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
 q
u
al
it
y
o
f 
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
ro
ce
ss
 o
u
tc
o
m
es
 (
p
ra
ct
it
io
n
er
s’
 b
eh
av
io
u
ra
l c
h
an
g
e)
P
ro
p
o
rt
io
n
 o
f 
p
at
ie
n
ts
 r
ec
ei
vi
n
g
 r
ec
o
m
m
en
d
ed
 c
o
u
n
se
lli
n
g
 a
ct
iv
it
ie
s,
 %
 [
95
%
 C
I]
 p
at
ie
n
ts
C
o
n
tr
o
l
T
u
to
ri
al
E
ff
ec
t
m
ea
su
re
 a
B
ef
o
re
n=
50
9
A
ft
er
n=
49
9
%
 c
h
an
g
e
B
ef
o
re
n=
51
3
A
ft
er
n=
64
2
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
C
ou
ns
el
lin
g 
by
 a
ny
 c
lin
ic
ia
n 
b
A
sk
ed
 a
bo
ut
sm
ok
in
g 
st
at
us
61
 [5
7,
 6
5]
67
 [6
3,
 7
1]
+
6.
0
58
 [5
3,
 6
2]
87
 [8
4,
 9
0]
+
29
.0
4.
8
p=
0.
02
A
sk
ed
 a
bo
ut
w
ill
in
gn
es
s 
to
 q
ui
t
26
 [2
2,
 3
0]
30
 [2
6,
34
]
+
4.
0
28
 [2
5,
 3
2]
73
 [6
9,
 7
6]
+
45
.0
11
.3
p<
0.
00
1
A
dv
is
ed
 to
 q
ui
t
32
 [2
8,
36
]
38
 [3
4,
 4
3]
+
6.
0
41
 [3
6,
 4
5]
47
 [4
4,
 5
1]
+
6.
0
1.
0
p=
0.
29
G
iv
en
 q
ui
t l
ite
ra
tu
re
4 
[2
, 5
]
3 
[2
, 5
]
-1
.0
3 
[1
, 4
]
38
 [3
4,
 4
2]
+
35
.0
35
.0
p<
0.
00
1
S
et
 q
ui
t d
at
e
1 
[0
, 2
]
1 
[0
, 2
]
0.
0
2 
[1
, 3
]
27
 [2
4,
 3
1]
+
25
.0
0
p<
0.
00
1
D
is
cu
ss
ed
ph
ar
m
ac
ot
he
ra
py
14
 [1
1,
 1
7]
14
 [1
1,
 1
7]
0.
0
15
 [1
2,
 1
8]
39
 [3
5,
 4
3]
+
24
.0
0
p<
0.
00
1
C
ou
ns
el
lin
g 
by
 in
ta
ke
 c
lin
ic
ia
n 
c
A
sk
ed
 a
bo
ut
sm
ok
in
g 
st
at
us
34
 [3
0,
 3
8]
46
 [4
1,
 5
0]
+
12
.0
30
 [2
7,
 3
5]
81
 [7
7,
 8
4]
+
51
.0
4.
3
p<
0.
00
1
A
sk
ed
 a
bo
ut
w
ill
in
gn
es
s 
to
 q
ui
t
6 
[4
, 7
]
10
 [8
, 1
3]
+
4.
0
5 
[3
, 7
]]
65
 [6
1,
 6
8]
+
60
.0
15
.0
p<
0.
00
1
A
dv
is
ed
 to
 q
ui
t
7 
[5
, 9
]
10
 [8
, 1
3]
+
3.
0
4 
[3
, 6
]
31
 [2
8,
 3
5]
+
27
.0
9.
0
p<
0.
00
1
G
iv
en
 q
ui
t l
ite
ra
tu
re
0 
[0
, 1
]
0 
[0
, 1
]
0.
0
0 
[0
, 1
]
36
 [3
2,
 4
0]
+
36
.0
0
(K
at
z 
et
 a
l.,
20
04
)
Le
ve
l I
I: 
C
lu
st
er
R
C
T
Q
ua
lit
y:
 G
oo
d
C
om
m
un
ity
-
ba
se
d 
pr
im
ar
y
ca
re
 c
lin
ic
s
(n
=
8)
,
S
ou
th
er
n
W
is
co
ns
in
, U
S
A
T
ut
or
ia
l e
nh
an
ce
d
w
ith
 in
di
vi
du
al
fe
ed
ba
ck
, p
ro
m
pt
s,
 a
n
of
fe
r 
of
 fr
ee
 n
ic
ot
in
e
re
pl
ac
em
en
t t
he
ra
py
,
pr
oa
ct
iv
e 
te
le
ph
on
e
co
un
se
lli
ng
S
et
 q
ui
t d
at
e
0 
[0
, 1
]
0 
[0
, 1
]
0.
0
0 
[0
, 1
]
23
 [2
0,
 2
6]
+
23
.0
0
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1
1
6
D
is
cu
ss
ed
ph
ar
m
ac
ot
he
ra
py
0 
[0
, 1
]
0 
[0
, 3
]
0.
0
0 
[0
, 1
]
29
 [2
6,
 3
3]
+
29
.0
0
p<
0.
00
1
P
ro
p
o
rt
io
n
 o
f 
n
u
rs
e 
co
n
su
lt
at
io
n
s 
w
h
er
e 
ke
y 
b
eh
av
io
u
rs
 o
cc
u
rr
ed
, %
C
o
n
tr
o
l
n=
32
 c
on
su
lta
tio
ns
T
ai
lo
re
d
 e
d
u
ca
ti
o
n
al
 t
ra
in
in
g
n=
36
 c
on
su
lta
tio
ns
 a
na
ly
se
d
p
-v
al
u
e 
d
P
at
ie
nt
 d
ec
id
es
 to
pi
c 
to
 d
is
cu
ss
72
.0
83
.0
N
S
P
at
ie
nt
 a
ffi
rm
s 
cu
rr
en
t b
eh
av
io
ur
81
.0
10
0.
0
0.
00
6
P
at
ie
nt
 in
iti
at
es
 d
is
cu
ss
io
n 
of
 c
ha
ng
e
25
.0
50
.0
0.
03
A
ny
 ta
rg
et
 s
et
41
.0
58
.0
N
S
P
at
ie
nt
 a
ct
ua
lly
 s
et
s 
ta
rg
et
28
.0
36
.0
N
S
(P
ill
 e
t a
l.,
19
98
)
Le
ve
l I
I: 
C
lu
st
er
R
C
T
Q
ua
lit
y:
 G
oo
d
G
en
er
al
pr
ac
tit
io
ne
rs
 a
nd
pr
ac
tic
e 
nu
rs
es
fr
om
 g
en
er
al
pr
ac
tic
es
(n
=
29
),
S
ou
th
G
la
m
or
ga
n,
 U
K
D
ia
be
tic
 p
at
ie
nt
s
(n
=
25
2)
T
ra
in
in
g 
(s
up
po
rt
ed
by
 p
re
vi
ou
s 
2-
ye
ar
pa
rt
ic
ip
at
io
n 
in
 C
M
E
en
ha
nc
ed
 w
ith
 a
ud
it)
en
ha
nc
ed
 w
ith
 fo
llo
w
-
up
 s
up
po
rt
 b
y 
a
re
se
ar
ch
 n
ur
se
,
ne
w
sl
et
te
rs
, g
ro
up
m
ee
tin
gs
P
at
ie
nt
 ta
ke
s 
le
ad
 in
 ta
rg
et
 s
et
tin
g
22
.0
28
.0
N
S
P
h
ys
ic
ia
n
s’
 s
ki
lls
 in
 t
h
e 
ap
p
lic
at
io
n
 o
f 
b
ri
ef
 c
o
g
n
it
iv
e 
b
eh
av
io
u
ra
l t
h
er
ap
y 
fo
r 
p
at
ie
n
ts
 w
it
h
 d
ep
re
ss
io
n
, m
ea
n
 ±
S
D
C
o
n
tr
o
l G
P
s 
e
n=
42
T
ra
in
ed
 G
P
s 
e
n=
42
E
ff
ec
t 
m
ea
su
re
M
ea
n
 d
if
fe
re
n
ce
 [
95
%
 C
I]
D
ep
re
ss
io
n 
A
tti
tu
de
 f
T
re
at
m
en
t a
tti
tu
de
 g
48
.2
±
8.
8
46
.3
±
10
.9
-1
.6
  [
-6
.9
, 3
.7
]
P
ro
fe
ss
io
na
l e
as
e 
h
47
.3
±
13
.9
42
.2
±
14
.0
-5
.1
 [-
11
.9
, 1
.7
]
D
ep
re
ss
io
n 
m
al
le
ab
ili
ty
 i
28
.1
±
12
.9
30
.8
±
9.
7
2.
0 
[-
2.
9,
 6
.8
]
D
ep
re
ss
io
n 
id
en
tif
ic
at
io
n 
j
36
.3
±
14
.4
36
.3
±
11
.4
-0
.5
 [-
7.
1,
 6
.0
]
C
B
T
 K
no
w
le
dg
e 
k
C
on
fid
en
ce
 in
 tr
ea
tin
g 
de
pr
es
si
on
29
.2
±
17
.4
20
.9
±
8.
3
-8
.2
 [-
15
.4
, -
1.
0]
(K
in
g 
et
 a
l.,
20
02
)
Le
ve
l I
I: 
C
lu
st
er
R
C
T
Q
ua
lit
y:
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fo
r 
tr
ea
tm
en
t
of
 a
rt
hr
iti
s
46
.1
55
.7
+
9.
6
46
.9
54
.8
+
7.
9
0.
8
p=
0.
88
N
u
rs
es
’ k
n
o
w
le
d
g
e 
o
f 
g
er
ia
tr
ic
 p
h
ar
m
ac
o
lo
g
y,
 m
ea
n
 t
es
t 
sc
o
re
s
T
ra
d
it
io
n
al
 c
o
n
fe
re
n
ce
n=
35
S
el
f-
in
st
ru
ct
io
n
 le
ar
n
in
g
 p
ac
ka
g
e
n=
28
E
ff
ec
t
m
ea
su
re
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
(S
ug
gs
 e
t
al
., 
19
98
)
Le
ve
l I
II-
3:
C
B
A
 d
es
ig
n
Q
ua
lit
y:
 A
ve
ra
ge
R
eg
is
te
re
d
nu
rs
es
 (
n=
63
),
H
ic
ko
ry
,
N
or
th
 C
ar
ol
in
a
an
d 
S
ou
th
C
ar
ol
in
a
M
ul
tim
ed
ia
,
se
lf-
in
st
ru
ct
io
n
ed
uc
at
io
na
l p
ac
ka
ge
vs
 d
id
ac
tic
 c
on
fe
re
nc
e
N
ur
se
s’
 k
no
w
le
dg
e
61
.7
77
.2
+
25
.1
63
.4
71
.8
+
13
.2
0.
5
N
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a 
co
m
pa
ris
on
s 
be
tw
ee
n 
co
nt
ro
l a
nd
 in
te
rv
en
tio
n 
gr
ou
ps
 a
re
 b
as
ed
 o
n 
hi
er
ar
ch
ic
al
 r
eg
re
ss
io
n 
m
od
el
s 
(a
dj
us
te
d 
fo
r 
pa
tie
nt
 c
ov
ar
ia
te
s:
 a
ge
, s
ex
, e
du
ca
tio
na
l l
ev
el
, a
lc
oh
ol
 u
se
, n
um
be
r 
of
 c
ig
ar
et
te
s 
sm
ok
ed
 p
er
 d
ay
,
se
lf-
re
po
rt
ed
 h
ea
lth
 s
ta
tu
s,
 a
nd
 p
re
se
nc
e 
of
 a
no
th
er
 s
m
ok
er
 in
 h
ou
se
ho
ld
);
 b
 a
ny
 c
lin
ic
ia
n 
re
fe
rs
 to
 in
ta
ke
 c
lin
ic
ia
ns
 o
r 
pr
im
ar
y 
ca
re
 c
lin
ic
ia
ns
 in
cl
ud
in
g 
ph
ys
ic
ia
ns
, n
ur
se
 p
ra
ct
iti
on
er
s 
an
d 
as
si
st
an
ts
; 
c  
in
ta
ke
cl
in
ic
ia
ns
 r
ef
er
s 
to
 r
eg
is
te
re
d 
nu
rs
es
, l
ic
en
se
d 
pr
ac
tic
al
 n
ur
se
s,
 a
nd
 m
ed
ic
al
 a
ss
is
ta
nt
s;
 d
 b
as
el
in
e 
m
ea
su
re
s 
no
t p
ro
vi
de
d,
 b
ut
 r
ep
or
te
d 
as
 s
im
ila
r;
 e
 s
co
re
s 
ar
e 
po
st
-in
te
rv
en
tio
n,
 b
as
el
in
e 
sc
or
es
 w
er
e 
ad
ju
st
ed
 fo
r
us
in
g 
lin
ea
r 
re
gr
es
si
on
; f
 B
ot
eg
a 
et
 a
l 1
99
2 
an
d 
K
er
r 
et
 a
l 1
99
5;
 g
 h
ig
h 
sc
or
e 
in
di
ca
te
s 
a 
pr
ef
er
en
ce
 fo
r 
bi
ol
og
ic
al
 th
eo
rie
s 
an
d 
an
tid
ep
re
ss
an
ts
; l
ow
 s
co
re
 in
di
ca
te
s 
an
 o
rie
nt
at
io
n 
to
 p
sy
ch
ot
he
ra
py
: i
de
al
 o
ut
co
m
e 
=
lo
w
 s
co
re
; h
 h
ig
h 
sc
or
e 
in
di
ca
te
s 
th
at
 G
P
 is
 u
nc
om
fo
rt
ab
le
 in
 d
ea
lin
g 
w
ith
 d
ep
re
ss
io
n 
an
d 
se
es
 it
 a
s 
un
re
w
ar
di
ng
: i
de
al
 o
ut
co
m
e 
=
 lo
w
 s
co
re
; i
 h
ig
h 
sc
or
e 
in
di
ca
te
s 
pe
ss
im
is
m
 a
bo
ut
 m
od
ify
in
g 
th
e 
co
ur
se
 o
f
de
pr
es
si
on
: i
de
al
 o
ut
co
m
e 
=
 lo
w
 s
co
re
; j
 h
ig
h 
sc
or
e 
in
di
ca
te
s 
di
ffi
cu
lty
 in
 d
iff
er
en
tia
tin
g 
de
pr
es
si
on
 fr
om
 u
nh
ap
pi
ne
ss
 a
nd
 li
ttl
e 
co
nf
id
en
ce
 in
 tr
ea
tm
en
ts
 b
ey
on
d 
th
os
e 
us
ua
lly
 p
ro
vi
de
d:
 id
ea
l o
ut
co
m
e 
=
 lo
w
 s
co
re
;
k 
qu
es
tio
nn
ai
re
 e
xp
lo
re
d 
G
P
s’
 k
no
w
le
dg
e 
of
 C
B
T
 a
nd
 th
e 
ex
te
nt
 to
 w
hi
ch
 th
ey
 fe
el
 c
on
fid
en
t i
n 
ap
pl
yi
ng
 it
 to
 p
ra
ct
ic
e;
 l  
hi
gh
 s
co
re
 fo
r 
co
nf
id
en
ce
 o
ut
co
m
es
 in
di
ca
te
s 
a 
la
ck
 o
f c
on
fid
en
ce
 in
 tr
ea
tin
g 
de
pr
es
si
on
 o
r
an
xi
et
y:
 id
ea
l o
ut
co
m
e 
=
 lo
w
 s
co
re
; 
m
 B
as
el
in
e 
sc
or
es
 n
ot
 p
ro
vi
de
d,
 b
ut
 r
ep
or
te
d 
as
 s
im
ila
r;
 n
 K
ru
sk
al
-W
al
lis
 te
st
 fo
r 
di
ffe
re
nc
es
 fr
om
 b
as
el
in
e 
an
d 
S
tu
de
nt
’s
 t-
te
st
 fo
r 
di
ffe
re
nc
es
 b
et
w
ee
n 
gr
ou
ps
; o
 S
el
f-
tr
ai
ni
ng
co
nt
ro
l =
 w
ai
tin
g 
lis
t g
ro
up
 r
ec
ei
ve
d 
m
an
ua
l a
nd
 tr
ai
ni
ng
 v
id
eo
ta
pe
s;
 p
 M
ot
iv
at
io
na
l I
nt
er
vi
ew
in
g 
sp
iri
t =
 g
lo
ba
l m
ea
su
re
 o
f M
I p
ro
fic
ie
nc
y.
 M
ea
su
re
s 
in
cl
ud
ed
 o
ve
ra
ll 
M
I s
pi
rit
, %
 M
I c
on
si
st
en
t r
es
po
ns
es
, r
at
io
 o
f
re
fle
ct
io
ns
 to
 q
ue
st
io
ns
, %
 q
ue
st
io
ns
 th
at
 w
er
e 
op
en
, %
 r
ef
le
ct
io
ns
 th
at
 w
er
e 
co
m
pl
ex
, %
 th
er
ap
is
t’s
 in
-s
es
si
on
 ta
lk
 ti
m
e;
 q
 e
st
im
at
ed
 r
el
at
iv
e 
ra
te
s 
w
er
e 
ba
se
d 
on
 a
 c
on
di
tio
na
l P
oi
ss
on
 r
eg
re
ss
io
n 
m
od
el
 w
ith
 d
oc
to
r-
sp
ec
ifi
c 
ra
te
 v
ar
ia
bl
es
; r
 2
x2
 fa
ct
or
ia
l d
es
ig
n 
- 
G
ro
up
s 
A
 a
nd
 B
 h
ad
 b
ee
n 
on
 a
 c
ou
rs
e;
 G
ro
up
s 
C
 a
nd
 D
 h
ad
 n
ot
, G
ro
up
s 
A
 a
nd
 C
 r
ec
ei
ve
d 
fe
ed
ba
ck
; g
ro
up
s 
B
 a
nd
 D
 d
id
 n
ot
. F
ol
lo
w
-u
p 
w
as
 3
 m
on
th
s;
 s
 p
re
- 
an
d 
po
st
-
sc
or
es
 w
er
e 
no
t i
nc
lu
de
d 
du
e 
to
 s
pa
ce
 r
es
tr
ic
tio
ns
 –
 a
va
ila
bl
e 
up
on
 r
eq
ue
st
; t
 a
nt
im
ic
ro
bi
al
s 
in
cl
ud
ed
 a
nt
ib
io
tic
s,
 c
he
m
ot
he
ra
pe
ut
ic
s 
an
d 
an
tia
m
oe
bi
cs
; u
 A
nt
id
ia
rr
ho
el
s 
in
cl
ud
ed
 s
pa
sm
ol
yt
ic
s,
 a
ds
or
be
nt
s 
an
d
an
tid
ia
rr
ho
ea
l f
ix
ed
 c
om
bi
na
tio
ns
; v
 k
no
w
le
dg
e 
sc
or
e 
ra
ng
ed
 fr
om
 0
-2
9 
(h
ig
h)
; w
 A
tti
tu
de
/s
ki
lls
 s
co
re
s 
ra
ng
ed
 fr
om
 2
5 
(v
er
y 
co
m
fo
rt
ab
le
 d
ea
lin
g 
w
ith
 b
re
as
t c
an
ce
r 
is
su
es
) 
to
 1
25
 (
un
co
m
fo
rt
ab
le
);
 x
 C
om
m
un
ic
at
io
n
sk
ill
s 
ba
se
d 
on
 r
at
in
g 
sy
st
em
 fo
r 
ea
ch
 u
tte
ra
nc
e 
by
 h
ea
lth
 c
ar
e 
pr
ov
id
er
 d
ur
in
g 
in
te
rv
ie
w
s.
 E
xa
m
pl
es
 o
f c
at
eg
or
ie
s 
ar
e 
gi
ve
n 
he
re
; 
y  
F
or
m
 o
f u
tte
ra
nc
e 
=
 s
ta
te
m
en
ts
 a
nd
 ty
pe
s 
of
 q
ue
st
io
ns
 (
8 
ca
te
go
rie
s)
;
z 
F
un
ct
io
n 
of
 u
tte
ra
nc
e 
=
 e
va
lu
at
iv
e,
 s
up
po
rt
iv
e,
 in
fo
rm
in
g,
 a
dv
is
in
g 
an
d 
in
te
rp
re
tiv
e 
fu
nc
tio
ns
 (
21
 c
at
eg
or
ie
s)
; a
a  
P
sy
ch
ol
og
ic
al
 d
ep
th
 o
f i
nt
er
vi
ew
s 
=
 u
tte
ra
nc
es
 a
bo
ut
 fe
el
in
gs
 r
at
he
r 
th
an
 fa
ct
s 
al
on
e;
 b
b  
K
no
w
le
dg
e
sc
or
e 
=
 n
um
be
r 
of
 c
or
re
ct
 a
ns
w
er
s 
to
 1
0 
qu
es
tio
ns
; c
c 
S
ki
lls
 m
ea
su
re
 =
 %
 o
f p
hy
si
ci
an
s 
w
ho
 in
di
ca
te
d 
us
in
g 
ce
ss
at
io
n 
te
ch
ni
qu
e;
 d
d 
N
ic
ot
in
e 
fa
di
ng
 is
 a
n 
in
ef
fe
ct
iv
e 
te
ch
ni
qu
e 
an
d 
de
cr
ea
se
 in
 r
ec
om
m
en
da
tio
ns
 is
an
 im
pr
ov
em
en
t i
n 
pr
ac
tic
e;
 e
e 
B
es
t p
ra
ct
ic
e 
in
 a
rt
hr
iti
s 
ca
re
 w
as
 a
ss
es
se
d 
us
in
g 
H
ea
lth
 A
ss
es
sm
en
t Q
ue
st
io
nn
ai
re
 a
nd
 M
ed
ic
al
 O
ut
co
m
e 
S
tu
dy
 S
ho
rt
 F
or
m
-3
6;
 ff
 C
hi
-s
qu
ar
e 
te
st
s 
w
er
e 
pe
rf
or
m
ed
 to
 a
ss
es
s
di
ffe
re
nc
es
; A
S
O
s 
=
 A
ID
S
 s
er
vi
ce
 o
rg
an
is
at
io
ns
; C
B
A
 =
 c
on
tr
ol
le
d 
be
fo
re
 a
nd
 a
fte
r 
st
ud
y;
 C
B
T
 =
 c
og
ni
tiv
e 
be
ha
vi
ou
r 
th
er
ap
y;
 C
I =
 c
on
fid
en
ce
 in
te
rv
al
; C
P
G
s 
=
 C
lin
ic
al
 P
ra
ct
ic
e 
G
ui
de
lin
es
; G
P
s 
=
 G
en
er
al
pr
ac
tit
io
ne
rs
; M
I =
 m
ot
iv
at
io
na
l i
nt
er
vi
ew
in
g;
 N
E
 =
 n
ot
 e
st
im
ab
le
; N
R
T
 =
 n
ic
ot
in
e 
re
pl
ac
em
en
t t
he
ra
py
; O
R
S
 =
 o
ra
l d
eh
yd
ra
tio
n 
so
lu
tio
n;
 P
H
C
 =
 p
rim
ar
y 
he
al
th
 c
ar
e;
 R
R
 =
 r
el
at
iv
e 
ra
te
; S
D
 =
 s
ta
nd
ar
d 
de
vi
at
io
n.
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1
2
4
 T
a
b
le
 4
5
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
e
d
u
c
a
ti
o
n
a
l 
m
e
e
ti
n
g
s
 (
C
M
E
) 
–
 P
a
ti
e
n
t 
o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
at
ie
n
t 
o
u
tc
o
m
es
 (
h
ea
lt
h
 s
ta
tu
s)
S
m
o
ki
n
g
 c
es
sa
ti
o
n
 o
u
tc
o
m
es
, %
 o
f 
p
at
ie
n
ts
C
o
n
tr
o
l
T
u
to
ri
al
E
ff
ec
t
m
ea
su
re
 a
B
ef
o
re
n=
50
9
A
ft
er
n=
49
9
%
 c
h
an
g
e
B
ef
o
re
n=
51
3
A
ft
er
n=
64
2
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
A
ny
 q
ui
t a
tte
m
pt
41
 [3
8,
 4
5]
50
 [4
6,
 5
5]
+
9.
0
44
 [4
0,
 4
8]
57
 [5
3,
 6
1]
+
13
.0
1.
4
p=
0.
06
<
10
 c
ig
ar
et
te
s
sm
ok
ed
/d
ay
48
 [3
8,
 5
8]
63
 [5
3,
 7
3]
+
15
.0
51
 [4
1,
 6
1]
58
 [4
9,
 6
7]
+
7.
0
0.
5
p=
0.
30
!1
0 
ci
ga
re
tte
s
sm
ok
ed
/d
ay
39
 [3
5,
 4
4]
47
 [4
2,
 5
2]
+
8.
0
42
 [3
7,
 4
7]
57
 [5
2,
 6
1]
+
15
.0
1.
9
p=
0.
02
2-
m
on
th
 q
ui
t r
at
e 
b
5 
[3
, 7
]
6 
[4
, 8
]
+
1.
0
5 
[3
, 7
]
16
 [1
3,
 1
9]
+
11
.0
11
.0
p<
0.
00
1
<
10
 c
ig
ar
et
te
s
sm
ok
ed
/d
ay
9 
[4
, 1
5]
9 
[3
, 1
5]
0.
0
9 
[3
, 1
5]
13
 [7
, 9
]
+
4.
0
0
p=
0.
71
!1
0 
ci
ga
re
tte
s
sm
ok
ed
/d
ay
4 
[2
, 6
]
5 
[3
, 7
]
+
1.
0
4 
[2
, 6
]
17
 [1
4,
 2
1]
+
13
.0
13
.0
p<
0.
00
1
6-
m
on
th
 q
ui
t r
at
e 
b
9 
[6
, 1
1]
10
 [7
, 1
2]
+
1.
0
8 
[5
, 1
0]
15
 [1
3,
 1
8]
+
7.
0
7.
0
p=
0.
00
9
<
10
 c
ig
ar
et
te
s
sm
ok
ed
/d
ay
15
 [8
, 2
2]
19
 [1
1,
 2
6]
+
4.
0
15
 [8
, 2
2]
20
 [1
3,
 2
7]
+
5.
0
1.
3
p=
0.
93
!1
0 
ci
ga
re
tte
s
sm
ok
ed
/d
ay
7 
[5
, 1
0]
8 
[5
,1
0]
+
1.
0
6 
[4
, 8
]
14
 [1
1,
 1
7]
+
8.
0
8.
0
p<
0.
00
1
C
on
tin
uo
us
 a
bs
tin
en
ce
 c
4 
[2
, 5
]
4 
[2
, 5
]
0.
0
3 
[1
. 4
]
11
 [8
, 1
3]
+
8.
0
0
p<
0.
00
1
(K
at
z 
et
 a
l.,
20
04
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
 G
oo
d
A
du
lt 
pa
tie
nt
s
w
ho
 s
m
ok
ed
 a
t
le
as
t o
ne
ci
ga
re
tte
 p
er
da
y 
an
d
pr
es
en
te
d 
fo
r
no
n-
em
er
ge
nc
y
ca
re
 d
ur
in
g 
th
e
ba
se
lin
e 
pe
rio
d
(n
=
21
63
)
S
ou
th
er
n
W
is
co
ns
in
,
U
S
A
T
ut
or
ia
l e
nh
an
ce
d
w
ith
 in
di
vi
du
al
pe
rf
or
m
an
ce
fe
ed
ba
ck
, u
se
 o
f a
m
od
ifi
ed
 v
ita
l s
ig
ns
st
am
p 
(p
ro
m
pt
),
 a
n
of
fe
r 
of
 fr
ee
 n
ic
ot
in
e
re
pl
ac
em
en
t t
he
ra
py
,
pr
oa
ct
iv
e 
te
le
ph
on
e
co
un
se
lli
ng
<
10
 c
ig
ar
et
te
s
sm
ok
ed
/d
ay
6 
[1
, 1
1]
5 
[1
, 1
0]
-1
.0
5 
[1
, 9
]
10
 [5
, 1
6]
+
5.
0
5.
0
p=
0.
22
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!1
0 
ci
ga
re
tte
s
sm
ok
ed
/d
ay
3 
[1
, 5
]
3 
[2
, 5
]
0.
0
2 
[1
, 4
]
11
 [8
, 1
4]
+
9.
0
0
p<
0.
00
1
Q
u
al
it
y 
o
f 
lif
e 
am
o
n
g
 p
at
ie
n
ts
 w
it
h
 a
st
h
m
a,
 m
ea
n
 s
q
u
ar
e 
ro
o
t 
[9
5%
 C
I]
 d
C
o
n
tr
o
l
n=
90
3
T
ea
ch
in
g
 s
es
si
o
n
s 
+
su
p
p
o
rt
n=
65
9
D
if
fe
re
n
ce
E
ff
ec
t 
m
ea
su
re
O
d
d
s 
ra
ti
o
 [
95
%
 C
I]
(P
re
m
ar
at
n
e 
et
 a
l.,
19
99
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
 G
oo
d
G
en
er
al
pr
ac
tic
es
 w
ith
 a
pr
ac
tic
e 
nu
rs
e
(n
=
41
),
A
ll 
re
gi
st
er
ed
pa
tie
nt
s 
ag
ed
15
-5
0 
ye
ar
s
(n
=
24
,0
00
)
G
re
en
w
ic
h,
Lo
nd
on
, U
K
6 
te
ac
hi
ng
 s
es
si
on
s
co
nd
uc
te
d 
by
 N
ur
se
sp
ec
ia
lis
ts
 in
 a
st
hm
a
an
d 
fo
llo
w
-u
p 
su
pp
or
t,
pr
ac
tic
e 
nu
rs
es
 in
 tu
rn
ed
uc
at
ed
 p
at
ie
nt
s 
in
th
e 
m
an
ag
em
en
t o
f
as
th
m
a 
ac
co
rd
in
g 
to
th
e 
B
rit
is
h 
T
ho
ra
ci
c
S
oc
ie
ty
’s
 g
ui
de
lin
es
Q
ua
lit
y 
of
 li
fe
, m
ea
n
sq
ua
re
 r
oo
t
1.
5
[1
.4
6,
 1
.5
4]
1.
5
[1
.4
7,
 1
.5
6]
-0
.0
1 
[0
.1
1,
 0
.0
9]
p=
0.
85
1.
07
 [0
.7
6,
 1
.5
2]
p=
0.
68
P
at
ie
n
ts
 e
m
o
ti
o
n
al
 s
ym
p
to
m
s,
 m
ea
n
 s
co
re
±
S
D
C
o
n
tr
o
l d
o
ct
o
rs
n=
13
5
T
ra
in
ed
 d
o
ct
o
rs
n=
13
7
E
ff
ec
t 
m
ea
su
re
M
ea
n
 d
if
fe
re
n
ce
[9
5%
 C
I]
B
ec
k 
de
pr
es
si
on
 in
ve
nt
or
y
16
.6
±
11
.5
17
.5
±
9.
6
-0
.2
 [-
2.
3,
 1
.9
]
p=
0.
84
S
ta
te
 a
nx
ie
ty
48
.2
±
14
.9
48
.6
±
13
.8
0.
8 
[-
2.
4,
 4
.0
]
p=
0.
62
T
ra
it 
an
xi
et
y
50
.4
±
13
.7
52
.3
±
13
.2
0.
9 
[-
2.
0,
 3
.8
]
p=
0.
53
S
F
-3
6 
di
m
en
si
on
s,
 %
 o
f p
at
ie
nt
s
%
 w
ith
 r
ol
e 
lim
ita
tio
ns
(e
m
ot
io
na
l) 
- 
al
l a
re
as
33
.0
47
.0
2.
7 
[1
.1
, 6
.4
]
p=
0.
03
S
oc
ia
l f
un
ct
io
n
29
.2
29
.7
-3
.1
 [-
9.
4,
 3
.1
]
p=
0.
32
M
en
ta
l h
ea
lth
21
.0
20
.8
0.
1 
[-
4.
4,
 4
.6
]
p=
0.
96
(K
in
g 
et
 a
l.,
20
02
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
A
ve
ra
ge
M
en
ta
l h
ea
lth
pa
tie
nt
s 
w
ho
sc
or
ed
 a
bo
ve
th
e 
th
re
sh
ol
d
fo
r
ps
yc
ho
lo
gi
ca
l
di
st
re
ss
 o
n 
th
e
ho
sp
ita
l a
nx
ie
ty
an
d 
de
pr
es
si
on
sc
al
e 
(n
=
27
2)
N
or
th
 L
on
do
n,
U
K
T
ra
in
in
g 
pa
ck
ag
e:
4-
ha
lf 
da
y 
co
gn
iti
ve
be
ha
vi
ou
ra
l t
he
ra
py
w
or
ks
ho
ps
 a
t o
ne
-
w
ee
k 
in
te
rv
al
s
E
ne
rg
y 
an
d 
vi
ta
lit
y
25
.1
21
.7
-1
.0
 [-
5.
7,
 3
.6
]
p=
0.
66
1
2
6
a 
co
m
pa
ris
on
s 
be
tw
ee
n 
co
nt
ro
l a
nd
 in
te
rv
en
tio
n 
gr
ou
ps
 a
re
 b
as
ed
 o
n 
hi
er
ar
ch
ic
al
 r
eg
re
ss
io
n 
m
od
el
s 
ad
ju
st
ed
 fo
r 
pa
tie
nt
 c
ov
ar
ia
te
s:
 a
ge
, s
ex
, e
du
ca
tio
na
l l
ev
el
, a
lc
oh
ol
 u
se
, n
um
be
r 
of
 c
ig
ar
et
te
s 
sm
ok
ed
 p
er
 d
ay
,
se
lf-
re
po
rt
ed
 h
ea
lth
 s
ta
tu
s,
 a
nd
 p
re
se
nc
e 
of
 a
no
th
er
 s
m
ok
er
 in
 h
ou
se
ho
ld
; b
 q
ui
t r
at
es
 =
 th
e 
pr
op
or
tio
n 
of
 p
at
ie
nt
s 
w
ho
 r
ep
or
t a
bs
tin
en
ce
 o
ve
r 
th
e 
pr
io
r 
7 
da
ys
 a
t 2
- 
an
d 
6-
m
on
th
 fo
llo
w
-u
p;
c 
co
nt
in
uo
us
 a
bs
tin
en
ce
 =
 s
el
f-
re
po
rt
ed
 a
bs
tin
en
ce
 a
t b
ot
h 
2-
 a
nd
 6
-m
on
th
 fo
llo
w
-u
p;
 d
 M
ea
n 
sq
ua
re
 r
oo
t q
ua
lit
y 
of
 li
fe
 h
ig
h 
sc
or
e 
of
 2
.5
 c
or
re
sp
on
de
d 
to
 a
ve
ra
ge
 a
ns
w
er
 o
f ‘
m
ild
ly
’ t
o 
20
 q
ue
st
io
ns
 (
no
ne
, m
ild
ly
,
m
od
er
at
el
y,
 s
ev
er
el
y,
 v
er
y 
se
ve
re
ly
);
 C
I =
 c
on
fid
en
ce
 in
te
rv
al
; R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l; 
S
D
 =
 s
ta
nd
ar
d 
de
vi
at
io
n.
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 T
a
b
le
 4
6
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
e
d
u
c
a
ti
o
n
a
l 
o
u
tr
e
a
c
h
 v
is
it
s
 –
 P
ro
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
ro
ce
ss
 o
u
tc
o
m
es
 (
p
ra
ct
it
io
n
er
s’
 b
eh
av
io
u
ra
l c
h
an
g
e)
G
P
s’
 m
an
ag
em
en
t 
o
f 
h
yp
er
te
n
si
o
n
 in
 e
ld
er
ly
 p
at
ie
n
ts
, r
ep
o
rt
ed
 t
h
re
sh
o
ld
 a
 f
o
r 
tr
ea
ti
n
g
 s
ys
to
lic
 h
yp
er
te
n
si
o
n
C
o
n
tr
o
l b
n=
9 
pr
ac
tic
es
; 3
5 
G
P
s
E
d
u
ca
ti
o
n
al
 o
u
tr
ea
ch
 v
is
it
: 
b
n=
9 
pr
ac
tic
es
; 3
4 
G
P
s
E
ff
ec
t
m
ea
su
re
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
(C
ra
nn
ey
 e
t
al
., 
19
99
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
 g
oo
d
P
H
C
 p
ra
ct
ic
es
(n
=
18
),
 g
en
er
al
pr
ac
tit
io
ne
rs
E
ld
er
ly
 p
at
ie
nt
s,
ag
ed
 7
0-
79
ye
ar
s,
 w
ith
hy
pe
rt
en
si
on
(n
=
69
)
U
K
P
ra
ct
ic
e-
ba
se
d
ed
uc
at
io
na
l o
ut
re
ac
h
vi
si
t: 
sm
al
l-g
ro
up
,
se
m
i-s
tr
uc
tu
re
d,
 o
ne
-
ho
ur
 s
es
si
on
 le
d 
by
tr
ai
ne
d 
ed
uc
at
io
na
l
fa
ci
lit
at
or
G
P
s’
 r
ep
or
te
d 
th
re
sh
ol
d
fo
r 
sy
st
ol
ic
 B
P
 (
m
m
H
g)
16
6.
6
16
7.
2
0.
4
17
2.
7
16
1.
8
-6
.3
15
.8
p=
0.
00
7
D
ru
g
 p
re
sc
ri
b
in
g 
c ,
 m
ea
n
 ±
S
D
C
o
n
tr
o
l
n=
7 
pr
ac
tic
es
; 3
6 
G
P
s
M
ai
le
d
 g
u
id
el
in
es
n=
6 
pr
ac
tic
es
; 3
6 
G
P
s
M
ai
le
d
 g
u
id
el
in
es
 +
E
d
u
ca
ti
o
n
al
 o
u
tr
ea
ch
 v
is
it
n=
7 
pr
ac
tic
es
; 3
5 
G
P
s
%
 c
h
an
g
e 
d
%
 c
h
an
g
e 
d
R
el
at
iv
e
ch
an
g
e
%
 c
h
an
g
e 
d
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
R
ec
om
m
en
de
d 
3 
N
S
A
ID
s,
%
 o
f t
ot
al
 N
S
A
ID
+
2.
8
+
4.
3
1.
5
+
5.
9
2.
1
p=
0.
29
T
op
 5
 N
S
A
ID
s,
 %
 o
f
to
ta
l N
S
A
ID
+
0.
3
+
1.
7
5.
7
+
3.
0
10
.0
p=
0.
00
9
Ib
up
ro
fe
n,
 D
D
D
s 
pe
r 
10
00
S
T
A
R
-P
U
s 
e
-4
.9
+
3.
8
0.
8
-5
.6
1.
1
p=
0.
44
Ib
up
ro
fe
n,
 %
 to
ta
l D
D
D
s
-7
.4
+
3.
2
0.
4
+
1.
8
0.
2
p=
0.
39
T
ot
al
 v
ol
um
e,
 D
D
D
s 
pe
r
10
00
 S
T
A
R
-P
U
s 
e
+
1.
4
+
0.
5
0.
4
-8
.8
6.
2
p=
0.
10
(W
at
so
n 
et
al
., 
20
01
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
 g
oo
d
G
en
er
al
P
ra
ct
ic
es
(n
=
20
),
A
vo
n,
 E
ng
la
nd
In
te
rv
en
tio
n 
1:
M
ai
le
d 
gu
id
el
in
es
 fo
r
th
e 
us
e 
of
 o
ra
l
N
S
A
ID
s 
in
 th
e
m
an
ag
em
en
t o
f o
ra
l
m
us
cu
lo
sk
el
et
al
di
so
rd
er
s
In
te
rv
en
tio
n 
2:
M
ai
le
d 
gu
id
el
in
es
 p
lu
s
2 
on
e-
to
-o
ne
ed
uc
at
io
na
l o
ut
re
ac
h
vi
si
t f
ro
m
 c
om
m
un
ity
ph
ar
m
ac
is
ts
T
ot
al
 c
os
t, 
N
IC
 (
£)
 p
er
10
00
 S
T
A
R
-P
U
s 
e
+
8.
9
+
4.
5
0.
5
-6
.2
0.
7
p=
0.
08
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1
3
0
N
ov
 ’9
6-
Ja
n 
’9
7
+
15
.0
+
12
.1
0.
8
F
eb
-A
pr
 ’9
7
+
13
.1
+
5.
7
0.
4
M
ay
-J
ul
 ‘9
7
+
24
.2
+
21
.3
0.
9
A
ug
-O
ct
 ‘9
7
+
21
.6
+
19
.0
0.
9
N
ov
 ’9
7-
Ja
n 
‘9
8
+
23
.5
+
19
.5
0.
8
N
ew
ca
st
le
 M
ay
-J
ul
 ‘9
6
+
13
.0
+
9.
5
0.
3
N
S
q
A
ug
-O
ct
 ‘9
6
+
15
.7
+
15
.5
1.
0
N
ov
 ’9
6-
Ja
n 
’9
7
+
21
.7
+
20
.3
0.
9
F
eb
-A
pr
 ’9
7
+
28
.7
+
32
.4
1.
1
M
ay
-J
ul
 ‘9
7
+
36
.5
+
32
.4
0.
9
A
ug
-O
ct
 ‘9
7
+
33
.9
+
29
.0
0.
8
N
ov
 ’9
7-
Ja
n 
‘9
8
+
42
.6
+
33
.1
0.
8
C
o
m
p
lia
n
ce
 w
it
h
 g
u
id
el
in
es
 f
o
r 
m
an
ag
em
en
t 
o
f 
h
el
ic
o
b
ac
te
r 
p
yl
o
ri
 e
ra
d
ic
at
io
n
o
, m
ea
n
 p
re
sc
ri
b
in
g
 f
o
r 
m
et
ro
n
id
az
o
le
 d
o
se
u
n
it
s 
p
er
 q
u
ar
te
r,
 p
er
 p
at
ie
n
t
M
ai
le
d
 c
lin
ic
al
 p
ra
ct
ic
e 
g
u
id
el
in
es
 %
 c
h
an
g
e 
p
N
or
th
 T
yn
es
id
e:
 n
=
16
; N
ew
ca
st
le
: n
=
22
E
d
u
ca
ti
o
n
al
 o
u
tr
ea
ch
 v
is
it
 +
 m
ai
le
d
 c
lin
ic
al
 p
ra
ct
ic
e 
g
u
id
el
in
es
 %
 c
h
an
g
e 
p
N
or
th
 T
yn
es
id
e:
 n
=
16
; N
ew
ca
st
le
: n
=
22
R
el
at
iv
e
ch
an
g
e
N
or
th
 T
yn
es
id
e
M
ay
-J
ul
 ‘9
6
0
0
0
N
S
q
A
ug
-O
ct
 ‘9
6
+
23
.1
+
22
.2
1.
0
N
ov
 ’9
6-
Ja
n 
’9
7
+
23
.1
+
44
.4
1.
9
F
eb
-A
pr
 ’9
7
+
30
.8
+
22
.2
0.
7
M
ay
-J
ul
 ‘9
7
+
23
.1
+
22
.2
1.
0
A
ug
-O
ct
 ‘9
7
+
46
.2
+
44
.4
1.
0
N
ov
 ’9
7-
Ja
n 
‘9
8
+
46
.2
+
66
.7
1.
4
N
ew
ca
st
le
 M
ay
-J
ul
 ‘9
6
+
17
.6
+
30
.8
1.
8
N
S
q
re
ce
iv
in
g 
ul
ce
r-
he
al
in
g 
dr
ug
s
w
ho
 m
ay
 b
e
el
ig
ib
le
 fo
r
he
lic
ob
ac
te
r
py
lo
ri
er
ad
ic
at
io
n
to
 p
os
ta
l d
is
tr
ib
ut
io
n 
of
ed
uc
at
io
na
l m
at
er
ia
ls
ba
se
d 
on
 th
e 
co
nt
en
t
of
 th
e 
gu
id
el
in
es
A
ug
-O
ct
 ‘9
6
+
5.
9
+
30
.8
5.
2
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N
ov
 ’9
6-
Ja
n 
’9
7
-5
.9
+
38
.5
6.
5
F
eb
-A
pr
 ’9
7
-1
1.
8
+
23
.1
2.
0
M
ay
-J
ul
 ‘9
7
+
17
.6
+
38
.5
2.
2
A
ug
-O
ct
 ‘9
7
+
23
.5
+
53
.8
2.
3
N
ov
 ’9
7-
Ja
n 
‘9
8
+
5.
9
+
38
.5
6.
5
R
at
e 
o
f 
an
ti
b
io
ti
c 
co
u
rs
es
 d
is
p
en
se
d
 t
o
 c
h
ild
re
n
 y
o
u
n
g
er
 t
h
an
 6
 y
ea
rs
 o
f 
ag
e,
 n
u
m
b
er
 o
f 
an
ti
b
io
ti
cs
 p
er
 p
er
so
n
 p
er
 y
ea
r 
r
C
o
n
tr
o
l
P
ra
ct
ic
e 
m
ee
ti
n
g
E
ff
ec
t
m
ea
su
re
B
ef
o
re
 s
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
 s
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
A
nt
im
ic
ro
bi
al
 c
ou
rs
es
di
sp
en
se
d 
(p
er
 p
er
so
n
ye
ar
s)
 C
hi
ld
re
n 
3 
ye
ar
s 
to
<
36
 m
on
th
s 
of
 a
ge
2.
9
2.
6
-1
0.
3
2.
2
1.
8
-1
8.
2
1.
8
p<
0.
00
01
(F
in
ke
ls
te
in
et
 a
l.,
20
01
)
Le
ve
l I
II-
1:
Q
ua
si
 R
C
T
Q
ua
lit
y:
av
er
ag
e
P
rim
ar
y 
he
al
th
ca
re
 p
ra
ct
ic
es
(n
=
12
) 
af
fil
ia
te
d
w
ith
 2
 M
C
O
s,
E
as
te
rn
M
as
sa
ch
us
et
ts
an
d 
N
or
th
-w
es
t
W
as
hi
ng
to
n
S
ta
te
C
hi
ld
re
n
(n
=
8,
81
5)
en
ro
lle
d 
in
 th
e
he
al
th
 p
la
ns
 o
f
th
e 
M
C
O
s 
an
d
pa
re
nt
s
90
-m
in
ut
e 
sm
al
l g
ro
up
pr
ac
tic
e 
m
ee
tin
g 
le
d
by
 a
 tr
ai
ne
d 
ph
ys
ic
ia
n
pe
er
 le
ad
er
 u
si
ng
C
D
C
 e
nd
or
se
d
su
m
m
ar
ie
s 
of
pr
es
cr
ib
in
g
re
co
m
m
en
da
tio
ns
pl
us
 fe
ed
ba
ck
; f
ol
lo
w
-
up
 m
ee
tin
g 
he
ld
 4
m
on
th
s 
la
te
r
A
nt
im
ic
ro
bi
al
 c
ou
rs
es
di
sp
en
se
d 
(p
er
 p
er
so
n
ye
ar
s)
 C
hi
ld
re
n 
36
 to
 <
72
m
on
th
s 
of
 a
ge
1.
7
1.
6
-5
.9
1.
4
1.
2
-1
4.
3
2.
4
p<
0.
00
01
P
h
ys
ic
ia
n
s’
 c
o
u
n
se
lli
n
g
 b
eh
av
io
u
r 
re
p
o
rt
ed
 b
y 
p
at
ie
n
t,
 %
 o
f 
p
at
ie
n
ts
18
 m
o
n
th
s 
fo
llo
w
-u
p
 t
24
 m
o
n
th
s 
fo
llo
w
-u
p
 t
C
o
n
tr
o
l u
%
 c
h
an
g
e 
v
E
d
u
ca
ti
o
n
al
o
u
tr
ea
ch
%
 c
h
an
g
e 
v
R
el
at
iv
e
ch
an
g
e
C
o
n
tr
o
l u
%
 c
h
an
g
e 
v
E
d
u
ca
ti
o
n
al
o
u
tr
ea
ch
%
 c
h
an
g
e 
v
R
el
at
iv
e
ch
an
g
e
P
hy
si
ci
an
s 
ta
lk
ed
ab
ou
t s
m
ok
in
g
-0
.7
+
7.
0
10
.0
N
S
-2
.7
-1
.0
0.
4
N
S
P
hy
si
ci
an
s 
ad
vi
se
d
pa
tie
nt
s 
to
 q
ui
t
-0
.8
+
6.
9
8.
6
N
S
-4
.5
-1
.2
0.
3
N
S
(G
ol
ds
te
in
et
 a
l.,
20
03
)
Le
ve
l I
II-
1:
Q
ua
si
-
ex
pe
rim
en
ta
l
st
ud
y
Q
ua
lit
y:
av
er
ag
e
P
rim
ar
y 
ca
re
ph
ys
ic
ia
ns
(n
=
25
9)
co
m
m
un
ity
ba
se
d 
P
H
C
pr
ac
tic
es
,
P
ro
vi
de
nc
e
B
ris
to
l c
ou
nt
ie
s,
K
en
t c
ou
nt
y
an
d 
N
ew
po
rt
W
as
hi
ng
to
n
co
un
tie
s,
R
ho
de
 Is
la
nd
,
N
ew
 E
ng
la
nd
4-
5 
ph
ys
ic
ia
n-
ce
nt
re
d
of
fic
e 
ed
uc
at
io
na
l
ou
tr
ea
ch
 v
is
its
 le
ad
 b
y
2 
m
as
te
rs
-le
ve
l O
ffi
ce
P
ra
ct
ic
e 
C
on
su
lta
nt
s
re
 N
C
I c
ou
ns
el
lin
g
ap
pr
oa
ch
 a
nd
 o
th
er
of
fic
e-
ba
se
d
st
ra
te
gi
es
 fo
r 
sm
ok
in
g
ce
ss
at
io
n,
 p
lu
s 
pa
tie
nt
ed
uc
at
io
n 
re
so
ur
ce
s,
m
at
er
ia
ls
 to
 id
en
tif
y
an
d 
tr
ac
k 
sm
ok
er
s,
re
fe
rr
al
 in
fo
rm
at
io
n,
po
ck
et
 c
ar
ds
 a
nd
de
sk
 p
ro
m
pt
s
P
hy
si
ci
an
s 
ar
ra
ng
ed
fo
llo
w
-u
p 
to
 q
ui
t
+
9.
0
+
18
.1
2.
0
N
S
-8
.9
-7
.1
0.
8
N
S
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1
3
2
A
ve
ra
ge
 n
um
be
r 
of
 d
ay
s 
w
ith
 u
nn
ec
es
sa
ry
 w
 ta
rg
et
 a
nt
ib
io
tic
s 
ad
m
in
is
te
re
d 
pe
r 
se
rv
ic
e,
 m
ea
n 
±
S
D
C
o
n
tr
o
l
n=
8 
se
rv
ic
es
P
ra
ct
ic
e 
m
ee
ti
n
g
s
n=
9 
se
rv
ic
es
E
ff
ec
t
m
ea
su
re
B
ef
o
re
A
ft
er
 x
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
 x
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
U
nn
ec
es
sa
ry
 u
se
of
 a
nt
ib
io
tic
s
7.
6±
4.
7
8.
8±
2.
2
+
15
.8
8.
5±
7.
8
5.
5±
2.
1
-3
5.
3
2.
2
p<
0.
00
1
D
is
co
nt
in
ua
tio
n 
of
 u
nn
ec
es
sa
ry
 o
rd
er
s,
 %
D
is
co
nt
in
ue
d 
or
de
rs
:
30
.0
70
.0
p=
0.
00
1
T
ar
ge
t a
nt
ib
io
tic
s
16
.0
55
.0
p=
0.
00
1
A
ll 
an
tib
io
tic
s
14
.0
14
.0
N
S
(S
ol
om
on
et
 a
l.,
20
01
)
Le
ve
l I
II-
1:
Q
ua
si
 R
C
T
Q
ua
lit
y:
av
er
ag
e/
po
or
P
hy
si
ci
an
s,
ge
ne
ra
l
m
ed
ic
al
,
on
co
lo
gy
 a
nd
ca
rd
io
lo
gy
se
rv
ic
es
 (
n=
17
)
B
rin
gh
am
 a
nd
W
om
en
’s
H
os
pi
ta
l
P
at
ie
nt
s
pr
es
cr
ib
ed
le
vo
flo
xa
ci
n 
or
ce
fta
zi
di
m
e
(n
=
49
0)
B
os
to
n,
M
as
sa
ch
us
et
ts
,
U
S
A
F
ac
e-
to
-f
ac
e 
or
te
le
ph
on
e 
pr
ac
tic
e
m
ee
tin
gs
 (
ap
pr
ox
. 1
0
m
in
ut
e 
du
ra
tio
n)
 p
lu
s
pe
rf
or
m
an
ce
 fe
ed
ba
ck
D
is
se
m
in
at
io
n 
of
gu
id
el
in
es
 fo
r 
fir
st
-li
ne
an
tib
io
tic
 th
er
ap
y 
as
po
ck
et
-s
iz
ed
la
m
in
at
ed
 b
ro
ch
ur
es
de
ve
lo
pe
d 
by
 th
e
ho
sp
ita
l’s
 D
iv
is
io
n 
of
In
fe
ct
io
us
 D
is
ea
se
s
R
ou
te
 c
ha
ng
es
(in
tr
av
en
ou
s 
to
 o
ra
l)
14
.0
14
.0
N
S
N
ew
 t
ar
g
et
 m
ed
ic
at
io
n
 f
o
r 
d
ia
b
et
es
 m
an
ag
em
en
t,
 %
 p
at
ie
n
ts
 p
re
sc
ri
b
ed
 n
ew
 m
ed
ic
at
io
n
V
is
it
s 
o
n
ly
 y
V
is
it
s 
p
lu
s 
o
u
tr
ea
ch
 s
er
vi
ce
 y
E
ff
ec
t
m
ea
su
re
T
ar
ge
t m
ed
ic
at
io
n
A
ft
er
A
ft
er
p
-v
al
u
e
A
ny
 ta
rg
et
 m
ed
ic
at
io
n
23
.5
25
.0
0.
73
B
lo
od
 p
re
ss
ur
e 
lo
w
er
in
g
14
.8
17
.2
0.
60
C
ho
le
st
er
ol
 lo
w
er
in
g
3.
8
6.
8
0.
21
(M
aj
um
da
r
et
 a
l.,
20
03
)
Le
ve
l I
II-
3:
C
B
A
 d
es
ig
n
Q
ua
lit
y:
 g
oo
d
R
ur
al
 h
ea
lth
re
gi
on
s 
(n
=
2)
,
N
or
th
er
n
A
lb
er
ta
P
at
ie
nt
s 
w
ith
T
yp
e 
II 
di
ab
et
es
(n
=
39
3)
,
C
an
ad
a
V
is
its
 b
y 
a 
T
ra
ve
lli
ng
D
ia
be
te
s 
R
es
ou
rc
e
P
ro
gr
am
 p
lu
s 
m
ul
ti-
di
sc
ip
lin
ar
y 
di
ab
et
es
ou
tr
ea
ch
 s
er
vi
ce
(g
ro
up
 a
nd
 o
ne
-o
n-
on
e 
ac
ad
em
ic
de
ta
ili
ng
) 
vs
 b
im
on
th
ly
vi
si
ts
 o
nl
y
G
lu
co
se
 lo
w
er
in
g
8.
2
13
.4
0.
22
a 
G
P
s’
 r
ep
or
te
d 
th
re
sh
ol
d 
is
 th
e 
le
ve
l a
bo
ve
 w
hi
ch
 th
e 
do
ct
or
 ty
pi
ca
lly
 c
om
m
en
ce
s 
tr
ea
tm
en
t f
or
 h
yp
er
te
ns
io
n;
 b
 M
an
n-
W
hi
tn
ey
 te
st
 w
as
 u
se
d 
to
 d
et
er
m
in
e 
si
gn
ifi
ca
nt
 d
iff
er
en
ce
s 
be
tw
ee
n 
in
te
rv
en
tio
n 
an
d 
co
nt
ro
l
gr
ou
ps
; c
  
D
es
ire
d 
pr
ac
tic
e 
w
as
 r
ed
uc
tio
n 
in
 th
e 
vo
lu
m
e 
an
d 
co
st
 o
f t
ot
al
 N
S
A
ID
 p
re
sc
rib
in
g 
an
d 
az
ap
ro
pa
zo
ne
 p
re
sc
rib
in
g 
an
d 
in
cr
ea
se
 in
 th
e 
vo
lu
m
e 
of
 p
re
sc
rib
in
g 
of
 th
re
e 
re
co
m
m
en
de
d 
N
S
A
ID
S
;
d 
an
al
ys
is
 o
f c
ov
ar
ia
nc
e 
w
as
 u
se
d 
to
 a
dj
us
t f
or
 b
as
el
in
e 
di
ffe
re
nc
es
; e
 S
T
A
R
-P
U
s 
=
 s
ta
nd
ar
d 
un
its
 fo
r 
ei
gh
t m
aj
or
 th
er
ap
eu
tic
 c
la
ss
es
, i
nc
lu
di
ng
  N
S
A
ID
s;
 f 
“c
or
re
ct
” 
te
st
 o
rd
er
in
g 
=
 d
ec
re
as
e 
in
 “
un
ne
ce
ss
ar
y”
 te
st
s;
g 
K
ru
sk
al
l-W
al
lis
 te
st
 w
as
 u
se
d 
to
 c
om
pa
re
 P
S
A
 te
st
in
g 
ra
te
s 
be
tw
ee
n 
st
ud
y 
gr
ou
ps
; h
 b
as
el
in
e 
P
S
A
 te
st
in
g 
ra
te
s 
w
er
e 
eq
ui
va
le
nt
 b
et
w
ee
n 
th
e 
st
ud
y 
gr
ou
ps
; i
 M
ea
n 
da
ta
 fo
r 
gr
ou
ps
 a
re
 a
va
ila
bl
e 
on
 r
eq
ue
st
;
j  
ba
se
lin
e 
da
ta
 n
ot
 p
ro
vi
de
d,
 y
et
 r
ep
or
te
d 
as
 s
im
ila
r;
 k
 c
om
pa
ris
on
s 
w
er
e 
m
ad
e 
us
in
g 
C
hi
-s
qu
ar
e 
st
at
is
tic
s 
ad
ju
st
in
g 
fo
r 
th
e 
cl
us
te
r 
ra
nd
om
is
ed
 d
es
ig
n;
 l 
an
al
ys
es
 a
dj
us
te
d 
fo
r 
ag
e,
 g
en
de
r,
 le
ve
l o
f c
ar
e,
 d
em
en
tia
an
d 
ba
se
lin
e 
va
lu
es
; m
 A
dd
iti
on
al
 s
im
ila
r 
ou
tc
om
es
 a
va
ila
bl
e 
on
 r
eq
ue
st
; n
 in
cl
ud
es
 b
en
zo
di
az
ep
in
es
, a
nt
i-p
sy
ch
ot
ic
s 
or
 a
nt
id
ep
re
ss
an
ts
; o
 H
 p
yl
or
i b
ac
te
riu
m
/in
fe
ct
io
n 
fo
un
d 
to
 b
e 
a 
m
aj
or
 c
au
se
 o
f p
ep
tic
 u
lc
er
s
(a
 s
or
e 
in
 th
e 
lin
in
g 
of
 th
e 
st
om
ac
h)
; p
 p
er
ce
nt
ag
e 
ch
an
ge
 fr
om
 b
as
el
in
e 
(F
eb
-A
pr
’9
6 
– 
3 
qu
ar
te
rs
 b
ef
or
e 
th
e 
fir
st
 e
du
ca
tio
na
l o
ut
re
ac
h 
vi
si
t)
, d
ue
 to
 s
pa
ce
 r
es
tr
ic
tio
ns
, p
re
- 
an
d 
po
st
-in
te
rv
en
tio
n 
sc
or
es
 a
re
 n
ot
pr
ov
id
ed
 -
 a
va
ila
bl
e 
on
 r
eq
ue
st
; q
 a
ll 
ou
tc
om
es
 a
re
 N
S
; 
r 
id
ea
l o
ut
co
m
e 
is
 a
 d
ec
re
as
e 
in
 th
e 
ra
te
 o
f a
nt
ib
io
tic
 d
is
pe
ns
in
g;
 s
 g
en
er
al
is
ed
 e
st
im
at
in
g 
eq
ua
tio
ns
 (
G
E
E
) 
w
er
e 
us
ed
 to
 a
dj
us
t f
or
 b
as
el
in
e 
di
ffe
re
nc
es
 in
an
tib
io
tic
 u
se
; a
ge
 a
nd
 M
C
O
; t
 1
8 
or
 2
4-
m
on
th
 fo
llo
w
-u
p 
af
te
r 
6-
m
on
th
 in
te
rv
en
tio
n;
 u
 C
on
tr
ol
 g
ro
up
 p
hy
si
ci
an
s 
w
er
e 
aw
ar
e 
of
 th
ei
r 
ro
le
 a
s 
co
nt
ro
ls
 in
 th
e 
st
ud
y 
an
d 
ha
d 
hi
gh
er
 r
at
es
 o
f t
al
ki
ng
, a
dv
is
in
g 
an
d 
fo
llo
w
in
g
up
 o
n 
pa
tie
nt
s 
co
m
pa
re
d 
to
 a
n 
ad
di
tio
na
l c
on
tr
ol
 g
ro
up
 o
f n
on
-p
ar
tic
ip
at
in
g 
ph
ys
ic
ia
ns
; v
 D
ue
 to
 s
pa
ce
 r
es
tr
ic
tio
ns
, p
re
- 
an
d 
po
st
-in
te
rv
en
tio
n 
da
ta
 a
re
 n
ot
 p
ro
vi
de
d 
– 
av
ai
la
bl
e 
on
 r
eq
ue
st
; w
 u
nn
ec
es
sa
ry
 u
se
 r
ef
er
s
to
 o
rd
er
s 
th
at
 fe
ll 
ou
ts
id
e 
th
e 
C
P
G
s;
 x
  B
as
el
in
e 
sc
or
es
 fo
r 
pr
es
cr
ib
in
g 
no
t p
ro
vi
de
d,
 b
ut
 m
ul
til
ev
el
 m
od
el
lin
g 
us
ed
 to
 a
dj
us
t f
or
 d
iff
er
en
ce
s 
in
 b
as
el
in
e 
sc
or
es
 d
ur
at
io
n 
of
 th
e 
in
te
rv
en
tio
n;
 y
 B
as
el
in
e 
da
ta
 n
ot
 p
ro
vi
de
d,
bu
t a
dj
us
te
d 
fo
r 
us
in
g 
m
ul
tiv
ar
ia
te
 r
eg
re
ss
io
n 
an
al
ys
is
; B
P
 =
 b
lo
od
 p
re
ss
ur
e;
 C
D
C
 =
 C
en
te
rs
 fo
r 
D
is
ea
se
 C
on
tr
ol
 a
nd
 P
re
ve
nt
io
n;
 C
P
G
s 
=
 C
lin
ic
al
 P
ra
ct
ic
e 
gu
id
el
in
es
; D
D
D
 =
 d
ef
in
ed
 d
ai
ly
 d
os
e;
 E
O
V
 =
 e
du
ca
tio
na
l
ou
tr
ea
ch
 v
is
its
; G
P
s 
=
 G
en
er
al
 p
ra
ct
iti
on
er
s;
 M
C
O
 =
 m
an
ag
ed
 c
ar
e 
or
ga
ni
sa
tio
ns
; N
C
I =
 N
at
io
na
l C
an
ce
r 
In
st
itu
te
 N
IC
 =
 n
et
 in
gr
ed
ie
nt
 c
os
t; 
N
S
A
ID
 =
 N
on
-s
te
ro
id
al
 a
nt
i-i
nf
la
m
m
at
or
y 
dr
ug
s;
 O
T
C
 =
 o
ve
r 
th
e 
co
un
te
r
P
H
C
 =
 p
rim
ar
y 
he
al
th
 c
ar
e;
 P
S
A
 =
 p
ro
st
ra
te
 s
pe
ci
fic
 a
nt
ig
en
; R
C
G
P
 =
 R
oy
al
 C
ol
le
ge
 o
f G
en
er
al
 P
ra
ct
iti
on
er
s.
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1
3
4
 T
a
b
le
 4
7
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
e
d
u
c
a
ti
o
n
a
l 
o
u
tr
e
a
c
h
 v
is
it
s
 –
 P
a
ti
e
n
t 
o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
at
ie
n
t 
o
u
tc
o
m
es
 (
h
ea
lt
h
 s
ta
tu
s)
P
ro
p
o
rt
io
n
 o
f 
p
at
ie
n
ts
 w
h
o
 f
el
l o
r 
w
er
e 
at
 r
is
k 
o
f 
st
ro
ke
, %
 o
f 
re
si
d
en
t 
p
at
ie
n
ts
C
o
n
tr
o
l
n=
33
4
E
d
u
ca
ti
o
n
al
 o
u
tr
ea
ch
 v
is
it
s
n=
38
1
E
ff
ec
t 
m
ea
su
re
 a
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e 
ri
sk
[9
5%
 C
I]
F
a
ll 
ra
te
s
R
es
id
en
ts
 w
ho
 fe
ll 
in
 p
rio
r
3 
m
on
th
s
19
.8
21
.9
+
3.
1
22
.0
25
.5
+
3.
5
1.
1 
[0
.8
6,
 1
.5
8]
N
S
R
is
k
 o
f 
s
tr
o
k
e
A
t r
is
k 
of
 s
tr
ok
e
59
.0
65
.0
+
6.
0
54
.9
57
.7
+
2.
8
0.
5 
[0
.3
9,
 1
.0
8]
N
S
O
n 
as
pi
rin
38
.9
41
.0
+
2.
1
33
.4
35
.4
+
2.
0
0.
9 
[0
.8
9,
 1
.0
6]
N
S
R
es
id
en
ts
 a
t r
is
k 
of
 s
tr
ok
e
on
 a
sp
iri
n
50
.3
52
.5
+
2.
2
41
.6
44
.1
+
2.
5
1.
1 
[0
.2
9,
 1
.0
0]
N
S
(C
ro
tty
 e
t
al
., 
20
04
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
 g
oo
d
/ a
ve
ra
ge
P
hy
si
ci
an
s
(n
=
12
0)
w
or
ki
ng
 in
re
si
de
nt
ia
l a
ge
d
ca
re
 fa
ci
lit
ie
s
(h
os
te
ls
 n
=
10
;
nu
rs
in
g 
ho
m
es
n=
10
),
m
et
ro
po
lit
an
A
de
la
id
e,
 S
ou
th
A
us
tr
al
ia
O
ld
er
 a
du
lt
pa
tie
nt
s 
in
re
si
de
nt
ia
l c
ar
e
(n
=
71
5)
E
du
ca
tio
na
l o
ut
re
ac
h
vi
si
ts
 (
2x
30
 m
in
ut
es
),
de
liv
er
ed
 b
y 
a
ph
ar
m
ac
is
t, 
de
si
gn
ed
to
 im
pr
ov
e 
th
e
im
pl
em
en
ta
tio
n 
of
E
vi
de
nc
e-
ba
se
d
cl
in
ic
al
 p
ra
ct
ic
e 
in
 th
e
ar
ea
 o
f f
al
ls
 r
ed
uc
tio
n
an
d 
st
ro
ke
 p
re
ve
nt
io
n
R
es
id
en
ts
 w
ith
 a
tr
ia
l
fib
ril
la
tio
n 
on
 w
ar
fa
rin
22
.6
17
.1
-5
.5
8.
6
16
.7
+
8.
1
-1
.5
 [0
.2
3,
 3
.5
9]
N
S
P
at
ie
n
t 
q
u
it
 r
at
es
 b
y 
as
se
ss
m
en
t 
p
o
in
t 
p
er
 in
te
rv
en
ti
o
n
 g
ro
u
p
, %
C
o
n
tr
o
l
P
C
S
P
C
S
 +
 h
o
m
e
in
te
rv
en
ti
o
n
 b
H
o
m
e 
in
te
rv
en
ti
o
n
 b
%
ch
an
g
e
%
ch
an
g
e
R
el
at
iv
e
ch
an
g
e
%
ch
an
g
e
R
el
at
iv
e
ch
an
g
e
%
ch
an
g
e
R
el
at
iv
e
ch
an
g
e
6 
m
on
th
s
+
7.
1
+
8.
4
1.
2
+
8.
9
1.
3
+
7.
6
1.
1
12
 m
on
th
s
+
16
.4
+
17
.0
1.
0
+
16
.9
1.
0
+
16
.5
1.
0
18
 m
on
th
s
+
20
.0
+
25
.2
1.
3
+
19
.2
1.
0
+
24
.8
1.
2
(G
ol
ds
te
in
et
 a
l.,
20
03
)
Le
ve
l I
II-
1:
Q
ua
si
-
ex
pe
rim
en
ta
l
st
ud
y
Q
ua
lit
y:
av
er
ag
e
P
rim
ar
y 
ca
re
ph
ys
ic
ia
ns
(n
=
25
9)
co
m
m
un
ity
ba
se
d 
P
H
C
pr
ac
tic
es
,
R
ho
de
 Is
la
nd
,
N
ew
 E
ng
la
nd
4-
5 
ed
uc
at
io
na
l
ou
tr
ea
ch
 v
is
its
 fo
r
sm
ok
in
g 
ce
ss
at
io
n,
pl
us
 p
at
ie
nt
 e
du
ca
tio
n
re
so
ur
ce
s,
 m
at
er
ia
ls
to
 id
en
tif
y 
an
d 
tr
ac
k
sm
ok
er
s,
 r
ef
er
ra
l
in
fo
rm
at
io
n,
 p
oc
ke
t
ca
rd
s;
 d
es
k 
pr
om
pt
s
24
 m
on
th
s
+
22
.6
+
33
.3
1.
5
p=
0.
00
6
+
25
.7
1.
1
+
26
.3
1.
2
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P
ro
p
o
rt
io
n
 o
f 
p
at
ie
n
ts
 a
ch
ie
vi
n
g
 1
0%
 im
p
ro
ve
m
en
t 
in
 q
u
al
it
y 
o
f 
d
ia
b
et
es
 c
ar
e,
 %
V
is
it
s 
o
n
ly
n
=
18
3
V
is
it
s 
p
lu
s 
o
u
tr
ea
ch
 s
er
vi
ce
n
=
21
0
E
ff
ec
t
m
ea
su
re
C
lin
ic
al
 a
re
a
A
ft
er
 c
A
ft
er
 c
p
-v
al
u
e
B
lo
od
 p
re
ss
ur
e
25
.0
42
.0
p=
0.
00
4
T
ot
al
 c
ho
le
st
er
ol
17
.0
13
.0
p=
0.
33
H
bA
 (
1c
)
14
.0
18
.0
p=
0.
44
P
at
ie
nt
 s
at
is
fa
ct
io
n 
w
ith
 c
ar
e 
pr
ov
id
ed
, a
dj
us
te
d 
m
ea
n 
ch
an
ge
 fr
om
 b
as
el
in
e 
c
S
at
is
fa
ct
io
n 
w
ith
 g
en
er
al
m
ed
ic
al
 c
ar
e
-1
1.
9
+
4.
1
p<
0.
00
1
(M
aj
um
da
r
et
 a
l.,
20
03
)
Le
ve
l I
II-
3:
C
B
A
 d
es
ig
n
Q
ua
lit
y:
 g
oo
d
R
ur
al
 h
ea
lth
re
gi
on
s 
(n
=
2)
,
N
or
th
er
n
A
lb
er
ta
,
P
at
ie
nt
s 
w
ith
ty
pe
 II
 d
ia
be
te
s
(n
=
39
3)
,
C
an
ad
a
V
is
its
 b
y 
a 
T
ra
ve
lli
ng
D
ia
be
te
s 
R
es
ou
rc
e
P
ro
gr
am
 p
lu
s 
m
ul
ti-
di
sc
ip
lin
ar
y 
di
ab
et
es
ou
tr
ea
ch
 s
er
vi
ce
(g
ro
up
 a
nd
 o
ne
-o
n-
on
e 
ac
ad
em
ic
de
ta
ili
ng
) 
vs
 b
im
on
th
ly
vi
si
ts
 o
nl
y
S
at
is
fa
ct
io
n 
w
ith
di
ab
et
es
 c
ar
e
-3
.7
+
4.
1
p=
0.
00
8
a 
A
na
ly
se
s 
ad
ju
st
ed
 fo
r 
ag
e,
 g
en
de
r,
 le
ve
l o
f c
ar
e,
 d
em
en
tia
 a
nd
 b
as
el
in
e 
va
lu
es
; b
 h
om
e-
ba
se
d 
sm
ok
in
g 
in
te
rv
en
tio
n 
de
ve
lo
pe
d 
by
 a
 g
ro
up
 o
f c
ol
la
bo
ra
tin
g 
in
ve
st
ig
at
or
s 
w
as
 im
pl
em
en
te
d 
si
m
ul
ta
ne
ou
sl
y 
w
ith
 th
e
P
hy
si
ci
an
s 
C
ou
ns
el
lin
g 
S
m
ok
er
s 
(P
C
S
) 
P
ro
je
ct
; c
 B
as
el
in
e 
m
ea
su
re
s 
no
t p
ro
vi
de
d,
 b
ut
 d
iff
er
en
ce
s 
ad
ju
st
ed
 fo
r 
us
in
g 
m
ul
tiv
ar
ia
te
 lo
gi
st
ic
 r
eg
re
ss
io
n 
(b
lo
od
 p
re
ss
ur
e,
 c
ho
le
st
er
ol
, H
bA
1c
) 
an
d 
A
N
C
O
V
A
 (
pa
tie
nt
sa
tis
fa
ct
io
n)
. N
o 
ad
ju
st
m
en
t f
or
 p
ot
en
tia
l c
lu
st
er
in
g 
ef
fe
ct
s;
 B
P
 =
 b
lo
od
 p
re
ss
ur
e;
 H
bA
1c
 =
 b
lo
od
 g
lu
co
se
 m
ea
su
re
.
appendix B data tables  117
1
3
6
 T
a
b
le
 4
8
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
lo
c
a
l 
o
p
in
io
n
 l
e
a
d
e
rs
 –
 P
ro
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
ro
ce
ss
 o
u
tc
o
m
es
 (
p
ra
ct
it
io
n
er
s’
 b
eh
av
io
u
ra
l c
h
an
g
e)
M
ed
ic
at
io
n
 c
o
n
tr
o
lle
r 
a  d
is
p
en
si
n
g
, m
ea
n
 a
b
so
lu
te
 c
h
an
g
e 
fr
o
m
 b
as
el
in
e,
 9
5%
 C
I
D
is
tr
ib
u
ti
o
n
 o
f
g
u
id
el
in
es
P
h
ys
ic
ia
n
 p
ee
r
le
ad
er
P
la
n
n
ed
 a
st
h
m
a
ca
re
M
ea
n
 c
h
an
g
e 
b
M
ea
n
 c
h
an
g
e 
b
A
d
ju
st
ed
in
te
rv
en
ti
o
n
ef
fe
ct
[9
5%
 C
I]
M
ea
n
 c
h
an
g
e 
b
A
d
ju
st
ed
in
te
rv
en
ti
o
n
ef
fe
ct
[9
5%
 C
I]
A
m
on
g 
pe
rs
is
te
nt
 a
st
hm
at
ic
s
!1
 c
on
tr
ol
le
r 
di
sp
en
se
d
0.
04
 [-
0.
04
, 0
.1
2]
0.
01
 [-
0.
07
, 0
.0
8]
0.
01
 [-
0.
07
, 0
.0
8]
0.
04
 [-
0.
02
, 0
.1
]
-0
.0
3 
[-
0.
09
, 0
.0
2]
!3
 c
on
tr
ol
le
rs
 d
is
pe
ns
ed
0.
01
 [-
0.
09
, 0
.1
1]
0.
02
 [-
0.
06
, 0
.1
0]
0.
02
 [-
0.
01
, 0
.1
0]
0.
11
 [0
.0
5,
 0
.1
7]
0.
03
 [-
0.
04
, 0
.1
0]
!1
 in
ha
le
d 
co
rt
ic
os
te
ro
id
0.
12
 [-
0.
01
, 0
.2
5]
0.
02
 [-
0.
11
, 0
.1
6]
0.
02
 [-
0.
11
, 0
.1
6]
0.
17
 [0
.0
8,
 0
.2
6]
-0
.0
2 
[-
0.
13
, 0
.0
9]
!3
 in
ha
le
d 
co
rt
ic
os
te
ro
id
0.
04
 [-
0.
07
, 0
.1
5]
0.
07
 [0
.0
2,
 0
.1
5]
0.
07
 [-
0.
02
, 0
.1
5]
0.
13
 [0
.0
8,
 0
.1
8]
0.
03
 [-
0.
04
, 0
.1
0]
A
m
on
g 
al
l p
at
ie
nt
s 
w
ith
 a
st
hm
a
!1
 c
on
tr
ol
le
r 
di
sp
en
se
d
0.
07
 [-
0.
01
, 0
.1
5]
0.
03
 [-
0.
08
, 0
.1
5]
0.
03
 [-
0.
08
, 0
.1
5]
0.
13
 [0
.0
7,
0.
19
]
0.
04
 [-
0.
06
, 0
.1
4]
!3
 c
on
tr
ol
le
rs
 d
is
pe
ns
ed
0.
04
 [-
0.
02
, 0
.1
0]
0.
02
 [-
0.
05
, 0
.0
9]
0.
02
 [-
0.
05
, 0
.0
9]
0.
11
 [0
.0
5,
 0
.1
7]
0.
04
 [-
0.
02
, 0
.0
9]
!1
 in
ha
le
d 
co
rt
ic
os
te
ro
id
0.
10
 [0
.0
0,
 0
.2
0]
0.
05
 [-
0.
08
, 0
.1
7]
0.
05
 [-
0.
08
, 0
.1
7]
0.
17
 [0
.1
1,
 0
.2
3]
0.
04
 [-
0.
06
, 0
.1
4]
!3
 in
ha
le
d 
co
rt
ic
os
te
ro
id
0.
03
 [-
0.
03
, 0
.0
9]
0.
04
 [-
0.
02
, 0
.1
0]
0.
04
 [-
0.
02
, 0
.1
0]
0.
09
 [0
.0
7,
 0
.1
1]
0.
03
 [-
0.
02
, 0
.0
7]
(F
in
ke
ls
te
in
et
 a
l.,
20
05
)
Le
ve
l I
I:
cl
us
te
r 
R
C
T
Q
ua
lit
y:
 g
oo
d
P
rim
ar
y 
ca
re
pr
ac
tic
es
(n
=
40
);
P
at
ie
nt
s:
ch
ild
re
n 
5-
17
ye
ar
s 
ol
d 
w
ith
as
th
m
a 
(n
=
63
8)
C
hi
ca
go
 o
r
M
as
sa
ch
us
et
ts
,
U
S
A
P
hy
si
ci
an
 p
ee
r 
le
ad
er
ed
uc
at
io
n 
(P
LE
)
P
ee
r 
le
ad
er
 e
du
ca
tio
n
en
ha
nc
ed
 w
ith
pl
an
ne
d 
as
th
m
a
ca
re
 (
P
A
C
)
!1
 o
ra
l s
te
ro
id
 d
is
pe
ns
ed
0.
02
 [-
0.
01
, 0
.0
5]
0.
06
 [0
.0
0,
 0
.1
2]
0.
06
 [0
, 0
.1
2]
0.
04
 [0
.0
0,
 0
.0
8]
0.
07
 [-
0.
02
, 0
.1
5]
N
eu
ro
lo
g
is
ts
’ a
d
h
er
en
ce
 t
o
 p
ra
ct
ic
e 
g
u
id
el
in
es
 f
o
r 
th
e 
ev
al
u
at
io
n
 a
n
d
 m
an
ag
em
en
t 
o
f 
d
em
en
ti
a,
 %
 o
f 
n
eu
ro
lo
g
is
ts
C
o
n
tr
o
l
n=
13
9
E
d
u
ca
ti
o
n
al
 p
ac
ka
g
e
n=
13
9
E
ff
ec
t
m
ea
su
re
6 
gu
id
el
in
e
re
co
m
m
en
da
tio
ns
 c
:
B
ef
o
re
 d
A
ft
er
%
 C
h
an
g
e
B
ef
o
re
 d
A
ft
er
%
 C
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
(G
iff
or
d 
et
al
., 
19
99
;
H
ol
lo
w
ay
 e
t
al
., 
19
99
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
 g
oo
d
U
rb
an
ne
ur
ol
og
is
ts
(n
=
41
7)
D
em
en
tia
pa
tie
nt
s
N
ew
 Y
or
k
S
ta
te
, U
S
A
E
du
ca
tio
na
l p
ac
ka
ge
:
m
ai
le
d 
C
M
E
 c
ou
rs
e;
pr
ac
tic
e-
ba
se
d 
to
ol
s;
in
te
ra
ct
iv
e 
ev
id
en
ce
-
ba
se
d 
se
m
in
ar
 le
d 
by
op
in
io
n 
le
ad
er
s;
fo
llo
w
-u
p 
m
ai
lin
gs
.
O
rd
er
 n
eu
ro
im
ag
in
g 
on
ly
 if
 c
lin
ic
al
 c
rit
er
ia
 p
re
se
nt
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S
ce
na
rio
 1
5.
6
5.
9
+
0.
3
5.
6
20
.2
+
14
.6
48
.7
p<
0.
01
S
ce
na
rio
 3
47
.6
42
.3
-5
.3
47
.6
60
.7
+
13
.1
2.
5
p<
0.
01
O
rd
er
el
ec
tr
oe
nc
ep
ha
lo
gr
ap
hy
 if
cl
in
ic
al
 c
rit
er
ia
 p
re
se
nt
S
ce
na
rio
 1
 &
 3
64
.4
67
.0
+
2.
6
64
.4
72
.3
+
7.
9
3.
0
p>
0.
2
S
cr
ee
n 
fo
r 
an
d 
tr
ea
t
de
pr
es
si
on
S
ce
na
rio
 2
80
.6
84
.3
+
43
.7
80
.6
86
.2
+
5.
6
0.
1
p>
0.
2
D
o 
no
t o
rd
er
ap
ol
ip
op
ro
te
in
 E
ge
no
ty
pe
 te
st
in
g 
to
pr
ed
ic
t o
r 
di
ag
no
se
A
lz
he
im
er
 d
is
ea
se
A
t l
ea
st
 1
 o
f 3
 s
ce
na
rio
s
87
.9
95
.0
+
7.
1
87
.9
94
.6
+
6.
7
0.
9
p>
0.
2
R
ef
er
 a
ll 
pa
tie
nt
s
an
d 
fa
m
ili
es
 to
 th
e
A
lz
he
im
er
’s
 A
ss
oc
ia
tio
n
A
t l
ea
st
 1
 o
f 3
 s
ce
na
rio
s
20
.4
23
.2
+
2.
8
20
.4
44
.1
+
23
.7
8.
5
p"
0.
01
E
nc
ou
ra
ge
 a
ll 
pa
tie
nt
s 
an
d
fa
m
ili
es
 to
 e
nr
ol
 in
 S
af
e
R
et
ur
n 
P
ro
gr
am
A
t l
ea
st
 1
 o
f 3
 s
ce
na
rio
s
1.
0
3.
2
+
2.
2
1.
0
18
.3
+
17
.3
7.
9
p"
0.
01
a 
C
on
tr
ol
le
r 
m
ed
ic
at
io
ns
 in
cl
ud
ed
 in
ha
le
d 
co
rt
ic
os
te
ro
id
s,
 c
ro
m
ol
yn
/n
ed
oc
ro
m
il,
 lo
ng
-a
ct
in
g 
ß
-a
go
ni
st
s 
an
d 
th
eo
ph
yl
lin
e.
 !
3 
di
sp
en
si
ng
s 
in
di
ca
te
d 
ch
ro
ni
c 
co
nt
ro
lle
r 
us
e;
 b
 M
ea
n 
ab
so
lu
te
 c
ha
ng
e 
w
as
 c
al
cu
la
te
d 
fr
om
ba
se
lin
e 
pr
op
or
tio
n 
in
 e
ac
h 
pr
ac
tic
e.
 B
as
el
in
e 
sc
or
es
 w
er
e 
re
po
rt
ed
 a
s 
si
m
ila
r.
 C
lu
st
er
in
g 
by
 p
ra
ct
ic
e 
w
as
 a
dj
us
te
d 
fo
r 
us
in
g 
ge
ne
ra
lis
ed
 e
st
im
at
in
g 
eq
ua
tio
ns
 (
G
E
E
) 
m
et
ho
d.
 P
os
si
bl
e 
im
ba
la
nc
es
 a
m
on
g 
tr
ea
tm
en
t
ar
m
s 
w
er
e 
id
en
tif
ie
d 
by
 lo
gi
st
ic
 r
eg
re
ss
io
n 
(a
cc
ou
nt
in
g 
fo
r 
ov
er
-d
is
pe
rs
io
n)
 fo
r 
di
ch
ot
om
ou
s 
ou
tc
om
es
 a
nd
 a
na
ly
si
s 
of
 v
ar
ia
nc
e 
(A
N
O
V
A
) 
fo
r 
or
di
na
l v
ar
ia
bl
es
; 
c 
A
dh
er
en
ce
 to
 g
ui
de
lin
e 
re
co
m
m
en
da
tio
ns
 w
as
 b
as
ed
on
 N
eu
ro
lo
gi
st
s’
 w
rit
te
n 
re
sp
on
se
s 
to
 th
re
e 
cl
in
ic
al
 s
ce
na
rio
s 
de
pi
ct
in
g 
a 
ty
pi
ca
l p
at
ie
nt
 w
ith
 d
em
en
tia
 p
re
se
nt
in
g 
fo
r 
an
 in
iti
al
 e
va
lu
at
io
n.
 S
ce
na
rio
 1
 a
nd
 3
 d
ep
ic
te
d 
pa
tie
nt
s 
w
ith
 c
ha
ra
ct
er
is
tic
s 
ty
pi
ca
l o
f A
lz
he
im
er
’s
di
se
as
e 
w
ho
 d
id
 n
ot
 m
ee
t a
ny
 o
f t
he
 r
ec
om
m
en
de
d 
cr
ite
ria
 fo
r 
or
de
rin
g 
ei
th
er
 a
 n
eu
ro
-im
ag
in
g 
st
ud
y 
or
 e
le
ct
ro
en
ce
ph
al
og
ra
ph
y,
 s
ce
na
rio
 2
 d
ep
ic
te
d 
a 
pa
tie
nt
 w
ith
 e
st
ab
lis
he
d 
A
lz
he
im
er
’s
 d
is
ea
se
 a
nd
 s
ym
pt
om
s 
of
m
aj
or
 d
ep
re
ss
io
n;
 d
 E
xt
er
na
l b
as
el
in
e 
gr
ou
p 
(n
=
13
9)
 u
se
d 
fo
r 
bo
th
 in
te
rv
en
tio
n 
an
d 
co
nt
ro
l g
ro
up
 c
om
pa
ris
on
s;
 s
el
ec
tio
n 
an
d 
ch
ar
ac
te
ris
tic
s 
of
 th
e 
ba
se
lin
e 
gr
ou
p 
w
as
 e
qu
iv
al
en
t t
o 
th
e 
in
te
rv
en
tio
n 
an
d 
co
nt
ro
l
gr
ou
ps
; C
I =
 c
on
fid
en
ce
 in
te
rv
al
; 
R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l.
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1
3
8
 T
a
b
le
 4
9
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
lo
c
a
l 
o
p
in
io
n
 l
e
a
d
e
rs
 –
 P
a
ti
e
n
t 
o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
at
ie
n
t 
o
u
tc
o
m
es
 (
h
ea
lt
h
 s
ta
tu
s)
H
ea
lt
h
 c
ar
e 
u
ti
lis
at
io
n
, 9
5%
 C
I
D
is
tr
ib
u
ti
o
n
 o
f
g
u
id
el
in
es
P
h
ys
ic
ia
n
 p
ee
r 
le
ad
er
P
la
n
n
ed
 a
st
h
m
a 
ca
re
M
ea
n
 c
h
an
g
e 
a
M
ea
n
 c
h
an
g
e 
a
A
d
ju
st
ed
in
te
rv
en
ti
o
n
ef
fe
ct
[9
5%
 C
I]
M
ea
n
 c
h
an
g
e 
a
A
d
ju
st
ed
in
te
rv
en
ti
o
n
ef
fe
ct
[9
5%
 C
I]
!1
 E
D
/h
os
pi
ta
lis
at
io
n
-0
.0
1[
0-
0.
04
, 0
.0
2]
-0
.0
1 
[-
0.
05
, 0
.0
3]
0 
[-
0.
06
, 0
.0
6]
0 
[-
0.
01
, 0
.0
1]
0.
03
 [-
0.
00
3,
 0
.0
6]
(F
in
ke
ls
te
in
et
 a
l.,
20
05
)
Le
ve
l I
I:
cl
us
te
r 
R
C
T
Q
ua
lit
y:
 g
oo
d
P
rim
ar
y 
ca
re
pr
ac
tic
es
(n
=
40
);
P
at
ie
nt
s:
ch
ild
re
n 
5-
17
ye
ar
s 
ol
d 
w
ith
as
th
m
a 
(n
=
63
8)
C
hi
ca
go
 o
r
M
as
sa
ch
us
et
ts
,
U
S
A
In
te
rv
en
tio
n 
1:
P
hy
si
ci
an
 p
ee
r 
le
ad
er
ed
uc
at
io
n 
(P
LE
)
In
te
rv
en
tio
n 
2:
 P
ee
r
le
ad
er
 e
du
ca
tio
n
en
ha
nc
ed
 w
ith
pl
an
ne
d 
as
th
m
a 
ca
re
(P
A
C
)
A
m
bu
la
to
ry
 v
is
its
-0
.0
1 
[-
0.
23
, 0
.2
1]
0.
17
 [-
0.
01
, 0
.3
5]
0.
06
 [-
0.
00
2,
 0
.1
4]
0.
21
 [0
.0
3,
 0
.3
9]
0.
08
 [-
0.
01
, 0
.1
8]
a 
M
ea
n 
ch
an
ge
 w
as
 c
al
cu
la
te
d 
fr
om
 b
as
el
in
e 
pr
op
or
tio
n 
in
 e
ac
h 
pr
ac
tic
e.
 B
as
el
in
e 
sc
or
es
 w
er
e 
re
po
rt
ed
 a
s 
si
m
ila
r.
 C
lu
st
er
in
g 
by
 p
ra
ct
ic
e 
w
as
 a
dj
us
te
d 
fo
r 
us
in
g 
ge
ne
ra
lis
ed
 e
st
im
at
in
g 
eq
ua
tio
ns
 (
G
E
E
) 
m
et
ho
d.
P
os
si
bl
e 
im
ba
la
nc
es
 a
m
on
g 
tr
ea
tm
en
t a
rm
s 
w
er
e 
id
en
tif
ie
d 
by
 lo
gi
st
ic
 r
eg
re
ss
io
n 
(a
cc
ou
nt
in
g 
fo
r 
ov
er
-d
is
pe
rs
io
n)
 fo
r 
di
ch
ot
om
ou
s 
ou
tc
om
es
 a
nd
 a
na
ly
si
s 
of
 v
ar
ia
nc
e 
(A
N
O
V
A
) 
fo
r 
or
di
na
l v
ar
ia
bl
es
; C
I =
 c
on
fid
en
ce
in
te
rv
al
; E
D
 =
 e
m
er
ge
nc
y 
de
pa
rt
m
en
t.
 T
a
b
le
 5
0
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
p
a
ti
e
n
t-
m
e
d
ia
te
d
 i
n
te
rv
e
n
ti
o
n
s
 –
 P
ro
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
at
ie
n
t 
o
u
tc
o
m
es
 (
h
ea
lt
h
 s
ta
tu
s)
D
o
cu
m
en
ta
ti
o
n
 o
f 
se
iz
u
re
 f
re
q
u
en
cy
, %
 o
f 
p
at
ie
n
ts
C
o
n
tr
o
l a
n=
39
2
P
at
ie
n
t-
h
el
d
 c
ar
d
 a
n=
36
8
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e 
ch
an
g
e
p
-v
al
u
es
 b
R
ec
or
de
d 
se
iz
ur
e
fr
eq
ue
nc
y
37
.8
42
.8
+
5.
0
36
.5
44
.6
+
8.
0
1.
6
p=
0.
49
R
ep
or
te
d 
se
iz
ur
e
fr
eq
ue
nc
y
48
.3
51
.5
+
3.
2
51
.6
56
.0
+
4.
4
1.
4
p=
0.
23
8
D
oc
um
en
ta
tio
n 
of
 p
he
ny
to
in
 s
er
um
 le
ve
ls
 in
 p
re
vi
ou
s 
ye
ar
, %
 o
f p
at
ie
nt
s
(T
ha
pa
r 
et
al
., 
20
02
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
 g
oo
d
P
rim
ar
y 
he
al
th
ca
re
 p
ra
ct
ic
es
(n
=
82
) 
tr
ea
tin
g
ad
ul
ts
 w
ith
ac
tiv
e 
ep
ile
ps
y
(n
=
12
75
),
M
an
ch
es
te
r,
 U
K
P
ro
m
pt
s 
+
 G
P
-
co
m
pl
et
ed
 r
em
in
de
r
ca
rd
 p
ro
vi
di
ng
ev
id
en
ce
-b
as
ed
in
fo
rm
at
io
n,
 u
se
d
op
po
rt
un
is
tic
al
ly
P
he
ny
to
in
 s
er
um
le
ve
ls
 c
he
ck
ed
31
.2
31
.5
+
0.
3
32
.6
39
.2
+
6.
6
22
.0
p=
0.
44
7
a 
G
E
E
 m
et
ho
d 
us
ed
 to
 a
dj
us
t f
or
 c
lu
st
er
in
g.
 b
 W
al
d 
C
hi
-s
qu
ar
e 
te
st
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 T
a
b
le
 5
1
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
p
a
ti
e
n
t-
m
e
d
ia
te
d
 i
n
te
rv
e
n
ti
o
n
s
 –
 P
a
ti
e
n
t 
o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
at
ie
n
t 
o
u
tc
o
m
es
 (
h
ea
lt
h
 s
ta
tu
s)
M
ed
ic
at
io
n
 u
se
 a
n
d
 s
id
e 
ef
fe
ct
s,
 %
 o
f 
p
at
ie
n
ts C
o
n
tr
o
l a
n=
39
2
P
at
ie
n
t-
h
el
d
 c
ar
d
 a
n=
36
8
E
ff
ec
t
m
ea
su
re
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
P
at
ie
nt
 o
n 
m
or
e 
th
an
 o
ne
ep
ile
ps
y 
dr
ug
28
.8
28
.9
+
0.
1
32
.1
29
.9
-2
.2
22
.0
p=
0.
25
3
M
ed
ic
at
io
n 
si
de
 e
ffe
ct
s
re
po
rt
ed
 b
y 
pa
tie
nt
52
.8
43
.6
-9
.2
53
.2
50
.8
-2
.4
0.
3
p=
0.
01
6
S
at
is
fa
ct
io
n 
w
ith
 c
ar
e 
pr
ov
id
ed
, %
 o
f p
at
ie
nt
s
S
at
is
fa
ct
io
n 
w
ith
in
fo
rm
at
io
n 
pr
ov
id
ed
67
.7
76
.1
+
8.
4
65
.1
76
.2
+
11
.1
1.
3
p=
0.
94
3
(T
ha
pa
r 
et
al
., 
20
02
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
 g
oo
d
P
H
C
 p
ra
ct
ic
es
A
du
lts
 w
ith
ac
tiv
e 
ep
ile
ps
y,
M
an
ch
es
te
r,
U
K
P
ro
m
pt
s 
+
 G
P
-
co
m
pl
et
ed
 r
em
in
de
r
ca
rd
 p
ro
vi
di
ng
ev
id
en
ce
-b
as
ed
in
fo
rm
at
io
n,
 u
se
d
op
po
rt
un
is
tic
al
ly
G
P
’s
 c
ar
e 
of
 e
pi
le
ps
y
ra
te
d 
as
 h
ig
h
77
.2
79
.0
+
1.
8
77
.5
83
.6
+
6.
1
3.
4
p=
0.
27
a 
G
E
E
 m
et
ho
d 
us
ed
 to
 a
dj
us
t f
or
 c
lu
st
er
in
g.
 G
P
 =
 g
en
er
al
 p
ra
ct
iti
on
er
; P
H
C
 =
 p
rim
ar
y 
he
al
th
 c
ar
e;
 R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l.
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1
4
0
 T
a
b
le
 5
2
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
p
ro
m
p
ts
 a
n
d
 r
e
m
in
d
e
rs
 (
in
c
lu
d
in
g
 d
e
c
is
io
n
 s
u
p
p
o
rt
) 
–
 P
ro
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
ro
ce
ss
 o
u
tc
o
m
es
 (
p
ra
ct
it
io
n
er
s’
 b
eh
av
io
u
ra
l c
h
an
g
e)
P
ro
p
o
rt
io
n
 o
f 
w
el
l c
h
ild
 c
ar
e 
vi
si
ts
 w
it
h
 m
is
se
d
 o
p
p
o
rt
u
n
it
ie
s 
fo
r 
im
m
u
n
is
at
io
n
, %
 (
n
u
m
b
er
/n
u
m
b
er
 e
lig
ib
le
)
C
o
n
tr
o
l
32
8 
vi
si
ts
; n
=
30
 r
es
id
en
ts
E
n
co
u
n
te
r-
b
as
ed
 p
ro
m
p
ts
29
8 
vi
si
ts
; n
=
22
 r
es
id
en
ts
E
ff
ec
t
m
ea
su
re
P
er
fo
rm
an
ce
B
ef
o
re
A
ft
er
%
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
!1
 m
is
se
d
op
po
rt
un
ity
/v
ac
ci
ne
ad
m
in
is
tr
at
io
n 
er
ro
r 
b
N
ot
pr
ov
id
ed
 a
21
.6
(7
1/
32
8)
N
E
N
ot
pr
ov
id
ed
 a
11
.4
(3
4/
29
8)
N
E
P
<
0.
00
1
K
no
w
le
dg
e
B
ef
o
re
n=
30
A
ft
er
n=
22
%
 c
h
an
g
e
B
ef
o
re
n=
22
A
ft
er
n=
16
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e 
c
(S
ha
w
 e
t
al
., 
20
00
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
 g
oo
d
P
ae
di
at
ric
re
si
de
nt
pr
ac
tit
io
ne
rs
(n
=
52
)
C
hi
ld
re
n 
<
5
ye
ar
s 
ol
d
at
te
nd
in
g 
cl
in
ic
fo
r 
a 
w
el
l-c
hi
ld
ca
re
 v
is
it
(n
=
49
5)
,
B
os
to
n,
U
S
A
E
nc
ou
nt
er
-b
as
ed
im
m
un
is
at
io
n
pr
om
pt
in
g 
sy
st
em
Im
m
un
is
at
io
n 
le
ct
ur
e
ex
am
 s
co
re
76
.5
81
.3
+
4.
8
75
.5
80
.7
+
5.
2
1.
1
N
S
R
ef
er
ra
ls
 f
o
r 
kn
ee
 a
n
d
 lu
m
b
ar
 s
p
in
e 
ra
d
io
g
ra
p
h
s 
p
er
 G
P
 p
ra
ct
ic
e 
d
, n
u
m
b
er
 o
f 
re
fe
rr
al
s 
an
d
  p
ra
ct
ic
e 
p
er
 m
o
n
th
, m
ea
n
±
S
D
C
o
n
tr
o
l
kn
ee
 n
=
40
 p
ra
ct
ic
es
lu
m
ba
r 
sp
in
e 
n=
39
 p
ra
ct
ic
es
E
d
u
ca
ti
o
n
al
 r
em
in
d
er
s
kn
ee
 n
=
41
 p
ra
ct
ic
es
 lu
m
ba
r 
sp
in
e 
n=
40
 p
ra
ct
ic
es
E
ffe
ct
 m
ea
su
re
A
ft
er
A
ft
er
A
b
so
lu
te
 m
ea
n
re
d
u
ct
io
n
 e
p
-v
al
u
e
K
ne
e 
ra
di
og
ra
ph
s
14
24
±
2.
97
92
0±
1.
87
1.
10
p=
0.
00
1
(R
am
sa
y 
et
al
., 
20
03
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
 g
oo
d
G
P
s
6 
ra
di
ol
og
y
de
pa
rt
m
en
ts
 in
N
or
th
-E
as
t
E
ng
la
nd
 a
nd
S
co
tla
nd
E
du
ca
tio
na
l r
em
in
de
r
m
es
sa
ge
s 
fo
r 
kn
ee
an
d 
lu
m
be
r 
sp
in
e
ra
di
og
ra
ph
s
Lu
m
ba
r 
sp
in
e 
ra
di
og
ra
ph
s
13
49
±
2.
88
84
7±
1.
76
1.
12
p=
0.
00
1
D
o
cu
m
en
ta
ti
o
n
 o
f 
se
iz
u
re
 f
re
q
u
en
cy
, %
 o
f 
p
at
ie
n
ts
C
o
n
tr
o
l f
n=
39
2
D
o
ct
o
r-
h
el
d
 c
ar
d
 f
n=
51
5
E
ff
ec
t 
m
ea
su
re
B
ef
o
re
A
ft
er
%
ch
an
g
e
B
ef
o
re
A
ft
er
%
ch
an
g
e
R
el
at
iv
e 
ch
an
g
e
p
-v
al
u
e
(E
cc
le
s 
et
al
., 
20
01
)
(T
ha
pa
r 
et
al
., 
20
02
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
 g
oo
d
P
rim
ar
y 
he
al
th
ca
re
 p
ra
ct
ic
es
(n
=
82
) 
tr
ea
tin
g
ad
ul
ts
 w
ith
ac
tiv
e 
ep
ile
ps
y
(n
=
12
75
),
M
an
ch
es
te
r,
 U
K
P
ro
m
pt
s 
+
 G
P
-
co
m
pl
et
ed
 r
em
in
de
r
ca
rd
 p
ro
vi
di
ng
ev
id
en
ce
-b
as
ed
in
fo
rm
at
io
n,
 u
se
d
op
po
rt
un
is
tic
al
ly
R
ec
or
di
ng
 s
ei
zu
re
fr
eq
ue
nc
y
37
.8
42
.8
+
5.
0
36
.6
57
.4
+
20
.8
4.
2
p=
0.
00
3
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R
ep
or
te
d 
se
iz
ur
e
fr
eq
ue
nc
y
48
.3
51
.5
+
3.
2
51
.6
56
.0
+
4.
4
1.
4
p=
0.
23
8
D
oc
um
en
ta
tio
n 
of
 p
he
ny
to
in
 s
er
um
 le
ve
ls
 in
 p
re
vi
ou
s 
ye
ar
, %
 o
f p
at
ie
nt
s
P
he
ny
to
in
 s
er
um
le
ve
ls
 c
he
ck
ed
31
.2
31
.5
+
0.
3
28
.1
28
.7
+
0.
6
2.
0
p=
0.
85
1
D
en
ti
st
s’
 c
o
m
p
lia
n
ce
 w
it
h
 g
u
id
el
in
es
, m
ea
n
 %
C
o
n
tr
o
l
n=
11
A
u
d
it
 a
n
d
 F
ee
d
b
ac
k
n=
12
C
o
m
p
u
te
r 
A
id
ed
 L
ea
rn
in
g
n=
11
A
&
F
 +
 C
A
L
n=
13
%
 c
h
an
g
e
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
(B
ah
ra
m
i e
t
al
., 
20
04
)
Le
ve
l I
I:
C
lu
st
er
 R
C
T
Q
ua
lit
y:
 g
oo
d
D
en
ta
l p
ra
ct
ic
es
ac
ro
ss
 S
co
tla
nd
se
le
ct
ed
 fr
om
th
e 
S
co
tti
sh
D
en
ta
l P
ra
ct
ic
e
B
oa
rd
 li
st
(n
=
51
)
16
-2
4-
ye
ar
 o
ld
pa
tie
nt
s
G
ui
de
lin
es
 a
nd
 p
os
t-
gr
ad
ua
te
 e
du
ca
tio
n
co
ur
se
 p
lu
s:
au
di
t a
nd
 fe
ed
ba
ck
(A
&
F
)
co
m
pu
te
r 
ai
de
d
le
ar
ni
ng
 (
C
A
L)
pa
ck
ag
e
A
&
F
 p
lu
s 
C
A
L
pa
ck
ag
e
+
4.
0
+
1.
0
0.
3
N
S
+
3.
0
0.
8
N
S
+
7.
0
1.
8
N
S
P
at
ie
n
ts
 w
it
h
 h
yp
er
te
n
si
ve
 m
ed
ic
at
io
n
 a
d
ju
st
ed
 a
cc
o
rd
in
g
 t
o
 B
P
 le
ve
l g
, %
 p
at
ie
n
ts
 w
it
h
 m
ed
ic
at
io
n
 a
d
ju
st
ed
C
o
n
tr
o
l
n
=1
35
%
 (
n
)
R
em
in
d
er
s
n
=1
26
%
 (
n
)
E
ff
ec
t
m
ea
su
re
O
d
d
s 
ra
ti
o
[9
5%
 C
I]
H
ig
h 
no
rm
al
(s
ys
to
lic
 1
30
-1
39
m
m
 H
g;
di
as
to
lic
 8
5-
89
 m
m
 H
g)
1.
8 
(1
/2
1)
14
.3
 (
3/
21
)
0.
32
[0
.0
1,
3.
79
]
S
ta
ge
 1
(s
ys
to
lic
 1
40
-1
59
m
m
 H
g;
di
as
to
lic
 9
0-
99
 m
m
 H
g)
28
.1
 (
20
/7
1)
33
.3
 2
8/
84
)
1.
19
[0
.5
4,
 2
.6
1]
S
ta
ge
 2
(s
ys
to
lic
 1
60
-1
79
m
m
 H
g;
di
as
to
lic
 1
00
-1
09
 m
m
 H
g)
75
.0
 (
12
/1
6)
57
.7
 (
15
/2
6)
2.
2
[0
.4
7,
 1
0.
93
]
S
ta
ge
 3
(s
ys
to
lic
 1
80
-2
09
m
m
 H
g;
di
as
to
lic
 1
10
-1
19
 m
m
 H
g)
10
0.
0 
(3
/3
)
10
0.
0 
(1
/1
)
(S
an
de
rs
 &
S
at
yv
av
ol
u,
20
02
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
av
er
ag
e
P
hy
si
ci
an
s
(n
=
22
)
P
rim
ar
y 
he
al
th
ca
re
 g
ro
up
pr
ac
tic
es
 (
n=
2)
V
et
er
an
s 
w
ith
 a
va
rie
ty
 o
f
ch
ro
ni
c
di
se
as
es
in
cl
ud
in
g
hy
pe
rt
en
si
on
,
di
ab
et
es
 &
 w
ith
hi
gh
 b
lo
od
pr
es
su
re
le
ve
ls
=
32
0;
 1
60
pe
r 
pr
ac
tic
e)
V
irg
in
ia
, U
S
A
C
ha
rt
 r
em
in
de
r
at
ta
ch
ed
 to
 o
ut
pa
tie
nt
m
ed
ic
al
 r
ec
or
ds
S
ta
ge
 4
(s
ys
to
lic
 >
21
0,
 d
ia
st
ol
ic
>
12
0)
10
0.
0 
(3
/3
)
10
0.
0 
(1
/1
)
(G
ol
db
er
g
et
 a
l.,
19
91
)
Le
ve
l I
II-
1:
Q
ua
si
 R
C
T
P
rim
ar
y 
he
al
th
ca
re
 p
ra
ct
ic
es
(n
=
3)
A
lc
oh
ol
 s
cr
ee
ni
ng
in
st
ru
m
en
t (
de
ci
si
on
su
pp
or
t)
P
at
ie
n
t 
re
fe
rr
ed
 f
o
r 
co
u
n
se
lli
n
g
, %
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1
4
2
C
o
n
tr
o
l g
ro
u
p
n=
40
2
N
u
rs
e 
re
fe
rr
al
n=
41
8
P
h
ys
ic
ia
n
 r
ef
er
ra
l
n=
50
8
E
ff
ec
t
m
ea
su
re
A
ft
er
 h
A
ft
er
 h
A
ft
er
 h
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
et
 a
l.,
19
91
)
Q
ua
si
 R
C
T
Q
ua
lit
y:
A
ve
ra
ge
ca
re
 p
ra
ct
ic
es
(n
=
3)
E
ng
lis
h-
sp
ea
ki
ng
 a
du
lts
vi
si
tin
g 
pr
ac
tic
e
(n
=
1,
32
8)
W
as
hi
ng
to
n,
U
S
A
in
st
ru
m
en
t (
de
ci
si
on
su
pp
or
t)
P
at
ie
nt
s 
re
fe
rr
ed
fo
r 
co
un
se
lli
ng
2.
3
12
.8
9.
1
p=
0.
00
6
P
ro
p
o
rt
io
n
 o
f 
n
u
rs
es
 r
ec
o
rd
in
g
 a
ss
es
sm
en
t 
it
em
s 
fo
r 
h
ea
rt
 f
ai
lu
re
 p
at
ie
n
ts
, %
C
o
n
tr
o
l
E
m
ai
l r
em
in
d
er
 i
E
m
ai
l r
em
in
d
er
 +
 p
ro
m
p
ts
 i
A
ft
er
 j
A
ft
er
 j
D
if
fe
re
n
ce
p
-v
al
u
e
A
ft
er
 j
D
if
fe
re
n
ce
p
-v
al
u
e
H
ea
rt
 fa
ilu
re
 s
ta
tu
s
3.
7
13
.3
+
10
.1
p=
0.
00
6
23
.9
+
20
.2
p<
0.
00
1
D
ie
t
27
.6
38
.2
+
10
.6
p=
0.
07
6
48
.7
+
21
.1
p=
0.
00
1
M
ed
ic
at
io
n 
kn
ow
le
dg
e
24
.8
31
.1
+
6.
3
p=
0.
28
5
34
.4
+
9.
6
p=
0.
10
9
M
ed
ic
at
io
n 
ad
he
re
nc
e
48
.2
62
.7
+
14
.5
p=
0.
02
4
59
.6
+
11
.4
p=
0.
07
7
M
ed
ic
at
io
n 
si
de
-e
ffe
ct
s
12
.7
15
.3
+
2.
6
p=
0.
55
8
23
.6
+
10
.9
p=
0.
03
0
N
ur
se
s 
in
st
ru
ct
io
n 
to
 p
at
ie
nt
 a
bo
ut
 s
ig
ns
 a
nd
 s
ym
pt
om
s 
of
 h
ea
rt
 fa
ilu
re
, %
S
ho
rt
ne
ss
 o
f b
re
at
h
18
.1
31
.1
+
13
.0
p=
0.
02
1
28
.9
+
10
.8
p=
0.
05
3
F
lu
id
 w
ei
gh
t g
ai
n
20
.6
29
.9
+
9.
3
p=
0.
09
7
39
.7
+
19
.1
p=
0.
00
1
F
at
ig
ue
11
.8
10
.5
-1
.3
p=
0.
75
2
15
.9
+
4.
1
p=
0.
35
3
G
lo
ba
l i
ns
tr
uc
tio
ns
 a
bo
ut
he
ar
t f
ai
lu
re
 s
ym
pt
om
s
42
.1
53
.9
+
11
.8
p=
0.
07
0
59
.5
+
17
.4
p=
0.
00
7
N
ur
se
s 
re
co
rd
in
g 
of
 o
th
er
 h
ea
rt
 fa
ilu
re
 m
an
ag
em
en
t i
ns
tr
uc
tio
ns
 g
iv
en
 to
 p
at
ie
nt
s,
 %
(M
ur
ta
ug
h
et
 a
l.,
20
05
)
Le
ve
l I
II-
1:
Q
ua
si
 R
C
T
Q
ua
lit
y:
A
ve
ra
ge
H
om
e 
ca
re
nu
rs
es
 (
n=
35
4)
E
m
ai
l r
em
in
de
rs
:
B
as
ic
 in
te
rv
en
tio
n:
on
e-
tim
e 
em
ai
l
re
m
in
de
r 
hi
gh
lig
ht
in
g
6 
cl
in
ic
al
re
co
m
m
en
da
tio
ns
A
ug
m
en
te
d
in
te
rv
en
tio
n:
em
ai
l r
em
in
de
r
su
pp
le
m
en
te
d 
w
ith
pr
ov
id
er
 p
ro
m
pt
s,
pa
tie
nt
 e
du
ca
tio
n
m
at
er
ia
l, 
cl
in
ic
al
 n
ur
se
sp
ec
ia
lis
t o
ut
re
ac
h
W
ei
gh
in
g 
se
lf
16
.0
37
.2
+
21
.2
p<
0.
00
1
48
.7
+
32
.7
p<
0.
00
1
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M
an
ag
in
g 
flu
id
 w
ei
gh
t g
ai
n
5.
7
8.
0
+
2.
3
p=
0.
50
5
11
.9
+
6.
2
p=
0.
11
6
Lo
w
 s
al
t d
ie
t
22
.7
40
.4
+
17
.7
p=
0.
00
3
49
.6
+
26
.9
p<
0.
00
1
M
ed
ic
at
io
n 
m
an
ag
em
en
t
51
.2
57
.0
+
5.
8
p=
0.
38
5
59
.7
+
8.
5
p=
0.
19
5
Im
pr
ov
in
g 
ad
he
re
nc
e
15
.0
26
.5
+
11
.5
p=
0.
03
0
18
.0
+
3.
0
p=
0.
53
2
C
on
ta
ct
in
g 
do
ct
or
27
.3
36
.2
+
8.
9
p=
0.
14
7
42
.8
+
15
.5
p=
0.
01
4
E
du
ca
tio
na
l m
at
er
ia
l
10
.5
17
.6
+
7.
1
p=
0.
11
3
46
.2
+
35
.7
p<
0.
00
1
P
ro
p
o
rt
io
n
 o
f 
p
at
ie
n
ts
 p
re
sc
ri
b
ed
 a
p
p
ro
p
ri
at
e 
m
ed
ic
at
io
n
, %
 e
lig
ib
le
 p
at
ie
n
ts
 k
C
o
n
tr
o
l l
n=
35
4
C
o
m
p
u
te
r-
g
en
er
at
ed
 +
 w
ri
tt
en
R
em
in
d
er
s 
l
n=
37
6
E
ff
ec
t
m
ea
su
re
 m
p
-v
al
u
e
A
ft
er
A
ft
er
R
ec
ei
vi
ng
 b
et
a-
bl
oc
ke
r
(%
 o
f p
at
ie
nt
s)
19
.8
16
.0
p=
0.
16
8
R
ec
ei
vi
ng
 c
ho
le
st
er
ol
-
lo
w
er
in
g 
ag
en
t
(%
 o
f p
at
ie
nt
s)
31
.9
36
.7
p=
0.
15
9
(F
ra
nc
es
 e
t
al
., 
20
01
)]
Le
ve
l I
II-
1:
Q
ua
si
-R
C
T
Q
ua
lit
y:
av
er
ag
e
P
rim
ar
y 
he
al
th
ca
re
 p
hy
si
ci
an
s
P
at
ie
nt
s 
w
ith
co
ro
na
ry
 h
ea
rt
di
se
as
e
S
an
 F
ra
nc
is
co
,
U
S
A
C
om
pu
te
r-
ge
ne
ra
te
d
an
d 
w
rit
te
n 
re
m
in
de
r
sy
st
em
 p
ro
vi
de
d
du
rin
g 
pa
tie
nt
 v
is
its
LD
L 
le
ve
l 1
00
m
g/
dL
(%
 o
f p
at
ie
nt
s)
73
.2
71
.0
p=
0.
51
2
P
ro
p
o
rt
io
n
 o
f 
p
at
ie
n
ts
 u
n
d
er
g
o
in
g
 a
p
p
ro
p
ri
at
e 
te
st
s 
in
 5
 s
tu
d
y 
ar
ea
s,
 %
C
o
n
tr
o
l
n=
19
89
C
o
m
p
u
te
r-
g
en
er
at
ed
 r
em
in
d
er
s
n=
60
2
E
ff
ec
t
M
ea
su
re
B
ef
o
re
 n
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
 n
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
H
yp
er
te
ns
io
n
84
.4
84
.3
-0
.1
80
.1
97
.6
+
17
.5
17
5.
0
p<
0.
05
(T
ot
h-
P
al
et
 a
l.,
20
04
)
Le
ve
l I
II-
1:
C
C
T
Q
ua
lit
y:
 p
oo
r
P
rim
ar
y 
he
al
th
ca
re
 p
hy
si
ci
an
s
ca
rin
g 
fo
r
el
de
rly
 p
at
ie
nt
s
S
to
ck
ho
lm
,
S
w
ed
en
C
om
pu
te
r-
ge
ne
ra
te
d
re
m
in
de
rs
 in
te
gr
at
ed
w
ith
 a
n 
el
ec
tr
on
ic
pa
tie
nt
 r
ec
or
d 
sy
st
em
fo
r 
op
po
rt
un
is
tic
sc
re
en
in
g 
in
el
de
rly
 p
at
ie
nt
s
A
na
em
ia
78
.4
82
.3
+
3.
9
77
.1
95
.2
+
18
.1
4.
6
p<
0.
05
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1
4
4
D
ia
be
te
s
61
.4
67
.0
+
5.
6
35
.3
93
.2
+
57
.9
10
.3
p<
0.
05
B
-1
2 
de
fic
ie
nc
y
20
.3
20
.2
-0
.1
11
.1
94
.7
+
83
.6
83
6.
0
p<
0.
05
H
yp
ot
hy
ro
id
is
m
33
.5
32
.4
-1
.1
21
.8
92
.9
+
71
.1
64
.6
p<
0.
05
P
ro
p
o
rt
io
n
 o
f 
el
ig
ib
le
 p
at
ie
n
ts
 s
cr
ee
n
ed
, %
  p
at
ie
n
ts
 o
C
o
n
tr
o
l
C
o
m
p
u
te
r-
g
en
er
at
ed
 r
em
in
d
er
s
E
ff
ec
t 
m
ea
su
re
B
ef
o
re
 p
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
 p
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
M
am
m
og
ra
m
: (
an
nu
al
 -
w
om
en
 a
ge
d 
50
-6
0;
bi
-a
nn
ua
l -
 w
om
en
 a
ge
d
60
-7
5)
31
.0
21
.0
-1
0
p=
0.
44
24
.0
61
.0
+
37
.0
p=
0.
03
3.
7
p=
0.
02
C
ol
or
ec
ta
l c
an
ce
r
sc
re
en
in
g 
w
ith
 fa
ec
al
oc
cu
lt 
bl
oo
d 
ca
rd
s
(m
en
 a
nd
 w
om
en
 a
ge
d
50
-7
5 
ev
er
y 
2 
ye
ar
s)
16
.0
18
.0
+
2
p=
0.
73
20
.0
25
.0
+
5
p=
0.
33
2.
5
p=
0.
77
(G
ol
db
er
g
et
 a
l.,
20
00
)
Le
ve
l I
II-
2:
C
T
S
Q
ua
lit
y:
av
er
ag
e
P
H
C
 P
hy
si
ci
an
s
W
as
hi
ng
to
n
C
om
pu
te
r-
ge
ne
ra
te
d
pr
ev
en
tiv
e 
re
m
in
de
rs
fo
r 
m
am
m
og
ra
ph
y,
co
lo
re
ct
al
 c
an
ce
r
sc
re
en
in
g 
an
d
ch
ol
es
te
ro
l t
es
tin
g
C
ho
le
st
er
ol
 d
et
er
m
in
at
io
ns
ev
er
y 
5 
ye
ar
s 
(m
en
 a
nd
w
om
en
 a
ge
d 
18
-6
5)
13
.0
7.
0
-6
p=
0.
03
18
.0
11
.0
-7
p=
0.
02
1.
2
p=
0.
75
M
ea
n
 p
re
sc
ri
p
ti
o
n
 c
o
st
s,
 m
ea
n
 U
S
$ 
±
 S
E C
o
n
tr
o
l g
ro
u
p
n=
19
In
te
rv
en
ti
o
n
 g
ro
u
p
n=
19
E
ff
ec
t
m
ea
su
re
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
N
ew
 p
re
sc
rip
tio
ns
38
.5
±
1.
60
41
.4
±
1.
61
+
7.
5
38
.5
±
1.
63
37
.3
±
1.
62
-3
.2
0.
4
p=
0.
02
N
ew
 a
nd
 r
ef
ill
ed
pr
es
cr
ip
tio
ns
44
.1
±
1.
59
45
.9
±
1.
59
+
4.
1
43
.7
±
1.
60
40
.6
±
1.
59
-7
.3
1.
7
p=
0.
01
P
re
sc
rip
tio
n 
co
st
s 
fo
r 
10
 h
ig
h-
co
st
 d
ru
g 
ca
te
go
rie
s:
(M
cM
ul
lin
et
 a
l.,
20
04
)
Le
ve
l I
II-
2:
C
oh
or
t s
tu
dy
Q
ua
lit
y:
av
er
ag
e
P
rim
ar
y 
he
al
th
ca
re
 p
hy
si
ci
an
s,
nu
rs
e
pr
ac
tit
io
ne
rs
,
ph
ys
ic
ia
ns
’
as
si
st
an
ts
 in
co
m
m
un
ity
-
ba
se
d,
am
bu
la
to
ry
se
tti
ng
at
 A
ffi
ni
ty
H
ea
lth
 S
ys
te
m
ne
tw
or
k 
of
 1
7
pr
im
ar
y 
ca
re
cl
in
ic
C
D
S
S
 th
at
 p
ro
vi
de
d
di
ag
no
si
s-
sp
ec
ifi
c,
ev
id
en
ce
-b
as
ed
in
fo
rm
at
io
n 
ab
ou
t t
he
re
la
tiv
e 
ef
fic
ac
y,
sa
fe
ty
 a
nd
 c
os
t o
f
di
ffe
re
nt
 th
er
ap
eu
tic
op
tio
ns
 d
ur
in
g 
th
e
el
ec
tr
on
ic
pr
es
cr
ib
in
g 
pr
oc
es
s
A
nt
ib
io
tic
s
29
.9
2±
2.
18
28
.8
8±
2.
26
-3
.5
27
.1
9±
2.
27
25
.0
4±
2.
29
-7
.9
2.
2
p=
0.
69
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A
nt
id
ep
re
ss
an
ts
62
.0
5±
2.
85
60
.2
2±
2.
93
-2
.9
60
.3
7±
2.
87
50
.5
9±
2.
83
-1
6.
2
5.
5
p=
0.
06
R
hi
ni
tis
 m
ed
ic
at
io
ns
62
.2
7±
2.
85
64
.4
8±
2.
10
3.
5
69
.1
1±
2.
21
66
.5
8±
2.
07
-3
.7
-1
.0
p=
0.
24
G
E
R
D
 m
ed
ic
at
io
ns
10
4.
73
±
6.
25
10
8.
83
±
5.
93
3.
9
96
.0
8±
6.
21
84
.3
8±
6.
04
-1
2.
2
-3
.1
p=
0.
10
A
st
hm
a 
m
ed
ic
at
io
ns
64
.8
4±
4.
47
61
.7
3±
4.
58
-4
.8
62
.6
5±
4.
54
49
.9
2±
4.
55
-2
0.
3
4.
2
p=
0.
25
D
ia
be
te
s 
m
ed
ic
at
io
n
59
.9
5±
4.
55
48
.2
2±
4.
83
-1
9.
6
53
.1
5±
4.
75
42
.0
9±
5.
14
-2
0.
8
1.
0
p=
0.
94
A
nt
ih
yp
er
te
ns
io
n
m
ed
ic
at
io
ns
, d
iu
re
tic
s
25
.8
3±
1.
18
22
.6
5±
1.
15
-1
2.
3
23
.5
2±
1.
19
18
.3
6±
1.
16
-2
2.
0
1.
8
p=
0.
30
Li
pi
d 
lo
w
er
in
g 
ag
en
ts
74
.8
5±
3.
76
62
.9
8±
3.
85
-1
5.
8
73
.0
6±
4.
07
66
.5
5±
3.
95
-2
8.
2
1.
8
p=
0.
49
T
rip
ta
ns
 a
nd
 h
ea
da
ch
e
m
ed
ic
at
io
ns
69
.2
6±
9.
69
88
.9
5±
9.
64
28
.4
94
.8
1±
9.
60
67
.0
2±
9.
22
-2
9.
3
-1
.0
p=
0.
01
W
is
co
ns
in
, U
S
A
C
O
X
-2
 in
hi
bi
to
rs
an
d 
N
S
A
ID
S
33
.0
0±
4.
63
40
.5
3±
4.
54
22
.8
25
.5
1±
4.
69
29
.5
3±
4.
64
15
.7
0.
6
p=
0.
59
a 
ba
se
lin
e 
da
ta
 n
ot
 p
ro
vi
de
d,
 b
ut
 r
ep
or
te
d 
as
 s
im
ila
r;
 b
 ’ m
is
se
d 
op
po
rt
un
ity
’ r
ef
er
s 
to
 1
 o
r 
m
or
e 
fa
ilu
re
s 
to
 im
m
un
is
e 
at
 a
 v
is
it;
 ‘n
o 
va
ria
nc
e’
 w
as
 d
ef
in
ed
 a
s 
co
m
pl
et
e 
ad
m
in
is
tr
at
io
n 
of
 th
e 
va
cc
in
es
 d
ue
, t
he
 c
om
pa
ris
on
of
 m
is
se
d 
op
po
rt
un
iti
es
 b
et
w
ee
n 
th
e 
in
te
rv
en
tio
n 
an
d 
co
nt
ro
l g
ro
up
s 
w
as
 c
al
cu
la
te
d 
us
in
g 
th
e 
C
hi
-s
qu
ar
e 
te
st
; c
 C
hi
-s
qu
ar
e 
te
st
; d
 s
tu
dy
 w
as
 a
ss
es
se
d 
in
 c
on
ju
nc
tio
n 
w
ith
 (
E
cc
le
s 
et
 a
l.,
 2
00
1)
, w
hi
ch
 a
ss
es
se
d
w
he
th
er
 a
ud
it 
an
d 
fe
ed
ba
ck
 a
nd
 e
du
ca
tio
na
l m
es
sa
ge
s 
re
du
ce
d 
G
P
s 
re
qu
es
ts
 fo
r 
ra
di
ol
og
ic
al
 te
st
s 
in
 a
cc
or
da
nc
e 
w
ith
 R
ad
io
lo
gi
st
s’
 G
ui
de
lin
es
, (
R
am
sa
y 
et
 a
l.,
 2
00
3)
 p
ro
vi
de
d 
ev
id
en
ce
 o
f a
 s
ta
tis
tic
al
ly
 s
ig
ni
fic
an
t
ef
fe
ct
 fo
r 
ed
uc
at
io
na
l r
em
in
de
r 
m
es
sa
ge
s,
 (
E
cc
le
s 
et
 a
l.,
 2
00
1)
 in
ve
st
ig
at
ed
 s
us
ta
in
ab
ili
ty
 o
f t
he
 s
ta
tis
tic
al
ly
 s
ig
ni
fic
an
t e
ffe
ct
 o
ve
r 
a 
12
-m
on
th
 fo
llo
w
-u
p 
pe
rio
d,
 b
as
el
in
e 
m
ea
su
re
s 
w
er
e 
re
po
rt
ed
 in
 (
T
ha
pa
r 
et
 a
l.,
20
02
);
 e
 a
bs
ol
ut
e 
m
ea
n 
re
du
ct
io
n 
in
 th
e 
nu
m
be
r 
of
 m
on
th
ly
 r
ef
er
ra
ls
 a
nd
 c
ha
ng
e 
in
 th
e 
nu
m
be
r 
of
 m
on
th
ly
 r
ef
er
ra
ls
 o
ve
r 
12
-m
on
th
 p
er
io
d 
w
as
 d
et
er
m
in
ed
 u
si
ng
 p
oi
ss
on
 r
eg
re
ss
io
n;
 f  
 in
te
rv
en
tio
n 
an
d 
co
nt
ro
l g
ro
up
s
w
er
e 
re
po
rt
ed
 a
s 
co
m
pa
ra
bl
e 
at
 b
as
el
in
e,
 u
si
ng
 b
in
ar
y 
lo
gi
st
ic
 r
eg
re
ss
io
n;
 g
 H
yp
er
te
ns
io
n 
w
as
 c
at
eg
or
is
ed
 a
cc
or
di
ng
 to
 th
e 
Jo
in
t N
at
io
na
l C
om
m
itt
ee
 o
n 
P
re
ve
nt
io
n,
 D
et
ec
tio
n,
 E
va
lu
at
io
n 
an
d 
T
re
at
m
en
t o
f H
ig
h
B
lo
od
 P
re
ss
ur
e 
(U
S
A
),
 s
tu
dy
 p
op
ul
at
io
n 
w
as
 s
tr
at
ifi
ed
 b
y 
st
ag
e 
of
 b
lo
od
 p
re
ss
ur
e;
  h
 B
as
el
in
e 
da
ta
 n
ot
 p
ro
vi
de
d,
 b
ut
 a
dj
us
te
d 
fo
r 
us
in
g 
lo
gi
st
ic
 r
eg
re
ss
io
n 
an
al
ys
is
; 
i ‘
B
as
ic
’ i
nt
er
ve
nt
io
n:
 o
ne
-t
im
e 
em
ai
l r
em
in
de
r
hi
gh
lig
ht
in
g 
6 
cl
in
ic
al
 r
ec
om
m
en
da
tio
ns
; ‘
au
gm
en
te
d’
 in
te
rv
en
tio
n:
 e
m
ai
l r
em
in
de
r 
en
ha
nc
ed
 w
ith
 p
ro
vi
de
r 
pr
om
pt
s,
 p
at
ie
nt
 e
du
ca
tio
n 
m
at
er
ia
l a
nd
 c
lin
ic
al
 n
ur
se
 s
pe
ci
al
is
t o
ut
re
ac
h;
 j 
B
as
el
in
e 
di
ffe
re
nc
es
 r
ep
or
te
d 
as
si
m
ila
r 
or
 a
dj
us
te
d 
fo
r 
us
in
g 
m
ul
tiv
ar
ia
te
 a
na
ly
si
s;
 k
 E
lig
ib
le
 p
at
ie
nt
s 
w
er
e 
th
os
e 
w
ho
 d
id
 n
ot
 h
av
e 
th
e 
di
ag
no
si
s 
in
 q
ue
st
io
n 
or
 c
or
re
sp
on
di
ng
 m
ed
ic
at
io
n 
re
co
rd
ed
 b
ef
or
e 
th
e 
st
ud
y 
an
d 
w
ou
ld
 h
av
e 
ha
d 
sc
re
en
in
g 
te
st
re
co
m
m
en
de
d;
 l  
S
am
pl
e 
si
ze
 a
dj
us
te
d 
to
 a
cc
ou
nt
 fo
r 
cl
us
te
rin
g.
 B
as
el
in
e 
di
ffe
re
nc
es
 a
dj
us
te
d 
fo
r;
 m
 C
hi
-s
qu
ar
e 
an
d 
t-
te
st
s;
 n
 b
as
el
in
e 
da
ta
 n
ot
 a
dj
us
te
d 
fo
r;
 o
 M
ea
n 
w
ee
kl
y 
co
nv
er
si
on
 r
at
es
: a
n 
‘o
pp
or
tu
ni
ty
’ t
o
un
de
rt
ak
e 
a 
pr
ev
en
tiv
e 
sc
re
en
in
g 
pr
oc
ed
ur
e 
w
as
 ‘c
on
ve
rt
ed
’ i
f t
he
 p
ro
ce
du
re
 w
as
 p
er
fo
rm
ed
 o
n 
a 
pa
tie
nt
 d
ue
 fo
r 
th
e 
pr
oc
ed
ur
e 
w
ith
in
 1
0 
da
ys
 o
f t
he
 in
de
x 
vi
si
t f
or
 c
ho
le
st
er
ol
 a
nd
 fa
ec
al
 o
cc
ul
t b
lo
od
 te
st
s,
 a
nd
 6
0
da
ys
 fo
r 
m
am
m
og
ra
m
; p
 L
og
is
tic
 r
eg
re
ss
io
n 
an
al
ys
is
 w
as
 u
se
d 
to
 a
dj
us
t f
or
 b
as
el
in
e 
di
ffe
re
nc
es
 a
nd
 to
 te
st
 fo
r 
st
at
is
tic
al
 s
ig
ni
fic
an
ce
. O
pp
or
tu
ni
ty
 c
on
ve
rs
io
n 
ra
te
s 
fo
r 
ea
ch
 r
em
in
de
r 
ar
e 
re
pr
es
en
te
d 
as
 th
e
pe
rc
en
ta
ge
 o
f o
pp
or
tu
ni
tie
s 
co
nv
er
te
d.
 B
P
 =
 b
lo
od
 p
re
ss
ur
e;
 C
D
S
S
 =
 c
lin
ic
al
 d
ec
is
io
n 
su
pp
or
t s
of
tw
ar
e;
 C
I =
 c
on
fid
en
ce
 in
te
rv
al
; C
O
X
-2
 in
hi
bi
to
rs
 =
 s
el
ec
tiv
e 
cy
cl
oo
xy
ge
na
se
 2
 in
hi
bi
to
rs
; C
T
S
 =
 c
on
tr
ol
le
d 
tim
e
se
rie
s 
st
ud
y 
de
si
gn
; G
E
R
D
 =
 g
at
ro
es
op
ha
ge
al
 r
ef
lu
x 
di
se
as
e;
 G
P
 =
 G
en
er
al
 p
ra
ct
iti
on
er
; L
D
L 
=
 lo
w
 d
en
si
ty
 li
po
pr
ot
ei
n;
 N
S
A
ID
S
 =
 n
on
st
er
oi
da
l a
nt
i-i
nf
la
m
m
at
or
y 
dr
ug
s;
 N
S
 =
 n
ot
 s
ig
ni
fic
an
t; 
P
H
C
 =
 p
rim
ar
y 
he
al
th
ca
re
; R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l; 
S
D
 =
 s
ta
nd
ar
d 
de
vi
at
io
n;
 S
E
 =
 s
ta
nd
ar
d 
er
ro
r.
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1
4
6
 T
a
b
le
 5
3
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
p
ro
m
p
ts
 a
n
d
 r
e
m
in
d
e
rs
 (
in
c
lu
d
in
g
 d
e
c
is
io
n
 s
u
p
p
o
rt
) 
–
 P
a
ti
e
n
t 
o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
D
is
se
m
in
at
io
n
S
tr
at
eg
y
P
at
ie
n
t 
o
u
tc
o
m
es
 (
h
ea
lt
h
 s
ta
tu
s)
M
ed
ic
at
io
n
 u
se
 a
n
d
 s
id
e 
ef
fe
ct
s,
 %
 o
f 
p
at
ie
n
ts C
o
n
tr
o
l
n=
39
2
D
o
ct
o
r-
h
el
d
 c
ar
d
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w
om
en
 w
ith
 h
ys
te
re
ct
om
y
In
ap
pr
op
ria
te
 p
re
sc
rib
in
g 
of
H
R
T
 in
 w
om
en
 >
30
(n
o 
hy
st
er
ec
to
m
y)
11
.3
8.
9
-2
.4
12
.2
6.
3
-5
.9
2.
5
a 
m
ul
ti-
le
ve
l m
od
el
lin
g 
– 
va
ria
tio
n 
be
tw
ee
n 
pr
ac
tic
es
 a
nd
 b
et
w
ee
n 
ye
ar
s 
w
as
 a
na
ly
se
d 
us
in
g 
a 
ra
nd
om
 e
ffe
ct
s 
m
od
el
, t
re
at
m
en
t e
ffe
ct
s 
w
er
e 
an
al
ys
ed
 u
si
ng
 a
 fi
xe
d 
ef
fe
ct
s 
m
od
el
, a
nd
 p
ra
ct
ic
e 
lis
t s
iz
e 
w
as
 w
ei
gh
te
d
us
in
g 
th
e 
le
as
t-
sq
ua
re
s 
pr
oc
ed
ur
e;
 b
 th
e 
ac
hi
ev
ab
le
 b
en
ch
m
ar
k 
re
pr
es
en
ts
 th
e 
av
er
ag
e 
pe
rf
or
m
an
ce
 fo
r 
th
e 
to
p 
10
%
 o
f t
he
 p
hy
si
ci
an
s 
be
in
g 
as
se
ss
ed
; c
 d
iff
er
en
ce
s 
at
 b
as
el
in
e 
w
er
e 
re
po
rt
ed
 a
s 
ad
ju
st
ed
 fo
r 
an
d
pa
ire
d 
t t
es
ts
 w
er
e 
us
ed
 to
 c
om
pa
re
 th
e 
m
ea
n 
ba
se
lin
e 
an
d 
fo
llo
w
-u
p 
pe
rf
or
m
an
ce
 o
f a
ch
ie
va
bl
e 
be
nc
hm
ar
k 
in
te
rv
en
tio
n 
ph
ys
ic
ia
ns
 -
 a
na
ly
si
s 
w
as
 r
ep
ea
te
d 
fo
r 
co
m
pa
ris
on
 p
hy
si
ci
an
s,
 g
en
er
al
is
ed
 li
ne
ar
 m
od
el
s
w
er
e 
us
ed
 to
 e
va
lu
at
e 
th
e 
st
at
is
tic
al
 s
ig
ni
fic
an
ce
 a
nd
 m
ag
ni
tu
de
 o
f t
he
 in
te
rv
en
tio
n 
ef
fe
ct
 –
 th
es
e 
m
od
el
s 
co
nt
ai
ne
d 
ba
se
lin
e 
pe
rf
or
m
an
ce
 a
s 
a 
co
va
ria
te
 to
 a
dj
us
t f
or
 a
ny
 p
re
-in
te
rv
en
tio
n 
pe
rf
or
m
an
ce
 d
iff
er
en
ce
s;
d  
A
sp
iri
n 
fe
ed
ba
ck
 g
ro
up
, w
hi
ch
 w
as
 th
e 
co
nt
ro
l g
ro
up
 in
 th
is
 s
tu
dy
, w
as
 th
e 
in
te
rv
en
tio
n 
gr
ou
p 
fo
r 
m
an
ag
em
en
t o
f h
ea
rt
 d
is
ea
se
 in
 a
 s
tu
dy
 p
ub
lis
he
d 
pr
ev
io
us
ly
 a
nd
 a
ss
es
se
d 
in
 J
am
tv
ed
t e
t a
l. 
(2
00
3)
;
A
C
Q
IP
 =
 A
m
bu
la
to
ry
 C
ar
e 
Q
ua
lit
y 
Im
pr
ov
em
en
t P
ro
je
ct
; H
R
T
 =
 h
or
m
on
e 
re
pl
ac
em
en
t t
he
ra
py
; N
S
 =
 n
ot
 s
ig
ni
fic
an
t; 
S
D
 =
 s
ta
nd
ar
d 
de
vi
at
io
n.
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15
0
 T
ab
le
 5
5.
 E
ffe
ct
iv
en
es
s 
of
 fi
na
nc
ia
l i
nc
en
tiv
es
 –
 P
ro
ce
ss
 o
ut
co
m
es
Re
fe
re
nc
e
Le
ve
l a
nd
 q
ua
lit
y
of
 ev
id
en
ce
Ta
rg
et
po
pu
lat
io
n
In
te
rv
en
tio
n
Pr
oc
es
s o
ut
co
m
es
 (p
ra
ct
iti
on
er
s’ 
be
ha
vio
ur
al 
ch
an
ge
)
Ph
ys
ici
an
 co
m
pl
ian
ce
 w
ith
 g
ui
de
lin
es
, m
ea
n 
ph
ys
ici
an
 co
m
pl
ian
ce
 sc
or
es
 p
er
 in
di
ca
to
r a
Co
nt
ro
l g
ro
up
%
 ch
an
ge
 b
In
te
rv
en
tio
n 
gr
ou
p
%
 ch
an
ge
 b
Ef
fe
ct
 m
ea
su
re
Re
lat
ive
 ch
an
ge
p-
va
lu
e c
Pa
p s
me
ar
Au
dit
 2
+1
00
.6
+6
8.1
0.6
8
Au
dit
 3
+2
06
.1
+1
13
.4
0.5
5
Au
dit
 4
+1
72
.1
+1
08
.7
0.6
3
Co
lor
ec
tal
 sc
re
en
ing
Au
dit
 2
+2
46
.3
+1
49
.7
0.6
1
Au
dit
 3
+3
28
.7
+2
60
.4
0.7
9
Au
dit
 4
+2
46
.3
+1
93
.3
0.7
8
Ma
mm
og
ra
ph
y
Au
dit
 2
+2
3.9
+1
2.5
0.5
2
Au
dit
 3
+7
2.4
+4
8.4
0.6
7
Au
dit
 4
+7
0.3
+5
5.5
0.7
9
Br
ea
st 
ex
am
Au
dit
 2
+7
6.4
+4
3.0
0.5
6
Au
dit
 3
+2
05
.4
+1
31
.3
0.6
4
Au
dit
 4
+1
28
.4
+1
04
.8
0.8
2
To
tal
 co
mp
lia
nc
e s
co
re
Au
dit
 2
+8
7.4
+6
0.0
0.6
9
Au
dit
 3
+1
52
.4
+1
07
.4
0.7
0
(H
illm
an
 et
al.
, 1
99
8)
Le
ve
l: I
II-
1 Q
ua
si-
RC
T
Qu
ali
ty:
 G
oo
d
Pr
im
ar
y h
ea
lth
ca
re
 pr
ac
tic
es
(n
=2
5 a
ud
it 1
;
26
 au
dit
 2,
3,4
)
Ph
ila
de
lph
ia,
US
A
Fin
an
cia
l in
ce
nti
ve
s
- s
em
i-a
nn
ua
l fe
ed
ba
ck
 on
ph
ys
ici
an
s’ 
co
mp
lia
nc
e w
ith
ca
nc
er
 sc
re
en
ing
 w
ith
 fin
an
cia
l
bo
nu
se
s f
or
 ‘g
oo
d’ 
pe
rfo
rm
er
s
Au
dit
 4
+1
28
.2
+9
7.0
0.7
6
a A
gg
re
ga
te 
co
mp
lia
nc
e s
co
re
s w
er
e t
he
 nu
mb
er
 of
 in
dic
ato
rs 
in 
co
mp
lia
nc
e d
ivi
de
d b
y t
he
 nu
mb
er
 of
 ap
pli
ca
ble
 ch
ar
ts.
 b 
Pe
rce
nt 
ch
an
ge
 fr
om
 ba
se
lin
e (
Au
dit
 1)
. D
ue
 to
 sp
ac
e r
es
tric
tio
ns
, p
re
 an
d p
os
t s
co
re
s a
re
no
t p
ro
vid
ed
, b
ut 
ar
e a
va
ila
ble
 on
 re
qu
es
t; c
 D
iffe
re
nc
es
 be
tw
ee
n c
on
tro
l a
nd
 in
ter
ve
nti
on
 gr
ou
ps
 ar
e n
ot 
sig
nif
ica
nt 
for
 al
l o
utc
om
es
; R
CT
 =
 ra
nd
om
ise
d c
on
tro
lle
d t
ria
l.
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 T
a
b
le
 5
6
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
e
le
c
tr
o
n
ic
 e
d
u
c
a
ti
o
n
a
l 
s
o
u
r
c
e
s
 –
 P
r
o
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
 q
u
al
it
y
o
f 
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
In
te
rv
en
ti
o
n
P
ro
ce
ss
 o
u
tc
o
m
es
 (
p
ra
ct
it
io
n
er
s’
 b
eh
av
io
u
ra
l c
h
an
g
e)
P
am
p
h
le
t
n=
55
C
D
-R
O
M
n=
64
In
te
rn
et
n=
69
%
 c
h
an
g
e
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
A
cc
es
si
bi
lit
y:
 F
re
qu
en
cy
 o
f s
ea
rc
hi
ng
 fo
r 
in
fo
rm
at
io
n,
 m
ea
n 
±
S
D
6 
m
on
th
s
-3
.8
+
3.
3
0.
6
-6
.8
1.
8
12
 m
on
th
s
+
2.
6
-3
.3
1.
3
-6
.8
2.
6
A
cc
es
si
bi
lit
y:
 R
el
ev
an
ce
 o
f m
at
er
ia
ls
 to
 p
op
ul
at
io
n,
 m
ea
n 
±
S
D
6 
m
on
th
s
-1
0.
6
+
25
.6
2.
4
-1
7.
6
1.
7
12
 m
on
th
s
+
6.
4
+
22
.2
3.
5
-1
4.
1
2.
2
A
cc
es
si
bi
lit
y:
 A
cc
es
si
bi
lit
y 
of
 in
fo
rm
at
io
n,
 m
ea
n 
±
S
D
6 
m
on
th
s
-0
.8
-3
.1
3.
9
p<
0.
05
0.
0
0.
0
12
 m
on
th
s
+
1.
1
-2
1.
9
-1
9.
9
p<
0.
05
-1
3.
7
12
.5
p<
0.
05
P
er
ce
iv
ed
 s
el
f e
ffi
ca
cy
: C
on
fid
en
ce
 in
 a
bi
lit
y 
to
 id
en
tif
y 
pr
og
ra
m
s,
 m
ea
n 
±
S
D
6 
m
on
th
s
-1
5.
2
-0
.9
0.
1
-4
.5
0.
3
12
 m
on
th
s
-2
9.
6
-3
.6
0.
1
-2
6.
4
0.
9
N
S
P
er
ce
iv
ed
 s
el
f e
ffi
ca
cy
: C
on
fid
en
ce
 in
 a
bi
lit
y 
to
 o
bt
ai
n 
pr
og
ra
m
s,
 m
ea
n 
±
S
D
6 
m
on
th
s
-3
.5
-1
2.
0
3.
4
p<
0.
05
-1
.0
0.
3
12
 m
on
th
s
-1
4.
7
-1
9.
7
1.
3
p<
0.
05
-1
4.
7
1.
0
p<
0.
05
P
er
ce
iv
ed
 s
el
f e
ffi
ca
cy
: C
on
fid
en
ce
 in
 a
bi
lit
y 
to
 r
ec
om
m
en
d 
pr
og
ra
m
s,
 m
ea
n 
±
S
D
6 
m
on
th
s
+
5.
5
+
9.
2
1.
7
-2
.6
0.
5
12
 m
on
th
s
+
6.
4
+
1.
7
0.
3
-2
1.
9
-3
.4
p<
0.
05
(D
i N
oi
a 
et
al
., 
20
03
)
Le
ve
l I
II-
1:
 Q
ua
si
-
R
C
T
Q
ua
lit
y:
 a
ve
ra
ge
P
ro
fe
ss
io
na
ls
em
pl
oy
ed
 in
sc
ho
ol
s,
co
m
m
un
ity
ag
en
ci
es
 a
nd
po
lic
y-
m
ak
in
g
bo
di
es
pr
ov
id
in
g 
yo
ut
h
se
rv
ic
es
(n
=
18
8)
,
N
ew
 Y
or
k,
U
S
A
S
ub
st
an
ce
 u
se
 p
re
ve
nt
io
n
pr
og
ra
m
 m
at
er
ia
ls
di
ss
em
in
at
ed
 v
ia
 C
D
-R
O
M
 a
nd
th
e 
In
te
rn
et
B
eh
av
io
ur
al
 in
te
nt
io
ns
: L
ik
el
ih
oo
d 
of
 r
eq
ue
st
in
g 
pr
og
ra
m
, m
ea
n 
±
S
D
132  appendix B data tables
1
5
2
6 
m
on
th
s
+
8.
0
+
1.
1
0.
1
-6
.0
0.
8
12
 m
on
th
s
+
11
.0
+
9.
8
0.
9
-8
.0
0.
7
B
eh
av
io
ur
al
 in
te
nt
io
ns
: L
ik
el
ih
oo
d 
of
 im
pl
em
en
tin
g 
pr
og
ra
m
,  
m
ea
n 
±
S
D
6 
m
on
th
s
-6
.3
-7
.4
1.
2
-7
.5
1.
2
12
 m
on
th
s
+
20
.5
+
25
.9
1.
3
+
2.
2
0.
1
B
eh
av
io
ur
al
 in
te
nt
io
ns
: L
ik
el
ih
oo
d 
of
 r
ec
om
m
en
di
ng
 p
ro
gr
am
,  
m
ea
n 
±
S
D
6 
m
on
th
s
-1
3.
7
-4
.0
0.
3
-1
5.
9
1.
2
12
 m
on
th
s
+
6.
2
-1
8.
5
3.
0
-2
9.
8
4.
8
p<
0.
05
R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l; 
S
D
 =
 s
ta
nd
ar
d 
de
vi
at
io
n
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1
5
4
S
cr
ee
ni
ng
 d
 in
 r
ec
om
m
en
de
d 
lo
ca
tio
n,
 a
ll 
pa
tie
nt
s
%
ch
an
g
e 
b
e
%
ch
an
g
e 
e
R
el
at
iv
e
ch
an
g
e
%
ch
an
g
e 
e
R
el
at
iv
e
ch
an
g
e
%
ch
an
g
e 
e
R
el
at
iv
e
ch
an
g
e
12
 m
on
th
s
+
5.
0
+
11
.0
2.
2
+
33
.0
6.
6
+
50
.0
10
.0
18
 m
on
th
s
+
5.
0
+
16
.0
3.
2
+
25
.0
5.
0
+
44
.0
8.
8
S
cr
ee
ni
ng
 in
 r
ec
om
m
en
de
d 
lo
ca
tio
n,
 a
t r
is
k 
pa
tie
nt
s 
f
12
 m
on
th
s
+
1.
0
+
10
.0
10
.0
+
30
.0
30
.0
+
53
.0
53
.0
18
 m
on
th
s
+
2.
0
+
16
.0
8.
0
+
23
.0
11
.5
+
47
.0
23
.5
R
is
k 
m
an
ag
em
en
t g
 in
fo
rm
at
io
n 
on
 m
ed
ic
al
 r
ec
or
d,
 a
t r
is
k 
pa
tie
nt
s 
f
12
 m
on
th
s
-1
.0
+
3.
0
3.
0
+
4.
0
4.
0
+
7.
0
7.
0
18
 m
on
th
s
+
6.
0
+
29
.0
4.
8
+
29
.0
4.
8
+
23
.0
3.
8
P
re
se
n
ce
 o
f 
ca
rd
io
va
sc
u
la
r 
d
is
ea
se
 in
fo
rm
at
io
n
 o
n
 r
ec
o
m
m
en
d
ed
 t
o
o
ls
 in
 t
h
e 
m
ed
ic
al
 r
ec
o
rd
 o
f 
ea
ch
p
h
ys
ic
ia
n
, %
 p
er
 lo
ca
ti
o
n
P
at
ie
nt
 q
ue
st
io
nn
ai
re
12
 m
on
th
s
+
13
.0
+
15
.0
1.
2
+
22
.0
1.
7
+
24
.0
1.
8
18
 m
on
th
s
+
21
.0
+
20
.0
1.
0
+
25
.0
1.
2
+
21
.0
1.
0
P
ro
bl
em
 li
st
12
 m
on
th
s
-8
.0
+
4.
0
0.
5
+
13
.0
1.
6
+
35
.0
4.
4
18
 m
on
th
s
-6
.0
0.
0
0.
0
+
10
.0
1.
7
+
31
.0
5.
2
F
lo
w
 c
ha
rt
12
 m
on
th
s
+
3.
0
+
14
.0
4.
7
+
22
.0
7.
3
+
20
.0
6.
7
M
in
ne
ap
ol
is
;
M
in
ne
so
ta
;
Io
w
a 
C
ity
, U
S
A
A
du
lt 
pa
tie
nt
s
(n
=
20
 m
ed
ic
al
re
co
rd
s
au
di
te
d)
In
te
rv
en
tio
n 
3:
C
on
fe
re
nc
e 
+
 Q
I c
on
su
lta
tio
ns
+
 p
re
ve
nt
io
n 
co
or
di
na
to
r
(n
=
11
)
F
or
 p
re
ve
nt
io
n 
of
ca
rd
io
va
sc
ul
ar
 d
is
ea
se
18
 m
on
th
s
+
3.
0
+
27
.0
9.
0
+
22
.0
7.
3
+
20
.0
6.
7
P
er
fo
rm
an
ce
 o
f 
b
re
as
t 
ca
n
ce
r 
sc
re
en
in
g
 f
o
r 
w
o
m
en
 a
g
e 
50
 y
ea
rs
 a
n
d
 o
ld
er
, %
 p
ra
ct
ic
es
C
o
n
tr
o
l
O
ff
ic
e-
sy
st
em
 in
te
rv
en
ti
o
n
E
ff
ec
t 
m
ea
su
re
 h
B
ef
o
re
n=
30
A
ft
er
n=
27
%
ch
an
g
e
B
ef
o
re
n=
32
A
ft
er
n=
31
%
ch
an
g
e
O
R
[9
5%
 C
I]
p
-v
al
u
e
(K
in
si
ng
er
 e
t
al
., 
19
98
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
 G
oo
d
F
am
ily
ph
ys
ic
ia
ns
 a
nd
ge
ne
ra
l
in
te
rn
is
ts
,
co
m
m
un
ity
pr
im
ar
y 
ca
re
pr
ac
tic
es
(n
=
62
)
F
em
al
e
pa
tie
nt
s 
!5
0
ye
ar
s 
w
ith
 n
o
pr
ev
io
us
di
ag
no
si
s 
of
ca
nc
er
(n
=
2,
88
7)
,
(n
=
40
-2
00
ch
ar
ts
 a
ud
ite
d
pe
r 
pr
ac
tic
e)
R
ur
al
 N
or
th
C
ar
ol
in
a,
 U
S
A
O
ffi
ce
 s
ys
te
m
 (
ta
ilo
re
d 
to
pr
ac
tic
e)
 +
 a
tte
nd
an
ce
 a
t e
nd
-
of
-in
te
rv
en
tio
n 
co
nf
er
en
ce
M
am
m
og
ra
m
 m
en
tio
n 
i
40
.5
44
.0
+
3.
5
38
.7
51
.4
+
12
.7
1.
5 
[1
.1
, 2
.0
]
p=
0.
01
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M
am
m
og
ra
m
 r
ep
or
t
30
.6
34
.0
+
3.
4
28
.0
32
.7
+
4.
7
1.
1.
 [0
.8
, 1
.4
]
p=
0.
56
C
lin
ic
al
 b
re
as
t e
xa
m
in
at
io
n
44
.6
43
.9
-0
.7
41
.1
46
.4
+
5.
3
1.
3 
[1
.0
, 1
.6
]
p=
0.
06
F
em
al
e
pa
tie
nt
s 
!5
0
ye
ar
s 
w
ith
 n
o
pr
ev
io
us
di
ag
no
si
s 
of
ca
nc
er
(n
=
2,
88
7)
,
(n
=
40
-2
00
ch
ar
ts
 a
ud
ite
d
pe
r 
pr
ac
tic
e)
R
ur
al
 N
or
th
C
ar
ol
in
a,
 U
S
A
M
am
m
og
ra
m
 m
en
tio
n 
+
cl
in
ic
al
 b
re
as
t e
xa
m
in
at
io
n
30
.3
32
.6
+
2.
3
28
.2
38
.7
+
10
.5
1.
4 
[1
.1
, 1
.9
]
p=
0.
01
P
ro
p
o
rt
io
n
 o
f 
el
ig
ib
le
 f
em
al
e 
p
at
ie
n
ts
 w
h
o
 r
ec
ei
ve
d
 c
an
ce
r 
p
re
ve
n
ti
o
n
an
d
 e
ar
ly
 d
et
ec
ti
o
n
 s
er
vi
ce
s,
 p
ra
ct
ic
e 
m
ea
n
 j
C
o
n
tr
o
l
n=
26
E
d
u
ca
ti
o
n
al
in
te
rv
en
ti
o
n
n=
26
O
ff
ic
e 
sy
st
em
n=
24
O
ff
ic
e 
sy
st
em
 +
E
d
u
ca
ti
o
n
al
in
te
rv
en
ti
o
n
n=
26
S
er
vi
ce
%
 c
h
an
g
e
%
ch
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
es
%
ch
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
es
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
es
M
am
m
og
ra
m
(a
ge
 >
50
 y
ea
rs
)
-1
.7
+
34
.0
20
.0
p<
0.
01
+
30
.5
17
.9
p<
0.
01
+
36
.8
21
.6
p<
0.
01
C
lin
ic
al
 b
re
as
t
ex
am
in
at
io
n
-5
.8
+
6.
0
1.
0
+
12
.9
2.
2
p<
0.
05
+
15
.9
2.
7
p<
0.
05
R
ec
om
m
en
da
tio
n 
fo
r
br
ea
st
 s
el
f
ex
am
in
at
io
n
-5
.3
+
7.
7
1.
5
+
16
.7
3.
2
+
19
.6
3.
7
p<
0.
05
C
er
vi
ca
l c
yt
ol
og
y
-3
.2
+
3.
3
1.
0
+
22
.4
7.
0
p<
0.
05
+
6.
6
2.
1
P
ro
p
o
rt
io
n
 o
f 
el
ig
ib
le
 p
at
ie
n
ts
 w
h
o
 r
ec
ei
ve
d
 c
an
ce
r 
p
re
ve
n
ti
o
n
 a
n
d
 e
ar
ly
 d
et
ec
ti
o
n
 s
er
vi
ce
s,
 p
ra
ct
ic
e 
m
ea
n
F
ae
ca
l o
cc
ul
t b
lo
od
te
st
  (
ag
e 
>
50
 y
ea
rs
)
+
2.
2
+
12
.5
0.
6
+
29
.2
13
.3
p<
0.
01
+
41
.9
19
.0
p<
0.
01
(D
ie
tr
ic
h 
et
al
., 
19
92
)
Le
ve
l I
II-
1:
 Q
ua
si
R
C
T
Q
ua
lit
y:
 G
oo
d
F
am
ily
ph
ys
ic
ia
ns
 a
nd
ge
ne
ra
l
in
te
rn
is
ts
 w
ith
in
am
bu
la
to
ry
ca
re
 p
ra
ct
ic
es
(n
=
98
),
P
at
ie
nt
s 
ag
ed
42
+
 y
ea
rs
N
ew
H
am
ps
hi
re
 &
V
er
m
on
t, 
U
S
A
In
te
rv
en
tio
n 
1:
O
ffi
ce
 s
ys
te
m
 (
ta
ilo
re
d
to
 p
ra
ct
ic
e)
In
te
rv
en
tio
n 
2:
E
du
ca
tio
na
l i
nt
er
ve
nt
io
n
In
te
rv
en
tio
n 
3:
O
ffi
ce
 s
ys
te
m
 (
ta
ilo
re
d 
to
pr
ac
tic
e)
 +
 e
du
ca
tio
na
l
in
te
rv
en
tio
n
R
ec
ta
l e
xa
m
in
at
io
n
+
5.
6
0.
0
0.
0
+
11
.9
2.
1
+
8.
6
1.
5
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1
5
6
S
ig
m
oi
do
sc
op
y
(a
ge
 >
50
 y
ea
rs
)
+
20
.0
+
7.
1
0.
4
+
24
.0
1.
2
+
12
.5
0.
6
R
ec
om
m
en
da
tio
n 
to
de
cr
ea
se
 d
ie
ta
ry
 fa
t
-4
.1
+
11
.6
2.
8
+
14
.3
3.
5
p<
0.
05
+
8.
5
-2
.0
R
ec
om
m
en
da
tio
n 
to
in
cr
ea
se
 fi
br
e 
in
ta
ke
+
11
.8
+
18
.8
1.
6
+
20
.0
1.
7
-1
7.
1
-1
.4
R
ec
om
m
en
da
tio
n 
fo
r
sm
ok
er
s 
to
 q
ui
t
-8
.2
+
8.
2
1.
0
+
1.
2
0.
1
p<
0.
05
+
2.
6
0.
3
a 
P
rim
in
g 
in
vo
lv
ed
 1
5-
m
in
ut
e 
au
di
o-
ta
pe
d 
“p
at
ie
nt
-p
rim
in
g”
 p
ro
gr
am
 o
n 
al
co
ho
l r
is
k 
be
ha
vi
ou
rs
; 
b  
ba
se
lin
e 
sc
or
es
 n
ot
 p
ro
vi
de
d,
 b
ut
 a
dj
us
te
d 
fo
r 
us
in
g 
ge
ne
ra
liz
ed
 e
st
im
at
in
g 
eq
ua
tio
ns
 (
G
E
E
) 
m
et
ho
d;
 c
 G
en
er
al
lin
ea
r 
m
ix
ed
 m
od
el
 r
eg
re
ss
io
n;
 d
 S
cr
ee
ni
ng
 in
fo
rm
at
io
n 
in
cl
ud
ed
 c
ho
le
st
er
ol
 le
ve
l, 
di
ag
no
si
s 
of
 h
yp
er
te
ns
io
n 
or
 s
m
ok
in
g 
st
at
us
 in
fo
rm
at
io
n;
 e
 B
as
el
in
e 
sc
or
es
 n
ot
 in
cl
ud
ed
 d
ue
 to
 s
pa
ce
 r
es
tr
ic
tio
ns
 a
nd
 w
er
e 
re
po
rt
ed
as
 a
dj
us
te
d 
fo
r 
us
in
g 
G
E
E
 m
et
ho
d;
 f 
A
t r
is
k 
pa
tie
nt
s 
ha
ve
 a
t l
ea
st
 o
ne
 o
f t
he
 fo
llo
w
in
g 
ch
ar
ac
te
ris
tic
s:
 s
el
f-
id
en
tif
ie
d 
sm
ok
er
, a
 m
ed
ic
al
 r
ec
or
d 
di
ag
no
si
s 
of
 h
yp
er
te
ns
io
n,
 a
 c
ho
le
st
er
ol
 le
ve
l o
f >
20
0;
g 
R
is
k 
m
an
ag
em
en
t i
nc
lu
de
s 
co
un
se
lli
ng
 o
r 
ph
ar
m
ac
eu
tic
al
 tr
ea
tm
en
t f
or
 a
t l
ea
st
 o
ne
 r
is
k 
fa
ct
or
, h
 L
og
is
tic
 r
eg
re
ss
io
n 
m
od
el
s 
us
ed
 in
 a
na
ly
si
s;
 i  
‘M
en
tio
n’
 in
cl
ud
es
 a
ll 
ca
se
s 
of
 ‘r
ep
or
te
d’
 m
am
m
og
ra
ph
y 
or
 w
he
re
m
am
m
og
ra
ph
y 
w
as
 c
on
si
de
re
d 
ev
en
 if
 th
e 
pa
tie
nt
 d
id
n’
t f
ol
lo
w
 th
ou
gh
; j
 T
w
o-
w
ay
 A
N
C
O
V
A
 a
rc
si
n 
tr
an
sf
or
m
ed
 p
ro
po
rt
io
ns
 w
ith
 b
as
el
in
e 
as
 c
ov
ar
ia
te
s;
 C
B
E
 =
 c
lin
ic
al
 b
re
as
t e
xa
m
in
at
io
n;
 C
I =
 c
on
fid
en
ce
 in
te
rv
al
s;
N
S
 =
 n
ot
 s
ig
ni
fic
an
t; 
O
R
 =
 o
dd
s 
ra
tio
; Q
I =
 q
ua
lit
y 
im
pr
ov
em
en
t R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l.
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 T
a
b
le
 5
8
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
re
c
o
rd
 a
n
d
/o
r 
o
ff
ic
e
 s
y
s
te
m
s
 –
 P
a
ti
e
n
t 
o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
 q
u
al
it
y
o
f 
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
In
te
rv
en
ti
o
n
P
at
ie
n
t 
o
u
tc
o
m
es
 (
h
ea
lt
h
 s
ta
tu
s)
A
lc
o
h
o
l u
se
 o
u
tc
o
m
es
 r
ep
o
rt
ed
, %
 o
f 
ad
o
le
sc
en
ts
C
o
n
tr
o
l v
s 
p
at
ie
n
t-
p
ri
m
in
g
 a
b
 o
n
ly
O
R
 [
95
%
 C
I]
C
o
n
tr
o
l v
s 
p
at
ie
n
t-
p
ri
m
in
g
 a
b
+
 p
ro
vi
d
er
 p
ro
m
p
ts
O
R
 [
95
%
 C
I]
A
lc
oh
ol
 u
se
 o
ut
co
m
e
A
ft
er
 6
 m
o
n
th
s
A
ft
er
 1
2 
m
o
n
th
s
A
ft
er
 6
 m
o
n
th
s
A
ft
er
 1
2 
m
o
n
th
s
H
un
g 
ar
ou
nd
 w
ith
 fr
ie
nd
s
w
hi
le
 th
ey
 d
ra
nk
1.
17
 [0
.5
7,
 2
.4
0]
1.
03
 [0
.6
3,
 1
.6
9]
1.
74
 [0
.9
0,
 3
.3
5]
1.
04
 [0
.6
0,
 1
.8
1]
R
ef
us
ed
 to
 d
rin
k 
w
he
n
as
ke
d 
by
 o
th
er
s
1.
27
 [0
.7
6,
 2
.1
3]
1.
19
 [0
.7
4,
 1
.9
2]
2.
08
 [1
.2
9,
 3
.3
5]
p<
0.
01
1.
50
 [0
.9
1,
 2
.4
6]
D
ra
nk
 la
st
 3
0 
da
ys
1.
29
 [0
.6
7,
 2
.4
9]
2.
31
 [1
.3
1,
 4
.0
7]
p<
0.
01
1.
49
 [0
.8
0,
 2
.8
0]
1.
25
 [0
.7
6,
 2
.0
6]
D
ra
nk
 la
st
 3
 m
on
th
s
1.
87
 [0
.8
1,
 4
.3
0]
1.
76
 [1
.1
2,
 2
.7
7]
p<
0.
05
1.
65
 [0
.9
8,
 2
.7
9]
1.
22
 [0
.7
9,
 1
.8
9]
(B
oe
ke
lo
o 
et
al
., 
20
03
;
B
oe
ke
lo
o 
et
al
., 
20
04
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
 G
oo
d
P
rim
ar
y 
he
al
th
ca
re
 p
ro
vi
de
rs
(n
=
26
),
W
as
hi
ng
to
n 
D
C
an
d 
M
ar
yl
an
d,
U
S
A
P
at
ie
nt
s 
ag
ed
12
 to
 1
7 
ye
ar
s
(n
=
44
4)
In
te
rv
e
n
ti
o
n
 1
:
A
do
le
sc
en
t p
rim
in
g 
a  
on
al
co
ho
l r
is
k 
be
ha
vi
ou
rs
 w
ith
ad
ol
es
ce
nt
 s
el
f-
as
se
ss
m
en
t
In
te
rv
e
n
ti
o
n
 2
:
A
do
le
sc
en
t p
rim
in
g 
a  
on
al
co
ho
l r
is
k 
be
ha
vi
ou
rs
 w
ith
ad
ol
es
ce
nt
 s
el
f-
as
se
ss
m
en
t
an
d 
ed
uc
at
io
na
l b
ro
ch
ur
e 
+
pr
ov
id
er
 p
ro
m
pt
in
g
B
in
ge
d 
la
st
 3
 m
on
th
s
3.
44
 [1
.0
7,
 1
1.
01
]
p<
0.
01
3.
00
 [1
.4
4,
 6
.2
4]
p<
0.
05
4.
71
 [1
.5
5,
 1
4.
30
]
p<
0.
01
2.
86
 [1
.1
3,
 7
.2
6]
p<
0.
05
C
h
an
g
e 
in
 p
at
ie
n
t 
o
u
tc
o
m
es
 f
ro
m
 b
as
el
in
e 
to
 1
2 
m
o
n
th
s 
fo
llo
w
-u
p
, l
ea
st
 s
q
u
ar
es
 m
ea
n
s 
c
P
at
ie
nt
 o
ut
co
m
e
C
o
n
tr
o
l
1 
- 
C
o
u
n
se
lli
n
g
tr
ai
n
in
g
2 
- 
C
o
u
n
se
lli
n
g
tr
ai
n
in
g
 +
o
ff
ic
e-
su
p
p
o
rt
M
ea
n
 d
if
fe
re
n
ce
b
et
w
ee
n
 1
 a
n
d
 2
 d
p
-v
al
u
e 
e
S
F
A
, %
 e
ne
rg
y
0.
0
-0
.4
-1
.1
-1
.1
0.
01
W
ei
gh
t, 
kg
0.
0
-1
.0
-2
.3
-2
.3
<
0.
00
1
LD
L 
ch
ol
es
te
ro
l,
-0
.0
1
0.
02
-0
.1
1
-0
.1
0
0.
10
T
ot
al
 fa
t, 
%
 e
ne
rg
y
-0
.7
-1
.0
-2
.3
1.
6
0.
11
T
ot
al
 c
ho
le
st
er
ol
,
m
m
ol
/L
 (
m
g/
dL
)
0.
03
0.
05
-0
.1
0
-0
.1
2
0.
07
H
D
L 
ch
ol
es
te
ro
l,
m
m
ol
/L
 (
m
g/
dL
)
-0
.0
2
0.
01
0.
01
0.
03
0.
09
(O
ck
en
e 
et
al
., 
19
99
)
Le
ve
l I
II-
1:
 q
ua
si
-
R
C
T
Q
ua
lit
y:
 a
ve
ra
ge
P
rim
ar
y 
ca
re
in
te
rn
is
ts
(n
=
45
)
M
as
sa
ch
us
et
ts
,
U
S
A
In
te
rv
e
n
ti
o
n
 1
:
T
ra
in
in
g 
pr
og
ra
m
 fo
r
ph
ys
ic
ia
n-
de
liv
er
ed
nu
tr
iti
on
 c
ou
ns
el
lin
g
In
te
rv
e
n
ti
o
n
 2
:
T
ra
in
in
g 
pr
og
ra
m
 +
 o
ffi
ce
 -
su
pp
or
t p
ro
gr
am
(in
cl
ud
in
g 
of
fic
e 
pr
om
pt
s,
al
go
rit
hm
s,
 s
im
pl
e 
di
et
ar
y
as
se
ss
m
en
t t
oo
ls
)
T
rig
ly
ce
rid
es
,
m
m
ol
/L
 (
m
g/
dL
)
0.
12
-0
.0
6
-0
.0
1
-0
.1
3
0.
03
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1
5
8
T
ot
al
-c
ho
le
st
er
ol
 -
H
D
L 
ra
tio
0.
1
0.
1
-0
.1
-0
.2
0.
00
4
a  
P
rim
in
g 
in
vo
lv
ed
 1
5-
m
in
ut
e 
au
di
o-
ta
pe
d 
“p
at
ie
nt
-p
rim
in
g”
 p
ro
gr
am
 o
n 
al
co
ho
l r
is
k 
be
ha
vi
ou
rs
; b
 C
on
tr
ol
lin
g 
fo
r 
co
ho
rt
, p
hy
si
ci
an
 s
ex
, o
ffi
ce
 lo
ca
tio
n,
 a
do
le
sc
en
t a
ge
, s
ex
, e
th
ni
ci
ty
 e
tc
; c
 M
ix
ed
 e
ffe
ct
s 
m
od
el
 A
N
O
V
A
ad
ju
st
ed
 fo
r 
ag
e,
 g
en
de
r 
an
d 
ed
uc
at
io
n;
 d
 P
os
t-
in
te
rv
en
tio
n 
(a
fte
r 
sc
or
es
) 
da
ta
 n
ot
 r
ep
or
te
d,
 o
nl
y 
ba
se
lin
e 
an
d 
ch
an
ge
 s
co
re
s 
re
po
rt
ed
; e
 T
-t
es
t c
om
pa
re
d 
le
as
t s
qu
ar
es
 m
ea
ns
 fo
r 
in
te
rv
en
tio
n 
gr
ou
p 
1 
an
d 
2;
C
I =
 c
on
fid
en
ce
 in
te
rv
al
s;
 H
D
L 
=
 h
ig
h-
de
ns
ity
 li
po
pr
ot
ei
n;
 L
D
L 
=
 lo
w
-d
en
si
ty
 li
po
pr
ot
ei
n;
 N
S
 =
 n
ot
 s
ig
ni
fic
an
t; 
O
R
 =
 o
dd
s 
ra
tio
; S
F
A
 =
 s
at
ur
at
ed
 fa
tty
 a
ci
ds
; R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l.
 T
a
b
le
 5
9
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
m
u
lt
i-
d
is
c
ip
li
n
a
ry
 (
in
te
g
ra
te
d
 c
a
re
) 
in
te
rv
e
n
ti
o
n
s
 –
 P
a
ti
e
n
t 
o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
 q
u
al
it
y
o
f 
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
In
te
rv
en
ti
o
n
P
at
ie
n
t 
o
u
tc
o
m
es
 (
h
ea
lt
h
 s
ta
tu
s)
P
at
ie
n
ts
’ m
et
ab
o
lic
 c
o
n
tr
o
l, 
m
ea
n
 ±
 S
D
C
o
n
ve
n
ti
o
n
al
 c
ar
e
In
te
g
ra
te
d
 c
ar
e
E
ff
ec
t
m
ea
su
re
M
et
ab
ol
ic
 c
on
tr
ol
in
di
ca
to
rs
B
ef
o
re
n≥
10
3
A
ft
er
n≥
10
6
%
 c
h
an
g
e
B
ef
o
re
n≥
11
7
A
ft
er
n≥
12
0
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
G
ly
ca
te
d
ha
em
og
lo
bi
n 
a  
(%
)
5.
3±
1.
4
5.
3±
1.
7
0
5.
3±
1.
4
5.
3±
1.
7
0
0
B
od
y 
m
as
s 
in
de
x
28
.3
±
5.
6
27
.9
±
4.
5
-1
.4
27
.6
±
8.
5
28
.7
±
7.
6
+
4.
0
2.
9
C
re
at
in
in
e 
(m
ol
/l)
90
.4
±
26
.3
10
0.
6±
29
.8
+
11
.3
88
.9
±
19
.1
10
2.
2±
28
.8
+
15
.0
1.
3
S
ys
to
lic
 b
lo
od
pr
es
su
re
 (
m
m
 H
g)
15
3.
9±
24
.8
15
6.
4±
25
.7
+
1.
6
15
5.
9±
27
.1
16
1.
5±
25
.1
+
3.
6
2.
2
(D
ia
be
te
s
In
te
gr
at
ed
C
ar
e
E
va
lu
at
io
n
T
ea
m
, 1
99
4)
Le
ve
l I
II-
1:
 q
ua
si
-
R
C
T
Q
ua
lit
y:
 a
ve
ra
ge
H
os
pi
ta
l
di
ab
et
ic
 c
lin
ic
,
ge
ne
ra
l
pr
ac
tic
e
gr
ou
ps
 (
n=
3)
,
A
du
lt 
di
ab
et
ic
pa
tie
nt
s
(n
=
27
4)
at
te
nd
in
g 
a
ho
sp
ita
l c
lin
ic
an
d 
re
gi
st
er
ed
w
 o
ne
 o
f 3
ge
ne
ra
l
pr
ac
tic
es
G
ra
m
pi
an
,
S
co
tla
nd
C
om
pu
te
r-
co
or
di
na
te
d
in
te
gr
at
ed
 c
ar
e 
(g
en
er
al
pr
ac
tic
e 
pl
us
 h
os
pi
ta
l
di
ab
et
es
 c
lin
ic
)
D
ia
st
ol
ic
 b
lo
od
pr
es
su
re
 (
m
m
 H
g)
84
.8
±
11
.5
83
.5
±
9.
9
-1
.5
85
.6
±
15
.6
84
.3
±
11
.1
+
0.
6
0.
4
a  
T
he
 c
om
pa
ris
on
 b
et
w
ee
n 
th
e 
st
ud
y 
gr
ou
ps
 o
n 
gl
yc
at
ed
 h
ae
m
og
lo
bi
n 
fo
r 
w
hi
ch
 w
e 
ha
d 
ba
se
lin
e 
in
fo
rm
at
io
n 
on
 a
 d
iff
er
en
t s
ca
le
 fr
om
 th
at
 c
ol
le
ct
ed
 a
t f
in
al
 r
ev
ie
w
, w
as
 p
er
fo
rm
ed
 b
y 
an
al
ys
is
 o
f c
ov
ar
ia
nc
e,
 th
e
m
ea
ns
 r
ep
or
te
d 
w
er
e 
ad
ju
st
ed
 a
t t
he
 m
ea
n 
le
ve
l o
f t
he
 b
as
el
in
e 
sc
al
e;
 R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l; 
S
D
 =
 s
ta
nd
ar
d 
de
vi
at
io
n.
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 T
a
b
le
 6
0
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
a
lt
e
rn
a
ti
v
e
 c
a
re
 a
p
p
ro
a
c
h
 –
 P
ro
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
 q
u
al
it
y
o
f 
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
In
te
rv
en
ti
o
n
P
ro
ce
ss
 o
u
tc
o
m
es
 (
p
ra
ct
it
io
n
er
s’
 b
eh
av
io
u
ra
l c
h
an
g
e)
R
en
al
 a
ss
es
sm
en
t 
ra
te
s,
 %
 o
f 
p
at
ie
n
ts U
su
al
 c
ar
e
n=
50
N
u
rs
e 
C
as
e 
M
an
ag
em
en
t
n=
51
E
ff
ec
t 
m
ea
su
re
p
-v
al
u
e
B
ef
o
re
A
ft
er
%
ch
an
g
e
B
ef
o
re
A
ft
er
%
ch
an
g
e
R
el
at
iv
e
ch
an
g
e
Q
ua
nt
ita
tiv
e
pr
ot
ei
n/
m
ic
ro
al
bu
m
in
18
.0
32
.0
+
14
.0
25
.6
52
.9
+
27
.3
1.
95
p<
0.
05
D
ip
st
ic
k 
te
st
70
.0
58
.0
-1
2.
0
68
.6
51
.0
-1
7.
6
1.
6
(S
ik
ka
 e
t a
l.,
19
99
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
 a
ve
ra
ge
P
rim
ar
y 
ca
re
ph
ys
ic
ia
ns
A
du
lt 
di
ab
et
ic
pa
tie
nt
s
(n
=
13
3)
Ja
ck
so
nv
ill
e
H
ea
lth
 C
ar
e
G
ro
up
, F
lo
rid
a,
U
S
A
N
ur
se
 c
as
e 
m
an
ag
em
en
t
co
nd
uc
te
d 
by
 a
 r
eg
is
te
re
d
nu
rs
e 
/ c
er
tif
ie
d 
di
ab
et
es
ed
uc
at
or
 tr
ai
ne
d 
to
fo
llo
w
 d
ia
be
te
s
m
an
ag
em
en
t a
lg
or
ith
m
s
F
ol
lo
w
-u
p 
te
st
 in
el
ig
ib
le
 p
at
ie
nt
s 
a
28
.1
51
.9
+
23
.8
33
.3
80
.7
+
47
.4
2.
0
p<
0.
05
E
ff
ec
t 
o
f 
n
u
rs
e-
ru
n
 c
lin
ic
s 
co
m
p
ar
ed
 t
o
 c
o
n
tr
o
l, 
O
R
 [
95
%
 C
I]
A
pp
ro
pr
ia
te
 b
se
co
nd
ar
y 
pr
ev
en
tio
n
N
u
rs
e-
ru
n
 c
lin
ic
 O
R
 [
95
%
 C
I]
p
-v
al
u
e 
c
A
sp
iri
n 
m
an
ag
em
en
t
3.
22
 [2
.1
5,
 4
.8
0]
<
0.
00
1
B
lo
od
 p
re
ss
ur
e 
m
an
ag
em
en
t
5.
32
 [3
.0
2,
 9
.4
1]
<
0.
00
1
Li
pi
ds
 m
an
ag
em
en
t
3.
19
 [2
.3
9,
 4
.2
6]
<
0.
00
1
M
od
er
at
e 
ph
ys
ic
al
 a
ct
iv
ity
1.
67
 [1
.2
3,
 2
.2
6]
0.
00
1
Lo
w
 fa
t d
ie
t
1.
47
 [1
.1
0,
 1
.9
6]
0.
00
9
N
on
-s
m
ok
in
g
0.
78
 [0
.4
7,
 1
.2
8]
0.
32
2
C
u
m
u
la
ti
ve
 s
co
re
 o
f 
se
co
n
d
ar
y 
p
re
ve
n
ti
o
n
 f
o
r 
n
u
rs
e-
ru
n
 c
lin
ic
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
(C
am
pb
el
l e
t
al
., 
19
98
;
R
af
te
ry
, Y
ao
,
M
ur
ch
ie
,
C
am
pb
el
l, 
&
R
itc
hi
e,
20
05
)
Le
ve
l I
I: 
R
C
T
Q
ua
lit
y:
 a
ve
ra
ge
G
en
er
al
pr
ac
tic
es
(n
=
19
)
P
at
ie
nt
s 
<
80
ye
ar
s
di
ag
no
se
d 
w
ith
co
ro
na
ry
 h
ea
rt
di
se
as
e,
(n
=
1,
26
5)
G
ra
m
pi
an
,
N
or
th
ea
st
S
co
tla
nd
N
ur
se
-r
un
 c
lin
ic
s 
im
pl
em
en
te
d
in
 g
en
er
al
 p
ra
ct
ic
e 
th
at
pr
om
ot
e 
m
ed
ic
al
 a
nd
 li
fe
st
yl
e
se
co
nd
ar
y 
pr
ev
en
tio
n 
fo
r
co
ro
na
ry
 h
ea
rt
 d
is
ea
se
3.
23
3.
29
1.
9
3.
31
3.
89
17
.5
9.
2
p<
0.
00
1
a  
E
lig
ib
le
 p
at
ie
nt
s 
fo
r 
fo
llo
w
-u
p 
qu
an
tit
at
iv
e 
pr
ot
ei
n/
m
ic
ro
ab
lb
um
in
 te
st
s 
w
er
e 
th
os
e 
w
ith
 n
eg
at
iv
e 
di
ps
tic
k 
or
 w
ith
ou
t b
as
el
in
e 
di
ps
tic
k 
te
st
; b
 A
pp
ro
pr
ia
te
 tr
ea
tm
en
t a
cc
or
di
ng
 to
 r
el
ev
an
t c
lin
ic
al
 p
ra
ct
ic
e 
gu
id
el
in
es
;
c  
C
on
tr
ol
lin
g 
fo
r 
ba
se
lin
e,
 a
ge
, s
ex
, p
ra
ct
ic
e;
 C
I =
 c
on
fid
en
ce
 in
te
rv
al
s;
 O
R
 =
 o
dd
s 
ra
tio
; R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l.
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1
6
0
 T
a
b
le
 6
1
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
c
o
n
ti
n
u
o
u
s
 q
u
a
li
ty
 i
m
p
ro
v
e
m
e
n
t 
–
 P
ro
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
 q
u
al
it
y
o
f 
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
In
te
rv
en
ti
o
n
P
ro
ce
ss
 o
u
tc
o
m
es
 (
p
ra
ct
it
io
n
er
s’
 b
eh
av
io
u
ra
l c
h
an
g
e)
Q
u
al
it
y 
in
d
ic
at
o
r 
sc
o
re
s,
 m
ea
n
C
o
n
tr
o
l
n=
33
Q
I w
o
rk
sh
o
p
 +
 f
ee
d
b
ac
k
n=
37
Q
I w
o
rk
sh
o
p
 +
 f
ee
d
b
ac
k 
p
lu
s
C
lin
ic
al
 C
o
n
su
lt
at
io
n
n=
36
Q
ua
lit
y 
in
di
ca
to
r
ou
tc
om
e 
m
ea
su
re
s
%
 c
h
an
g
e 
a
%
 c
h
an
g
e 
a
R
el
at
iv
e
ch
an
g
e
%
 c
h
an
g
e 
a
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e
In
ci
de
nc
e 
of
 n
ew
 fr
ac
tu
re
-3
5.
5
-4
3.
3
1.
2
-3
5.
3
1.
0
P
re
va
le
nc
e 
of
 fa
lls
-2
.6
+
1.
5
0.
6
-1
0.
0
3.
8
p!
0.
1
P
re
va
le
nc
e 
of
 b
eh
av
io
ur
al
sy
m
pt
om
s 
af
fe
ct
in
g 
ot
he
rs
+
9.
0
-9
.4
1.
0
-3
.6
0.
4
p!
0.
1
U
se
 o
f 9
 o
r 
m
or
e
di
ffe
re
nt
 m
ed
ic
at
io
ns
+
20
.0
-2
0.
9
1.
1
+
14
.4
0.
7
P
re
va
le
nc
e 
of
 o
cc
as
io
na
l o
r
fr
eq
ue
nt
 b
la
dd
er
 o
r 
bo
w
l
in
co
nt
in
en
ce
 w
ith
ou
t a
to
ile
tin
g 
pl
an
-3
.0
-1
6.
6
5.
5
-1
5.
2
5.
1
P
re
va
le
nc
e 
of
in
dw
el
lin
g 
ca
th
et
er
s
+
41
.2
-3
3.
3
0.
8
+
13
.0
0.
3
P
re
va
le
nc
e 
of
 fe
ca
l i
m
pa
ct
io
n
+
22
.6
-1
0.
0
0.
4
-4
3.
5
1.
9
P
re
va
le
nc
e 
of
 w
ei
gh
t l
os
s
-9
.5
-2
3.
1
2.
4
+
9.
3
1.
0
P
re
va
le
nc
e 
of
 b
ed
fa
st
 r
es
id
en
ts
+
23
.9
-3
9.
1
1.
6
-5
.1
0.
2
P
re
va
le
nc
e 
of
 d
ai
ly
ph
ys
ic
al
 r
es
tr
ai
nt
s
-1
.9
-2
2.
2
11
.7
-9
.5
5.
0
P
re
va
le
nc
e 
of
 li
ttl
e 
or
 n
o 
ac
tiv
ity
-8
.0
-2
7.
3
3.
4
-1
7.
4
2.
2
p!
0.
1
(R
an
tz
 e
t a
l.,
20
01
)
Le
ve
l: 
III
-1
: q
ua
si
-
R
C
T
Q
ua
lit
y:
 A
ve
ra
ge
N
ur
si
ng
fa
ci
lit
ie
s
(n
=
11
3)
,
nu
rs
in
g 
ho
m
e
re
si
de
nt
s,
M
is
so
ur
i, 
U
S
A
A
ss
es
se
d 
2 
qu
al
ity
im
pr
ov
em
en
t (
Q
I)
in
te
rv
en
tio
ns
:
In
te
rv
e
n
ti
o
n
 1
: w
or
ks
ho
p 
to
te
ac
h 
st
af
f a
bo
ut
 Q
I a
nd
 h
ow
to
 u
se
 Q
I r
ep
or
t (
fe
ed
ba
ck
)
th
at
 r
ec
ei
ve
 q
ua
rt
er
ly
th
ro
ug
ho
ut
 s
tu
dy
In
te
rv
e
n
ti
o
n
 2
: 
w
or
ks
ho
p 
an
d
Q
I f
ee
db
ac
k 
re
po
rt
s 
pl
us
ad
di
tio
na
l c
on
su
lta
tio
n 
su
pp
or
t
by
 c
lin
ic
al
 n
ur
se
 s
pe
ci
al
is
t t
o
as
si
st
 fa
ci
lit
ie
s 
in
 in
te
rp
re
tin
g
Q
I r
ep
or
t
P
re
va
le
nc
e 
of
 s
ta
ge
 1
-4
pr
es
su
re
 u
lc
er
s
-1
.1
-2
8.
6
26
.0
+
4.
1
3.
7
p!
0.
1
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P
re
va
le
nc
e 
of
 s
ta
ge
 1
-4
pr
es
su
re
 u
lc
er
s 
(lo
w
 r
is
k)
-6
.9
-6
.1
0.
9
+
8.
0
1.
2
p!
0.
1
C
h
an
g
e 
in
 b
eh
av
io
u
r 
an
d
 C
Q
I k
n
o
w
le
d
g
e,
 m
ea
n
±
S
D
C
o
n
tr
o
l (
d
el
ay
ed
 in
te
rv
en
ti
o
n
)
n=
10
 te
am
s
C
Q
I i
n
te
rv
en
ti
o
n
n=
15
 te
am
s
E
ff
ec
t
m
ea
su
re
 c
B
ef
o
re
A
ft
er
 b
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
 b
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
C
Q
I k
no
w
le
dg
e 
sc
or
es
 d
49
.6
±
7.
2
62
.3
±
6.
0
+
25
.6
52
.6
±
9.
3
64
.1
±
7.
6
+
21
.9
0.
9
F
un
ct
io
na
l g
ro
up
 in
te
ra
ct
io
n 
sc
or
es
 e
3.
3±
0.
2
3.
3±
0.
2
0
3.
2±
0.
4
3.
4±
0.
3
+
6.
3
N
E
D
ys
fu
nc
tio
na
l g
ro
up
 in
te
ra
ct
io
ns
 s
co
re
s
3.
9±
0.
2
4.
0±
0.
2
+
2.
6
3.
9±
0.
2
3.
9±
0.
2
0
0
T
ea
m
 s
uc
ce
ss
 a
t i
m
pr
ov
in
g 
pa
tie
nt
 o
ut
co
m
es
 a
nd
 p
ro
ce
ss
es
 o
f c
ar
e 
f
S
u
cc
es
s 
ra
ti
n
g
Im
p
ro
ve
d
 o
u
tc
o
m
e
m
ea
n
±
S
D
N
o
 im
p
ro
ve
d
 o
u
tc
o
m
e
m
ea
n
±
S
D
p
-v
al
u
e 
g
C
ha
ng
e 
in
 C
Q
I k
no
w
le
dg
e
10
.6
±
6.
3
13
.0
±
7.
7
N
S
C
ha
ng
e 
in
 fu
nc
tio
na
l
gr
ou
p 
in
te
ra
ct
io
n 
h
0.
1±
0.
1
0.
1±
0.
2
N
S
(I
rv
in
e 
D
or
an
et
 a
l.,
 2
00
2)
Le
ve
l I
II-
1:
 q
ua
si
-
R
C
T
Q
ua
lit
y:
 p
oo
r
H
ea
lth
 c
ar
e
pr
of
es
si
on
al
s
(n
=
14
9)
 in
 2
5
C
Q
I h
ea
lth
 c
ar
e
te
am
s,
O
nt
ar
io
,
C
an
ad
a
C
Q
I 
in
te
rv
e
n
ti
o
n
: C
Q
I
ed
uc
at
io
n,
 p
at
ie
nt
 c
ar
e 
tr
ai
ni
ng
,
co
nf
lic
t m
an
ag
em
en
t,
ap
pl
ic
at
io
n 
of
 C
Q
I i
n
cl
in
ic
al
 p
ra
ct
ic
e
C
ha
ng
e 
in
 d
ys
fu
nc
tio
na
l
gr
ou
p 
in
te
ra
ct
io
n
0.
0±
0.
2
0.
1±
0.
2
N
S
a 
be
fo
re
 a
nd
 a
fte
r 
sc
or
es
 n
ot
 p
ro
vi
de
d 
du
e 
to
 s
pa
ce
 r
es
tr
ic
tio
ns
; a
na
ly
si
s 
by
 lo
gi
st
ic
 r
eg
re
ss
io
n 
an
d 
ad
ju
st
m
en
ts
 u
si
ng
 G
E
E
 m
et
ho
d;
 b
 3
 m
on
th
s 
af
te
r 
in
te
rv
en
tio
n,
 b
ef
or
e 
de
la
ye
d 
in
te
rv
en
tio
n 
(c
on
tr
ol
);
 c
 R
ep
ea
te
d
m
ea
su
re
s 
A
N
O
V
A
 –
 d
iff
er
en
ce
s 
co
m
pa
re
d 
to
 b
as
el
in
e 
fo
r 
C
Q
I k
no
w
le
dg
e 
an
d 
M
A
N
O
V
A
 fo
r 
gr
ou
p 
in
te
ra
ct
io
ns
; d
 C
Q
I k
no
w
le
dg
e 
m
ea
su
re
d 
us
in
g 
ne
w
ly
-d
ev
el
op
ed
 3
6-
ite
m
 in
st
ru
m
en
t; 
e  
m
ea
su
re
d 
us
in
g 
sc
al
e 
of
ef
fe
ct
iv
e 
gr
ou
p 
in
te
ra
ct
io
ns
 (
W
at
so
n 
an
d 
M
ic
ha
el
se
n)
; f
 E
ffe
ct
 o
f c
ha
ng
es
 in
 C
Q
I k
no
w
le
dg
e,
 fu
nc
tio
na
l g
ro
up
 in
te
ra
ct
io
ns
 a
nd
 te
am
 p
ro
bl
em
-s
ol
vi
ng
 e
ffe
ct
iv
en
es
s 
on
 im
pr
ov
em
en
t i
n 
pa
tie
nt
 o
ut
co
m
es
 a
nd
pr
oc
es
se
s 
of
 c
ar
e 
– 
ra
te
d 
by
 in
de
pe
nd
en
t r
ev
ie
w
er
s;
 g
 in
de
pe
nd
en
t s
am
pl
es
 t-
te
st
 b
et
w
ee
n 
su
cc
es
sf
ul
 a
nd
 u
ns
uc
ce
ss
fu
l t
ea
m
s;
 h
 g
ro
up
s 
di
ffe
re
d 
si
gn
ifi
ca
nt
ly
 a
t b
as
el
in
e,
 th
er
ef
or
e 
st
at
is
tic
al
 a
na
ly
si
s 
of
 b
et
w
ee
n-
gr
ou
p 
di
ffe
re
nc
es
 in
 ‘c
ha
ng
e 
fr
om
 b
as
el
in
e’
 a
re
 n
ot
 p
ro
vi
de
d 
(p
ot
en
tia
lly
 m
is
le
ad
in
g)
; C
Q
I =
 c
on
tin
uo
us
 q
ua
lit
y 
im
pr
ov
em
en
t; 
N
E
 =
 n
ot
 e
st
im
ab
le
; N
S
 =
 n
ot
 s
ta
tis
tic
al
ly
 s
ig
ni
fic
an
t (
p>
0.
05
);
 R
C
T
 =
 r
an
do
m
is
ed
co
nt
ro
lle
d 
tr
ia
l; 
S
D
 =
 s
ta
nd
ar
d 
de
vi
at
io
n.
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1
6
2
 T
a
b
le
 6
2
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
m
a
il
 o
u
ts
 –
 P
ro
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
 q
u
al
it
y
o
f 
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
In
te
rv
en
ti
o
n
P
ro
ce
ss
 o
u
tc
o
m
es
 (
ch
an
g
e 
in
 o
rg
an
is
at
io
n
al
 s
tr
u
ct
u
re
 o
r 
ef
fi
ci
en
cy
)
C
h
an
g
e 
in
 r
ad
io
g
ra
p
h
y 
re
fe
rr
al
s 
p
er
 m
o
n
th
 a
ft
er
 g
u
id
el
in
es
, a
b
so
lu
te
 c
h
an
g
e 
[9
5%
 C
I]
R
ad
io
lo
gy
 e
xa
m
in
at
io
ns
E
ff
ec
t 
m
ea
su
re
 a
A
b
so
lu
te
 c
h
an
g
e
[9
5%
 C
I]
T
ot
al
 e
xa
m
in
at
io
ns
-3
2.
0 
[-
22
6.
8,
 2
91
.5
]
A
bd
om
in
al
 u
ltr
as
ou
nd
3.
8 
[-
28
.3
, 5
8.
9]
A
nk
le
 x
-r
ay
s
4.
0[
-5
.8
, 1
3.
9]
B
ar
iu
m
 m
ea
ls
13
.5
 [2
3.
1,
 5
0.
2]
C
he
st
 x
-r
ay
s
35
.0
 [-
62
.1
, 1
32
.1
]
C
er
vi
ca
l s
pi
ne
 x
-r
ay
-5
.1
 [-
31
.8
, 2
0.
9]
F
oo
t a
nd
 to
e 
x-
ra
y
1.
2 
[-
10
.8
, 1
3.
1]
H
an
d 
an
d 
fin
ge
r 
x-
ra
ys
1.
7 
[-
10
.7
, 1
4.
1]
H
ip
 x
-r
ay
s
-9
.3
 [-
25
.8
, 7
.2
]
K
id
ne
y,
 u
re
te
rs
 a
nd
 b
la
dd
er
27
.0
 [-
70
.9
, 6
4.
8]
K
ne
e 
x-
ra
ys
2.
8 
[-
22
.1
, 2
7.
8]
Lu
m
ba
r 
sp
in
e 
x-
ra
ys
-7
.7
 [-
24
.7
, 4
0.
2]
P
el
vi
c 
ul
tr
as
ou
nd
4.
9 
[-
14
.4
, 2
4.
3]
P
el
vi
s 
x-
ra
ys
30
.6
 [0
,6
1.
2]
S
ho
ul
de
r 
x-
ra
ys
-4
.6
 [-
15
.9
, 6
.7
]
S
in
us
 x
-r
ay
s
-3
.1
 [-
11
.4
, 5
.2
]
T
es
tic
ul
ar
 u
ltr
as
ou
nd
-6
.8
 [-
19
.8
, 6
.1
]
(M
at
ow
e 
et
al
., 
20
02
)
Le
ve
l I
II-
3:
In
te
rr
up
te
d 
tim
e
se
rie
s 
w
ith
no
 c
on
tr
ol
Q
ua
lit
y:
 G
oo
d
37
6 
ge
ne
ra
l
pr
ac
tit
io
ne
rs
, 8
7
pr
ac
tic
es
,
G
ra
m
pi
an
,
S
co
tla
nd
P
os
ta
l d
is
se
m
in
at
io
n 
of
 R
oy
al
C
ol
le
ge
 o
f R
ad
io
lo
gi
st
s 
(R
C
R
)
G
ui
de
lin
es
 o
n 
ge
ne
ra
l
pr
ac
tit
io
ne
r 
re
fe
rr
al
s
fo
r 
ra
di
og
ra
ph
y
T
ho
ra
ci
c 
sp
in
e 
x-
ra
ys
-5
.8
 [-
16
.0
, 4
.4
]
a 
tim
e 
se
rie
s 
re
gr
es
si
on
s 
w
er
e 
us
ed
 to
 e
st
im
at
e 
ef
fe
ct
s;
 C
I =
 c
on
fid
en
ce
 in
te
rv
al
s.
appendix B data tables  143
 T
a
b
le
 6
3
. 
E
ff
e
c
ti
v
e
n
e
s
s
 o
f 
m
u
lt
i-
fa
c
e
te
d
 i
n
te
rv
e
n
ti
o
n
s
 –
 P
ro
c
e
s
s
 o
u
tc
o
m
e
s
R
ef
er
en
ce
L
ev
el
 a
n
d
q
u
al
it
y 
o
f
ev
id
en
ce
T
ar
g
et
p
o
p
u
la
ti
o
n
In
te
rv
en
ti
o
n
P
ro
ce
ss
 o
u
tc
o
m
es
 (
p
ra
ct
it
io
n
er
s’
 b
eh
av
io
u
ra
l c
h
an
g
e)
R
ec
o
rd
ed
 r
is
k 
fa
ct
o
rs
, %
 o
f 
p
at
ie
n
ts
C
o
n
tr
o
l
n=
25
4
In
fo
rm
at
io
n
 o
n
ly
n=
25
7
E
vi
d
en
ce
 o
n
ly
n=
24
0
In
fo
rm
at
io
n
 &
 e
vi
d
en
ce
n=
22
3
M
ea
n
 %
ch
an
g
e 
a
[9
5%
 C
I]
M
ea
n
 %
ch
an
g
e 
a
[9
5%
 C
I]
R
el
at
iv
e
ch
an
g
e
M
ea
n
 %
ch
an
g
e 
a
[9
5%
 C
I]
R
el
at
iv
e
ch
an
g
e
M
ea
n
 %
ch
an
g
e 
a
[9
5%
 C
I]
R
el
at
iv
e
ch
an
g
e
S
m
ok
in
g 
st
at
us
-5
.4
[-
25
.7
, 1
5.
0]
-5
.2
[-
16
.0
, 5
.6
]
1.
0
-1
.2
[-
14
.1
, 1
2.
1]
0.
2
+
13
.7
[-
6.
5,
 3
4.
0]
2.
5
B
lo
od
 p
re
ss
ur
e
-1
6.
2
[-
30
.7
, -
1.
7]
-1
.1
[-
23
.1
, 2
0.
8]
14
.7
-1
4.
1
[-
48
.7
, 2
0.
5]
0.
9
+
0.
7
[-
33
.0
, 3
4.
3]
0.
0
C
ho
le
st
er
ol
+
12
.3
[-
9.
1,
 3
3.
8]
+
11
.5
[5
.3
, 1
7.
8]
1.
1
+
7.
2
[-
8.
1,
 2
2.
4]
0.
6
+
22
.5
[7
.9
, 3
7.
2]
1.
8
A
ll 
ris
k 
fa
ct
or
s
+
6.
5
[-
8.
1,
 2
1.
3]
+
6.
6
[-
14
.5
, 2
7.
7]
1.
0
+
7.
2
[-
19
.4
, 3
3.
9]
1.
1
+
19
.9
[0
.5
, 3
9.
3]
3.
1
P
re
sc
ri
b
in
g
 b
eh
av
io
u
r,
 %
 o
f 
p
at
ie
n
ts
 r
ec
ei
vi
n
g
 m
ed
ic
at
io
n
A
sp
iri
n
+
3.
4
[-
0.
5,
 7
.3
]
-8
.7
[-
23
.8
, 6
.4
]
2.
6
-2
.2
[-
10
.5
, 6
.1
]
0.
6
+
2.
0
[-
11
.3
, 1
5.
3]
0.
6
A
nt
i-
hy
pe
rt
en
si
ve
s
-1
6.
7
[-
61
.0
, 2
7.
6]
-2
2.
5
[-
70
.8
, 2
5.
8]
1.
4
-9
.3
[-
24
.6
, 1
3.
2]
0.
6
-2
7.
3
[-
48
.6
, -
5.
9]
1.
6
(L
an
gh
am
et
 a
l.,
 2
00
2)
Le
ve
l I
I: 
C
lu
st
er
R
C
T
G
oo
d 
qu
al
ity
17
 g
en
er
al
pr
ac
tic
es
Lo
nd
on
 U
K
In
fo
rm
at
io
n:
tr
ai
ni
ng
 a
nd
 s
up
po
rt
fo
r 
or
ga
ni
sa
tio
n 
of
pa
tie
nt
 in
fo
rm
at
io
n
E
vi
de
nc
e:
tr
ai
ni
ng
 a
nd
 s
up
po
rt
fo
r 
ac
ce
ss
in
g 
an
d
in
te
rp
re
tin
g 
ev
id
en
ce
In
fo
rm
at
io
n 
an
d 
ev
id
en
ce
Li
pi
d-
lo
w
er
in
g
ag
en
ts
+
3.
0
[-
1.
7,
 7
.7
]
+
6.
0
[-
0.
5,
 1
2.
5]
2.
0
+
4.
0
[-
30
.4
, 1
1.
8]
1.
3
+
4.
4
[1
.3
, 7
.5
]
1.
5
C
h
an
g
es
 in
 s
m
o
ki
n
g
 c
es
sa
ti
o
n
 a
d
vi
ce
, p
o
st
te
st
 v
 b
as
el
in
e 
O
R
 [
95
%
 C
I]
 b
C
o
n
tr
o
l
n=
98
2
M
u
lt
if
ac
et
ed
 In
te
rv
en
ti
o
n
n=
74
5
A
sk
ed
 a
bo
ut
 s
m
ok
in
g 
st
at
us
(a
ll 
pa
tie
nt
s)
 c
1.
67
 [1
.6
0,
 1
.7
5]
1.
74
 [1
.3
1,
 2
.3
1]
A
dv
is
e 
sm
ok
er
 to
 q
ui
t
1.
76
 [0
.7
8,
 3
.9
8]
1.
92
 [1
.0
6,
 3
.4
9]
D
is
cu
ss
 h
ea
lth
 r
is
ks
 o
f s
m
ok
in
g
1.
73
 [0
.8
0,
 3
.7
2]
2.
60
 [1
.4
3,
 4
.7
4]
D
is
cu
ss
 p
as
si
ve
 s
m
ok
in
g
2.
17
 [0
.9
4,
 1
.6
1]
2.
49
 [0
.9
0,
 6
.8
8]
(Y
ou
ng
 e
t
al
., 
20
02
)
Le
ve
l I
I: 
C
lu
st
er
R
C
T
G
oo
d 
qu
al
ity
F
am
ily
P
hy
si
ci
an
s
(n
=
60
),
 in
pr
ac
tic
es
(n
=
39
),
P
at
ie
nt
s
at
te
nd
in
g
fa
m
ily
 p
ra
ct
ic
es
(n
=
1,
24
1)
A
us
tr
al
ia
A
ca
de
m
ic
 d
et
ai
lin
g;
 a
ud
it
an
d 
fe
ed
ba
ck
; r
es
ou
rc
es
(p
at
ie
nt
 a
nd
 p
ra
ct
ic
e-
ba
se
d)
1.
 E
du
ca
tio
na
l o
ut
re
ac
h
(c
or
e)
2.
 A
ud
it 
an
d 
fe
ed
ba
ck
3.
 P
at
ie
nt
 e
du
ca
tio
n
m
at
er
ia
ls
P
ro
vi
de
 p
ra
ct
ic
al
 a
dv
ic
e
1.
19
 [0
.5
5,
 2
.5
8]
2.
81
 [1
.4
6,
 5
.4
1]
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1
6
4
S
et
 a
 “
qu
it 
da
te
”
2.
28
 [0
.9
4,
 5
.5
2]
4.
96
 [1
.8
5,
 1
3.
32
]
P
ro
vi
de
 w
rit
te
n 
m
at
er
ia
ls
1.
72
 [0
.6
5,
 2
.5
8]
6.
49
 [2
.5
1,
 1
6.
76
]
R
ec
om
m
en
d 
ni
co
tin
e 
gu
m
0.
52
 [0
.2
2,
 1
.2
4]
5.
31
 [2
.6
8,
 1
0.
51
]
p<
0.
00
1
R
ec
om
m
en
d 
ni
co
tin
e 
pa
tc
he
s
0.
66
 [0
.3
2,
 1
.3
8]
2.
70
 [1
.4
4,
 4
.4
0]
p<
0.
01
A
rr
an
ge
 fo
llo
w
-u
p 
ap
po
in
tm
en
t
3.
44
 [0
.7
4,
 2
.7
7]
4.
85
 [1
.3
6,
 1
7.
3]
R
ef
er
 to
 a
 s
m
ok
in
g 
cl
in
ic
1.
23
 [0
.2
0,
 7
.4
8]
1.
68
 [0
.3
3,
 8
.4
8]
D
oc
um
en
t s
m
ok
in
g 
st
at
us
 (
al
l p
at
ie
nt
s)
 d
2.
88
 [1
.1
8,
 7
.0
4]
2.
47
 [1
.7
5,
 3
.5
0]
D
oc
um
en
t s
m
ok
in
g 
ce
ss
at
io
n 
ad
vi
ce
1.
40
 [0
.4
1,
 4
.7
9]
3.
33
 [1
.3
9,
 7
.9
7]
P
ro
p
o
rt
io
n
 o
f 
p
at
ie
n
ts
 f
o
r 
w
h
o
m
 e
ac
h
 a
n
d
 a
ll 
re
co
m
m
en
d
at
io
n
s 
o
f 
th
e 
C
P
G
s 
w
er
e 
fu
lf
ill
ed
, %
R
ec
om
m
en
da
tio
n
C
P
G
s 
o
n
ly
n=
25
3
M
u
lt
if
ac
et
ed
 In
te
rv
en
ti
o
n
n=
24
7
E
ff
ec
t 
m
ea
su
re
 e
O
R
 [
95
%
 C
I]
Li
m
it 
nu
m
be
r 
of
 s
es
si
on
s 
in
no
rm
al
 c
ou
rs
e
13
.0
27
.0
2.
39
 [1
.1
2,
 5
.1
2]
S
et
 fu
nc
tio
na
l t
re
at
m
en
t g
oa
ls
71
.0
79
.0
1.
99
 [1
.0
6,
 3
.7
2]
U
se
 m
ai
nl
y 
ac
tiv
e 
in
gr
ed
ie
nt
s
60
.0
77
.0
2.
79
 [1
.1
9,
 6
.5
5]
G
iv
e 
ad
eq
ua
te
 in
fo
rm
at
io
n
87
.0
96
.0
3.
59
 [1
.3
5,
 9
.5
5]
(B
ek
ke
rin
g
et
 a
l.,
 2
00
5)
Le
ve
l I
I: 
C
lu
st
er
R
C
T
A
ve
ra
ge
 q
ua
lit
y
P
hy
si
ot
he
ra
pi
st
s
(n
=
11
3)
,
pa
tie
nt
s
re
fe
rr
ed
 fo
r 
lo
w
ba
ck
 p
ai
n
(n
=
50
0)
,
pr
iv
at
e
pr
ac
tic
es
(n
=
68
)
N
et
he
rla
nd
s
C
P
G
s;
 e
du
ca
tio
n;
di
sc
us
si
on
; r
ol
e 
pl
ay
in
g;
fe
ed
ba
ck
; r
em
in
de
rs
1.
 L
oc
al
 c
on
se
ns
us
pr
oc
es
se
s
2.
 E
du
ca
tio
na
l m
ee
tin
gs
3.
 A
ud
it 
an
d 
fe
ed
ba
ck
4.
 P
ro
m
pt
s 
an
d 
re
m
in
de
rs
A
ll 
fo
ur
 r
ec
om
m
en
da
tio
ns
30
.0
42
.0
2.
05
 [1
.1
5,
 3
.6
5]
G
yn
ae
co
lo
g
is
ts
’ c
o
m
p
lia
n
ce
 w
it
h
 C
P
G
 r
ec
o
m
m
en
d
at
io
n
s,
 %
 m
ea
n
 u
n
it
 c
o
m
p
lia
n
ce
 ±
S
D
R
ec
om
m
en
da
tio
n
(t
ot
al
 n
um
be
r 
el
ig
ib
le
 c
as
es
)
P
ri
n
te
d
 C
P
G
 s
u
m
m
ar
y
M
u
lt
if
ac
et
ed
 In
te
rv
en
ti
o
n
E
ff
ec
t 
m
ea
su
re
 e
O
R
 [
95
%
 C
I]
A
pp
oi
nt
m
en
t w
ith
 g
yn
ae
co
lo
gi
st
w
ith
in
 5
 d
ay
s 
of
 r
ef
er
ra
l
(n
=
14
30
)
40
.5
±
18
.3
35
.5
 ±
17
.1
0.
89
 [0
.5
0,
 1
.5
8]
A
sc
er
ta
in
m
en
t o
f c
er
vi
ca
l
cy
to
lo
gy
 h
is
to
ry
 (
n=
10
74
)
60
.2
 ±
32
.1
58
.5
 ±
29
.2
0.
93
 [0
.3
6,
 2
.4
0]
O
ffe
r 
of
 c
on
tr
ac
ep
tiv
e 
su
pp
lie
s
if 
re
qu
ire
d 
pr
io
r 
to
 d
is
ch
ar
ge
(n
=
14
74
)
73
.0
 ±
24
.9
72
.1
 ±
17
.7
1.
11
 [0
.4
8,
 2
.5
3]
(F
oy
 e
t a
l.,
20
04
)
Le
ve
l I
I: 
C
lu
st
er
R
C
T
P
oo
r 
qu
al
ity
H
os
pi
ta
l
gy
na
ec
ol
og
y
un
its
 p
ro
vi
di
ng
in
du
ce
d
ab
or
tio
n 
ca
re
(n
=
26
),
 w
om
en
pa
tie
nt
s
un
de
rg
oi
ng
in
du
ce
d
ab
or
tio
n
S
co
tla
nd
A
ud
it 
an
d 
fe
ed
ba
ck
;
ed
uc
at
io
na
l m
ee
tin
gs
;
di
ss
em
in
at
io
n 
of
 s
tr
uc
tu
re
d
ca
se
 r
ec
or
ds
; p
ro
m
ot
io
n 
of
pa
tie
nt
 in
fo
rm
at
io
n 
bo
ok
le
t
*i
nt
er
ve
nt
io
n 
ba
se
d 
on
T
he
or
y 
of
 P
la
nn
ed
B
eh
av
io
ur
1.
 A
ud
it 
an
d 
fe
ed
ba
ck
2.
 E
du
ca
tio
na
l m
ee
tin
gs
3.
 P
at
ie
nt
 e
du
ca
tio
n
m
at
er
ia
ls
A
nt
ib
io
tic
 p
ro
ph
yl
ax
is
 o
r
sc
re
en
in
g 
fo
r 
lo
w
er
 g
en
ita
l t
ra
ct
or
ga
ni
sm
s 
(n
=
14
74
)
96
.5
 (
90
.1
-9
8.
6)
 j
10
0 
(9
5.
2-
10
0)
 j
1.
70
 [0
.7
1,
 5
.9
9]
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M
is
op
ro
st
ol
 c
os
t e
ffe
ct
iv
e
al
te
rn
at
iv
e 
to
 g
em
ep
ro
st
(n
=
14
72
)
10
0 
(9
7.
3-
10
0)
 f
10
0 
(8
6.
5-
10
0)
 f
1.
00
 [0
.2
7,
 1
.7
7]
P
h
ys
ic
ia
n
s’
 u
se
 o
f 
re
se
ar
ch
 in
fo
rm
at
io
n
 in
 p
ra
ct
ic
e,
 m
ea
n
 s
co
re
±
S
D
 g
A
cc
es
s 
to
 li
b
ra
ry
 s
er
vi
ce
s 
h
n=
75
M
u
lt
if
ac
et
ed
 in
te
rv
en
ti
o
n
 h
n=
73
p
-v
al
u
e 
i
H
yp
ot
he
tic
al
 a
ss
ig
nm
en
t
n=
50
1.
8±
1.
2
2.
1±
1.
3
0.
15
4
A
dd
iti
on
al
 q
ue
st
io
ns
n=
46
1.
7±
1.
0
2.
2±
1.
4
0.
06
3
S
el
f-
re
p
o
rt
ed
 s
ea
rc
h
in
g
 o
f 
C
o
ch
ra
n
e 
an
d
 M
ed
lin
e,
 %
 o
f 
p
h
ys
ic
ia
n
s
A
cc
es
s 
to
 li
b
ra
ry
 s
er
vi
ce
s 
h
n=
60
M
u
lt
if
ac
et
ed
 in
te
rv
en
ti
o
n
 h
n=
55
E
ff
ec
t 
M
ea
su
re
C
h
i-
sq
u
ar
e
S
ea
rc
he
d 
C
oc
hr
an
e
38
.3
61
.8
6.
3
p=
0.
01
S
ea
rc
he
d 
M
ed
lin
e
53
.3
56
.4
0.
1
p=
0.
74
C
h
an
g
e 
in
 k
n
o
w
le
d
g
e,
 m
ea
n
 ±
S
D
A
cc
es
s 
to
 li
b
ra
ry
 s
er
vi
ce
s 
h
n=
61
M
u
lt
if
ac
et
ed
 in
te
rv
en
ti
o
n
 h
n=
58
M
ea
n
 d
if
fe
re
n
ce
 [
95
%
 C
I]
S
ou
rc
e 
kn
ow
le
dg
e
0.
7±
0.
5
1.
1±
0.
6
0.
4 
[0
.2
, 0
.6
]
(F
or
se
tlu
nd
et
 a
l.,
 2
00
3)
Le
ve
l I
I: 
R
C
T
G
oo
d 
qu
al
ity
P
ub
lic
 h
ea
lth
ph
ys
ic
ia
ns
w
or
ki
ng
m
un
ic
ip
al
iti
es
w
ith
 m
or
e 
th
an
30
00
in
ha
bi
ta
nt
s
N
or
w
ay
W
or
ks
ho
p 
+
 n
ew
sl
et
te
r 
+
ac
ce
ss
 to
 in
fo
rm
at
io
n
se
rv
ic
e,
 d
at
ab
as
es
 a
nd
el
ec
tr
on
ic
 d
is
cu
ss
io
n 
lis
t
M
ul
tif
ac
et
ed
 in
te
rv
en
tio
n:
1.
 E
du
ca
tio
na
l m
at
er
ia
ls
2.
 E
du
ca
tio
na
l m
ee
tin
gs
3 
B
eh
av
io
ur
al
 tr
ai
ni
ng
4 
D
is
cu
ss
io
n 
lis
t
5 
T
ai
lo
re
d 
se
rv
ic
es
C
on
tr
ol
 g
ro
up
:
A
cc
es
s 
to
 li
br
ar
y
se
rv
ic
es
 o
nl
y
C
on
ce
pt
 k
no
w
le
dg
e
1.
1±
0.
4
1.
3±
0.
4
0.
2 
[0
.0
, 0
.3
]
G
P
s’
 c
o
m
p
lia
n
ce
 w
it
h
 r
ec
o
m
m
en
d
at
io
n
s,
 c
o
m
p
lia
n
ce
 r
at
e 
%
 b
as
ed
 o
n
 n
u
m
b
er
 o
f 
d
ec
is
io
n
s
C
o
n
tr
o
l
n=
62
M
u
lt
i-
fa
ce
te
d
 in
te
rv
en
ti
o
n
n=
61
E
ff
ec
t
m
ea
su
re
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
O
R
 [
95
%
 C
I]
 j
F
oo
t e
xa
m
39
.0
48
.0
+
8.
0
43
.0
62
.0
+
19
.0
2.
4
1.
7 
[1
.2
, 2
.4
]
p=
0.
00
4
(F
rij
lin
g 
et
al
., 
20
02
)
Le
ve
l I
I: 
R
C
T
G
oo
d 
qu
al
ity
G
en
er
al
pr
ac
tit
io
ne
rs
N
et
he
rla
nd
s
E
du
ca
tio
n
F
ee
db
ac
k
F
ee
db
ac
k 
an
d 
su
pp
or
t,
in
cl
ud
in
g 
ed
uc
at
io
n 
an
d
gu
id
an
ce
 fr
om
 a
 fa
ci
lit
at
or
E
ye
 e
xa
m
67
.0
65
.0
-2
.0
70
.0
79
.0
+
9.
0
4.
5
1.
5 
[1
.1
, 2
.2
]
p=
0.
02
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1
6
6
M
ed
ic
at
io
n 
re
vi
ew
61
.0
66
.0
+
5.
0
65
.0
73
.0
+
8.
0
1.
6
1.
5 
[1
.0
, 2
.3
]
p<
0.
05
B
P
 m
ea
su
re
m
en
t
92
.0
95
.0
+
3.
0
94
.0
97
.0
+
3.
0
1.
0
1.
3 
[0
.7
, -
2.
5]
p=
37
M
ed
ic
at
io
n
ch
an
ge
37
.0
47
.0
+
10
.0
33
.0
44
.0
+
11
.0
1.
1
1.
1 
[0
.7
, 1
.9
]
p=
0.
61
S
ch
ed
ul
e 
fo
llo
w
-
up
70
.0
65
.0
-5
.0
70
.0
66
.0
-4
.0
0.
8
1.
0 
[0
.7
, 1
.5
]
p=
0.
81
B
M
I r
ev
ie
w
59
.0
64
.0
+
5.
0
62
.0
66
.0
+
4.
0
0.
8
1.
0 
[0
.7
, 1
.5
]
p=
0.
96
C
h
an
g
e 
in
 c
o
m
p
lia
n
ce
 r
at
es
 k
, %
C
o
n
tr
o
l
M
ea
n
 %
 c
h
an
g
e 
[9
5%
 C
I]
 l
In
te
rv
en
ti
o
n
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A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
p
-v
al
u
e 
z
U
se
 o
f a
nt
ib
io
tic
s
50
.8
49
.5
-1
.3
48
.1
43
.8
-4
.3
3.
3
p=
0.
03
U
se
 o
f l
ab
 te
st
s
41
.9
39
.7
-2
.2
44
.6
42
.0
-2
.6
1.
2
p=
0.
64
U
se
 o
f t
el
ep
ho
ne
co
ns
ul
ta
tio
ns
12
.5
14
.1
+
1.
6
12
.5
12
.9
+
0.
4
0.
3
p=
0.
13
U
ri
n
ar
y 
tr
ac
t 
in
fe
ct
io
n
(F
lo
tto
rp
 e
t
al
., 
20
03
)
Le
ve
l I
II-
1:
qu
as
i-R
C
T
P
oo
r 
qu
al
ity
14
2 
ge
ne
ra
l
pr
ac
tic
es
N
or
w
ay
E
le
ct
ro
ni
c 
an
d 
pr
in
te
d
ed
uc
at
io
na
l m
at
er
ia
ls
D
ec
is
io
n 
su
pp
or
t s
ys
te
m
re
m
in
de
rs
In
te
ra
ct
iv
e 
co
ur
se
F
in
an
ci
al
 in
ce
nt
iv
e
C
o
n
tr
o
l (
S
o
re
 t
h
ro
at
)
M
u
lt
if
ac
et
ed
 in
te
rv
en
ti
o
n
appendix B data tables  153
154  appendix B data tables
1
7
4
B
ef
o
re
n=
62
A
ft
er
n=
69
%
 c
h
an
g
e
B
ef
o
re
n=
22
5
A
ft
er
n=
23
0
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
D
ia
gn
os
tic
ev
al
ua
tio
ns
 r
el
at
iv
e
to
 p
op
ul
at
io
n 
ag
ed
65
 y
ea
rs
0.
1
[0
.1
, 0
.2
]
0.
1
[0
.1
, 0
.2
]
0
0.
2
[0
.2
, 0
.2
]
0.
2
[0
.2
, 0
.2
]
0
0 N
S
de
m
en
tia
(n
=
72
7)
G
en
er
al
P
ra
ct
ic
es
(n
=
53
5)
,
F
re
de
rik
sb
or
g
an
d 
V
ib
or
g
D
en
m
ar
k
sm
al
l g
ro
up
 tr
ai
ni
ng
1.
 L
oc
al
 c
on
se
ns
us
pr
oc
es
se
s
2.
 E
du
ca
tio
na
l m
ee
tin
gs
3.
 E
du
ca
tio
na
l o
ut
re
ac
h
4.
 R
em
in
de
rs
D
ia
gn
os
tic
ev
al
ua
tio
ns
 le
ad
in
g 
to
sp
ec
ia
lis
t r
ef
er
ra
l
40
.0
[2
9.
0,
53
.0
]
49
.0
[3
8.
0,
61
.0
]
9.
0
44
.0
[3
8.
0,
51
.0
]
47
.0
[4
0.
0,
60
.0
]
3.
0
0.
3
N
S
C
o
m
p
lia
n
ce
 w
it
h
 C
P
G
s 
re
co
m
m
en
d
at
io
n
s,
 %
 o
f 
p
at
ie
n
ts
C
o
n
tr
o
l
n 
pr
ac
tic
es
=
99
M
u
lt
if
ac
et
ed
 In
te
rv
en
ti
o
n
n 
pr
ac
tic
es
=
89
E
ff
ec
t
m
ea
su
re
 a
a
C
P
G
re
co
m
m
en
da
tio
ns
 o
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
B
ef
o
re
A
ft
er
%
 c
h
an
g
e
R
el
at
iv
e
ch
an
g
e
[9
5%
 C
I]
A
st
hm
a
S
m
ok
in
g 
st
at
us
74
.0
86
.0
+
12
.0
59
.0
75
.0
+
16
.0
1.
3 
[-
14
, 0
]
In
ha
le
r 
te
ch
ni
qu
e
33
.0
50
.0
+
17
.0
27
.0
47
.0
+
20
.0
1.
2 
[-
2,
 6
]
A
ng
in
a
S
m
ok
in
g 
st
at
us
71
.0
83
.0
+
12
.0
66
.0
73
.0
+
7.
0
0.
6 
[1
5,
 2
7]
B
lo
od
 p
re
ss
ur
e
71
.0
92
.0
+
21
.0
73
.0
95
.0
+
22
.0
1.
0 
[-
13
, -
1]
A
sp
iri
n 
pr
es
cr
ib
ed
 /
co
nt
ra
in
di
ca
te
d 
/
se
lf-
m
ed
ic
at
in
g
69
.0
76
.0
+
7.
0
67
.0
78
.0
+
11
.0
1.
6 
[-
16
, -
4]
(W
rig
ht
 e
t
al
., 
20
03
)
Le
ve
l I
II-
3:
 N
on
-
ra
nd
om
is
ed
,
la
tin
 s
qu
ar
e
(c
ro
ss
-o
ve
r)
de
si
gn
A
ve
ra
ge
 q
ua
lit
y
G
en
er
al
pr
ac
tic
es
(n
=
18
0)
 in
 2
ne
ig
hb
ou
rin
g
he
al
th
 d
is
tr
ic
ts
,
B
ra
df
or
d 
&
A
ire
da
le
, a
nd
H
ud
de
rs
fie
ld
 &
D
ew
sb
er
y,
 a
nd
pa
tie
nt
s 
w
ith
ei
th
er
 a
st
hm
a
or
 a
ng
in
a
U
ni
te
d
K
in
gd
om
M
ai
l o
ut
 o
f C
P
G
s 
fo
r 
an
gi
na
or
 a
st
hm
a;
 e
du
ca
tio
na
l
m
ee
tin
gs
; e
du
ca
tio
na
l
ou
tr
ea
ch
 v
is
it;
 a
ud
it;
 p
at
ie
nt
m
ed
ic
at
ed
 in
te
rv
en
tio
ns
e.
g.
, w
ai
tin
g 
ro
om
 p
os
te
rs
;
re
m
in
de
rs
; m
ar
ke
tin
g
st
ra
te
gi
es
 (
e.
g.
, l
oc
al
 m
ed
ia
ca
m
pa
ig
ns
, p
at
ie
nt
ad
vo
ca
te
 g
ro
up
s,
el
ec
tr
on
ic
 s
ou
rc
es
)
1.
 L
oc
al
 c
on
se
ns
us
pr
oc
es
se
s
2.
 E
du
ca
tio
na
l m
ee
tin
gs
3.
 E
du
ca
tio
na
l o
ut
re
ac
h
4.
 P
at
ie
nt
 m
ed
ic
at
ed
in
te
rv
en
tio
ns
5.
 R
em
in
de
rs
6.
 M
ar
ke
tin
g 
st
ra
te
gi
es
B
et
a-
bl
oc
ke
r
pr
es
cr
ib
ed
 /
co
nt
ra
in
di
ca
te
d
44
.0
49
.0
+
5.
0
48
.0
54
.0
+
6.
0
1.
2 
[-
5,
 1
]
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a  
B
ef
or
e/
af
te
r 
sc
or
es
 n
ot
 p
ro
vi
de
d 
du
e 
to
 s
pa
ce
 r
es
tr
ic
tio
ns
. A
va
ila
bl
e 
on
 r
eq
ue
st
; b
 lo
gi
st
ic
 r
eg
re
ss
io
n 
an
al
ys
is
 c
on
du
ct
ed
 u
si
ng
 g
en
er
al
is
ed
 e
st
im
at
in
g 
eq
ua
tio
ns
 (
G
E
E
),
 d
iff
er
en
ce
s 
be
tw
ee
n 
gr
ou
ps
 a
ss
es
se
d 
by
C
hi
-s
qu
ar
e 
an
d 
W
ilc
ox
on
’s
 r
an
k 
su
m
 te
st
s;
 M
cN
em
ar
’s
 te
st
 u
se
d 
fo
r 
pa
ire
d 
pr
op
or
tio
ns
, F
is
he
r’s
 e
xa
ct
 te
st
 u
se
d 
w
he
re
 e
xp
ec
te
d 
fr
eq
ue
nc
ie
s 
w
er
e 
le
ss
 th
an
 5
; c
 a
dj
us
te
d 
fo
r 
pa
tie
nt
’s
 a
ge
 a
nd
 s
ta
ge
 o
f c
ha
ng
e 
fo
r
sm
ok
in
g 
ce
ss
at
io
n;
 d
 a
dj
us
te
d 
fo
r 
pa
tie
nt
’s
 s
m
ok
in
g 
st
at
us
; e
 L
og
is
tic
 m
ul
til
ev
el
 a
na
ly
si
s 
to
 a
dj
us
t f
or
 c
lu
st
er
in
g 
an
d 
ba
se
lin
e 
sc
or
es
; f
 M
ed
ia
n 
(in
te
rq
ua
rt
ile
 r
an
ge
) 
an
d 
m
ed
ia
n 
di
ffe
re
nc
e 
fo
r 
sk
ew
ed
 d
at
a;
 g
 S
co
re
s 
on
sc
al
es
 r
an
ge
d 
fr
om
 1
-5
 (
hi
gh
);
 h
 v
al
ue
s 
ar
e 
po
st
-t
es
t; 
ba
se
lin
e 
sc
or
es
 a
dj
us
te
d 
fo
r 
us
in
g 
m
ul
tip
le
 r
eg
re
ss
io
n 
(c
ov
ar
ia
nc
e)
 a
na
ly
si
s;
 i  
 te
st
ed
 b
y 
M
an
n-
W
hi
tn
ey
; j
 O
R
 a
dj
us
te
d 
in
 m
ul
ti-
le
ve
l a
na
ly
si
s 
fo
r 
ba
se
lin
e
co
m
pl
ia
nc
e,
 p
ra
ct
ic
e 
ch
ar
ac
te
ris
tic
s,
 p
at
ie
nt
s’
 a
ge
 a
nd
 g
en
de
r;
 k
 c
om
pl
ia
nc
e 
ra
te
s 
=
 n
um
be
r 
of
 d
ec
is
io
ns
 c
on
co
rd
an
t w
ith
 g
ui
de
lin
e 
re
co
m
m
en
da
tio
ns
 fo
r 
an
 in
di
ca
to
r/
to
ta
l n
um
be
r 
of
 d
ec
is
io
ns
 m
ad
e 
fo
r 
th
at
in
di
ca
to
r;
 l  
m
ea
n 
%
 c
ha
ng
e 
=
 m
ea
n 
pe
rc
en
t c
ha
ng
e 
fr
om
 b
as
el
in
e 
va
lu
es
; m
 m
ul
ti-
le
ve
l l
og
is
tic
 r
eg
re
ss
io
n 
an
al
ys
is
 a
dj
us
te
d 
fo
r 
ba
se
lin
e 
co
m
pl
ia
nc
e 
ra
te
s 
an
d 
pr
ac
tic
e 
ty
pe
; n
 im
m
un
is
at
io
ns
 a
nd
 s
cr
ee
ni
ng
 fo
r
tu
be
rc
ul
os
is
, a
na
em
ia
 a
nd
 le
ad
; o
 R
at
io
 o
f i
nt
er
ve
nt
io
n 
vs
 c
on
tr
ol
 u
si
ng
 lo
gi
st
ic
 r
an
do
m
 r
eg
re
ss
io
n 
m
od
el
 a
nd
 T
ay
lo
r 
se
rie
s 
ap
pr
ox
im
at
io
ns
; p
 T
w
o-
sa
m
pl
e 
t-
te
st
s 
w
ith
 9
5%
 c
on
fid
en
ce
 le
ve
ls
 fo
r 
m
ea
n 
di
ffe
re
nc
es
 to
co
m
pa
re
 c
ha
ng
es
 in
 s
tu
dy
 g
ro
up
s;
 q
 C
hi
-s
qu
ar
e 
te
st
, c
or
re
ct
ed
 fo
r 
cl
us
te
r 
sa
m
pl
in
g 
us
in
g 
2n
d -
or
de
r 
co
rr
ec
tio
n 
of
 R
ao
 a
nd
 S
co
tt,
 w
as
 u
se
d 
to
 d
et
er
m
in
e 
di
ffe
re
nc
es
 b
et
w
ee
n 
in
te
rv
en
tio
n 
an
d 
co
nt
ro
l a
nd
 b
et
w
ee
n
ba
se
lin
e 
an
d 
fo
llo
w
-u
p 
pa
tie
nt
s.
 S
ig
ni
fic
an
ce
 o
f c
ha
ng
es
 w
as
 a
ss
es
se
d 
us
in
g 
m
ul
tiv
ar
ia
te
 lo
gi
st
ic
 r
eg
re
ss
io
n 
to
 a
dj
us
t f
or
 h
os
pi
ta
l t
yp
e 
an
d 
pa
tie
nt
 c
ha
ra
ct
er
is
tic
s;
 r  
ge
ne
ra
l l
in
ea
r 
m
od
el
 –
 r
ep
ea
te
d 
m
ea
su
re
s;
s  
gu
id
el
in
es
 r
ec
om
m
en
d 
an
 in
cr
ea
se
 in
 th
es
e 
ac
tiv
iti
es
; t
 g
ui
de
lin
es
 r
ec
om
m
en
d 
a 
de
cr
ea
se
 in
 th
es
e 
ac
tiv
iti
es
; u
 li
ne
ar
 r
eg
re
ss
io
n 
m
od
el
 u
se
d 
to
 a
dj
us
t f
or
 b
as
el
in
e 
di
ffe
re
nc
es
; v
 G
oa
l w
as
 fo
r 
G
P
s 
to
 p
re
sc
rib
e 
be
ta
-
bl
oc
ki
ng
 a
ge
nt
s 
an
d 
di
ur
et
ic
s 
ra
th
er
 th
an
 c
al
ci
um
 c
ha
nn
el
 b
lo
ck
er
s 
an
d 
ag
en
ts
 a
ct
in
g 
on
 th
e 
re
nn
in
-a
ng
io
te
ns
in
 s
ys
te
m
; w
 G
oa
l w
as
 to
 d
ec
re
as
e 
pr
es
cr
ib
in
g 
in
 g
en
er
al
 a
nd
 p
er
 p
re
sc
rip
tio
n 
an
d 
to
 in
cr
ea
se
pr
es
cr
ib
in
g 
of
 H
2-
re
ce
pt
or
 a
nt
ag
on
is
ts
; 
x  
G
oa
l w
as
 fo
r 
G
P
s 
to
 fo
cu
s 
m
or
e 
on
 d
ep
re
ss
io
n 
an
d 
to
 in
cr
ea
se
 p
re
sc
rib
in
g 
ov
er
al
l r
at
he
r 
th
an
 to
 in
flu
en
ce
 c
ho
ic
e 
of
 d
ru
gs
; 
y  
S
tu
dy
 g
ro
up
s 
al
lo
ca
te
d 
ge
og
ra
ph
ic
al
ly
 -
B
ra
df
or
d 
an
d 
A
ire
da
le
 w
er
e 
al
lo
ca
te
d 
as
th
m
a 
gu
id
el
in
e 
fo
r 
ac
tiv
e 
im
pl
em
en
ta
tio
n;
 H
ud
de
rs
fie
ld
 a
nd
 D
ew
sb
ur
y 
w
er
e 
al
lo
ca
te
d 
th
e 
st
ab
le
 a
ng
in
a 
gu
id
el
in
e;
 z
 h
ie
ra
rc
hi
ca
l l
og
is
tic
 r
eg
re
ss
io
n.
 A
ut
ho
rs
 r
ep
or
te
d
eq
ui
va
le
nt
 b
as
el
in
e 
m
ea
su
re
s 
be
tw
ee
n 
gr
ou
ps
;  
aa
 A
na
ly
se
d 
us
in
g 
A
N
O
V
A
 a
nd
 r
eg
re
ss
io
n 
m
od
el
s;
 A
C
E
 =
 a
ng
io
te
ns
in
-c
on
ve
rt
in
g 
en
zy
m
e;
 B
M
I =
 b
od
y 
m
as
s 
in
de
x;
 B
P
 =
 b
lo
od
 p
re
ss
ur
e;
 C
I =
 c
on
fid
en
ce
 in
te
rv
al
s;
C
M
E
 =
 c
on
tin
ui
ng
 m
ed
ic
al
 e
du
ca
tio
n;
 C
P
G
 =
 c
lin
ic
al
 p
ra
ct
ic
e 
gu
id
el
in
e;
 C
M
E
 =
 c
on
tin
ui
ng
 m
ed
ic
al
 e
du
ca
tio
n;
 C
T
 =
 c
om
pu
te
r 
to
m
og
ra
ph
y;
 D
 &
 C
 =
 D
ila
ta
tio
n 
an
d 
C
ur
et
ta
ge
; G
P
 =
 g
en
er
al
 p
ra
ct
iti
on
er
;
M
R
I =
 m
ag
ne
tic
 r
es
on
an
ce
 im
ag
in
g;
 N
E
 =
 n
ot
 e
st
im
ab
le
; N
S
 =
 n
ot
 s
ig
ni
fic
an
t; 
O
R
 =
 o
dd
s 
ra
tio
s;
 P
H
C
 =
 p
rim
ar
y 
he
al
th
 c
ar
e;
 P
S
D
A
 =
 P
la
n,
 S
tu
dy
, D
o,
 A
ct
; R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l; 
S
D
 =
 s
ta
nd
ar
d
de
vi
at
io
n;
 S
T
D
 =
 s
ex
ua
lly
 tr
an
sm
itt
ed
 d
is
ea
se
.
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6
 T
ab
le
 6
4.
 E
ffe
ct
iv
en
es
s 
of
 m
ul
ti-
fa
ce
te
d 
in
te
rv
en
tio
ns
 –
 P
at
ie
nt
 o
ut
co
m
es
Re
fe
re
nc
e
Le
ve
l a
nd
 q
ua
lit
y
of
 ev
id
en
ce
Ta
rg
et
po
pu
lat
io
n
In
te
rv
en
tio
n
Pa
tie
nt
 o
ut
co
m
es
 (h
ea
lth
 st
at
us
)
Co
nt
ro
l o
f r
isk
, %
 o
f p
at
ien
ts
Co
nt
ro
l
In
fo
rm
at
io
n 
on
ly
Ev
id
en
ce
 o
nl
y
In
fo
rm
at
io
n 
& 
ev
id
en
ce
Me
an
 %
ch
an
ge
[9
5%
 C
I] 
a
Me
an
 %
ch
an
ge
[9
5%
 C
I] 
a
Re
lat
ive
ch
an
ge
Me
an
 %
ch
an
ge
[9
5%
 C
I] 
a
Re
lat
ive
ch
an
ge
Me
an
 %
ch
an
ge
[9
5%
 C
I] 
a
Re
lat
ive
ch
an
ge
Cu
rre
nt 
sm
ok
er
s
+0
.4
[-1
1.7
, 1
2.6
]
-1
.0
[-9
.3,
 7.
3]
2.5
+0
.5
[-6
.6,
 7.
6]
1.3
+6
.5
[0.
8, 
12
.2]
16
.3
BP
: m
ea
n s
ys
tol
ic
(m
mH
g)
-1
.7
[-3
.1,
 -0
.4]
-2
.5
[-8
.3,
 3.
3]
1.5
-0
.1
[-1
3.6
, 1
3.3
]
0.1
+1
.5
[-6
.8,
 9.
7]
0.9
BP
: m
ea
n d
ias
tol
ic
(m
mH
g)
-2
.7
[-7
.3,
 1.
8]
-2
.0
[-5
.6,
 0.
0]
0.7
+1
.5
[-3
.9,
 6.
9]
0.6
-0
.3
[-3
.5,
 2.
8]
0.1
BP
 <
 16
0/9
5
-1
0.2
[-1
9.0
, 1
.4]
-6
.8
[-2
1.9
, 8
.3]
0.7
-6
.5
[-1
9.7
, 6
.7]
0.6
-3
.2
[-1
9.6
, 1
3.2
]
0.3
To
tal
 ch
ole
ste
ro
l
(m
mo
l/l)
, m
ea
n
-0
.1
[-0
.8,
 0.
6]
-0
.2
[-0
.5,
 0.
0]
2.0
-0
.2
[-0
.2,
 0.
0]
2.0
-0
.7
[-1
.3,
 0.
0]
7.0
(L
an
gh
am
 et
al.
, 2
00
2)
Le
ve
l II
: c
lus
ter
RC
T
Go
od
 qu
ali
ty
17
 ge
ne
ra
l
pr
ac
tic
es
Lo
nd
on
 U
K
In
fo
rm
at
ion
: tr
ain
ing
 an
d
su
pp
or
t fo
r o
rg
an
isa
tio
n o
f
pa
tie
nt 
inf
or
ma
tio
n
Ev
ide
nc
e:
 tr
ain
ing
 an
d
su
pp
or
t fo
r a
cc
es
sin
g a
nd
int
er
pr
eti
ng
 ev
ide
nc
e
In
fo
rm
at
ion
 a
nd
 e
vid
en
ce
To
tal
ch
ole
ste
ro
l <
5.5
+6
.6
[-2
.3,
 15
.4]
+1
.2
[-6
.2,
 8.
6]
0.2
-0
.3
[-9
.9,
 9.
4]
0.0
+0
.9
[-7
.9,
 9.
7]
0.1
Un
co
nt
ro
lle
d 
bl
oo
d 
gl
uc
os
e, 
%
 p
at
ien
ts
Co
nt
ro
l
Mu
lti
fa
ce
te
d 
in
te
rv
en
tio
n
Ef
fe
ct
m
ea
su
re
Be
fo
re
Af
te
r
%
 ch
an
ge
Be
fo
re
Af
te
r
%
 ch
an
ge
Re
lat
ive
ch
an
ge
p-
va
lu
e
(F
rijl
ing
 et
al.
, 2
00
2)
Le
ve
l II
: R
CT
Go
od
 qu
ali
ty
Ge
ne
ra
l
pr
ac
titi
on
er
s
Ne
the
rla
nd
s
Ed
uc
ati
on
Fe
ed
ba
ck
Fe
ed
ba
ck
 an
d s
up
po
rt,
inc
lud
ing
 ed
uc
ati
on
 an
d
gu
ida
nc
e f
ro
m 
a f
ac
ilit
ato
r
37
.1
33
.8
-3
.3
39
.0
35
.6
-3
.4
1.1 p>
0.3
Le
ng
th
 o
f h
os
pi
ta
l s
ta
y, 
m
ea
n 
da
ys
Co
nt
ro
l
Mu
lti
fa
ce
te
d 
in
te
rv
en
tio
n
Ef
fe
ct
 m
ea
su
re
(P
hil
bin
 et
al.
, 2
00
0)
Le
ve
l II
I-1
: q
ua
si-
RC
T
Go
od
 qu
ali
ty
10
 ho
sp
ita
ls
Pa
tie
nts
 w
ith
dia
gn
os
ed
he
ar
t fa
ilu
re
Ne
w 
Yo
rk
Int
er
dis
cip
lin
ar
y t
ea
m
CM
E
Pa
tie
nt 
ed
uc
ati
on
al 
ma
ter
ial
Fe
ed
ba
ck
Be
fo
re
n=
64
0
Af
te
r
n=
66
4
%
 ch
an
ge
Be
fo
re
n=
76
2
Af
te
r
n=
84
0
%
 ch
an
ge
Re
lat
ive
 ch
an
ge
in
te
rv
en
tio
n
ef
fe
ct
 [9
6%
 C
I] 
b
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7.
7
7.
0
-9
.1
8.
0
6.
2
-2
2.
5
2.
5
-1
.1
 [-
2.
9,
 0
.7
]
M
o
rt
al
it
y,
 %
 o
f 
p
at
ie
n
ts
5.
4
3.
7
-1
.7
5.
9
5.
2
-0
.7
0.
4
1.
0 
[-
3.
0,
 5
.0
]
P
at
ie
n
t 
q
u
al
it
y 
o
f 
lif
e,
 m
ea
n
 L
ad
d
er
 o
f 
L
if
e 
sc
o
re
6.
3
6.
5
+
3.
2
6.
6
6.
5
-1
.5
0.
5
-0
.3
 [-
1.
6,
 1
.0
]
C
h
an
g
e 
in
 r
ap
p
o
rt
, s
at
is
fa
ct
io
n
 a
n
d
 c
o
n
fi
d
en
ti
al
it
y,
 m
ea
n
 [
95
%
 C
I]
C
o
n
tr
o
l
n=
51
M
u
lt
if
ac
et
ed
 in
te
rv
en
ti
o
n
n=
54
B
ef
o
re
D
if
fe
re
n
ce
 a
ft
er
7 
m
o
n
th
s
B
ef
o
re
D
if
fe
re
n
ce
 a
ft
er
7 
m
o
n
th
s
p
-v
al
u
e 
b
S
ta
nd
ar
di
se
d 
pa
tie
nt
s’
ra
pp
or
t a
nd
 s
at
is
fa
ct
io
n
57
.9
 [6
1.
4,
 7
4.
5]
-0
.5
 [-
6.
1,
 5
.0
]
57
.9
 [6
4.
9,
 7
0.
9]
6.
0 
[2
.6
, 9
.5
]
p=
0.
12
(S
an
ci
 e
t a
l.,
20
00
)
Le
ve
l I
II-
1:
 q
ua
si
-
R
C
T
G
oo
d 
qu
al
ity
10
5 
ge
ne
ra
l
pr
ac
tit
io
ne
rs
M
el
bo
ur
ne
E
du
ca
tio
na
l s
tr
at
eg
ie
s
(w
or
ks
ho
p,
 m
at
er
ia
ls
,
fe
ed
ba
ck
, o
pi
ni
on
 le
ad
er
s,
of
fic
e 
sy
st
em
s)
S
ta
nd
ar
di
se
d 
pa
tie
nt
s’
co
nf
id
en
tia
lit
y
35
.2
 [2
9.
3,
 4
1.
1]
4.
0 
[-
10
.3
, 1
8.
3]
42
.2
 [3
1.
0,
 5
3.
4]
53
.5
 [4
9.
3,
 5
7.
8]
p<
0.
01
S
m
o
ki
n
g
 c
es
sa
ti
o
n
 s
er
vi
ce
s 
re
ce
iv
ed
, %
S
m
o
ki
n
g
 c
es
sa
ti
o
n
 C
P
G
s 
o
n
ly
n=
29
25
M
u
lt
if
ac
et
ed
 in
te
rv
en
ti
o
n
n=
27
53
E
ff
ec
t
m
ea
su
re
S
er
vi
ce
s
B
ef
o
re
A
ft
er
%
ch
an
g
e
B
ef
o
re
A
ft
er
%
ch
an
g
e
R
el
at
iv
e
ch
an
g
e
O
R
 [
95
%
 C
I]
U
se
d 
m
ed
ic
at
io
ns
in
 la
st
 y
ea
r
33
.8
41
.1
+
7.
3
31
.2
26
.1
-5
.1
0.
7
0.
6 
[0
.3
, 1
.0
]
(J
os
ep
h 
et
al
., 
20
04
)
Le
ve
l I
II-
1:
 Q
ua
si
R
C
T
P
oo
r 
qu
al
ity
V
et
er
an
 A
ffa
irs
(V
A
) 
m
ed
ic
al
ce
nt
re
s 
(n
=
20
)
an
d 
al
l p
at
ie
nt
s
pr
es
en
tin
g 
fo
r
ca
re
 (
n=
56
78
),
M
in
ne
so
ta
U
S
A
S
m
ok
in
g 
ce
ss
at
io
n 
C
P
G
s 
+
or
ga
ni
sa
tio
na
l s
up
po
rt
 –
tr
ai
ni
ng
 m
ee
tin
g;
 s
tu
dy
m
ee
tin
gs
; a
ca
de
m
ic
 d
et
ai
lin
g
1.
 L
oc
al
 c
on
se
ns
us
pr
oc
es
se
s
2.
 E
du
ca
tio
na
l m
ee
tin
gs
3.
 E
du
ca
tio
na
l o
ut
re
ac
h
P
la
n 
to
 q
ui
t i
n 
ne
xt
30
 d
ay
s
40
.1
44
.1
+
4.
0
40
.2
41
.4
+
1.
2
0.
3
0.
9 
[0
.5
, 1
.5
]
a  
B
ef
or
e/
af
te
r 
sc
or
es
 n
ot
 p
ro
vi
de
d 
du
e 
to
 s
pa
ce
 r
es
tr
ic
tio
ns
. A
va
ila
bl
e 
on
 r
eq
ue
st
; b
 li
ne
ar
 r
eg
re
ss
io
n 
m
od
el
 u
se
d 
to
 a
dj
us
t f
or
 b
as
el
in
e 
di
ffe
re
nc
es
; B
P
 =
 b
lo
od
 p
re
ss
ur
e;
 C
I =
 c
on
fid
en
ce
 in
te
rv
al
s;
 C
M
E
 =
 C
on
tin
ui
ng
M
ed
ic
al
 E
du
ca
tio
n;
 C
P
G
 =
 c
lin
ic
al
 p
ra
ct
ic
e 
gu
id
el
in
e;
 O
R
 =
 o
dd
s 
ra
tio
s;
 R
C
T
 =
 r
an
do
m
is
ed
 c
on
tr
ol
le
d 
tr
ia
l.



